0001213900-22-049719.txt : 20220819 0001213900-22-049719.hdr.sgml : 20220819 20220819163228 ACCESSION NUMBER: 0001213900-22-049719 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 72 CONFORMED PERIOD OF REPORT: 20220630 FILED AS OF DATE: 20220819 DATE AS OF CHANGE: 20220819 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Generation Hemp, Inc. CENTRAL INDEX KEY: 0001527102 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 263119496 STATE OF INCORPORATION: CO FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-55019 FILM NUMBER: 221181269 BUSINESS ADDRESS: STREET 1: 5128 HORSESHOE TRAIL CITY: DALLAS STATE: TX ZIP: 75209 BUSINESS PHONE: (469) 209-6154 MAIL ADDRESS: STREET 1: P.O. BOX 540308 CITY: DALLAS STATE: TX ZIP: 75354 FORMER COMPANY: FORMER CONFORMED NAME: Home Treasure Finders, Inc. DATE OF NAME CHANGE: 20110801 10-Q 1 f10q0622_generation.htm QUARTERLY REPORT

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2022

 

or

 

 TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from         to        

 

Commission File Number: 000-55019

 

GENERATION HEMP, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   26-3119496
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)
     
8533 Midway Road    
Dallas, Texas   75209
(Address of principal executive offices)   (Zip code)

 

(469) 209-6154

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which
registered
         

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No 

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes  No 

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer Accelerated filer
Non-accelerated filer Smaller reporting company
Emerging growth company    

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  No 

 

As of August 19, 2022, the registrant had 113,154,002 shares of common stock outstanding.

 

 

 

 

 

 

TABLE OF CONTENTS

 

    Page
     
  PART I. FINANCIAL INFORMATION  
     
Item 1. Financial Statements 1
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 16
Item 3. Quantitative and Qualitative Disclosures about Market Risk 21
Item 4. Controls and Procedures 21
     
  PART II. OTHER INFORMATION  
Item 1. Legal Proceedings 22
Item 1A. Risk Factors 22
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 22
Item 4. Mine Safety Disclosures 22
Item 5. Other Information 22
Item 6. Exhibits 23
     
SIGNATURES 24

 

i

 

 

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

This Quarterly Report on Form 10-Q (the “Quarterly Report”) includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended (the “Securities Act”) and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). All statements, other than statements of historical fact included in this report, regarding our strategy, future operations, financial position, estimated revenue, projected costs, prospects, plans and objectives of management are forward-looking statements. When used in this Quarterly Report, the words “could,” “believe,” “anticipate,” “intend,” “estimate,” “expect,” “project” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain such identifying words. These forward-looking statements are based on management’s current expectations and assumptions about future events and are based on currently available information as to the outcome and timing of future events. When considering forward-looking statements, you should keep in mind the risk factors and other cautionary statements described under, but not limited to, the heading “Item 1A. Risk Factors” included in the Annual Report of Generation Hemp, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2021 (the “Annual Report”) and our other filings with the Securities and Exchange Commission (“SEC”).

 

Forward-looking statements may include statements about:

 

  the risk that our results could be adversely affected by natural disaster, public health crises (including, without limitation, the COVID-19, outbreak), political crises, negative global climate patterns, or other catastrophic events;

 

  the marketability of our products;

 

  financial condition and liquidity of our customers;

 

  competition in the hemp markets;

 

  industry and market conditions;

 

  requisition of our services by major customers and our ability to renew processing and services contracts;

 

  credit and performance risks associated with customers, suppliers, banks and other financial counterparties;

 

  availability, timing of delivery and costs of key supplies, capital equipment or commodities;

 

  our future capital requirements and our ability to raise additional capital to finance our activities;

 

  the future trading of our common stock;

 

  legal and regulatory risks associated with OTC Markets;

 

  our ability to operate as a public company;

 

  our ability to protect our proprietary information;

 

  general economic and business conditions; the volatility of our operating results and financial condition;

 

  our ability to attract or retain qualified senior management personnel and research and development staff;

 

  timing for completion of major acquisitions or capital projects;

  

  our ability to obtain additional financing on favorable terms, if required, to complete acquisitions as currently contemplated or to fund the operations and growth of our business;

 

  operating or other expenses or changes in the timing thereof;

 

  compliance with stringent laws and regulations, as well as changes in the regulatory environment, the adoption of new or revised laws, regulations and permitting requirements, especially with respect to the industry in which we operate;

 

  potential legal proceedings and regulatory inquiries against us; and

 

  other risks identified in this report that are not historical.

 

We caution you that these forward-looking statements are subject to a number of risks, uncertainties and assumptions, which are difficult to predict and many of which are beyond our control, including risks specific to the industry in which we operate. Moreover, we operate in a very competitive and rapidly changing environment and new risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. Although we believe that our plans, intentions and expectations reflected in or suggested by the forward-looking statements we make in this Quarterly Report are reasonable, we can give no assurance that these plans, intentions or expectations will be achieved or occur, and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. Given these risks and uncertainties, investors should not place undue reliance on forward-looking statements as a prediction of actual results.

 

All forward-looking statements, expressed or implied, included in this report are expressly qualified in their entirety by this cautionary statement and speak only as of the date of this Quarterly Report. This cautionary statement should also be considered in connection with any subsequent written or oral forward-looking statements that we or persons acting on our behalf may issue.

 

Except as otherwise required by applicable law, we disclaim any duty to update any forward-looking statements, all of which are expressly qualified by the statements in this section, to reflect events or circumstances after the date of this report.

 

ii

 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

Generation Hemp, Inc.

Unaudited Condensed Consolidated Balance Sheets

 

   June 30,   December 31, 
   2022   2021 
Assets        
Current Assets:        
Cash  $4,289   $20,656 
Accounts receivable   91,185    
-
 
Inventories   212,518    212,518 
Prepaid expenses   55,791    4,723 
Total current assets   363,783    237,897 
           
Property and equipment, net   2,391,678    2,580,662 
Operating lease right-of-use asset   213,706    263,065 
Intangible assets, net   1,564,652    1,857,908 
Goodwill   799,888    799,888 
Other assets   407,000    407,000 
           
Total Assets  $5,740,707   $6,146,420 
           
Liabilities and Equity (Deficit)          
Current Liabilities:          
Accounts payable  $1,169,006   $883,485 
Accrued liabilities   421,234    410,990 
Payables to related parties   382,197    204,007 
Operating lease liability - related party   106,406    101,238 
Notes payable – related parties   3,241,120    2,183,551 
Other indebtedness - current   473,192    501,668 
Current liabilities of discontinued operations held for sale   160,057    153,482 
Total current liabilities   5,953,212    4,438,421 
Operating lease liability - related party, net of current portion   107,300    161,827 
Long-term liabilities of discontinued operations held for sale   193,816    162,948 
Total liabilities   6,254,328    4,763,196 
           
Commitments and contingencies   
 
    
 
 
           
Series B redeemable preferred stock, no par value, $10,000 stated value, 300 shares authorized, 118 and 135 shares issued and outstanding at June 30, 2022 and December 31, 2021   591,558    591,558 
           
Equity (Deficit):          
Preferred stock, $0.00001 par value; 200,000,000 shares authorized, none outstanding   
-
    
-
 
Common stock, $0.00001 par value; 200,000,000 shares authorized, 113,154,002 and 113,094,002 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively   1,132    1,131 
Additional paid-in capital   31,887,994    29,150,258 
Accumulated deficit   (32,748,818)   (28,118,245)
Generation Hemp equity   (859,692)   1,033,144 
Noncontrolling interest   (245,487)   (241,478)
Total equity (deficit)   (1,105,179)   791,666 
           
Total Liabilities and Equity (Deficit)  $5,740,707   $6,146,420 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements. 

 

1

 

 

Generation Hemp, Inc.

Unaudited Condensed Consolidated Statements of Operations

 

   For the three months ended
June 30,
   For the six months ended
June 30,
 
   2022   2021   2022   2021 
                 
Revenue:                
Post-harvest and midstream services  $331,900   $3,355   $331,933   $47,965 
Rental   22,500    22,500    45,000    45,000 
Total revenue   354,400    25,855    376,933    92,965 
                     
Costs and Expenses:                    
Cost of revenue (exclusive of items shown separately below)   164,479    112,195    268,844    270,260 
Depreciation and amortization   261,491    341,447    482,240    691,075 
Merger and acquisition costs   
-
    
-
    
-
    16,115 
General and administrative   1,914,644    514,299    3,892,528    1,635,231 
Total costs and expenses   2,340,614    967,941    4,643,612    2,612,681 
                     
Operating loss   (1,986,214)   (942,086)   (4,266,679)   (2,519,716)
                     
Other expense (income):                    
Interest and other income   
-
    (25,424)   
-
    (25,424)
Change in fair value of marketable security   
-
    
-
    
-
    (11,770)
Interest expense   123,763    232,462    287,273    496,302 
Total other expense   123,763    207,038    287,273    459,108 
                     
Loss from continuing operations   (2,109,977)   (1,149,124)   (4,553,952)   (2,978,824)
Loss from discontinued operations   (27,567)   (6,205)   (40,263)   (9,719)
                     
Net loss  $(2,137,544)  $(1,155,329)  $(4,594,215)  $(2,988,543)
Less: net income (loss) attributable to noncontrolling interests   (2,422)   (2,815)   (4,009)   853 
                     
Net loss attributable to Generation Hemp  $(2,135,122)  $(1,152,514)  $(4,590,206)  $(2,989,396)
                     
Earnings (loss) per common share:                    
Loss from continuing operations                    
Basic  $(0.02)  $(0.03)  $(0.04)  $(0.11)
Diluted  $(0.02)  $(0.03)  $(0.04)  $(0.11)
Loss from discontinued operations                    
Basic  $
-
   $
-
   $
-
   $
-
 
Diluted  $
-
   $
-
   $
-
   $
-
 
Earnings (loss) per share                    
Basic  $(0.02)  $(0.03)  $(0.04)  $(0.11)
Diluted  $(0.02)  $(0.03)  $(0.04)  $(0.11)

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

2

 

 

Generation Hemp, Inc.

Unaudited Condensed Consolidated Statements of Equity (Deficit)

 

   Series B
Redeemable
Preferred Stock
   Series A Preferred Stock   Common Stock   Additional   Accumulated   Noncontrolling   Total 
   Shares   Amount   Shares   Amount   Shares   Amount   Paid-In Capital   Deficit   Interest   Equity (Deficit) 
                                         
Balance at January 1, 2021   135   $ 729,058    6,328,948   $ 4,975,503    17,380,317   $6,083,480   $4,436,018   $(18,220,705)  $(239,231)  $(2,964,935)
Acquisition of Certain Assets of Halcyon Thruput, LLC   -    -    -    -    6,250,000    2,500,000    -    -    -    2,500,000 
Issuances of common stock units   -    -    -    -    800,000    136,707    263,293    -    -    400,000 
Warrant exercises   -    -    -    -    8,428,976    4,771,669    (1,804,669)   -    -    2,967,000 
Issuance of common shares for Convertible Promissory Note   -    -    -    -    618,660    217,769    -    -    -      217,769 
Issuance of common shares for Senior Secured Promissory Note   -    -    -    -    1,000,000    1,942,500    -    -    -    1,942,500 
Series B preferred stock dividend   -    -    -    -    -    -    -    (20,250)   -    (20,250)
Stock-based compensation   -    -    -    -    500,000    42,250    -    -    -    42,250 
Net loss   -    -    -    -    -    -    -    (1,836,882)   3,668    (1,833,214)
                                                   
Balance at March 31, 2021   135    729,058    6,328,948    4,975,503    34,977,953    15,694,375    2,894,642    (20,077,837)   (235,563)   3,251,120 
Series B preferred stock dividend   -    -    -    -    -    -    -    
 
    -    - 
Stock-based compensation   -    -    -    -         
 
    -    -    -    - 
Net loss   -    -    -    -    -    -    -    (1,152,514)   (2,815)   (1,155,329)
                                                   
Balance at June 30, 2021   135   $729,058    6,328,948   $4,975,503    34,977,953   $15,694,375   $2,894,642   $(21,230,351)  $(238,378)  $2,095,791 
                                                   
Balance at January 1, 2022   118   $591,558    -   $-    113,094,002   $1,131   $29,150,258   $(28,118,245)  $(241,478)  $791,666 
Issuance of common shares for extension of secured note   -    -    -    -    20,000    -    11,480    -    -    11,480 
Modification of warrants for extension of promissory note to investor                                 68,756              68,756 
Series B preferred stock dividend   -    -    -    -    -    -    -    (20,992)   -    (20,992)
Stock-based compensation   -    -    -    -    -    -    1,315,750    -    -    1,315,750 
Net loss   -    -    -    -    -    -    -    (2,455,084)   (1,587)   (2,456,671)
                                                   
Balance at March 31, 2022   118    591,558    -    -    113,114,002    1,131    30,546,244    (30,594,321)   (243,065)   (290,011)
Issuance of common shares for extensions of secured note   -    -    -    -    40,000    1    26,000    -    -    26,001 
Series B preferred stock dividend   -    -    -    -    -    -    -    (19,375)   -    (19,375)
Stock-based compensation   -    -    -    -    -    -    1,315,750    -    -    1,315,750 
Net loss   -    -    -    -    -    -    -    (2,135,122)   (2,422)   (2,137,544)
                                                   
Balance at June 30, 2022   118   $591,558    -   $-    113,154,002   $1,132   $31,887,994   $(32,748,818)  $(245,487)  $(1,105,179)

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

  

3

 

 

Generation Hemp, Inc.

Unaudited Condensed Consolidated Statements of Cash Flows

 

   For the six months ended
June 30,
 
   2022   2021 
Cash Flows From Operating Activities        
Net loss  $(4,594,215)  $(2,988,543)
Loss from discontinued operations   (40,263)   (9,719)
Net loss from continuing operations   (4,553,952)   (2,978,824)
Adjustments to reconcile net loss from continuing operations to net cash from operating activities:          
Depreciation and amortization   482,240    691,075 
Amortization of debt discount   37,481    328,320 
Stock-based compensation   2,631,500    81,000 
Modification of warrants for extension of promissory note to investor   68,756    
-
 
Other income - PPP Loan forgiveness   
-
    (25,424)
Change in fair value of marketable securities   
-
    (11,770)
Changes in operating assets and liabilities:          
Accounts receivable   (91,185)   70,530 
Prepaid expenses   (51,068)   (10,298)
Accounts payable and accrued liabilities   433,588    (244,741)
Net cash from operating activities – continuing operations   (1,042,640)   (2,100,132)
Net cash from operating activities – discontinued operations   (2,820)   
-
 
Net cash from operating activities   (1,045,460)   (2,100,132)
           
Cash Flows From Investing Activities          
Capital expenditures   
-
    (40,220)
Acquisition of certain assets of Halcyon Thruput, LLC, net of acquired cash of $224,530   
-
    (1,525,470)
Proceeds from sale of investment in common stock   
-
    34,847 
Net cash from investing activities – continuing operations   
-
    (1,530,843)
Net cash from investing activities – discontinued operations   
-
    
-
 
Net cash from investing activities   
-
    (1,530,843)
           
Cash Flows From Financing Activities          
Issuance of common stock units   
-
    350,000 
Redemptions of Series B preferred stock        (137,500)
Series B preferred stock dividends paid        (16,500)
Proceeds from warrant exercises   
-
    2,967,000 
Repayment of Halcyon bank note   
-
    (995,614)
Proceeds from notes payable - related parties   1,107,569    
-
 
Repayment of subordinated notes   (50,000)   (1,100,000)
Payment of mortgage payable   (28,476)   (1,938)
Net cash from financing activities – continuing operations   1,029,093    1,065,448 
Net cash from financing activities – discontinued operations   
-
    
-
 
Net cash from financing activities   1,029,093    1,065,448 
           
Net change in cash   (16,367)   (2,565,527)
           
Cash, beginning of period   20,656    2,776,425 
Cash, end of period  $4,289   $210,898 

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

4

 

 

Generation Hemp, Inc.

Notes to Unaudited Condensed Consolidated Financial Statements

 

1. Business

 

Generation Hemp, Inc. (the “Company”) was incorporated on August 21, 2021 in the State of Delaware. The Company was originally incorporated as Home Treasure Finders, Inc. (“HTF”) on July 28, 2008 in the State of Colorado. On November 27, 2019, HTF purchased approximately 94% of the common stock of Energy Hunter Resources, Inc. (“EHR”) in a series of transactions accounted for as a reverse merger. Upon closing, HTF changed its name to Generation Hemp, Inc.

 

On January 11, 2021, we completed the acquisition of certain assets of Halcyon Thruput, LLC (“Halcyon”). With this acquisition, we commenced providing post-harvest and midstream services to growers by drying, processing, cleaning and stripping harvested hemp directly from the field and wetbaled at our 48,000 square foot leased facility located in Hopkinsville, Kentucky. Additionally, the Company offers safe storage services for processed hemp, which enables farmers to maximize strategic market timing. In August 2021, the Company launched its small animal bedding consumer goods product line (“Rowdy Rooster”) made from the hemp hurd byproduct that is produced from its hemp processing operations.

 

We also generate revenue from rental of our “Cannabis Zoned” (Hemp) warehouse property located in Denver, Colorado currently leased to an unaffiliated hemp seed company.

 

As of June 30, 2022, EHR held an approximate 8% working interest in an oil & gas property located in Cochran County, Texas within the Slaughter-Levelland Field of the San Andres formation in the Northwest Shelf of West Texas. EHR’s oil & gas activities are currently held for sale and are presented in these consolidated financial statements as discontinued operations for each of the periods presented.

 

Our management team has been and continues to actively review acquisition candidates involved in the hemp industry that operate within a number of vertical businesses, predominantly within the midstream sector that are attractive to us and are within the hemp supply chain.

 

New Business Line – During the second quarter of 2022, management and the Board decided to enter a new but related line of business – bitcoin mining. Management determined after research that hemp biomass can be burned in a biomass boiler to generate heat and steam to drive a turbine for generating electricity. The BTU value of hemp is similar to wood waste generated at saw mills. Hemp plants grow to maturity within six to eight months whereas trees mature in excess of ten years.

 

The Company subsequently formed a new company, GenCrypto, LLC (a Delaware limited liability company) with a 50% partner, Cerberus Digital, LLC, an affiliate of Cryptech Solutions, Inc. Cryptech is one of the largest resellers of bitcoin mining equipment in North America.

 

GenCrypto now has approximately ten different bitcoin locations identified and either under contract, under letter of intent, or in final negotiating status, located in three states and in Costa Rica. All of these site locations are deemed “green” based upon the power being provided either from the local utility or co-op. They range in power size from 1.1 megawatts to 50 megawatts. GenCrypto has been contacted by several larger bitcoin mining operators concerning utilizing some of these mining locations under “hosting” arrangements.

 

The Company anticipates closing its first acquisition which is currently operational in September 2022.

 

Liquidity and Going Concern – The Company is dependent upon obtaining additional funding to continue ongoing operations and to pursue its strategy and execute its acquisition plans.

 

In the six months ended June 30, 2022, the Company used $1.0 million of cash for its operating activities. At June 30, 2022, the Company’s current liabilities, including financing obligations due within one year, totaled $6.0 million as compared with its current assets of $364 thousand.

 

The Company will continue to pursue additional capital raising opportunities in order to fund future acquisitions and meet its obligations as they become due. We may not be successful in obtaining additional financing needed. In the event financing cannot be obtained, the Company may not be able to satisfy these plans and obligations. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Impact of COVID-19 Pandemic on Our Business – Our business, results of operations and financial condition were adversely affected by the COVID-19 pandemic. The COVID-19 pandemic and measures taken to contain it subjected our business, results of operations, financial condition, stock price and liquidity to a number of material risks and uncertainties, all of which may continue or may worsen.

 

5

 

 

2. Summary of Significant Accounting Policies

 

Basis of Presentation – These interim financial statements are unaudited and have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain disclosures have been condensed or omitted from these financial statements. Accordingly, they do not include all the information and notes required by accounting principles generally accepted in the United States of America (“GAAP”) for complete consolidated financial statements, and should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2021.

 

In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring adjustments, necessary to fairly present the financial position as of, and the results of operations for, all periods presented. In preparing the accompanying financial statements, management has made certain estimates and assumptions that affect reported amounts in the condensed consolidated financial statements and disclosures of contingencies. Actual results may differ from those estimates. The results for interim periods are not necessarily indicative of annual results. Certain reclassifications have been made to the prior period’s consolidated financial statements and related footnotes to conform them to the current period presentation. Intercompany balances and transactions between consolidated entities are eliminated.

 

Fair Value Measurement – Our financial assets and liabilities consist of cash, accounts receivable, accounts payable and indebtedness. The fair values of these instruments approximate their carrying amounts at each reporting date.

 

Major Customer and Concentration of Credit Risk – We estimate an allowance for doubtful accounts based on an analysis of specific customers, taking into consideration the age of past due accounts and an assessment of the customer’s ability to pay. An allowance for doubtful accounts was not needed as of June 30, 2022 or December 31, 2021.

 

During the three and six months ended June 30, 2022, one customer accounted for 99% of our post-harvest and midstream services revenue. A total of $91,185 was outstanding from this customer at June 30, 2022.

 

Our rental revenue is derived from a single lessee on a commercial warehouse owned by the Company. There were no amounts due from this customer at June 30, 2022 or December 31, 2021.

 

Recent Accounting Pronouncements – There are no other new accounting pronouncements that are expected to have a material impact on the consolidated financial statements.

 

3. Property and Equipment

 

Property and equipment consisted of the following:

 

   Useful   June 30,   December 31, 
   Life (yrs)   2022   2021 
             
Land       $96,000   $96,000 
Warehouse   30    916,500    916,500 
Leasehold Improvements   3    473,601    473,601 
Machinery and equipment   5-7     1,506,447    1,506,447 
Vehicles   4    149,440    149,440 
Computer equipment and software   3    46,825    46,825 
Office furniture and equipment   3-5     17,294    17,294 
                
Subtotal        3,206,107    3,206,107 
Less accumulated depreciation and amortization        (814,429)   (625,445)
                
Total property and equipment, net       $2,391,678   $2,580,662 

 

6

 

 

4. Intangible and Other Assets

 

The following table summarizes information related to definite-lived intangible assets:

 

   June 30, 2022   December 31, 2021 
   Gross Carrying Amount   Accumulated Amortization   Net   Gross Carrying Amount   Accumulated Amortization   Net 
                         
Customer relationships  $2,612,649   $(1,079,585)  $1,533,064   $2,612,649   $(796,858)  $1,815,791 
Non-competition agreements   63,176    (31,588)   31,588    63,176    (21,059)   42,117 
                               
Total  $2,675,825   $(1,111,173)  $1,564,652   $2,675,825   $(817,917)  $1,857,908 

 

Other assets included $407,000 at June 30, 2022 and December 31, 2021 for the Company’s option to purchase the 48,000 square foot facility located in Hopkinsville, Kentucky presently leased from Halcyon. Under this option agreement, the Company may purchase the facility on or before August 25, 2022, as amended, for a purchase price of $993,000.

 

5. Notes Payable – Related Parties

 

Notes payable – related parties consisted of the following:

 

   June 30,   December 31, 
   2022   2021 
         
Subordinated Promissory Note to CEO  $523,551   $523,551 
Convertible Promissory Note to CEO   1,037,069    410,000 
Secured Promissory Note to Coventry Asset Management, LTD.   1,000,000    1,000,000 
Subordinated Promissory Note to Investor   200,000    250,000 
Promissory Note to Investment Hunter, LLC   480,500    
-
 
           
Total notes payable – related parties  $3,241,120   $2,183,551 

 

Subordinated Promissory Note to CEO – Our CEO made advances to the Company during 2020 under a subordinated promissory note initially due September 30, 2021. This note was amended to a new maturity date of September 30, 2022. If the Company raises new equity capital of $3 million or more, then the full amount outstanding under the note is due within five days. The note bears interest at 10% per annum. Accrued interest on this subordinated promissory note totaled $33,565 at June 30, 2022.

 

Convertible Promissory Note to CEO – In 2021, our CEO made advances totaling $410,000 to the Company under a convertible promissory note. Additional advances made in 2022 through June 30 totaled $627,069. The convertible note initially matured on January 1, 2022 but was subsequently amended to extend the maturity date to September 30, 2022. If the Company raises new equity capital of $3 million or more, then the full amount outstanding under the note is due within five days. The note bears interest at 10%. The principal and interest due on the convertible note may be converted, at the option of the holder, into restricted shares of the Company’s common stock at an initial conversion price of $0.50 per share but that was lowered in July 2022 to $0.30 per share. Accrued interest on this convertible promissory note totaled $52,291 at June 30, 2022.

 

7

 

 

Secured Promissory Note and Warrants to Coventry Asset Management, LTD. – On December 30, 2020, the Company received proceeds from issuance of a secured promissory note in principal amount of $1,000,000 to Coventry Asset Management, LTD, a Company stockholder. The promissory note is secured by the property acquired in the acquisition of certain assets of Halcyon. The unpaid balance of the secured promissory note bears interest at a rate of 10% per annum and initially matured on June 30, 2021. The promissory note has been extended six times including the issuance of 20,000 restricted common shares as extension fees each for the first five extensions and the issuance of 50,000 restricted common shares for the sixth extension. The maturity date of the promissory note is December 31, 2022, as amended. If before December 31, 2022, the Company raises new equity capital of $5 million or more, then the full amount outstanding under the promissory note is due within five days. As amended, a payment of 25% of the principal balance of the note is due by October 31, 2022. If the promissory note is not paid in full by December 31, 2022, the interest rate increases to 14% per annum. Accrued interest on this secured note totaled $149,864 at June 30, 2022.

 

Subordinated Promissory Note and Warrants to Investor – On December 30, 2020, the Company issued a subordinated promissory note in principal amount of $500,000 to an accredited investor who is also a Company stockholder. The unpaid balance of the Subordinated Note bears interest at a rate of 10% per annum. The Company made a principal payment of $250,000 in April 2021. The subordinated note principal together with accrued and unpaid interest was due, as previously amended, on March 31, 2022 but was subsequently extended. As subsequently amended, a payment of $50,000 was made in April 2022 and the remaining principal of $200,000 together with accrued interest was due on June 30, 2022. The Company did not make the principal payment due on June 30, 2022 and, as a result, this note is presently in default. Accrued interest on this subordinated promissory note totaled $29,932 at June 30, 2022.

 

The holder of the subordinated note received a warrant to purchase 500,000 shares of common stock exercisable for cash at an exercise price of $0.352 per share. As consideration for the April 2022 extension, the term of this warrant was extended by one year to December 30, 2023. The Company recognized $68,756 of interest expense in 2022 for this extension of the warrant term.

 

Promissory Note to Investment Hunter, LLC – In 2022, Investment Hunter, LLC, a Texas LLC controlled by our CEO, made advances totaling $492,000 to the Company under a promissory note due September 30, 2022, as amended. If the Company raises new equity capital of $3 million or more, then the full amount outstanding under the note is due within five days. The note bears interest at 10% per annum. Accrued interest on this subordinated promissory note totaled $17,864 at June 30, 2022.

  

6. Other Indebtedness

 

The Company is obligated under a mortgage payable dated September 15, 2014 secured by its warehouse property located in Denver, Colorado. The note provided for a 25-year amortization period and an initial interest rate of 9% annually. The note has been amended several times to a maturity date of September 30, 2022. In the latest extension, the Company made a principal payment of $25,000 plus accrued interest on July 18, 2022 and agreed to another principal payment of $25,000 plus accrued interest on August 31, 2022. The interest rate on the mortgage payable is 12%. If before the final maturity of the mortgage payable, the Company raises new equity capital of $5 million or more, then the full amount outstanding is due within ten days. The principal balance of this mortgage note payable as of June 30, 2022 was $473,192.

 

The Company leases the Denver warehouse property to a tenant under an operating lease which was renewed with a new tenant and extended to August 1, 2023 for a monthly rent of $7,500. The lease requires a true-up with the tenant for property taxes and insurance paid by the Company and requires the tenant to maintain the interior and exterior of the warehouse (except for the roof). The lease provides for a rent abatement in the first and last month of the contracted extension. Minimum future rents for the remainder of 2022 are $45,000 and for 2023 are $52,500.

 

8

 

 

7. Commitments and Contingencies

 

Leases – The Company leases office space in Fort Worth, Texas for managerial offices. This lease requires monthly payments of $2,000 and is month-to-month. Lease expense for this facility totaled $4,000 and $12,000 for the three and six months ended June 30, 2022, respectively. In the three and six months ended June 30. 2021, lease expense for this facility was $6,000 and $10,000, respectively.

 

The Company leases its operating facility in Kentucky from Oz Capital, LLC, a related party, under a lease expiring May 31, 2024. The lease provides for monthly payments of $10,249. Oz Capital, LLC is responsible for all taxes and maintenance under the lease. Lease expense for this facility totaled $31,147 and $61,494 in the three months ended June 30, 2022, respectively. In the three and six months ended June 30. 2021, lease expense for this facility was $30,747 and $57,857, respectively. A right-of-use asset and lease liability is recorded for this lease. As the lease does not provide an implicit rate, the Company used its estimated incremental borrowing rate of 10% in determining the present value of the lease payments.

 

Litigation – From time to time, we are subject to various litigation and other claims in the normal course of business. Below is a discussion of specific matters. We cannot estimate the ultimate outcome of these matters.

 

Generation Hemp, Inc. v. Colorado Mills Equipment, LLC

 

The Defendant sold to the Company a faulty piece of equipment for $16,000 and will not refund the Company the purchase price after repeated attempts to return their equipment. An original lawsuit was filed by the Company against Colorado Mills in January 2022 in Dallas County, subsequently dismissed, and a second lawsuit has been filed El Paso County, Colorado and is currently pending.

 

Halcyon Thruput, LLC, Plaintiff v. United National Insurance Company, Defendant, United States District Court for the Northern District of Texas, Dallas Division, Case No. 3:21-CV-3136-K.

 

Halcyon Thruput, LLC (Halcyon) obtained an all-risks commercial insurance policy, including an Equipment Breakdown Endorsement (Policy) from United National Insurance Company (UNIC) to provide substantial coverages for Halcyon Thruput LLC’s (Halcyon) $1,203,735 hemp processing dryer (Dryer) at its facility in Hopkinsville, Kentucky. During the Policy period, the Dryer caught fire due to the Dryer being defectively designed.

 

While UNIC paid a number of Halcyon’s claims, Halcyon’s claim for the cost of the replacement Dryer of $1,498,848 was denied as described below.

  

Buyer, a wholly owned subsidiary of the Company, pursuant to an Asset Purchase Agreement as twice amended, then acquired all the assets of Halcyon, except for the right to the proceeds of UNIC’s insurance policy since the Policy prohibited assignment. Halcyon and Buyer agreed that Buyer’s principal, Gary C. Evans, had the right to control the litigation, engage counsel for Halcyon and make all decisions relating to any proceeds received in the litigation by settlement or otherwise.

 

Halcyon’s suit against UNIC, which was removed to federal court, seeks $796,865.53 (the cost of the replacement dryer of $1,498,848, less a credit for $583,508.47 previously paid by UNIC to Halcyon for the Dryer fire=$915,339.53) plus statutory interest on that sum from August 10, 2020 for violating the Texas Insurance Code’s requirement that claims be promptly paid, additional statutory penalties, and attorneys’ fees. Certain documents have been executed between the Company, Halcyon and legal counsel, which provide for a sharing of costs and expenses and awards, if any, against UNIC. Mediation of the case was held in April 2022 where no agreement was reached by the parties. Depositions of the Company’s expert witnesses were completed in July 2022.

 

9

 

 

JDONE, LLC v. Grand Traverse Holdings, LLC and John Gallegos, Denver District Court Case No. 2019CV33723

 

JDONE, LLC (“JDONE”) is a wholly owned subsidiary of the Company and landlord of a commercial warehouse building that was previously leased to Grand Traverse Holdings, LLC on December 31, 2018 for a term of 61 months, with a personal guaranty from Defendant, John Gallegos. On April 12, 2019, Grand Traverse presented JDONE with an alleged forged, signed copy of the draft early termination amendment that JDONE had previously rejected. JDONE has suffered damages due to Defendant’s alleged misconduct of approximately $823,504 plus interest and attorney’s fees exceeding $400,000. A court ordered mediation was held in May 2020 without success. All material defendant motions have been denied by the court. The case is set for jury trial in July 2022. We believe that Grand Traverse Holdings, LLC and John Gallegos are jointly liable for the asserted damages which exceed $1 million plus attorney’s fees and we continue to vigorously pursue our claims.

 

KBSIII Tower at Lake Carolyn, LLC and Prime US-Tower at Lake Carolyn, LLC (collectively – “KBSIII” v. Energy Hunter Resources, Inc.)

 

Plaintiff/Counterdefendant KBSIII was seeking lost rent on office space for periods after EHR vacated office premises located in Las Colinas, Texas. EHR filed a counter suit alleging specific damages due to uninhabitable premises of the office space due to the intolerable conduct of other tenants located on the same floor. On December 23, 2020, the trial court entered a summary judgment against EHR for $230,712. The judgment provides for post-judgment interest at a rate of 5% per annum until paid and further provides for additional amounts owed should EHR pursue unsuccessful appeals to higher courts. At June 30, 2022, the Company had accrued $252,583 for this judgment, which is exclusively an EHR obligation.

 

8. Income Taxes

 

Income tax provisions for interim quarterly periods are generally based on an estimated annual effective income tax rate calculated separately from the effect of significant, infrequent or unusual items related specifically to interim periods. An income tax benefit for the three or six months ended June 30, 2022 or 2021 was not recognized because tax losses incurred were fully offset by a valuation allowance against deferred tax assets. There were no uncertain tax positions as of June 30, 2022.

 

9. Equity

 

Series A Preferred Stock Our Series A Preferred Stock was originally issued in connection with HTF’s acquisition of EHR in 2019. On September 8, 2021, holders of the Company’s Series A Preferred Stock elected to convert such shares into shares of the Company’s common stock. As a result, 6,328,948 shares of Series A Preferred Stock were converted into 75,947,376 shares of common stock, with each share of Series A Preferred Stock converting into 12 shares of restricted common stock pursuant to the applicable Certificate of Designations.

 

Series B Preferred Stock Units – On December 30, 2020, the Company sold to certain accredited investors, including Gary C. Evans, our Chief Executive Officer, an aggregate of 135 preferred stock units comprised of (i) one share of Series B Redeemable Convertible Preferred Stock, no par value, and (ii) one warrant exercisable for 50,000 shares of common stock of the Company until December 30, 2022 at an exercise price of $0.352 per share.

 

10

 

 

The sale of the preferred stock units for $10,000 each resulted in aggregate gross proceeds of approximately $1.35 million, before deducting estimated offering expenses payable by the Company. Substantially all of the proceeds raised in the offering were used to fund the acquisition of assets of Halcyon, expenses related thereto and for general corporate purposes.

 

Each share of Series B Preferred Stock is initially convertible into 25,000 shares of common stock, subject to adjustment. Holders of Series B Preferred Stock are entitled to receive dividends of 6.00% per annum based on the stated value equal to $10,000 per share. Except as otherwise required by law, the Series B Preferred Stock does not have voting rights. However, as long as any shares of Series B Preferred Stock are outstanding, the Company will not, without the affirmative vote of the holders of a majority of the then outstanding shares of the Series B Preferred Stock, (a) alter or change adversely the powers, preferences or rights given to the Series B Preferred Stock, (b) alter or amend the related certificate of designation, (c) amend its certificate of incorporation or other charter documents in any manner that adversely affects any rights of the holders of Series B Preferred Stock, (d) repay, repurchase or offer to repay, repurchase or otherwise acquire more than a de minimis number of shares of its common stock, (e) enter into any agreement with respect to any of the foregoing, or (f) pay cash dividends or distributions on any equity securities of the Company other than pursuant to the terms of the outstanding Series B Preferred Stock. The Series B Preferred Stock does not have a preference upon any liquidation, dissolution or winding-up of the Company.

 

Any or all of the Series B Preferred Stock may be converted, at their holder’s option, into 25,000 shares of common stock, as adjusted for any stock dividends, splits, combinations or similar events.

 

At any time after the occurrence of a “Qualifying Event,” the Company, upon 5-day written notice, shall have the right to cause each share of Series B Preferred Stock (and all accrued in-kind dividends with respect thereto) to be converted into common stock. For purposes of this automatic conversion of the Series B Preferred Stock, a “Qualifying Event” shall have occurred if (A) (1) the rolling five-trading day volume-weighted average trading price of shares of the common stock exceeds $1.00, and (2) there shall be an effective registration statement under the Securities Act of 1933, as amended covering all of the shares of common stock which would be issuable upon conversion of all of the outstanding shares of Series B Preferred Stock or (B) the Company closes a firm commitment underwriting of the common stock on a Form S-1 Registration Statement with aggregate gross proceeds of at least $5,000,000 at a price per share equal to or greater than $1.00. In each instance, a conversion may not be made unless the Company has filed an amendment to its Articles of Incorporation effecting an increase in its authorized common stock so that the Company has a sufficient number of authorized and unissued shares of common stock so as to permit the conversion of all outstanding shares.

 

The Series B Preferred Stock may be redeemed by the Company for its stated value, plus accrued and unpaid dividends, at any time. Initially, redemption payments of 12.5% each of the total amount of Series B Preferred Stock then outstanding plus accrued dividends were due from the Company to each Holder of Series B Preferred Stock at the end of each calendar quarter of 2021. The first required redemption payments totaling $137,500 were made in April 2021. In May, June and October of 2021, the three holders of the Series B Preferred Stock, including the Company’s chief executive officer, entered into transactions in which they accepted the mandatory redemption payment required pursuant to the Series B Preferred Stock certificate of designation in a number of Series B Units to effectively waive the redemption requirement. All other terms of the Series B Units remain unchanged and the holders’ ownership interest in the Series B Preferred Units remains the same as it was before such transactions.

 

11

 

 

Common Stock – At June 30, 2022, the Company had 113,154,002 common shares outstanding. Following is a discussion of common stock issuances during the periods presented:

 

Acquisition of Certain Assets of Halcyon – In January 2021, the Company issued 6,250,000 shares of common stock valued at $2.5 million ($0.40 per share; restricted from trading for a period of up to one year) in the acquisition.

 

2021 First Quarter Issuances of Common Stock Units – In the first quarter of 2021, the Company issued 800,000 common stock units for total proceeds of $400,000. Each common stock unit consists of one share of common stock and a warrant for the purchase of two shares of common stock for $0.50 each. Each warrant is exercisable any time before its expiration on the second anniversary of its issuance. The Company allocated the total proceeds based on the relative fair values of the common stock and warrants. The fair value of the warrants was determined using an options valuation model with key assumptions including a risk-free interest rate of 0.11% and historical volatility of 272%. A total of $263,293 was allocated to the warrants and reported in additional paid-in capital.

 

Warrant Exercises – In the first quarter of 2021, the Company received $2,967,000 for the exercise of 8,428,976 outstanding warrants. In the fourth quarter of 2021, the Company received $375,000 for the exercise of 1,065,340 outstanding warrants.

 

Issuances for Exchange or Conversion of Debt – The Company issued a total of 1,618,660 common shares for the exchange or conversion of outstanding debt in the first quarter of 2021.

 

Stock-based Compensation – The Company issued 500,000 restricted common shares valued at $155,000 as incentive compensation to two executives who joined the Company in the first quarter of 2021.

 

Issuance for Extension of Secured Note – The Company issued 60,000 common shares as consideration for extensions of the maturity of a senior note in 2022. Refer to Note 5.

 

Common Stock Warrants Outstanding – Following is a summary of warrants outstanding as of June 30, 2022:

 

   # of Warrants   Exercise Price
(each)
   Expiration Date  Method of Exercise
               
Issued in December 2020 with Series B preferred units (1)   5,500,000   $               0.352   December 30, 2022  Cash
Issued in December 2020 with subordinated note to investor   500,000   $0.352   December 30, 2022  Cash
Issued in Q1 2021 with common stock units (1)   1,600,000   $0.500   January-February, 2023  Cash
Issued in Q4 2021 with common stock units (1)   958,333   $0.600   October-December, 2023  Cash
Total warrants outstanding at June 30, 2022   8,558,333            

 

(1)May be redeemed for $0.0001 per warrant at the Company’s option with 30 days advanced notice should the weighted average market price of common stock exceed $1.00 for any five out of seven consecutive trading days with a minimum average daily trading volume for such seven-day period of at least 25,000 shares of common stock.

 

12

 

 

Following is a summary of outstanding stock warrants activity for the periods presented:

 

       Weighted 
       Average 
   # of Warrants   Exercise Price 
         
Warrants as of December 31, 2021   8,808,333   $0.407 
Cancelled   (250,000)  $0.400 
Warrants as of June 30, 2022   8,558,333   $0.407 

 

10. Stock-Based Compensation

 

We award restricted stock or stock options as incentive compensation to employees. Generally, these awards include vesting periods of up to three years from the date of grant.

 

The 2021 Omnibus Incentive Plan (“2021 Plan”) was adopted by our Board on July 1, 2021. The 2021 Plan provides for the initial reservation of 15 million shares of common stock for issuance, and provides that the maximum number of shares that may be issued pursuant to the exercise of ISOs is 15 million. The number of shares of common stock available for issuance under the 2021 Plan constituted approximately 13.1% of the Company’s fully diluted common shares outstanding as of the date of Board approval, including shares issuable upon the conversion of preferred shares, as calculated on an as-converted basis. On the one-year anniversary date of the 2021 Plan, the number of shares of common stock reserved for issuance thereunder shall automatically increase to 20% of the fully diluted common shares outstanding, including shares issuable upon the conversion of preferred shares, as calculated on an as-converted basis.

 

In the first quarter of 2021, the Company issued 500,000 restricted shares valued at $155,000 as incentive compensation to two executives who joined the Company. Compensation expense related to these awards totaled $38,750 and $81,000 for the three and six months ended June 30, 2021, respectively. These awards became fully vested in January 2022.

 

In the fourth quarter of 2021, the Company awarded options for 13,850,000 shares of the Company’s common stock as incentive compensation. One-third of the awarded options vested immediately with the remaining options vesting in two equal annual tranches over the next two years. Vested options may be exercised at any time until their expiration after 10 years at an exercise price of $0.76 per share. Unvested options are forfeited upon termination of employment.

 

Compensation expense for stock option grants was recognized based on the fair value at the date of grant using the Black-Scholes option pricing model. Key assumptions included a risk-free interest rate ranging from 1.18% to 1.28%, historical volatility ranging from 331% to 643% and an expected life of the stock options ranging from five to six years. We recognized $1.3 million of compensation expense for these option awards in each of the quarters ended June 30, 2022. As of June 30, 2022, there was $3.5 million of total unrecognized compensation cost related to options to be recognized over a remaining weighted average period of 18 months.

 

The following table summarizes options outstanding, as well as activity for the periods presented:

 

   Shares   Weighted
Average
Grant Date
Fair Value
   Weighted
Average
Exercise
Price
   Aggregate
Intrinsic
Value
 
                 
Outstanding at December 31, 2021   13,850,000   $0.76   $0.76    
   -
 
Granted   
-
   $
-
   $
-
    
-
 
Outstanding at June 30, 2022   13,850,000   $0.76   $0.76    
-
 

 

The remaining weighted average contractual life of exercisable options at June 30, 2022 was 9.3 years.

 

13

 

 

11. Discontinued Operations

 

In 2019, management determined to fully divest of EHR’s oil and gas activities. As such, these activities are presented as discontinued operations for each of the periods presented.

 

The following is a summary of the carrying amounts of major classes of assets and liabilities of the discontinued operations to assets and liabilities held for sale:

 

   June 30,   December 31, 
   2022   2021 
Assets -        
Oil and natural gas properties held for sale, at cost  $1,874,849   $1,874,849 
Accumulated DD&A   (1,874,849)   (1,874,849)
Total assets of discontinued operations held for sale  $
-
   $
-
 
           
Liabilities          
Accrued liabilities  $55,572   $48,997 
Asset retirement obligations   52,368    52,368 
Revenue payable   52,117    52,117 
Current liabilities of discontinued operations held for sale   160,057    153,482 
           
Asset retirement obligations -          
Long-term liabilities of discontinued operations held for sale   193,816    162,948 
Total liabilities of discontinued operations held for sale  $353,873   $316,430 

 

The following is a summary of the major classes of line items constituting loss on discontinued operations shown in the consolidated statements of operations:

 

   For the three months ended
June 30,
   For the six months ended
June 30,
 
   2022   2021   2022   2021 
Revenue -                
Oil and gas sales  $36,925   $16,119   $75,793   $38,108 
                     
Costs and Expenses                    
Lease operating expense   41,140    18,067    85,188    40,795 
Accretion   23,352    4,257    30,868    7,032 
Total costs and expenses   64,492    22,324    116,056    47,827 
                     
Loss from discontinued operations  $(27,567)  $(6,205)  $(40,263)  $(9,719)

 

12. Supplemental Cash Flow Information

 

   For the six months ended
June 30,
 
   2022   2021 
         
Cash paid for interest  $39,295   $45,342 
Cash paid for taxes   
-
    
-
 
           
Noncash investing and financing activities:          
Acquisition of certain assets of Halcyon Thruput, LLC          
- issuance of common shares   
-
    2,500,000 
- issuance of subordinated note   
-
    850,000 
- assumption of Halcyon bank note   
-
    995,614 
Series B preferred stock dividend payable   40,367    24,000 
Issuance of common stock units previously subscribed   
-
    50,000 
Issuances of common shares for exchange or conversion of debt   
-
    2,160,269 

 

14

 

 

13. Earnings (Loss) per Share

 

The following is the computation of earnings (loss) per basic and diluted share:

 

   For the three months ended
June 30,
   For the six months ended
June 30,
 
   2022   2021   2022   2021 
Amounts attributable to Generation Hemp:                
Numerator                
Loss from continuing operations attributable to common stockholders  $(2,109,281)  $(1,146,697)  $(4,553,952)  $(2,980,285)
Loss from discontinued operations   (25,841)   (5,817)   (40,263)   (9,111)
Less: preferred stock dividends   (20,992)   (20,250)   (20,992)   (40,500)
Net loss attributable to common stockholders  $(2,156,114)  $(1,172,764)  $(4,615,207)  $(3,029,896)
                     
Denominator                    
Weighted average shares used to compute basic EPS   113,145,211    34,977,953    113,122,510    26,691,992 
Dilutive effect of convertible note   1,164,773    
-
    1,164,773    
-
 
Dilutive effect of preferred stock   2,950,000    79,322,376    2,953,125    79,322,376 
Dilutive effect of common stock options   
-
    
-
    
-
    
-
 
Dilutive effect of common stock warrants   1,518,226    11,654,942    2,436,954    11,787,111 
Weighted average shares used to compute diluted EPS   118,778,209    125,955,271    119,677,362    117,801,479 
                     
Earnings (loss) per share:                    
Loss from continuing operations                    
Basic  $(0.02)  $(0.03)  $(0.04)  $(0.11)
Diluted  $(0.02)  $(0.03)  $(0.04)  $(0.11)
Loss from discontinued operations                    
Basic  $
-
   $
-
   $
-
   $
-
 
Diluted  $
-
   $
-
   $
-
   $
-
 
Earnings (loss) per share                    
Basic  $(0.02)  $(0.03)  $(0.04)  $(0.11)
Diluted  $(0.02)  $(0.03)  $(0.04)  $(0.11)

 

The computation of diluted earnings per common share excludes the assumed conversion of the Series B Preferred Stock and outstanding convertible notes and exercise of common stock options and warrants in periods when we report a loss. The dilutive effect of the assumed exercise of outstanding options and warrants was calculated using the treasury stock method.

 

14. Subsequent Events

 

Advances under Convertible Promissory Note – In the third quarter of 2022 through the date of this filing, our CEO made advances totaling $58,000 to the Company under the existing convertible promissory note due September 30, 2022.

 

Advances under Promissory Note to Investment Hunter, LLC – In the third quarter of 2022 through the date of this filing, Investment Hunter, LLC made advances totaling $11,500 to the Company under the existing promissory note due September 30, 2022.

 

Sale of inventories – In July 2022, the Company entered into an agreement for the sale of 66,782 pounds of dried hemp biomass from its inventories on-hand for a sales price of $1.50 per pound. Deliveries and payment of the $100,173 sales proceeds are scheduled monthly through December 2022. The Company received an initial down payment of $40,069.

 

New indebtedness – In August 2022, the Company received proceeds totaling $105,000 from new notes payable to three board directors. The notes bear interest at 10% per annum and mature on September 12, 2022.

 

* * * * *

 

15

 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

The following discussion and analysis of our financial condition and results of operations should be read in conjunction with the “Management’s Discussion and Analysis of Financial Condition and Results of Operations” contained in our Annual Report on Form 10-K (“Annual Report”) for the year ended December 31, 2021 filed with the Securities and Exchange Commission (“SEC”), as well as the financial statements and related notes appearing therein and elsewhere in this Quarterly Report. The following discussion contains forward-looking statements that reflect our future plans, estimates, beliefs and expected performance. The forward-looking statements are dependent upon events, risks and uncertainties that may be outside our control. We caution you that our actual results could differ materially from those discussed in these forward-looking statements. Factors that could cause or contribute to such differences are discussed elsewhere in this Quarterly Report, particularly in the “Cautionary Note Regarding Forward-Looking Statements” and in our Annual Report under the heading “Item 1A. Risk Factors,” all of which are difficult to predict. In light of these risks, uncertainties and assumptions, the forward-looking events discussed may not occur. We do not undertake any obligation to publicly update any forward-looking statements except as otherwise required by applicable law.

  

Overview

 

We are a holding company active within the “hemp” space. We were incorporated on August 21, 2021 in the State of Delaware. The Company was originally incorporated on July 28, 2008 in the State of Colorado. On November 27, 2019, we purchased approximately 94% of the common stock of Energy Hunter Resources, Inc. (“EHR”) in a series of transactions accounted for as a reverse merger. Upon closing, we changed our name to Generation Hemp, Inc.

 

There is limited historical financial information about our Company upon which to base an evaluation of our future performance. We cannot guarantee that we will be successful in the hemp business. We are subject to the risks associated with the regulatory environment in the industry in which we operate. In addition, we are subject to risks inherent in a small company, including limited capital resources, delays and cost overruns due to price and cost increases. There is no assurance that future financing will be available to our Company on acceptable terms. Additional equity financing could result in dilution to existing shareholders.

 

We provide post-harvest and midstream services to growers by drying, processing, cleaning and stripping harvested hemp directly from the field and wetbaled at our 48,000 square foot facility located in Hopkinsville, Kentucky. Additionally, we offer safe storage services for processed hemp, which enables farmers to maximize strategic market timing. In August 2021, the Company launched its animal bedding consumer goods product line made from the hemp hurd byproduct that is produced from its hemp processing operations.

 

We also generate revenue from rental of our “Cannabis Zoned” (Hemp) warehouse property located in Denver, Colorado currently leased to a hemp seed company.

 

As of June 30, 2022, EHR held an approximate 8% working interest in an oil & gas property located in Cochran County, Texas within the Slaughter-Levelland Field of the San Andres formation in the Northwest Shelf of West Texas. EHR’s oil & gas activities are currently held for sale and are presented in the consolidated financial statements as discontinued operations.

 

16

 

 

Recent Activities

 

New Business Line – During the second quarter of 2022, management and the Board decided to enter a new but related line of business – bitcoin mining. Management determined after research that hemp biomass can be burned in a biomass boiler to generate heat and steam to drive a turbine for generating electricity. The BTU value of hemp is similar to wood waste generated at saw mills. Hemp plants grow to maturity within six to eight months whereas trees mature in excess of ten years.

 

The Company subsequently formed a new company, GenCrypto, LLC (a Delaware limited liability company) with a 50% partner, Cerberus Digital, LLC, an affiliate of Cryptech Solutions, Inc. Cryptech is one of the largest resellers of bitcoin mining equipment in North America.

 

GenCrypto now has approximately ten different bitcoin locations identified and either under contract, under letter of intent, or in final negotiating status, located in three states and in Costa Rica. All of these site locations are deemed “green” based upon the power being provided either from the local utility or co-op. They range in power size from 1.1 megawatts to 50 megawatts. Additionally, GenCrypto has been contacted by several larger bitcoin mining operators concerning utilizing some of these mining locations under “hosting” arrangements.

 

The Company anticipates closing its first acquisition which is currently operational in September 2022.

 

Grant Funding Opportunity – The U.S. Department of Agriculture has recently made available a funding opportunity for the Partnerships for Climate-Smart Commodities projects of up to $1 billion in order to build markets and invest in America’s climate-smart farmers, ranchers and forest owners to strengthen U.S. rural and agricultural communities. Within this opportunity is the goal to develop markets and promote the resulting climate-smart commodities. The Company, through its wholly-owned subsidiary GENH Halcyon Acquisition, LLC, is an established floral hemp processor that has provided years of drying, cleaning, stripping and storing hemp, along with acting as a conduit between the supply side of hemp through farmers and the demand side of hemp through extraction labs, buyers and downstream products. Since its inception, the Company has also been a proponent and developer of climate-smart applications of fiber hemp for industry and has helped develop two new U.S. market products to utilize hemp hurd that was previously a waste product.

 

On May 6, 2022, the Company applied for a substantial grant under this funding opportunity that will contractually engage farmers to grow specific hemp genetics, thereby providing them lower risk costs that will be included in grant funding. Under this project, the Company will also build out a hemp supercenter from the nucleus of its current, established operation that will provide the necessary processing capacity for all varieties of hemp at one central location. This will include storage, logistics, testing and tracking capabilities. The Company has obtained a large group of commitments from industry players who have agreed to participate in the program.

 

Liquidity – The Company is dependent upon obtaining additional funding to continue ongoing operations and to pursue its strategy and execute its acquisition plans.

 

In the six months ended June 30, 2022, the Company used $1.0 million of cash for its operating activities. At June 30, 2022, the Company’s current liabilities, including financing obligations due within one year, totaled $6.0 million as compared with its current assets of $364 thousand.

 

The Company will continue to pursue additional capital raising opportunities in order to fund future acquisitions and meet its obligations as they become due. We may not be successful in obtaining additional financing needed. In the event financing cannot be obtained, the Company may not be able to satisfy these plans and obligations. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Impact of COVID-19 Pandemic on Our Business – Our business, results of operations and financial condition were adversely affected by the COVID-19 pandemic. The COVID-19 pandemic and measures taken to contain it subjected our business, results of operations, financial condition, stock price and liquidity to a number of material risks and uncertainties, all of which may continue or may worsen.

 

17

 

 

Results of Operations

 

Three Months Ended June 30, 2022 Compared to Three Months Ended June 30, 2021

 

The net loss for the three months ended June 30, 2022 was $2.1 million as compared with a net loss of $1.2 million for the same period of 2021. The net loss for the three months ended June 30, 2022 includes $1.3 million of stock-based compensation expense for stock options issued to executives and our board of directors and $261 thousand for depreciation and amortization largely due to the Halcyon acquisition. Excluding these non-cash items, the Company’s cash loss was $560 thousand in the three months ended June 30, 2022 as compared with a loss of $775 thousand in the same period of 2021. The first part of each calendar year is typically a slower period for midstream operations within the hemp industry until the annual harvest begins in late-summer. In 2022, we commenced processing of six million pounds of hemp biomass for last year’s harvest of our largest customer.

 

The Company reports its oil & gas activities as discontinued operations. Loss from discontinued operations was $28 thousand for the three months ended June 30, 2022 as compared with a loss of $6 thousand in the 2021 period, principally consisting of non-cash items each period. Results of operations for the Company’s remaining oil & gas activities have been significantly reduced due to lower field productivity.

 

Revenue. Revenue from continuing operations for the first quarter of 2022 totaled $354 thousand as compared with $26 thousand for the same period of 2021. We generate revenue from post-harvest and midstream services in the hemp industry and from rental to a hemp seed company of our warehouse property located in Colorado.

 

Our post-harvest and midstream services revenue totaled $332 thousand in the second quarter of 2022 as compared with $3 thousand in the 2021 period. In June 2022, we commenced hemp processing of six million pounds of hemp biomass from last year’s harvest of our largest customer. This customer had delayed processing in 2021 due to weaker hemp product pricing. We processed 862 thousand pounds of this stored hemp biomass in June 2022 and are continuing processing at this time.

 

Rental revenue totaled $23 thousand in the 2022 and 2021 periods. The lease of the Company’s Denver warehouse expires on August 1, 2023 and provides for a rental of $7.5 thousand per month.

 

Cost of Revenue. Cost of revenue for the second quarter of 2022 was $164 thousand as compared with $112 thousand in the same period of last year. Our gross margin on hemp processing in the second quarter of 2022 was 50%. We expect these stronger margins to continue during processing periods. In periods when we are not processing, we take steps to reduce our operating expenses.

 

General and Administrative Expense. General and administrative expenses totaled $1.9 million for the three months ended June 30, 2022 as compared with $514 thousand in 2021 period. The increase in general and administrative expense is principally due to non-cash charges for stock-based compensation which totaled $1.3 million in the three months ended June 30, 2022 as compared with $39 thousand in the 2021 period.

 

Depreciation and Amortization. Depreciation and amortization expense totaled $261 thousand in the three months ended June 30, 2022 as compared with $341 thousand for the same period of 2021.

 

Other Income/Expense. Total other expense was $124 thousand for the three months ended June 30, 2022 as compared with $207 thousand for the comparable 2021 period. The largest item of total other expense is interest expense which has decreased due to conversions of indebtedness to equity in 2021.

 

Loss from Discontinued Operations. In the three months ended June 30, 2022, we recognized a loss from discontinued operations of $28 thousand as compared with a loss of $6 thousand in the three months ended June 30, 2021. The major classes of line items constituting the loss on discontinued operations are presented in Item I, “Financial Statements – Note 11 – Discontinued Operations.” In the 2022 period, we revised our estimates of future asset retirement obligations for changes in inflation and interest rates. Until we fully dispose of our remaining oil & gas property interests, we expect lower future revenues and costs as production activities have declined substantially. We do not anticipate making future investment of growth capital into these properties.

 

18

 

 

Six Months Ended June 30, 2022 Compared to Six Months Ended June 30, 2021

 

The net loss for the six months ended June 30, 2022 was $4.6 million as compared with a net loss of $3.0 million for the same period of 2021. The net loss for the 2022 period includes $2.6 million of stock-based compensation expense for stock options to our executives and board of directors and $482 thousand for depreciation and amortization largely due to the Halcyon acquisition. Excluding these non-cash items, the Company’s cash loss was $1.5 million in the six months ended June 30, 2022 as compared with a loss of $2.2 million in the same period of 2021. The first part of each calendar year is typically a slower period for midstream operations within the hemp industry until the annual harvest begins in late-summer. The Company’s hemp processing facilities were shut-in for much of the first six months of each year to limit operating expenditures. As mentioned above, we commenced processing in June 2022 of hemp biomass harvested last year by our largest customer.

 

Loss from discontinued operations was $40 thousand for the six months ended June 30, 2022 as compared with a loss of $10 thousand in the 2021 period, principally consisting of non-cash items each period. Results of operations for the Company’s remaining oil & gas activities have been significantly reduced due to lower field productivity.

 

Revenue. Revenue from continuing operations for the first six months of 2022 totaled $377 thousand as compared with $93 thousand for the same period of 2021.

 

Our post-harvest and midstream services revenue totaled $332 thousand in the 2022 period as compared with $48 thousand in the 2021 period. The Company’s hemp processing facilities were shut-in for much of the first half of each year to limit operating expenditures. As mentioned, we commenced processing of hemp biomass for our largest customer in June 2022. In 2021, our processing was limited until the late-summer harvest.

 

Rental revenue totaled $45 thousand in the 2022 and 2021 periods. The lease of the Company’s Denver warehouse expires on August 1, 2023 and provides for a rental of $7.5 thousand per month.

 

Cost of Revenue. Cost of revenue for the first six months of 2022 was $269 thousand as compared with $270 thousand in the same period of last year. Our gross margin on post-harvest processing and midstream services are expected to be 50% or more during peak operating periods. In the first part of each year we take steps to reduce operating costs by idling our facilities.

  

Merger and Acquisition Costs. We incurred $16 thousand of costs for acquisition costs in the 2021 period for closing of the Halcyon acquisition. The amount of future expenses of this type that we incur will depend upon our future acquisition activities. The Company incurred no such expenses during the six months ended June 30, 2022.

 

General and Administrative Expense. General and administrative expenses totaled $3.9 million for the six months ended June 30, 2022 as compared with $1.6 million in 2021 period. The increase in general and administrative expense is principally due to non-cash charges for stock-based compensation which totaled $2.6 million in the 2022 period as compared with $81 thousand in the 2021 period. The Company had lower legal and professional expenses during the 2022 period.

 

Depreciation and Amortization. Depreciation and amortization expense totaled $482 thousand in the six months ended June 30, 2022 as compared with $691 thousand for the same period of 2021.

 

Other Income/Expense. Total other expense was $287 thousand for the six months ended June 30, 2022 as compared with $459 thousand for the comparable 2021 period. The largest item of total other expense is interest expense which has decreased due to conversions of indebtedness to equity in 2021.

 

Loss from Discontinued Operations. In the six months ended June 30, 2022, we recognized a loss from discontinued operations of $40 thousand as compared with a loss of $10 thousand in the same period of 2021. The major classes of line items constituting the loss on discontinued operations are presented in Item I, “Financial Statements – Note 11 – Discontinued Operations.” As noted above, we revised our estimates of future asset retirement obligations for changes in inflation and interest rates in the 2022 period resulting in higher non-cash expense. Until we fully dispose of our remaining oil & gas property interests, we expect lower future revenues and costs as production activities have declined substantially. We do not anticipate making future investment of growth capital into these properties.

 

19

 

 

Liquidity and Capital Resources

 

Our primary source of cash from continuing operations includes post-harvest and midstream services and rental revenue. Our primary uses of cash include our operating costs, general and administrative expenses and merger and acquisition expenses.

 

Cash flow information from continuing operations for the first six months of 2022 was as follows:

 

Cash used in operating activities was $1 million principally due to the net loss adjusted for non-cash items.

 

The Company had no net cash used for investing activities during the period.

 

Net cash from financing activities totaled $1 million from advances under notes payable made by our CEO and his related company to fund our cash needs.

 

We used $3 thousand of cash for discontinued operations in the first six months of 2022.

 

Funding Requirements

 

We expect to continue to incur significant expenses and operating losses for the foreseeable future. We anticipate that our expenses may increase substantially as we grow our hemp business.

 

We expect that we will require additional capital to fund operations, including hiring additional employees, completing acquisitions and funding capital expenditures during the next twelve-month period.

 

Because of the numerous risks and uncertainties associated with the development and commercialization of our business, we are unable to estimate the amounts of increased capital outlays and operating expenses. Our future capital requirements will depend on many factors, including:

 

our success in identifying and making acquisitions of profitable operations;

 

our ability to negotiate operating contracts with growers and others within the hemp industry on favorable terms, if at all;

 

deriving revenue from our assets and operations; and

 

the cost of such operations and costs of being a public company.

 

Until such time, if ever, as we can generate substantial revenues, we expect to finance our cash needs through a combination of equity offerings and debt financings. We do not have any committed external source of funds. To the extent that we raise additional capital through the sale of equity or convertible debt securities, the ownership interest of our shareholders will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of common shareholders. Debt financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If we are unable to raise additional funds through equity or debt financings when needed, we may be required to delay, limit, reduce or terminate our growth plans and future commercialization efforts.

 

Indebtedness

 

The Company’s indebtedness at June 30, 2022 is presented in Item I, “Financial Statements – Note 5 – Notes Payable – Related Parties” and in Item I, “Financial Statements—Note 6 – Other Indebtedness.”

 

Subsequently, the Company has received additional advances under new and existing note arrangements. Refer to Item I, “Financial Statements—Note 14 – Subsequent Events.”

 

Off-Balance Sheet Arrangements

 

As of June 30, 2022, we had no material off-balance sheet arrangements.

 

20

 

 

Item 3. Quantitative and Qualitative Disclosures about Market Risk

 

Quantitative and qualitative disclosures about market risk are included in Item 7A, “Quantitative and Qualitative Disclosures about Market Risk,” of our Annual Report.

 

Item 4. Controls and Procedures

 

Disclosure Controls and Procedures

 

As required by Rule 13a-15(b) of the Exchange Act, we have evaluated, under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of the end of the period covered by this quarterly report. Our disclosure controls and procedures are designed to provide reasonable assurance that the information required to be disclosed by us in reports that we file under the Exchange Act is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure, and is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the SEC. Based upon that evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures were ineffective as of June 30, 2022 due to the material weaknesses previously identified as described below.

 

Previously Reported Material Weaknesses

 

A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements would not be prevented or detected on a timely basis.

 

We previously identified material weaknesses in our internal control over financial reporting. Based on our assessment for the year ended December 31, 2021, management identified a material weakness in internal control over financial reporting related to the accounting for business combination transactions.

 

Management Plans to Remediate Material Weakness. The Company has continued the process of designing and implementing effective internal control measures to improve its internal controls over financial reporting and remediate the reported material weakness. The Company’s efforts include implementing additional reviews of business combination transactions and modifying the Company’s instructions to valuation specialists and reviews of their work product. We will consider the material weakness remediated after the applicable controls operate for a sufficient period of time, and management has concluded, through testing, that the controls are operating effectively.

 

Changes in Internal Control over Financial Reporting

 

We regularly review our system of internal control over financial reporting and make changes to our processes and systems to improve controls and increase efficiency, while ensuring that we maintain an effective internal control environment. Changes may include such activities as implementing new, more efficient systems, consolidating activities and migrating processes.

 

We are taking actions to remediate the material weaknesses relating to our internal control over financial reporting, as described above. Except as otherwise described herein, there have been no changes in our internal control over financial reporting during the quarter ended June 30, 2022 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

21

 

 

PART II. OTHER INFORMATION

 

Item 1. Legal Proceedings

 

Due to the nature of our business, we may become, from time to time, involved in routine litigation or subject to disputes or claims related to our business activities. While the outcome of these proceedings cannot be predicted with certainty, in the opinion of our management, there are no pending litigation, disputes or claims against us which, if decided adversely, individually or in the aggregate, will have a material adverse effect on our financial condition, cash flows or results of operations. For a description of our legal proceedings, see Item I, “Financial Statements – Note 7 – Commitments and Contingencies” in the Condensed Consolidated Financial Statements included in Part I of this Quarterly Report.

 

Item 1A. Risk Factors

 

In addition to the other information set forth in this Quarterly Report, you should carefully consider the risk factors and other cautionary statements described under the heading “Item 1A. Risk Factors” included in our Annual Report and the risk factors and other cautionary statements contained in our other SEC filings, which could materially affect our businesses, financial condition or future results.

 

Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or future results. There have been no material changes in our risk factors from those described in our Annual Report.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

Since January 1, 2022, we have sold or issued securities without registering the securities under the Securities Act as shown below:

 

Issuance for Extension of Secured Note – The Company issued 60,000 common shares as consideration extensions of the maturity of a senior note in the first six months of 2022. Refer to Item I, “Financial Statements – Note 5 – Notes Payable – Related Parties”.

 

Item 4. Mine Safety Disclosures

 

No response required.

 

Item 5. Other Information

 

No response required.

 

22

 

 

Item 6. Exhibits

 

10.1*   Amended and Restated Promissory Note by Generation Hemp, Inc. with Gary C. Evans as holder, dated July 1, 2022
     
10.2*   Revised and Extended Unsecured Promissory Note, dated May 19, 2022, with Investment Hunter, LLC as holder, dated July 1, 2022
     
10.3*   Letter Agreement, dated July 31, 2022, with Coventry Asset Management, LTD
     
10.4*   Amendment and Extension Agreement, dated July 18, 2022, to Promissory Note and Deed of Trust between JDONE LLC, Thomas S. Yang, and Gary C. Evans
     
10.5*   Amended and Restated Subordinated Promissory Note, by Generation Hemp, Inc. with Gary C. Evans as holder, dated July 1, 2022
     
10.6*   Unsecured Promissory Note by Generation Hemp, Inc. with Gary Elliston as holder, dated August 12, 2022
     
10.7*   Unsecured Promissory Note by Generation Hemp, Inc. with John Harris as holder, dated August 12, 2022
     
10.8*   Unsecured Promissory Note by Generation Hemp, Inc. with Joe L. McClaugherty as holder, dated August 12, 2022
     
10.9*   Real Estate Option to Purchase Contract, as amended August 16, 2022
     
31.1*   Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
     
32.1**   Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
     
101.INS   Inline XBRL Instance Document
101.SCH   Inline XBRL Schema Document
101.CAL   Inline XBRL Calculation Linkbase Document
101.DEF   Inline XBRL Definition Linkbase Document
101.LAB   Inline XBRL Label Linkbase Document
101.PRE   Inline XBRL Presentation Linkbase Document
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

 

*Exhibit filed herewith.

 

**Furnished herewith. Pursuant to SEC Release No. 33-8212, this certification will be treated as “accompanying” this Quarterly Report on Form 10-Q and not “filed” as part of such report for purposes of Section 18 of the Exchange Act or otherwise subject to the liability under Section 18 of the Exchange Act, and this certification will not be deemed to be incorporated by reference into any filing under the Securities Act, except to the extent that the registrant specifically incorporates it by reference.

 

23

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  GENERATION HEMP, INC.
     
August 19, 2022 By: /s/ Gary C. Evans
    Gary C. Evans
    Chairman and Chief Executive Officer

 

 

24

 

 

May be redeemed for $0.0001 per warrant at the Company’s option with 30 days advanced notice should the weighted average market price of common stock exceed $1.00 for any five out of seven consecutive trading days with a minimum average daily trading volume for such seven-day period of at least 25,000 shares of common stock. false --12-31 Q2 0001527102 0001527102 2022-01-01 2022-06-30 0001527102 2022-08-19 0001527102 2022-06-30 0001527102 2021-12-31 0001527102 genh:SeriesBRedeemablePreferredStockMember 2022-06-30 0001527102 genh:SeriesBRedeemablePreferredStockMember 2021-12-31 0001527102 2022-04-01 2022-06-30 0001527102 2021-04-01 2021-06-30 0001527102 2021-01-01 2021-06-30 0001527102 genh:SeriesBRedeemablePreferredStockMember 2020-12-31 0001527102 us-gaap:PreferredStockMember 2020-12-31 0001527102 us-gaap:CommonStockMember 2020-12-31 0001527102 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001527102 us-gaap:RetainedEarningsMember 2020-12-31 0001527102 us-gaap:NoncontrollingInterestMember 2020-12-31 0001527102 2020-12-31 0001527102 genh:SeriesBRedeemablePreferredStockMember 2021-01-01 2021-03-31 0001527102 us-gaap:PreferredStockMember 2021-01-01 2021-03-31 0001527102 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001527102 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001527102 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001527102 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-03-31 0001527102 2021-01-01 2021-03-31 0001527102 genh:SeriesBRedeemablePreferredStockMember 2021-03-31 0001527102 us-gaap:PreferredStockMember 2021-03-31 0001527102 us-gaap:CommonStockMember 2021-03-31 0001527102 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001527102 us-gaap:RetainedEarningsMember 2021-03-31 0001527102 us-gaap:NoncontrollingInterestMember 2021-03-31 0001527102 2021-03-31 0001527102 genh:SeriesBRedeemablePreferredStockMember 2021-04-01 2021-06-30 0001527102 us-gaap:PreferredStockMember 2021-04-01 2021-06-30 0001527102 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001527102 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001527102 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001527102 us-gaap:NoncontrollingInterestMember 2021-04-01 2021-06-30 0001527102 genh:SeriesBRedeemablePreferredStockMember 2021-06-30 0001527102 us-gaap:PreferredStockMember 2021-06-30 0001527102 us-gaap:CommonStockMember 2021-06-30 0001527102 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001527102 us-gaap:RetainedEarningsMember 2021-06-30 0001527102 us-gaap:NoncontrollingInterestMember 2021-06-30 0001527102 2021-06-30 0001527102 genh:SeriesBRedeemablePreferredStockMember 2021-12-31 0001527102 us-gaap:PreferredStockMember 2021-12-31 0001527102 us-gaap:CommonStockMember 2021-12-31 0001527102 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001527102 us-gaap:RetainedEarningsMember 2021-12-31 0001527102 us-gaap:NoncontrollingInterestMember 2021-12-31 0001527102 genh:SeriesBRedeemablePreferredStockMember 2022-01-01 2022-03-31 0001527102 us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001527102 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001527102 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001527102 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001527102 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0001527102 2022-01-01 2022-03-31 0001527102 genh:SeriesBRedeemablePreferredStockMember 2022-03-31 0001527102 us-gaap:PreferredStockMember 2022-03-31 0001527102 us-gaap:CommonStockMember 2022-03-31 0001527102 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001527102 us-gaap:RetainedEarningsMember 2022-03-31 0001527102 us-gaap:NoncontrollingInterestMember 2022-03-31 0001527102 2022-03-31 0001527102 genh:SeriesBRedeemablePreferredStockMember 2022-04-01 2022-06-30 0001527102 us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001527102 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001527102 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001527102 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001527102 us-gaap:NoncontrollingInterestMember 2022-04-01 2022-06-30 0001527102 genh:SeriesBRedeemablePreferredStockMember 2022-06-30 0001527102 us-gaap:PreferredStockMember 2022-06-30 0001527102 us-gaap:CommonStockMember 2022-06-30 0001527102 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001527102 us-gaap:RetainedEarningsMember 2022-06-30 0001527102 us-gaap:NoncontrollingInterestMember 2022-06-30 0001527102 genh:EnergyHunterResourcesIncMember 2019-11-02 2019-11-27 0001527102 2021-01-05 2021-01-11 0001527102 genh:OneCustomerMember 2022-04-01 2022-06-30 0001527102 genh:OneCustomerMember 2022-01-01 2022-06-30 0001527102 us-gaap:LandMember 2022-06-30 0001527102 us-gaap:LandMember 2021-12-31 0001527102 pf0:WarehouseMember 2022-01-01 2022-06-30 0001527102 pf0:WarehouseMember 2022-06-30 0001527102 pf0:WarehouseMember 2021-12-31 0001527102 us-gaap:LeaseholdImprovementsMember 2022-01-01 2022-06-30 0001527102 us-gaap:LeaseholdImprovementsMember 2022-06-30 0001527102 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001527102 pf0:MinimumMember us-gaap:MachineryAndEquipmentMember 2022-01-01 2022-06-30 0001527102 pf0:MaximumMember us-gaap:MachineryAndEquipmentMember 2022-01-01 2022-06-30 0001527102 us-gaap:MachineryAndEquipmentMember 2022-06-30 0001527102 us-gaap:MachineryAndEquipmentMember 2021-12-31 0001527102 us-gaap:VehiclesMember 2022-01-01 2022-06-30 0001527102 us-gaap:VehiclesMember 2022-06-30 0001527102 us-gaap:VehiclesMember 2021-12-31 0001527102 us-gaap:ComputerEquipmentMember 2022-01-01 2022-06-30 0001527102 us-gaap:ComputerEquipmentMember 2022-06-30 0001527102 us-gaap:ComputerEquipmentMember 2021-12-31 0001527102 pf0:MinimumMember us-gaap:FurnitureAndFixturesMember 2022-01-01 2022-06-30 0001527102 pf0:MaximumMember us-gaap:FurnitureAndFixturesMember 2022-01-01 2022-06-30 0001527102 us-gaap:FurnitureAndFixturesMember 2022-06-30 0001527102 us-gaap:FurnitureAndFixturesMember 2021-12-31 0001527102 us-gaap:CustomerRelationshipsMember 2022-06-30 0001527102 us-gaap:CustomerRelationshipsMember 2021-12-31 0001527102 us-gaap:NoncompeteAgreementsMember 2022-06-30 0001527102 us-gaap:NoncompeteAgreementsMember 2021-12-31 0001527102 genh:SubordinatedPromissoryNoteToCEOMember 2022-01-01 2022-06-30 0001527102 genh:SubordinatedPromissoryNoteToCEOMember 2022-06-30 0001527102 genh:ConvertiblePromissoryNoteToCEOMember 2021-12-31 0001527102 genh:ConvertiblePromissoryNoteToCEOMember 2022-01-01 2022-06-30 0001527102 genh:ConvertiblePromissoryNoteToCEOMember 2022-06-30 0001527102 2022-07-31 0001527102 genh:ConventryAssetManagementLTDMember 2020-12-30 0001527102 us-gaap:ConvertibleNotesPayableMember 2020-12-01 2020-12-30 0001527102 genh:ConventryAssetManagementLTDMember 2020-12-01 2020-12-30 0001527102 2020-12-01 2020-12-30 0001527102 pf0:ScenarioForecastMember genh:ConventryAssetManagementLTDMember 2022-12-01 2022-12-31 0001527102 genh:ConventryAssetManagementLTDMember 2022-06-30 0001527102 genh:ConventryAssetManagementLTDMember 2022-01-01 2022-06-30 0001527102 genh:ConventryAssetManagementLTDMember 2022-01-01 2022-12-31 0001527102 genh:AccreditedInvestorMember 2020-12-30 0001527102 genh:SubordinatedPromissoryNoteMember 2020-12-01 2020-12-30 0001527102 genh:SubordinatedPromissoryNoteMember 2021-04-30 0001527102 genh:PromissoryNoteToInvestmentHunterLLCMember 2022-01-01 2022-06-30 0001527102 genh:SubordinatedPromissoryNoteMember 2022-06-30 0001527102 genh:SubordinatedPromissoryNoteMember 2021-12-31 0001527102 genh:SecuredPromissoryNoteToCoventryAssetManagementLtdMember 2022-06-30 0001527102 genh:SecuredPromissoryNoteToCoventryAssetManagementLtdMember 2021-12-31 0001527102 genh:SubordinatedPromissoryNoteToInvestorMember 2022-06-30 0001527102 genh:SubordinatedPromissoryNoteToInvestorMember 2021-12-31 0001527102 genh:PromissoryNoteToInvestmentHunterLLCMember 2022-06-30 0001527102 genh:PromissoryNoteToInvestmentHunterLLCMember 2021-12-31 0001527102 genh:OzCapitalLLCMember 2022-01-01 2022-06-30 0001527102 genh:OzCapitalLLCMember 2022-04-01 2022-06-30 0001527102 genh:OzCapitalLLCMember 2021-04-01 2021-06-30 0001527102 genh:OzCapitalLLCMember 2021-01-01 2021-06-30 0001527102 genh:HalcyonThruputLLCsMember 2022-01-01 2022-06-30 0001527102 genh:GrandTraverseHoldingsLLCMember 2018-12-31 0001527102 genh:GrandTraverseHoldingsLLCMember 2019-04-01 2019-04-12 0001527102 2019-04-01 2019-04-12 0001527102 genh:JohnGallegosMember genh:GrandTraverseHoldingsLLCMember 2019-04-01 2019-04-12 0001527102 2020-12-01 2020-12-23 0001527102 us-gaap:SeriesAPreferredStockMember 2021-09-08 0001527102 us-gaap:SeriesBPreferredStockMember 2020-12-30 2020-12-30 0001527102 us-gaap:SeriesBPreferredStockMember 2022-06-30 0001527102 us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-06-30 0001527102 2021-04-30 0001527102 us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001527102 us-gaap:WarrantMember 2022-06-30 0001527102 genh:DecemberTwoThousandTwentyMember genh:SeriesBPreferredStockUnitsMember 2022-06-30 0001527102 genh:DecemberTwoThousandTwentyMember genh:SeriesBPreferredStockUnitsMember 2022-01-01 2022-06-30 0001527102 genh:DecemberTwoThousandTwentyMember genh:SubordinatedNoteToInvestorMember 2022-06-30 0001527102 genh:DecemberTwoThousandTwentyMember genh:SubordinatedNoteToInvestorMember 2022-01-01 2022-06-30 0001527102 genh:MarchTwoThousandTwentyOneMember genh:CommonStockUnitsMember 2022-06-30 0001527102 genh:MarchTwoThousandTwentyOneMember genh:CommonStockUnitsMember 2022-01-01 2022-06-30 0001527102 genh:DecemberTwoThousandTwentyOneMember genh:CommonStockUnitsMember 2022-06-30 0001527102 genh:DecemberTwoThousandTwentyOneMember genh:CommonStockUnitsMember 2022-01-01 2022-06-30 0001527102 genh:TwoThousandTwentyOnePlanMember 2021-01-01 2021-12-31 0001527102 2021-01-01 2021-12-31 0001527102 us-gaap:RestrictedStockMember 2021-01-01 2021-03-31 0001527102 pf0:MinimumMember 2022-01-01 2022-06-30 0001527102 pf0:MaximumMember 2022-01-01 2022-06-30 0001527102 us-gaap:SegmentDiscontinuedOperationsMember 2022-06-30 0001527102 us-gaap:SegmentDiscontinuedOperationsMember 2021-12-31 0001527102 us-gaap:SegmentDiscontinuedOperationsMember 2022-04-01 2022-06-30 0001527102 us-gaap:SegmentDiscontinuedOperationsMember 2021-04-01 2021-06-30 0001527102 us-gaap:SegmentDiscontinuedOperationsMember 2022-01-01 2022-06-30 0001527102 us-gaap:SegmentDiscontinuedOperationsMember 2021-01-01 2021-06-30 0001527102 pf0:ScenarioForecastMember 2022-07-01 2022-09-30 0001527102 pf0:ScenarioForecastMember 2022-09-30 0001527102 us-gaap:SubsequentEventMember 2022-07-01 2022-07-31 0001527102 us-gaap:SubsequentEventMember 2022-07-31 0001527102 pf0:ScenarioForecastMember 2022-08-01 2022-08-31 0001527102 pf0:ScenarioForecastMember 2022-08-31 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure iso4217:USD utr:sqft
EX-10.1 2 f10q0622ex10-1_generation.htm AMENDED AND RESTATED PROMISSORY NOTE BY GENERATION HEMP, INC. WITH GARY C. EVANS AS HOLDER, DATED JULY 1, 2022

Exhibit 10.1

 

AMENDED AND RESTATED PROMISSORY NOTE

 

$1,095,069.28 July 1, 2022

 

For value received, GENERATION HEMP, INC., a Delaware corporation (the “Borrower”), promises to pay to GARY C. EVANS, an individual, or his assigns (the “Holder”), the principal sum of $1,095,069.28 (U.S. Dollars), together with all accrued and unpaid interest thereon as set forth below. It is expressly understood that the commitment to provide the principal sums set forth on Exhibit A were agreed to on the dates thereon and all provisions of this unsecured promissory note shall be deemed effective as of such dates and all financial obligations shall accrue from such dates with respect to such amounts. All payments of principal and interest hereunder shall be made by check or wire transfer pursuant to wire transfer instructions that may be provided by the Holder to the Borrower from time to time.

 

1.Payments; Conversion. The Borrower shall make the principal payment on September 30, 2022 to the Holder, together with accrued and unpaid interest hereunder. Notwithstanding to the contrary, all outstanding principal and all accrued and unpaid interest hereunder shall be due and payable in full at that time. In addition, the Holder shall have the option to convert the then outstanding balance of principal and interest under this Note into restricted shares of the Borrower’s Common Stock at a conversion price equal to $0.30 per share of Common Stock.

 

2.Alternative Payment. Any time prior to September 30, 2022, if Borrower raises new equity capital in the amount of three million dollars ($3,000,000.00) or greater, then within five (5) business days of closing, repayment of all outstanding principal and interest on this Convertible Promissory Note will be due.

 

3.Interest Rate. Simple interest on the unpaid principal balance of this Note shall accrue at the lesser of ten percent (10%) per annum and the highest rate permitted by law. If an Event of Default (as defined below) shall occur under this Note, interest shall immediately commence accruing at a default rate of fourteen percent (14%) per annum.

 

4.Default. The occurrence of any of the following events of default (each, an “Event of Default”) shall, at the option of the Holder thereof, make all principal and interest (to the extend accrued) then remaining unpaid hereon and all other amounts payable hereunder immediately due and payable, upon written demand, without presentment, or grace period, all of which hereby are expressly waived, except as set forth below:

 

(a)Failure to Pay Principal or Interest. The Borrower fails to pay any installment of principal or interest due under this Note when due and such failure continues for a period of five (5) days after written notice.

 

(b)Receiver or Trustee. The Borrower shall make an assignment for the benefit of creditors, or applies for or consents to the appointment of a receiver or trustee for it or for a substantial part of its property or business; or such a receiver of trustee shall otherwise be appointed without the consent of the Borrower, which shall constitute an automatic Event of Default and shall result in all remaining unpaid principal and interest due hereon immediately due and payable without the written demand from the Holder.

 

PROMISSORY NOTE – Page 1

 

 

 

 

(c)Bankruptcy. Bankruptcy, insolvency, reorganization, or liquidation proceedings or other proceedings or relief under any bankruptcy law or any law, or the issuance of any notice in relation to such event, for the relief of debtors shall be instituted by or against the Borrower, which shall constitute an automatic Event of Default and shall result in all remaining unpaid principal and interest due hereon immediately due and payable without the written demand from the Holder.

 

5.Termination. Upon payment of all cash amounts due to the Holder as provided in this Note, the Borrower will forever be released from all of its payment obligations and liabilities under this Note and the Holder agrees to promptly return to the Borrower the Note marked “paid in full”. This Note may be prepaid, in whole or in part, without the prior consent of the Holder.

 

6.Miscellaneous

 

(a)Successors and Assigns. This Note shall be binding upon successors and assigns of the Borrower, and shall inure to the benefit of the successors and permitted assigns of the Holder.

 

(b)Severability. The unenforceability or invalidity of any provision or provisions of this Note shall not render any other provision or provisions herein contained unenforceable or invalid.

 

(c)Notice. Any notice or communication required to be given hereunder may be delivered by hand or deposited with an overnight courier (with overnight delivery instructions), if to the Borrower, to the address of the Borrower’s corporate headquarters, and if to the Holder, to the last address of the Holder set forth in the Borrower’s books and records. Notice shall be deemed given and received on the date sent if sent by personal delivery; and one (1) day after the date sent if sent by overnight courier.

 

(d)Entire Agreement. This Note contains the entire and complete understanding between the parties concerning its subject matter and all representations, agreements, arrangements, and understandings between or among the parties, whether oral or written, have been fully merged herein and are superseded thereby, except for representations, agreements, and understandings between or among the parties made pursuant to the Purchase Agreement and any other agreements entered into in connection therewith and herewith. The Note may be modified only by a writing signed by both parties.

 

PROMISSORY NOTE – Page 2

 

 

 

 

(e)Governing Law; Attorneys’ Fees. This Note shall be governed by and construed in accordance with the laws of the State of Texas, without giving effect to its principles regarding conflicts of law. Upon default, the breaching party agrees to pay to the non-breaching party reasonable attorneys’ fees, plus all other reasonable expenses, incurred by the non-breaching party in exercising any of the non-breaching party’s rights and remedies.

 

(f)Jurisdiction. The parties (a) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of the State of Texas, Dallas County, and to the jurisdiction of the United States District Court for the State of Texas, for the purpose of any suit, action, or other proceeding arising out of or based upon this Note; (b) agree not to commence any suit, action, or other proceeding arising out of or based upon this Note except in the state courts of the State of Texas, Dallas County, or the United States District Court for the State of Texas; and (c) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action, or proceeding, any claim that it is not subject personally to the jurisdiction of the above named courts, that its property is exempt or immune from attachment or execution, that the suit, action, or proceeding is brought in an inconvenient forum, that the venue of the suit, action, or proceeding is improper or that this Note or the subject matter hereof may not be enforced in or by such court.

 

(g)FINAL AGREEMENT. THIS NOTE AND ALL OTHER INSTRUMENTS, DOCUMENTS, AND AGREEMENTS EXECUTED AND DELIVERED BY THE BORROWER IN CONNECTION WITH THE INDEBTEDNESS EVIDENCED BY THIS NOTE EMBOTY THE FINAL, ENTIRE AGREEMENT OF THE BORROWER AND THE HOLDER WITH RESPECT TO THE INDEBTEDNESS EVIDENCED BY THIS NOTE AND SUPERSEDE ANY AND ALL PRIOR COMMITMENTS, AGREEMENTS, REPRESENTATIONS, AND UNDERSTANDINGS, WHETHER WRITTEN OR ORAL, RELATING TO THE INDEBTEDNESS EVIDENCED BYT HIS NOTE AND MAY NOT BE CONTRADICTED OR VARIED BY EVIDENCE OF PRIOR, CONTEMPORANEOUS OR SUBSEQUENT ORAL AGREEMENTS OR DISCUSSIONS OF THE BORROWER AND THE HOLDER. THERE ARE NO ORAL AGREEMENTS BETWEEN THE BORROWER AND THE HOLDER.

 

(h)Subordination. By its acceptance hereof, the Holder agrees that the indebtedness evidenced by this Note, including the principal of and interest thereon, shall be subordinate to and subject in right of payment, to the extent hereinafter set forth, to the prior payment in full of all principal, interest, and any other sums then due on all existing or future Senior Indebtedness of the Borrower. The term “Senior Indebtedness” shall mean secured and unsecured indebtedness of the Borrower, or with respect to which the Borrower is a guarantor, for money borrowed by the Borrower from any financial institution or other sources prior to the date of this unsecured promissory note.

 

Signature Page Follows

 

PROMISSORY NOTE – Page 3

 

 

 

 

IN WITNESS WHEREOF, the Borrower has executed this Note as of the date set forth above.

 

  GENERATION HEMP, INC.,
  a Delaware Corporation
   
  By: /s/ Joe McClaugherty   8/12/2022
    Joe McClaugherty   Date
    Lead Director    

 

PROMISSORY NOTE – Page 4

 

 

 

 

PROMISSORY NOTE

Exhibit A

Schedule of Principal Sums Drawn under Promissory Note

 

Principal Sum Draw Date  Principal Sum Drawn 
July 20, 2021  $100,000.00 
August 3, 2021   100,000.00 
August 23, 2021   100,000.00 
September 9, 2021   50,000.00 
September 23, 2021   50,000.00 
September 29, 2021   220,000.00 
October 19, 2021   15,000.00 
November 10, 2021   50,000.00 
November 29, 2021 reduction in principal   (299,999.74)
December 8, 2021   25,000.00 
March 24, 2022   10,000.00 
March 30, 2022   37,069.02 
April 4, 2022   250,000.00 
April 14, 2022   100,000.00 
April 21, 2022   50,000.00 
April 27, 2022   100,000.00 
May 17, 2022   10,000.00 
May 19, 2022   20,000.00 
May 24, 2022   50,000.00 
August 4, 2022   51,000.00 
August 8, 2022   7,000.00 
      
Total  $1,095,069.28 

 

PROMISSORY NOTE – Page 5

 

 

EX-10.2 3 f10q0622ex10-2_generation.htm REVISED AND EXTENDED UNSECURED PROMISSORY NOTE, DATED MAY 19, 2022, WITH INVESTMENT HUNTER, LLC AS HOLDER, DATED JULY 1, 2022

Exhibit 10.2

 

REVISED AND AMENDED UNSECURED PROMISSORY NOTE

 

$492,000.00July 1, 2022

 

For value received, GENERATION HEMP, INC., a Delaware corporation (the “Borrower”), promises to pay to Investment Hunter, LLC, a Texas LLC, or its assigns (the “Holder”), the principal sum of $492,000.00 (U.S. Dollars), together with all accrued and unpaid interest thereon as set forth below. It is expressly understood that the commitment to provide the individual principal sums which total $492,000.00 was agreed to on the date of each individual loan advance, as presented in Exhibit A, attached hereto, and all provisions of this unsecured promissory note shall be deemed effective as of such date and all financial obligations shall accrue from such date with respect to each amount.

 

All payments of principal and interest hereunder shall be made by check or wire transfer pursuant to wire transfer instructions that may be provided by the Holder to the Borrower from time to time.

 

1.Payments. The Borrower shall make the principal payment on September 30, 2022 to the Holder, together with accrued and unpaid interest hereunder. Notwithstanding to the contrary, all outstanding principal and all accrued and unpaid interest hereunder shall be due and payable in full at that time.

 

2.Alternative Payment. Any time prior to September 30, 2022, if Borrower raises new equity capital in the amount of three million dollars ($3,000,000.00) or greater, then within five (5) business days of closing, repayment of all outstanding principal and interest on this Convertible Promissory Note will be due.

 

3.Interest Rate. Simple interest on the unpaid principal balance of this Note shall accrue at the lesser of ten percent (10%) per annum and the highest rate permitted by law. If an Event of Default (as defined below) shall occur under this Note, interest shall immediately commence accruing at a default rate of fourteen percent (14%) per annum.

 

4.Default. The occurrence of any of the following events of default (each, an “Event of Default”) shall, at the option of the Holder thereof, make all principal and interest (to the extend accrued) then remaining unpaid hereon and all other amounts payable hereunder immediately due and payable, upon written demand, without presentment, or grace period, all of which hereby are expressly waived, except as set forth below:

 

(a)Failure to Pay Principal or Interest. The Borrower fails to pay any installment of principal or interest due under this Note when due and such failure continues for a period of five (5) days after written notice.

 

(b)Receiver or Trustee. The Borrower shall make an assignment for the benefit of creditors, or applies for or consents to the appointment of a receiver or trustee for it or for a substantial part of its property or business; or such a receiver of trustee shall otherwise be appointed without the consent of the Borrower, which shall constitute an automatic Event of Default and shall result in all remaining unpaid principal and interest due hereon immediately due and payable without the written demand from the Holder.

 

(c)Bankruptcy. Bankruptcy, insolvency, reorganization, or liquidation proceedings or other proceedings or relief under any bankruptcy law or any law, or the issuance of any notice in relation to such event, for the relief of debtors shall be instituted by or against the Borrower, which shall constitute an automatic Event of Default and shall result in all remaining unpaid principal and interest due hereon immediately due and payable without the written demand from the Holder.

 

5.Termination. Upon payment of all cash amounts due to the Holder as provided in this Note, the Borrower will forever be released from all of its payment obligations and liabilities under this Note and the Holder agrees to promptly return to the Borrower the Note marked “paid in full”. This Note may be prepaid, in whole or in part, without the prior consent of the Holder.

 

INVESTMENT HUNTER, LLC

PROMISSORY NOTE – Page 1

 

 

6.Miscellaneous

 

(a)Successors and Assigns. This Note shall be binding upon successors and assigns of the Borrower, and shall inure to the benefit of the successors and permitted assigns of the Holder.

 

(b)Severability. The unenforceability or invalidity of any provision or provisions of this Note shall not render any other provision or provisions herein contained unenforceable or invalid.

 

(c)Notice. Any notice or communication required to be given hereunder may be delivered by hand or deposited with an overnight courier (with overnight delivery instructions), if to the Borrower, to the address of the Borrower’s corporate headquarters, and if to the Holder, to the last address of the Holder set forth in the Borrower’s books and records. Notice shall be deemed given and received on the date sent if sent by personal delivery; and one (1) day after the date sent if sent by overnight courier.

 

(d)Entire Agreement. This Note contains the entire and complete understanding between the parties concerning its subject matter and all representations, agreements, arrangements, and understandings between or among the parties, whether oral or written, have been fully merged herein and are superseded thereby, except for representations, agreements, and understandings between or among the parties made pursuant to the Purchase Agreement and any other agreements entered into in connection therewith and herewith. The Note may be modified only by a writing signed by both parties.

 

(e)Governing Law; Attorneys’ Fees. This Note shall be governed by and construed in accordance with the laws of the State of Texas, without giving effect to its principles regarding conflicts of law. Upon default, the breaching party agrees to pay to the non-breaching party reasonable attorneys’ fees, plus all other reasonable expenses, incurred by the non-breaching party in exercising any of the non-breaching party’s rights and remedies.

 

(f)Jurisdiction. The parties (a) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of the State of Texas, Dallas County, and to the jurisdiction of the United States District Court for the State of Texas, for the purpose of any suit, action, or other proceeding arising out of or based upon this Note; (b) agree not to commence any suit, action, or other proceeding arising out of or based upon this Note except in the state courts of the State of Texas, Dallas County, or the United States District Court for the State of Texas; and (c) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action, or proceeding, any claim that it is not subject personally to the jurisdiction of the above named courts, that its property is exempt or immune from attachment or execution, that the suit, action, or proceeding is brought in an inconvenient forum, that the venue of the suit, action, or proceeding is improper or that this Note or the subject matter hereof may not be enforced in or by such court.

 

(g)FINAL AGREEMENT. THIS NOTE AND ALL OTHER INSTRUMENTS, DOCUMENTS, AND AGREEMENTS EXECUTED AND DELIVERED BY THE BORROWER IN CONNECTION WITH THE INDEBTEDNESS EVIDENCED BY THIS NOTE EMBOTY THE FINAL, ENTIRE AGREEMENT OF THE BORROWER AND THE HOLDER WITH RESPECT TO THE INDEBTEDNESS EVIDENCED BY THIS NOTE AND SUPERSEDE ANY AND ALL PRIOR COMMITMENTS, AGREEMENTS, REPRESENTATIONS, AND UNDERSTANDINGS, WHETHER WRITTEN OR ORAL, RELATING TO THE INDEBTEDNESS EVIDENCED BYT HIS NOTE AND MAY NOT BE CONTRADICTED OR VARIED BY EVIDENCE OF PRIOR, CONTEMPORANEOUS OR SUBSEQUENT ORAL AGREEMENTS OR DISCUSSIONS OF THE BORROWER AND THE HOLDER. THERE ARE NO ORAL AGREEMENTS BETWEEN THE BORROWER AND THE HOLDER.

 

(h)Subordination. By its acceptance hereof, the Holder agrees that the indebtedness evidenced by this Note, including the principal of and interest thereon, shall be subordinate to and subject in right of payment, to the extent hereinafter set forth, to the prior payment in full of all principal, interest, and any other sums then due on all existing or future Senior Indebtedness of the Borrower. The term “Senior Indebtedness” shall mean secured and unsecured indebtedness of the Borrower, or with respect to which the Borrower is a guarantor, for money borrowed by the Borrower from any financial institution or other sources prior to the date of this unsecured promissory note.

 

Signature Page Follows

 

INVESTMENT HUNTER, LLC

PROMISSORY NOTE – Page 2

 

 

IN WITNESS WHEREOF, the Borrower has executed this Note as of the date set forth above.

 

GENERATION HEMP, INC.   GENERATION HEMP, INC.
a Delaware Corporation   a Delaware Corporation
     
/s/ Gary C. Evans   /s/ Joe L. McClaugherty
By: Gary C. Evans, CEO   By: Joe L. McClaugherty, Lead Director

 

INVESTMENT HUNTER, LLC

PROMISSORY NOTE – Page 3

 

 

PROMISSORY NOTE

 

Exhibit A

Schedule of Principal Sums Drawn under Promissory Note

 

Principal Sum Draw Date  Principal Sum
Drawn
 
1/4/22  $60,000.00 
1/11/22   25,000.00 
1/20/22   60,000.00 
1/28/22   75,000.00 
2/10/22   25,000.00 
2/14/22   25,000.00 
2/17/22   65,000.00 
3/1/22   40,000.00 
3/3/22   20,000.00 
3/17/22   44,000.00 
3/23/22   1,500.00 
5/11/22   40,000.00 
7/21/22   10,500.00 
8/11/22   1,000.00 
      
Total  $492,000.00 

 

INVESTMENT HUNTER, LLC

PROMISSORY NOTE – Page 4

EX-10.3 4 f10q0622ex10-3_generation.htm LETTER AGREEMENT, DATED JULY 31, 2022, WITH COVENTRY ASSET MANAGEMENT, LTD

Exhibit 10.3

 

Generation Hemp, Inc.

8533 Midway Road

Dallas, Texas 75209

 

July 31, 2022

 

Coventry Asset Management, Ltd.

2048 Coventry Ct.

Keller, Texas 76262

 

Re:In reference to that certain Secured Promissory Note Issued by Halcyon Thruput, LLC, dated December 30, 2020 (the “Note”).

 

Coventry Assert Management, Ltd.:

 

To Coventry Asset Management, Ltd. (“Coventry”), this letter agreement (the “Agreement”) is being issued by Generation Hemp, Inc. (the “Company”) to amend certain terms and conditions of the Note referenced above. All terms used herein shall have the meanings ascribed to such terms in the Note.

 

All principal payments shall be suspended until the Maturity Date of the Note, except as outlined below. The Maturity Date of the Note shall be amended to reflect that it is December 31, 2022; provided however that if the Company successfully completes a public equity offering equal to or in excess of $5,000,000 (the “Offering”) prior to such date, then the Company will pay all outstanding principal and interest payments due under the Note within five business days of the closing of such offering.

 

The Company agrees to make a principal payment in the amount of 25% of the outstanding principal balance of this Note on or by October 31, 2022.

 

The interest rate on the remaining principal balance of this Note shall increase to 14% per annum if the Note is not paid in full by December 31, 2022.

 

In consideration of such modifications to the Note, the Company agrees to issue to Coventry 50,000 shares of the Company’s common stock. These shares will be unregistered restricted securities and shall be subject to the restrictions placed on such shares through both Blue-Sky Laws of the applicable states and the rules and regulations of the United States Securities and Exchange Commission and applicable laws and regulatory authorities.

 

Except as modified by this Agreement, all other terms of the Note shall remain in full force and effect.

 

Coventry Asset Management, Ltd. Note Extension

 

page 1

 

 

 

  

Agreed to and Accepted by Generation Hemp, Inc.

 

  /s/ Gary C. Evans   August 10, 2022
  Gary C. Evans, Chairman and   DATE
  Chief Executive Officer    

 

Agreed and Accepted by Coventry Asset Management, Ltd.

 

/s/ Gen Fukunaga   August 15, 2022
Gen Fukunaga, Managing Partner   DATE

 

Coventry Asset Management, Ltd. Note Extension

page 2

 

 

EX-10.4 5 f10q0622ex10-4_generation.htm AMENDMENT AND EXTENSION AGREEMENT, DATED JULY 18, 2022, TO PROMISSORY NOTE AND DEED OF TRUST BETWEEN JDONE LLC, THOMAS S. YANG, AND GARY C. EVANS

Exhibit 10.4

 

SECURED PROMISSORY NOTE AMENDMENT AND EXTENSION AGREEMENT

 

This Secured Promissory Note Amendment and Extension Agreement (the “Agreement”) is entered into by JDone LLC, a Colorado limited liability company (the “Borrower”) and Thomas S. Yang (the “Holder”), as of July 18, 2022 and effective as of June 15, 2022.

 

Reference is made to that certain original Secured Promissory Note between the Borrower and the Holder, dated as of September 15, 2014 and amended on October 1, 2019, and most recently April 15, 2022, together with all amendments thereto (the “Note”), together with all associated notes, pledge agreements, guaranties, deeds of trust, security agreements, affidavits and other instruments and documents executed and delivered by the Borrower, the Holder and any Guarantors (the “Loan Documents”). Each of the Loan Documents shall be deemed to be amended in connection with the terms of this Agreement and the terms of this Agreement and the Note, as amended and extended hereby, shall be the controlling document with respect to the Note and the Loan Documents.

 

All capitalized terms used herein, but not otherwise defined, shall have the meaning ascribed to such terms in the Note and the Loan Documents.

 

At the execution of this Agreement, the Borrower shall undertake the following, and the Note shall be amended as follows:

 

(i)The Holder and Borrower agree that the outstanding principal balance under the Note is currently $473,190.48 after application of the June 2022 payment;

 

(ii)the Borrower shall pay a principal payment in the amount of $25,000 plus accrued interest on July 18, 2022;

 

(iii)the Borrower shall pay a principal payment in the amount of $25,000 plus accrued interest on August 31, 2022;

 

(iv)the Note shall be amended to change the Maturity Date to September 30, 2022;

 

(v)after the July and August 2022 principal and interest payments, the outstanding principal balance under the note as of September 30, 2022 will be $423,190.49; and

 

(vi)Borrower may pay off the loan at any time prior to the Maturity Date without penalty.

 

(vii)Any time prior to August 1, 2022, if Borrower raises new equity capital in the amount of five million dollars ($5,000,000.00) or greater, then within ten (10) business days of closing, repayment of all outstanding principal and interest on this Secured Promissory Note will be due to Holder.

 

All other terms contained in the Note and the Loan Documents shall remain unchanged and in full force and effect.

 

 

 

 

IN WITNESS WHEREOF, the Borrower and the Holder have executed this Agreement as of the date first written above and effective as the date stated above.

 

BORROWER:  
   
JDone LLC  
   
By: Generation Hemp, Inc.  
   
By: /s/ Gary C. Evans
Gary C. Evans  
   
Chairman and Chief Executive Officer  
   
ACKNOWLEDGED AND AGREED:  
   
HOLDER:  
   
By: /s/ Thomas S. Yang  
Thomas S. Yang  

 

 

EX-10.5 6 f10q0622ex10-5_generation.htm AMENDED AND RESTATED SUBORDINATED PROMISSORY NOTE, BY GENERATION HEMP, INC. WITH GARY C. EVANS AS HOLDER, DATED JULY 1, 2022

Exhibit 10.5

 

AMENDED AND RESTATED SUBORDINATED PROMISSORY NOTE

 

Dated July 1, 2022

 

Principal Amount $523,550.92

 

FOR VALUE, Generation Hemp, Inc., a Delaware corporation (“Borrower”), whose mailing address is P.O. Box 540308, Dallas, Texas 75354, promises and agrees to pay to the order of Gary C. Evans, a Texas resident (“Lender”), whose address is 8533 Midway Road, Dallas, Texas 75209, or at such other location as the holder of this Amended and Restated Subordinated Promissory Note (the “Note”), originally issued on November 20, 2020 (the “Original Note”), may designate by written notice to Borrower, the sum of five hundred twenty-three thousand five hundred fifty dollars and ninety-two cents ($523,550.92) in the lawful currency of the United States with interest at a rate of 10 % per annum, but in no event higher than the Highest Lawful Rate (as hereinafter defined). This Note amends and restates the Original Note and all amendments, allonges and modifications thereto, in its collective entirety.

 

“Highest Lawful Rate” means the maximum nonusurious rate of interest permitted by applicable federal or Texas law from time to time.

 

Interest on this Note shall be computed for the actual number of days elapsed and on the basis of a year consisting of 360 days, and a month consisting of 30 days, unless the Highest Lawful Rate would thereby be exceeded, in which event, to the extent necessary to avoid exceeding the Highest Lawful Rate, interest shall be computed on the basis of the actual number of days elapsed in the applicable calendar year in which accrued. It is understood that interest will begin to accrue on the date of each principal amount advanced as outlined on Exhibit “A.” If an Event of Default (as defined below) shall occur under this Note, interest shall immediately commence accruing at a default rate of fourteen percent (14%) per annum.

 

The principal amount of this Note and all accrued, unpaid interest thereon is due and payable in full on the 30th day of September, 2022 (the “Payment Date”). This Note may be prepaid in whole or in part at any time prior to the payment date stated in the preceding sentence without penalty as to principal, and any partial payments shall be applied to the principal due on this Note in inverse order of maturity with interest being adjusted accordingly.

 

Any time prior to September 30, 2022, if Borrower raises new equity capital in the amount of three million dollars ($3,000,000.00) or greater, then within five (5) business days of closing, repayment of all outstanding principal and interest on this Subordinated Promissory Note will be due.

 

If one of the following events occurs, Maker shall be in default (“Default”) and this Note shall, at Lender’s option, become immediately due and payable without demand or notice:

 

(i) the failure of Borrower to pay the principal and any accrued interest in full on or before the Payment Date;

 

(ii) the filing of bankruptcy proceedings involving the Borrower as a debtor;

 

(iii) the making of a general assignment for the benefit of the Borrower’s creditors; or the uncured breach by Borrower under any of the security documents executed in conformity with this Note, which remains uncured following any applicable cure period.

 

If any payment date falls on a Saturday, Sunday, or a federal holiday, then payment will be due on the next business day and such extension of time shall in such case be included in the computation or payment of interest hereunder. All past due principal and interest on this Note shall bear interest at the Highest Lawful Rate.

 

To the extent that waiver of notice is permitted by applicable law, the Borrower and any and all co-makers, endorsers, guarantors, and sureties jointly and severally waive notice (including, but not limited to, notice of intent to accelerate and notice of acceleration), demand, presentment for payment, protest and the filing of suit for the purpose of fixing liability and consent that the time of payment hereof may be extended and re-extended from time to time without notice to them or any of them, and each agree that his, her, or its liability on or with respect to this Note shall not be affected by any release of or change in any security at any time existing or by any failure to perfect or to maintain perfection of any lien on or security interest in any such security.

 

This Note has been executed and delivered in Dallas, Dallas County, Texas, and shall be governed by and construed in accordance with the laws of the State of Texas and the United States of America from time to time in effect without regard to the choice of law provisions thereof, and shall be enforceable in Dallas County, Texas.

 

Regardless of any provision contained in this Note, the Payee shall never be deemed to have contracted for or be entitled to receive, collect or apply as interest on the Note, any amount in excess of the maximum rate of interest permitted to be charged by applicable law and, in the event Payee ever receives, collects or applies as interest any such excess, such amount which would be excessive interest shall be applied to the reduction of the unpaid principal balance of this Note; and, if the principal balance of this Note is paid in full, any remaining excess shall forthwith be paid to Maker. In determining whether or not the interest paid or payable under any specific contingency exceeds the highest lawful rate, Maker and Payee shall, to the maximum extent permitted under applicable law, (i) exclude voluntary prepayments and the effect thereof, and (ii) spread the total amount of interest throughout the entire contemplated term of this Note so that the interest rate is uniform throughout such term.

 

This Promissory Note is intended to be an obligation of Borrower and, by the execution of this Promissory Note, Borrower agrees that Borrower shall not be entitled to sell, transfer, assign, or convey in any manner whatsoever, this Promissory Note and Borrower shall remain obligated under this Promissory Note until the obligation set forth herein is paid in full.

 

If this Note is placed in the hands of any attorney for collection, or if it is collected through any legal proceedings at law or in equity or in bankruptcy, receivership or other court proceedings, Maker joint and severally agrees to pay all costs of collection, including, but not limited court costs and reasonable attorney’s fees.

 

Promissory Note – Page 1

 

 

 

 

IN WITNESS WHEREOF, the undersigned Borrower has duly executed this Note effective as of the date first written above.

 

  By: /s/ Joe McClaugherty
  Name: Joe McClaugherty
  Title: Generation Hemp, Inc. Lead Director

 

Promissory Note – Page 2

 

 

EX-10.6 7 f10q0622ex10-6_generation.htm UNSECURED PROMISSORY NOTE BY GENERATION HEMP, INC. WITH GARY ELLISTON AS HOLDER, DATED AUGUST 12, 2022

Exhibit 10.6

 

UNSECURED PROMISSORY NOTE

 

$35,000.00 August 12, 2022

 

For value received, GENERATION HEMP, INC., a Delaware corporation (the “Borrower”), promises to pay to Gary D. Elliston, or his assigns (the “Holder”), the principal sum of $35,000.00 (U.S. Dollars), together with all accrued and unpaid interest thereon as set forth below. It is expressly understood that the commitment to provide the principal sum of $35,000.00 was agreed to on the date above, and all provisions of this unsecured promissory note shall be deemed effective as of such date and all financial obligations shall accrue from such date with respect to the loan amount.

 

All payments of principal and interest hereunder shall be made by check or wire transfer pursuant to wire transfer instructions that may be provided by the Holder to the Borrower from time to time.

 

1.Payments. The Borrower shall make the principal payment on September 12, 2022 to the Holder, together with accrued and unpaid interest hereunder. Notwithstanding to the contrary, all outstanding principal and all accrued and unpaid interest hereunder shall be due and payable in full at that time.

 

2.Interest Rate. Simple interest on the unpaid principal balance of this Note shall accrue at the lesser of ten percent (10%) per annum and the highest rate permitted by law. If an Event of Default (as defined below) shall occur under this Note, interest shall immediately commence accruing at a default rate of fourteen percent (14%) per annum.

 

3.Default. The occurrence of any of the following events of default (each, an “Event of Default”) shall, at the option of the Holder thereof, make all principal and interest (to the extend accrued) then remaining unpaid hereon and all other amounts payable hereunder immediately due and payable, upon written demand, without presentment, or grace period, all of which hereby are expressly waived, except as set forth below:

 

(a)Failure to Pay Principal or Interest. The Borrower fails to pay any installment of principal or interest due under this Note when due and such failure continues for a period of five (5) days after written notice.

 

(b)Receiver or Trustee. The Borrower shall make an assignment for the benefit of creditors, or applies for or consents to the appointment of a receiver or trustee for it or for a substantial part of its property or business; or such a receiver of trustee shall otherwise be appointed without the consent of the Borrower, which shall constitute an automatic Event of Default and shall result in all remaining unpaid principal and interest due hereon immediately due and payable without the written demand from the Holder.

 

GARY D. ELLISTON

PROMISSORY NOTE – Page 1

 

 

 

 

(c)Bankruptcy. Bankruptcy, insolvency, reorganization, or liquidation proceedings or other proceedings or relief under any bankruptcy law or any law, or the issuance of any notice in relation to such event, for the relief of debtors shall be instituted by or against the Borrower, which shall constitute an automatic Event of Default and shall result in all remaining unpaid principal and interest due hereon immediately due and payable without the written demand from the Holder.

 

4.Termination. Upon payment of all cash amounts due to the Holder as provided in this Note, the Borrower will forever be released from all of its payment obligations and liabilities under this Note and the Holder agrees to promptly return to the Borrower the Note marked “paid in full”. This Note may be prepaid, in whole or in part, without the prior consent of the Holder.

 

5.Miscellaneous

 

(a)Successors and Assigns. This Note shall be binding upon successors and assigns of the Borrower, and shall inure to the benefit of the successors and permitted assigns of the Holder.

 

(b)Severability. The unenforceability or invalidity of any provision or provisions of this Note shall not render any other provision or provisions herein contained unenforceable or invalid.

 

(c)Notice. Any notice or communication required to be given hereunder may be delivered by hand or deposited with an overnight courier (with overnight delivery instructions), if to the Borrower, to the address of the Borrower’s corporate headquarters, and if to the Holder, to the last address of the Holder set forth in the Borrower’s books and records. Notice shall be deemed given and received on the date sent if sent by personal delivery; and one (1) day after the date sent if sent by overnight courier.

 

(d)Entire Agreement. This Note contains the entire and complete understanding between the parties concerning its subject matter and all representations, agreements, arrangements, and understandings between or among the parties, whether oral or written, have been fully merged herein and are superseded thereby, except for representations, agreements, and understandings between or among the parties made pursuant to the Purchase Agreement and any other agreements entered into in connection therewith and herewith. The Note may be modified only by a writing signed by both parties.

 

(e)Governing Law; Attorneys’ Fees. This Note shall be governed by and construed in accordance with the laws of the State of Texas, without giving effect to its principles regarding conflicts of law. Upon default, the breaching party agrees to pay to the non-breaching party reasonable attorneys’ fees, plus all other reasonable expenses, incurred by the non-breaching party in exercising any of the non-breaching party’s rights and remedies.

 

GARY D. ELLISTON

PROMISSORY NOTE – Page 2

 

 

 

 

(f)Jurisdiction. The parties (a) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of the State of Texas, Dallas County, and to the jurisdiction of the United States District Court for the State of Texas, for the purpose of any suit, action, or other proceeding arising out of or based upon this Note; (b) agree not to commence any suit, action, or other proceeding arising out of or based upon this Note except in the state courts of the State of Texas, Dallas County, or the United States District Court for the State of Texas; and (c) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action, or proceeding, any claim that it is not subject personally to the jurisdiction of the above named courts, that its property is exempt or immune from attachment or execution, that the suit, action, or proceeding is brought in an inconvenient forum, that the venue of the suit, action, or proceeding is improper or that this Note or the subject matter hereof may not be enforced in or by such court.

 

(g)FINAL AGREEMENT. THIS NOTE AND ALL OTHER INSTRUMENTS, DOCUMENTS, AND AGREEMENTS EXECUTED AND DELIVERED BY THE BORROWER IN CONNECTION WITH THE INDEBTEDNESS EVIDENCED BY THIS NOTE EMBODY THE FINAL, ENTIRE AGREEMENT OF THE BORROWER AND THE HOLDER WITH RESPECT TO THE INDEBTEDNESS EVIDENCED BY THIS NOTE AND SUPERSEDE ANY AND ALL PRIOR COMMITMENTS, AGREEMENTS, REPRESENTATIONS, AND UNDERSTANDINGS, WHETHER WRITTEN OR ORAL, RELATING TO THE INDEBTEDNESS EVIDENCED BY THIS NOTE AND MAY NOT BE CONTRADICTED OR VARIED BY EVIDENCE OF PRIOR, CONTEMPORANEOUS, OR SUBSEQUENT ORAL AGREEMENTS OR DISCUSSIONS OF THE BORROWER AND THE HOLDER. THERE ARE NO ORAL AGREEMENTS BETWEEN THE BORROWER AND THE HOLDER.

 

(h)Subordination. By its acceptance hereof, the Holder agrees that the indebtedness evidenced by this Note, including the principal of and interest thereon, shall be subordinate to and subject in right of payment, to the extent hereinafter set forth, to the prior payment in full of all principal, interest, and any other sums then due on all existing or future Senior Indebtedness of the Borrower. The term “Senior Indebtedness” shall mean secured and unsecured indebtedness of the Borrower, or with respect to which the Borrower is a guarantor, for money borrowed by the Borrower from any financial institution or other sources prior to the date of this unsecured promissory note.

 

Signature Page Follows

 

GARY D. ELLISTON

PROMISSORY NOTE – Page 3

  

 

 

 

IN WITNESS WHEREOF, the Borrower has executed this Note as of the date set forth above.

 

GENERATION HEMP, INC.,
  a Delaware Corporation
     
  By: /s/ Gary C. Evans
    Gary C. Evans, CEO

 

GARY D. ELLISTON

PROMISSORY NOTE – Page 4

 

 

 

 

EX-10.7 8 f10q0622ex10-7_generation.htm UNSECURED PROMISSORY NOTE BY GENERATION HEMP, INC. WITH JOHN HARRIS AS HOLDER, DATED AUGUST 12, 2022

Exhibit 10.7

 

UNSECURED PROMISSORY NOTE

 

$35,000.00August 12, 2022

 

For value received, GENERATION HEMP, INC., a Delaware corporation (the “Borrower”), promises to pay to John Harris, or his assigns (the “Holder”), the principal sum of $35,000.00 (U.S. Dollars), together with all accrued and unpaid interest thereon as set forth below. It is expressly understood that the commitment to provide the principal sum of $35,000.00 was agreed to on the date above, and all provisions of this unsecured promissory note shall be deemed effective as of such date and all financial obligations shall accrue from such date with respect to the loan amount.

 

All payments of principal and interest hereunder shall be made by check or wire transfer pursuant to wire transfer instructions that may be provided by the Holder to the Borrower from time to time.

 

1.Payments. The Borrower shall make the principal payment on September 12, 2022 to the Holder, together with accrued and unpaid interest hereunder. Notwithstanding to the contrary, all outstanding principal and all accrued and unpaid interest hereunder shall be due and payable in full at that time.

 

2.Interest Rate. Simple interest on the unpaid principal balance of this Note shall accrue at the lesser of ten percent (10%) per annum and the highest rate permitted by law. If an Event of Default (as defined below) shall occur under this Note, interest shall immediately commence accruing at a default rate of fourteen percent (14%) per annum.

 

3.Default. The occurrence of any of the following events of default (each, an “Event of Default”) shall, at the option of the Holder thereof, make all principal and interest (to the extend accrued) then remaining unpaid hereon and all other amounts payable hereunder immediately due and payable, upon written demand, without presentment, or grace period, all of which hereby are expressly waived, except as set forth below:

 

(a)Failure to Pay Principal or Interest. The Borrower fails to pay any installment of principal or interest due under this Note when due and such failure continues for a period of five (5) days after written notice.

 

(b)Receiver or Trustee. The Borrower shall make an assignment for the benefit of creditors, or applies for or consents to the appointment of a receiver or trustee for it or for a substantial part of its property or business; or such a receiver of trustee shall otherwise be appointed without the consent of the Borrower, which shall constitute an automatic Event of Default and shall result in all remaining unpaid principal and interest due hereon immediately due and payable without the written demand from the Holder.

 

(c)Bankruptcy. Bankruptcy, insolvency, reorganization, or liquidation proceedings or other proceedings or relief under any bankruptcy law or any law, or the issuance of any notice in relation to such event, for the relief of debtors shall be instituted by or against the Borrower, which shall constitute an automatic Event of Default and shall result in all remaining unpaid principal and interest due hereon immediately due and payable without the written demand from the Holder.

 

4.Termination. Upon payment of all cash amounts due to the Holder as provided in this Note, the Borrower will forever be released from all of its payment obligations and liabilities under this Note and the Holder agrees to promptly return to the Borrower the Note marked “paid in full”. This Note may be prepaid, in whole or in part, without the prior consent of the Holder.

 

5.Miscellaneous

 

(a)Successors and Assigns. This Note shall be binding upon successors and assigns of the Borrower, and shall inure to the benefit of the successors and permitted assigns of the Holder.

 

(b)Severability. The unenforceability or invalidity of any provision or provisions of this Note shall not render any other provision or provisions herein contained unenforceable or invalid.

 

(c)Notice. Any notice or communication required to be given hereunder may be delivered by hand or deposited with an overnight courier (with overnight delivery instructions), if to the Borrower, to the address of the Borrower’s corporate headquarters, and if to the Holder, to the last address of the Holder set forth in the Borrower’s books and records. Notice shall be deemed given and received on the date sent if sent by personal delivery; and one (1) day after the date sent if sent by overnight courier.

 

JOHN HARRIS

PROMISSORY NOTE – Page 1

 

 

 

 

(d)Entire Agreement. This Note contains the entire and complete understanding between the parties concerning its subject matter and all representations, agreements, arrangements, and understandings between or among the parties, whether oral or written, have been fully merged herein and are superseded thereby, except for representations, agreements, and understandings between or among the parties made pursuant to the Purchase Agreement and any other agreements entered into in connection therewith and herewith. The Note may be modified only by a writing signed by both parties.

 

(e)Governing Law; Attorneys’ Fees. This Note shall be governed by and construed in accordance with the laws of the State of Texas, without giving effect to its principles regarding conflicts of law. Upon default, the breaching party agrees to pay to the non-breaching party reasonable attorneys’ fees, plus all other reasonable expenses, incurred by the non-breaching party in exercising any of the non-breaching party’s rights and remedies.

 

(f)Jurisdiction. The parties (a) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of the State of Texas, Dallas County, and to the jurisdiction of the United States District Court for the State of Texas, for the purpose of any suit, action, or other proceeding arising out of or based upon this Note; (b) agree not to commence any suit, action, or other proceeding arising out of or based upon this Note except in the state courts of the State of Texas, Dallas County, or the United States District Court for the State of Texas; and (c) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action, or proceeding, any claim that it is not subject personally to the jurisdiction of the above named courts, that its property is exempt or immune from attachment or execution, that the suit, action, or proceeding is brought in an inconvenient forum, that the venue of the suit, action, or proceeding is improper or that this Note or the subject matter hereof may not be enforced in or by such court.

 

(g)FINAL AGREEMENT. THIS NOTE AND ALL OTHER INSTRUMENTS, DOCUMENTS, AND AGREEMENTS EXECUTED AND DELIVERED BY THE BORROWER IN CONNECTION WITH THE INDEBTEDNESS EVIDENCED BY THIS NOTE EMBODY THE FINAL, ENTIRE AGREEMENT OF THE BORROWER AND THE HOLDER WITH RESPECT TO THE INDEBTEDNESS EVIDENCED BY THIS NOTE AND SUPERSEDE ANY AND ALL PRIOR COMMITMENTS, AGREEMENTS, REPRESENTATIONS, AND UNDERSTANDINGS, WHETHER WRITTEN OR ORAL, RELATING TO THE INDEBTEDNESS EVIDENCED BY THIS NOTE AND MAY NOT BE CONTRADICTED OR VARIED BY EVIDENCE OF PRIOR, CONTEMPORANEOUS, OR SUBSEQUENT ORAL AGREEMENTS OR DISCUSSIONS OF THE BORROWER AND THE HOLDER. THERE ARE NO ORAL AGREEMENTS BETWEEN THE BORROWER AND THE HOLDER.

 

(h)Subordination. By its acceptance hereof, the Holder agrees that the indebtedness evidenced by this Note, including the principal of and interest thereon, shall be subordinate to and subject in right of payment, to the extent hereinafter set forth, to the prior payment in full of all principal, interest, and any other sums then due on all existing or future Senior Indebtedness of the Borrower. The term “Senior Indebtedness” shall mean secured and unsecured indebtedness of the Borrower, or with respect to which the Borrower is a guarantor, for money borrowed by the Borrower from any financial institution or other sources prior to the date of this unsecured promissory note.

 

Signature Page Follows

 

JOHN HARRIS

PROMISSORY NOTE – Page 2

 

 

 

 

IN WITNESS WHEREOF, the Borrower has executed this Note as of the date set forth above.

 

  GENERATION HEMP, INC.,
  a Delaware Corporation
   
  By: /s/ Gary C. Evans
    Gary C. Evans, CEO

 

JOHN HARRIS

PROMISSORY NOTE – Page 3

 

 

 

 

EX-10.8 9 f10q0622ex10-8_generation.htm UNSECURED PROMISSORY NOTE BY GENERATION HEMP, INC. WITH JOE L. MCCLAUGHERTY AS HOLDER, DATED AUGUST 12, 2022

Exhibit 10.8

 

UNSECURED PROMISSORY NOTE

 

$35,000.00 August 12, 2022

 

For value received, GENERATION HEMP, INC., a Delaware corporation (the “Borrower”), promises to pay to Joe L. McClaugherty, or his assigns (the “Holder”), the principal sum of $35,000.00 (U.S. Dollars), together with all accrued and unpaid interest thereon as set forth below. It is expressly understood that the commitment to provide the principal sum of $35,000.00 was agreed to on the date above, and all provisions of this unsecured promissory note shall be deemed effective as of such date and all financial obligations shall accrue from such date with respect to the loan amount.

 

All payments of principal and interest hereunder shall be made by check or wire transfer pursuant to wire transfer instructions that may be provided by the Holder to the Borrower from time to time.

 

1.Payments. The Borrower shall make the principal payment on September 12, 2022 to the Holder, together with accrued and unpaid interest hereunder. Notwithstanding to the contrary, all outstanding principal and all accrued and unpaid interest hereunder shall be due and payable in full at that time.

 

2.Interest Rate. Simple interest on the unpaid principal balance of this Note shall accrue at the lesser of ten percent (10%) per annum and the highest rate permitted by law. If an Event of Default (as defined below) shall occur under this Note, interest shall immediately commence accruing at a default rate of fourteen percent (14%) per annum.

 

3.Default. The occurrence of any of the following events of default (each, an “Event of Default”) shall, at the option of the Holder thereof, make all principal and interest (to the extend accrued) then remaining unpaid hereon and all other amounts payable hereunder immediately due and payable, upon written demand, without presentment, or grace period, all of which hereby are expressly waived, except as set forth below:

 

(a)Failure to Pay Principal or Interest. The Borrower fails to pay any installment of principal or interest due under this Note when due and such failure continues for a period of five (5) days after written notice.

 

(b)Receiver or Trustee. The Borrower shall make an assignment for the benefit of creditors, or applies for or consents to the appointment of a receiver or trustee for it or for a substantial part of its property or business; or such a receiver of trustee shall otherwise be appointed without the consent of the Borrower, which shall constitute an automatic Event of Default and shall result in all remaining unpaid principal and interest due hereon immediately due and payable without the written demand from the Holder.

 

JOE L. McCLAUGHERTY

PROMISSORY NOTE – Page 1

 

 

 

 

(c)Bankruptcy. Bankruptcy, insolvency, reorganization, or liquidation proceedings or other proceedings or relief under any bankruptcy law or any law, or the issuance of any notice in relation to such event, for the relief of debtors shall be instituted by or against the Borrower, which shall constitute an automatic Event of Default and shall result in all remaining unpaid principal and interest due hereon immediately due and payable without the written demand from the Holder.

 

4.Termination. Upon payment of all cash amounts due to the Holder as provided in this Note, the Borrower will forever be released from all of its payment obligations and liabilities under this Note and the Holder agrees to promptly return to the Borrower the Note marked “paid in full”. This Note may be prepaid, in whole or in part, without the prior consent of the Holder.

 

5.Miscellaneous

 

(a)Successors and Assigns. This Note shall be binding upon successors and assigns of the Borrower, and shall inure to the benefit of the successors and permitted assigns of the Holder.

 

(b)Severability. The unenforceability or invalidity of any provision or provisions of this Note shall not render any other provision or provisions herein contained unenforceable or invalid.

 

(c)Notice. Any notice or communication required to be given hereunder may be delivered by hand or deposited with an overnight courier (with overnight delivery instructions), if to the Borrower, to the address of the Borrower’s corporate headquarters, and if to the Holder, to the last address of the Holder set forth in the Borrower’s books and records. Notice shall be deemed given and received on the date sent if sent by personal delivery; and one (1) day after the date sent if sent by overnight courier.

 

(d)Entire Agreement. This Note contains the entire and complete understanding between the parties concerning its subject matter and all representations, agreements, arrangements, and understandings between or among the parties, whether oral or written, have been fully merged herein and are superseded thereby, except for representations, agreements, and understandings between or among the parties made pursuant to the Purchase Agreement and any other agreements entered into in connection therewith and herewith. The Note may be modified only by a writing signed by both parties.

 

(e)Governing Law; Attorneys’ Fees. This Note shall be governed by and construed in accordance with the laws of the State of Texas, without giving effect to its principles regarding conflicts of law. Upon default, the breaching party agrees to pay to the non-breaching party reasonable attorneys’ fees, plus all other reasonable expenses, incurred by the non-breaching party in exercising any of the non-breaching party’s rights and remedies.

 

JOE L. McCLAUGHERTY

PROMISSORY NOTE – Page 2

 

 

 

 

(f)Jurisdiction. The parties (a) hereby irrevocably and unconditionally submit to the jurisdiction of the state courts of the State of Texas, Dallas County, and to the jurisdiction of the United States District Court for the State of Texas, for the purpose of any suit, action, or other proceeding arising out of or based upon this Note; (b) agree not to commence any suit, action, or other proceeding arising out of or based upon this Note except in the state courts of the State of Texas, Dallas County, or the United States District Court for the State of Texas; and (c) hereby waive, and agree not to assert, by way of motion, as a defense, or otherwise, in any such suit, action, or proceeding, any claim that it is not subject personally to the jurisdiction of the above named courts, that its property is exempt or immune from attachment or execution, that the suit, action, or proceeding is brought in an inconvenient forum, that the venue of the suit, action, or proceeding is improper or that this Note or the subject matter hereof may not be enforced in or by such court.

 

(g)FINAL AGREEMENT. THIS NOTE AND ALL OTHER INSTRUMENTS, DOCUMENTS, AND AGREEMENTS EXECUTED AND DELIVERED BY THE BORROWER IN CONNECTION WITH THE INDEBTEDNESS EVIDENCED BY THIS NOTE EMBODY THE FINAL, ENTIRE AGREEMENT OF THE BORROWER AND THE HOLDER WITH RESPECT TO THE INDEBTEDNESS EVIDENCED BY THIS NOTE AND SUPERSEDE ANY AND ALL PRIOR COMMITMENTS, AGREEMENTS, REPRESENTATIONS, AND UNDERSTANDINGS, WHETHER WRITTEN OR ORAL, RELATING TO THE INDEBTEDNESS EVIDENCED BY THIS NOTE AND MAY NOT BE CONTRADICTED OR VARIED BY EVIDENCE OF PRIOR, CONTEMPORANEOUS, OR SUBSEQUENT ORAL AGREEMENTS OR DISCUSSIONS OF THE BORROWER AND THE HOLDER. THERE ARE NO ORAL AGREEMENTS BETWEEN THE BORROWER AND THE HOLDER.

 

(h)Subordination. By its acceptance hereof, the Holder agrees that the indebtedness evidenced by this Note, including the principal of and interest thereon, shall be subordinate to and subject in right of payment, to the extent hereinafter set forth, to the prior payment in full of all principal, interest, and any other sums then due on all existing or future Senior Indebtedness of the Borrower. The term “Senior Indebtedness” shall mean secured and unsecured indebtedness of the Borrower, or with respect to which the Borrower is a guarantor, for money borrowed by the Borrower from any financial institution or other sources prior to the date of this unsecured promissory note.

 

Signature Page Follows

 

JOE L. McCLAUGHERTY

PROMISSORY NOTE – Page 3

 

 

 

 

IN WITNESS WHEREOF, the Borrower has executed this Note as of the date set forth above.

 

  GENERATION HEMP, INC.,
  a Delaware Corporation
     
  By: /s/ Gary C. Evans
  Gary C. Evans, CEO

 

JOE L. McCLAUGHERTY

PROMISSORY NOTE – Page 4

 

 

 

 

EX-10.9 10 f10q0622ex10-9_generation.htm REAL ESTATE OPTION TO PURCHASE CONTRACT, AS AMENDED AUGUST 16, 2022

Exhibit 10.9

 

REAL PROPERTY OPTION TO PURCHASE CONTRACT

 

This amended REAL PROPERTY OPTION TO PURCHASE CONTRACT (this “Contract”) was initially executed on March 25, 2022 as of March 23rd, 2022, by and between

 

OZ CAPITAL, LLC  
a Texas limited liability company  
222 West Exchange Street  
Fort Worth, Texas 76164 (“Grantor”)
and  
GENH HALCYON ACQUISITION, LLC  
a Texas limited liability company  
PO Box 540308  
Dallas, Texas 75354 (“Optionee”).

 

This agreement has been modified by the parties hereto from its original version as of March 23, 2022 under paragraph number 2 below titled “Option Purchase Price” to the originally agreed purchase price of $993,000.

 

RECITALS

 

A. Grantor is the owner in fee simple of the Property (hereinafter defined).

 

B. Grantor issued Optionee an option to purchase and acquire the Property under the terms of the Contract dated January 11, 2021 and such option expired by its amended terms on June 30, 2022.

 

C. Grantor and Optionee desire to grant Optionee an option to purchase and acquire the Property, pursuant to the terms and conditions contained in this Contract.

 

NOW, THEREFORE, in consideration of the mutual representations, benefits and covenants contained herein, and other good and valuable consideration, the receipt and sufficiency of which are acknowledged and confirmed, Grantor and Optionee covenant and agree as follows:

 

TERMS AND CONDITIONS

 

1. The Property. The real property consists of one parcel located at 400 Mitsubishi Lane, Christian County, Kentucky 42240, as more particularly described on EXHIBIT “A”, together with any and all improvements now existing or hereafter located thereon (the “Property”).

 

2. Option Purchase Price. Optionee shall be granted an option to acquire the Property from Grantor free and clear of all liens for a purchase price of $993,000.00 for a period commencing on the date of Optionee satisfies all of its obligations in Paragraphs 3 and 4 of this Contract and ending on August 25th, 2022. The conveyance of the Property to Optionee following the exercise of the Option in accordance with this Contract must be completed no later than August 25th, 2022.

 

3. Rent Owed. The Optionee pays to the Grantor during the month of August rent obligation as tenant of the Property through the date of exercise of the Option, including but not limited to the $10,249.00 specified in Exhibit B that is outstanding as of the date of this Contract.

 

4. Rent Due. The Optionee pays rent expenses due to the Grantor no later than the 3rd day of each month in accordance with its lease obligation for the duration of this agreement until the date in which property is sold.

 

REAL PROPERTY OPTION TO PURCHASE CONTRACT – Page 1

 

 

 

 

5. Closing; Closing Costs; Closing Documents.

 

(a) Closing Costs. In the event of the exercise of this option by the Optionee, Optionee shall pay the recording fee for the general warranty deed. Optionee shall pay for preparation of the deed, the transfer tax on the deed and all title examination fees and title insurance premiums, if any, necessary to provide Optionee with an owner’s policy of title insurance (the “Title Policy”). Grantor and Optionee shall be responsible for the payment of their own respective attorneys’ fees and expenses.

 

(b) General Warranty Deed. On the closing date specified in the exercise of this Option that is not later August 25th, 2022 (the “Option Closing Date”), Grantor shall convey to Optionee an unencumbered, marketable fee simple title to the Property by recordable deed of general warranty, free and clear of all liens and encumbrances, except liens for real property taxes and assessments for the current year not yet due and payable and thereafter, and all exceptions to title contained in the Title Policy.

 

(c) Real Property Taxes. All real property ad valorem taxes and assessments against or on the Property, due and payable in the year of Closing, shall be prorated between Optionee and Grantor as of the Option Closing Date on a calendar year or fiscal year basis, whichever is appropriate.

 

(d) Utility Charges. Grantor shall pay all charges for utility services rendered before the Option Closing Date with respect to the Property, and Optionee shall pay all charges for utility services rendered on or after the Option Closing Date. All utility meters with respect to the Property, if any, shall be read by a representative of each utility company on the Option Closing Date.

 

6. Possession. Exclusive possession of the Property shall be delivered to Optionee on the Closing Date.

 

7. As Is Condition. Optionee acknowledges and agrees that, except as specifically set forth herein, Grantor is not making and has not at any time made any warranties or representations of any kind or character, express or implied, with respect to the Property, including, but not limited to, any warranties or representations as to the habitability, merchantability, fitness for a particular purpose, zoning, physical defects or condition, environmental condition, compliance with applicable laws, rules and regulations or any other matter whatsoever regarding the Property, except as provided herein. Subject to Grantor’s representations and warranties specifically set forth herein, Optionee acknowledges and agrees that upon Closing, Grantor shall sell and convey the Property to Optionee and Optionee shall accept the Property “AS IS AND WITH ALL FAULTS.” Optionee has not relied and will not rely on, and Grantor is not liable for or bound by, any expressed or implied warranties, guaranties, statements, representations, or information pertaining to the Property or relating thereto made or furnished by any agent representing or purporting to represent Grantor.

 

8. Risk of Loss. All risk of loss with respect to the Property shall remain with Grantor until the closing and delivery of the deed to Optionee on the Option Closing Date.

 

9. Default. If, following the full execution of this Contract, either party defaults in the performance of its duties or obligations under this Contract, then:

 

(a) if Optionee is the party in default and such default is not cured within seven (7) days, (i) this Contract shall become null and void; and (ii) Grantor may pursue any other remedy available at law or in equity; and

 

(b) if Grantor is the party in default and such default is not cured within seven (7) days after written notice, (i) Optionee may declare this Contract null and void; and (ii) Optionee may pursue any other remedy available at law or in equity.

 

REAL PROPERTY OPTION TO PURCHASE CONTRACT – Page 2

 

 

 

 

10. Notice.

 

(a) Delivery. Any notice or consent authorized or required by this Contract shall be in writing and (i) delivered personally; (ii) sent postage prepaid by certified mail or registered mail, return receipt requested; or (iii) sent by a nationally recognized overnight carrier that guarantees next day delivery, directed to the other party at the address first set forth above or such other parties or addresses as may be designated by either Optionee or Grantor by notice given from time to time in accordance with this Paragraph 11.

 

(b) Receipt. A notice or consent given in accordance with this Paragraph 11 shall be deemed received (i) upon delivering it in person; (ii) three days after depositing it in an office of the United States Postal Service or any successor governmental agency; or (iii) one day after giving it to a nationally recognized overnight carrier.

 

11. Benefit and Binding Effect. This Contract shall be binding upon, and shall inure to the benefit of, the parties hereto, their respective heirs, legal representatives, successors and assigns.

 

12. Time of the Essence. Time is of the essence for this Contract.

 

13. Governing Law. This Contract shall be governed by and construed in accordance with the laws of the Commonwealth of Kentucky.

 

14. Entire Agreement. This Contract contains the entire agreement between the parties hereto with respect to the matters to which it pertains, and may be amended only by written agreement signed by both Optionee and Grantor.

 

15. Headings. The paragraph headings used herein are for convenience purposes only and do not constitute matters to be construed in interpreting this Contract.

 

16. Assignment. Optionee may not assign this Contract to any party, without the consent of Grantor.

 

17. Further Assurances. The parties hereto shall take such further action and execute such documents and instruments as shall be reasonably necessary to consummate the transactions contemplated by this Contract.

 

Signature Page Follows

 

REAL PROPERTY OPTION TO PURCHASE CONTRACT – Page 3

 

 

 

 

IN WITNESS WHEREOF, the parties acting by and through their duly authorized representatives, duly executed this Contract as of the date first set forth above, but actually on the dates set forth below.

 

  GRANTOR:
   
  OZ CAPITAL, LLC,
  a Texas limited liability company
     
  By: /s/ Watt P. Stephens
  Name:  Watt P. Stephens
  Title: Partner
     
  Date: August 16th, 2022
     
  OPTIONEE:
   
  GENH HALCYON ACQUISITION, LLC,
  a Texas limited liability company
     
  By: /s/ Gary C. Evans
  Name: Gary C. Evans
  Title: Chairman and CEO
     
  Date: August 10, 2022

 

REAL PROPERTY OPTION TO PURCHASE CONTRACT – Signature Page

 

 

 

 

EXHIBIT A

 

BEING Lot 4, Hopkinsville Industrial Park, as shown by plat of record in Plat Cabinet 4, File 467, in the Office of the Clerk of Christian County, Kentucky.

 

THERE IS EXCEPTED FROM the foregoing Lot 4, so much thereof as was conveyed to the Commonwealth of Kentucky, for the use and benefit of the Transportation Cabinet, Department of Highways, by Deed dated December 12, 1994, and recorded in Deed Book 516 at Page 140, Christian County Clerk’s Office, as amended by a Deed of Correction dated July 14, 1995, and recorded in Deed Book 522, at Page 325, same office, which property is described as follows:

 

Beginning at a point 40.00 feet right of US41 Nashville Rd. Station 27+24.44; thence South 50o 12’ 02” East, 92.69 feet to a point 40.00 feet right of US41 Nashville Rd. station 28+17.13; thence South 41o 26’ 45” East, 164.26 feet to a point 65.00 feet right of US41 Nashville Rd station 29+79.48; thence South 39o 48’ 06” West, 14.32 feet to a point 79.32 feet right of US41 Nashville Rd. station 29+79.48; thence North 48o 17’ 29” West, 214.77 feet to a point 72.16 feet right of US41 Nashville Rd. station 27+64.83; North 11o 40’ 29” West, 51.63 feet to the point of beginning, containing .146 acres (6,345 sq. ft.), more or less.

 

Source of Title:

 

Being the same property acquired by MetoKote Corporation, an Ohio corporation, by General Warranty Deed of Conveyance dated June 30, 2000, of record in Deed Book 569, Page 318, in the Office of the Clerk of Christian County, Kentucky.

 

TOGETHER with the right to use, for ingress and egress, the 50 foot, non-exclusive access easement as set out in Easement dated February 7, 1995, of record in Misc. Book 40, Page 721, state out in Deed Book 568, Page 313, and as shown as proposed 50 foot right of way on Plat recorded in Plat Cabinet 5, Page 273, all in the office aforesaid.

 

REAL PROPERTY OPTION TO PURCHASE CONTRACT

 

 

 

 

EXHIBIT B

 

August 2022 Inv. 082047 $10,249.00

 

 

 

 

 

REAL PROPERTY OPTION TO PURCHASE CONTRACT

 

 

 

EX-31.1 11 f10q0622ex31-1_generation.htm CERTIFICATION

Exhibit 31.1

 

CERTIFICATION PURSUANT TO SECTION 302

OF THE SARBANES-OXLEY ACT OF 2002 

 

I, Gary C. Evans, certify that:

 

1)I have reviewed this Quarterly Report of Generation Hemp, Inc. on Form 10-Q;

 

2)Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3)Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the Registrant as of, and for, the periods presented in this report;

 

4)I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f))  for the Registrant and have;

 

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure the material information relating to the Registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

(c)Evaluated the effectiveness of the Registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation.

 

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5)I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the Registrant’s auditors and the audit committee of the Registrant’s board of directors (or persons performing the equivalent functions):

 

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the Registrant’s ability to record, process summarize and report financial information; and

 

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the Registrant’s internal controls over financial reporting.

 

DATE: August 19, 2022 By: /s/ Gary C. Evans
    Gary C. Evans
    Chairman
    Chief Executive Officer
    (Principal Executive Officer and
   

Principal Accounting and Financial Officer)

 

EX-32.1 12 f10q0622ex32-1_generation.htm CERTIFICATION

Exhibit 32.1

 

CERTIFICATION PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT 0F 2002

  

In connection with the Quarterly Report of Generation Hemp, Inc. (the Company”) on Form 10-Q for the period ended herein as filed with the Securities and Exchange Commission (the “Report”), I. Gary C. Evans, Chairman and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. ss.1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

 

  (1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

 

  (2) The information contained in the Report fully presents, in all material respects, the financial condition and results of operations or the Company.

 

DATE: August 19, 2022 By: /s/ Gary C. Evans
    Gary C. Evans
    Chairman
    Chief Executive Officer
    (Principal Executive Officer and
   

Principal Accounting and Financial Officer)

 

 

EX-101.SCH 13 genh-20220630.xsd XBRL SCHEMA FILE 001 - Statement - Unaudited Condensed Consolidated Balance Sheets link:presentationLink link:definitionLink link:calculationLink 002 - Statement - Unaudited Condensed Consolidated Balance Sheets (Parentheticals) link:presentationLink link:definitionLink link:calculationLink 003 - Statement - Unaudited Condensed Consolidated Statements of Operations link:presentationLink link:definitionLink link:calculationLink 004 - Statement - Unaudited Condensed Consolidated Statements of Equity (Deficit) link:presentationLink link:definitionLink link:calculationLink 005 - Statement - Unaudited Condensed Consolidated Statements of Cash Flows link:presentationLink link:definitionLink link:calculationLink 006 - Disclosure - Business link:presentationLink link:definitionLink link:calculationLink 007 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 008 - Disclosure - Property and Equipment link:presentationLink link:definitionLink link:calculationLink 009 - Disclosure - Intangible and Other Assets link:presentationLink link:definitionLink link:calculationLink 010 - Disclosure - Notes Payable – Related Parties link:presentationLink link:definitionLink link:calculationLink 011 - Disclosure - Other Indebtedness link:presentationLink link:definitionLink link:calculationLink 012 - Disclosure - Commitments and Contingencies link:presentationLink link:definitionLink link:calculationLink 013 - Disclosure - Income Taxes link:presentationLink link:definitionLink link:calculationLink 014 - Disclosure - Equity link:presentationLink link:definitionLink link:calculationLink 015 - Disclosure - Stock-Based Compensation link:presentationLink link:definitionLink link:calculationLink 016 - Disclosure - Discontinued Operations link:presentationLink link:definitionLink link:calculationLink 017 - Disclosure - Supplemental Cash Flow Information link:presentationLink link:definitionLink link:calculationLink 018 - Disclosure - Earnings (Loss) Per Share link:presentationLink link:definitionLink link:calculationLink 019 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 020 - Disclosure - Accounting Policies, by Policy (Policies) link:presentationLink link:definitionLink link:calculationLink 021 - Disclosure - Property and Equipment (Tables) link:presentationLink link:definitionLink link:calculationLink 022 - Disclosure - Intangible and Other Assets (Tables) link:presentationLink link:definitionLink link:calculationLink 023 - Disclosure - Notes Payable – Related Parties (Tables) link:presentationLink link:definitionLink link:calculationLink 024 - Disclosure - Equity (Tables) link:presentationLink link:definitionLink link:calculationLink 025 - Disclosure - Stock-Based Compensation (Tables) link:presentationLink link:definitionLink link:calculationLink 026 - Disclosure - Discontinued Operations (Tables) link:presentationLink link:definitionLink link:calculationLink 027 - Disclosure - Supplemental Cash Flow Information (Tables) link:presentationLink link:definitionLink link:calculationLink 028 - Disclosure - Earnings (Loss) Per Share (Tables) link:presentationLink link:definitionLink link:calculationLink 029 - Disclosure - Business (Details) link:presentationLink link:definitionLink link:calculationLink 030 - Disclosure - Summary of Significant Accounting Policies (Details) link:presentationLink link:definitionLink link:calculationLink 031 - Disclosure - Property and Equipment (Details) - Schedule of property and equipment link:presentationLink link:definitionLink link:calculationLink 032 - Disclosure - Intangible and Other Assets (Details) link:presentationLink link:definitionLink link:calculationLink 033 - Disclosure - Intangible and Other Assets (Details) - Schedule of intangible asset link:presentationLink link:definitionLink link:calculationLink 034 - Disclosure - Notes Payable – Related Parties (Details) link:presentationLink link:definitionLink link:calculationLink 035 - Disclosure - Notes Payable – Related Parties (Details) - Schedule of notes payable – related parties link:presentationLink link:definitionLink link:calculationLink 036 - Disclosure - Other Indebtedness (Details) link:presentationLink link:definitionLink link:calculationLink 037 - Disclosure - Commitments and Contingencies (Details) link:presentationLink link:definitionLink link:calculationLink 038 - Disclosure - Equity (Details) link:presentationLink link:definitionLink link:calculationLink 039 - Disclosure - Equity (Details) - Schedule of warrants outstanding link:presentationLink link:definitionLink link:calculationLink 040 - Disclosure - Equity (Details) - Schedule of outstanding stock warrants activity link:presentationLink link:definitionLink link:calculationLink 041 - Disclosure - Stock-Based Compensation (Details) link:presentationLink link:definitionLink link:calculationLink 042 - Disclosure - Stock-Based Compensation (Details) - Schedule of summarizes options outstanding link:presentationLink link:definitionLink link:calculationLink 043 - Disclosure - Discontinued Operations (Details) - Schedule of discontinued operations to assets and liabilities held for sale link:presentationLink link:definitionLink link:calculationLink 044 - Disclosure - Discontinued Operations (Details) - Schedule of discontinued operations shown in the consolidated statements of operations link:presentationLink link:definitionLink link:calculationLink 045 - Disclosure - Supplemental Cash Flow Information (Details) - Schedule of supplemental cash flow information link:presentationLink link:definitionLink link:calculationLink 046 - Disclosure - Earnings (Loss) Per Share (Details) - Schedule of earnings (loss) per basic and diluted share link:presentationLink link:definitionLink link:calculationLink 047 - Disclosure - Subsequent Events (Details) link:presentationLink link:definitionLink link:calculationLink 000 - Document - Document And Entity Information link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 14 genh-20220630_cal.xml XBRL CALCULATION FILE EX-101.DEF 15 genh-20220630_def.xml XBRL DEFINITION FILE EX-101.LAB 16 genh-20220630_lab.xml XBRL LABEL FILE EX-101.PRE 17 genh-20220630_pre.xml XBRL PRESENTATION FILE XML 18 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Document And Entity Information - shares
6 Months Ended
Jun. 30, 2022
Aug. 19, 2022
Document Information Line Items    
Entity Registrant Name GENERATION HEMP, INC.  
Document Type 10-Q  
Current Fiscal Year End Date --12-31  
Entity Common Stock, Shares Outstanding   113,154,002
Amendment Flag false  
Entity Central Index Key 0001527102  
Entity Current Reporting Status Yes  
Entity Filer Category Non-accelerated Filer  
Document Period End Date Jun. 30, 2022  
Document Fiscal Year Focus 2022  
Document Fiscal Period Focus Q2  
Entity Small Business true  
Entity Emerging Growth Company false  
Entity Shell Company false  
Document Quarterly Report true  
Document Transition Report false  
Entity File Number 000-55019  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 26-3119496  
Entity Address, Address Line One 8533 Midway Road  
Entity Address, City or Town Dallas  
Entity Address, State or Province TX  
Entity Address, Postal Zip Code 75209  
City Area Code (469)  
Local Phone Number 209-6154  
Entity Interactive Data Current Yes  
XML 19 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Unaudited Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Current Assets:    
Cash $ 4,289 $ 20,656
Accounts receivable 91,185
Inventories 212,518 212,518
Prepaid expenses 55,791 4,723
Total current assets 363,783 237,897
Property and equipment, net 2,391,678 2,580,662
Operating lease right-of-use asset 213,706 263,065
Intangible assets, net 1,564,652 1,857,908
Goodwill 799,888 799,888
Other assets 407,000 407,000
Total Assets 5,740,707 6,146,420
Current Liabilities:    
Accounts payable 1,169,006 883,485
Accrued liabilities 421,234 410,990
Payables to related parties 382,197 204,007
Operating lease liability - related party 106,406 101,238
Notes payable – related parties 3,241,120 2,183,551
Other indebtedness - current 473,192 501,668
Current liabilities of discontinued operations held for sale 160,057 153,482
Total current liabilities 5,953,212 4,438,421
Operating lease liability - related party, net of current portion 107,300 161,827
Long-term liabilities of discontinued operations held for sale 193,816 162,948
Total liabilities 6,254,328 4,763,196
Commitments and contingencies
Series B redeemable preferred stock, no par value, $10,000 stated value, 300 shares authorized, 118 and 135 shares issued and outstanding at June 30, 2022 and December 31, 2021 591,558 591,558
Equity (Deficit):    
Preferred stock, $0.00001 par value; 200,000,000 shares authorized, none outstanding
Common stock, $0.00001 par value; 200,000,000 shares authorized, 113,154,002 and 113,094,002 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively 1,132 1,131
Additional paid-in capital 31,887,994 29,150,258
Accumulated deficit (32,748,818) (28,118,245)
Generation Hemp equity (859,692) 1,033,144
Noncontrolling interest (245,487) (241,478)
Total equity (deficit) (1,105,179) 791,666
Total Liabilities and Equity (Deficit) $ 5,740,707 $ 6,146,420
XML 20 R3.htm IDEA: XBRL DOCUMENT v3.22.2.2
Unaudited Condensed Consolidated Balance Sheets (Parentheticals) - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Preferred stock, par value (in Dollars per share) $ 0.00001 $ 0.00001
Preferred stock, shares authorized 200,000,000 200,000,000
Preferred stock, shares outstanding
Common stock, par value (in Dollars per share) $ 0.00001 $ 0.00001
Common stock, shares authorized 200,000,000 200,000,000
Common stock, shares issued 113,154,002 113,094,002
Common stock, shares outstanding 113,154,002 113,094,002
Series B Redeemable Preferred Stock    
Preferred stock, par value (in Dollars per share)
Preferred stock, Stated Value (in Dollars) $ 10,000 $ 10,000
Preferred stock, shares authorized 300 300
Preferred stock, shares issued 118 135
Preferred stock, shares outstanding 118 135
XML 21 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Unaudited Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Revenue:        
Post-harvest and midstream services $ 331,900 $ 3,355 $ 331,933 $ 47,965
Rental 22,500 22,500 45,000 45,000
Total revenue 354,400 25,855 376,933 92,965
Costs and Expenses:        
Cost of revenue (exclusive of items shown separately below) 164,479 112,195 268,844 270,260
Depreciation and amortization 261,491 341,447 482,240 691,075
Merger and acquisition costs 16,115
General and administrative 1,914,644 514,299 3,892,528 1,635,231
Total costs and expenses 2,340,614 967,941 4,643,612 2,612,681
Operating loss (1,986,214) (942,086) (4,266,679) (2,519,716)
Other expense (income):        
Interest and other income (25,424) (25,424)
Change in fair value of marketable security (11,770)
Interest expense 123,763 232,462 287,273 496,302
Total other expense 123,763 207,038 287,273 459,108
Loss from continuing operations (2,109,977) (1,149,124) (4,553,952) (2,978,824)
Loss from discontinued operations (27,567) (6,205) (40,263) (9,719)
Net loss (2,137,544) (1,155,329) (4,594,215) (2,988,543)
Less: net income (loss) attributable to noncontrolling interests (2,422) (2,815) (4,009) 853
Net loss attributable to Generation Hemp $ (2,135,122) $ (1,152,514) $ (4,590,206) $ (2,989,396)
Loss from continuing operations        
Basic (in Dollars per share) $ (0.02) $ (0.03) $ (0.04) $ (0.11)
Diluted (in Dollars per share) (0.02) (0.03) (0.04) (0.11)
Loss from discontinued operations        
Basic (in Dollars per share)
Diluted (in Dollars per share)
Earnings (loss) per share        
Basic (in Dollars per share) (0.02) (0.03) (0.04) (0.11)
Diluted (in Dollars per share) $ (0.02) $ (0.03) $ (0.04) $ (0.11)
XML 22 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Unaudited Condensed Consolidated Statements of Equity (Deficit) - USD ($)
Total
Series B Redeemable Preferred Stock
Series A Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Noncontrolling Interest
Balance at Dec. 31, 2020 $ (2,964,935) $ 729,058 $ 4,975,503 $ 6,083,480 $ 4,436,018 $ (18,220,705) $ (239,231)
Balance (in Shares) at Dec. 31, 2020   135 6,328,948 17,380,317      
Acquisition of Certain Assets of Halcyon Thruput, LLC 2,500,000 $ 2,500,000
Acquisition of Certain Assets of Halcyon Thruput, LLC (in Shares)   6,250,000      
Issuances of common stock units 400,000 $ 136,707 263,293
Issuances of common stock units (in Shares)   800,000      
Warrant exercises 2,967,000 $ 4,771,669 (1,804,669)
Warrant exercises (in Shares)   8,428,976      
Issuance of common shares for Convertible Promissory Note 217,769 $ 217,769
Issuance of common shares for Convertible Promissory Note (in Shares)   618,660      
Issuance of common shares for Senior Secured Promissory Note 1,942,500 $ 1,942,500
Issuance of common shares for Senior Secured Promissory Note (in Shares)   1,000,000      
Series B preferred stock dividend (20,250) (20,250)
Stock-based compensation 42,250 $ 42,250
Stock-based compensation (in Shares)   500,000      
Net loss (1,833,214) (1,836,882) 3,668
Balance at Mar. 31, 2021 3,251,120 $ 729,058 $ 4,975,503 $ 15,694,375 2,894,642 (20,077,837) (235,563)
Balance (in Shares) at Mar. 31, 2021   135 6,328,948 34,977,953      
Balance at Dec. 31, 2020 (2,964,935) $ 729,058 $ 4,975,503 $ 6,083,480 4,436,018 (18,220,705) (239,231)
Balance (in Shares) at Dec. 31, 2020   135 6,328,948 17,380,317      
Net loss (2,988,543)            
Balance at Jun. 30, 2021 2,095,791 $ 729,058 $ 4,975,503 $ 15,694,375 2,894,642 (21,230,351) (238,378)
Balance (in Shares) at Jun. 30, 2021   135 6,328,948 34,977,953      
Balance at Mar. 31, 2021 3,251,120 $ 729,058 $ 4,975,503 $ 15,694,375 2,894,642 (20,077,837) (235,563)
Balance (in Shares) at Mar. 31, 2021   135 6,328,948 34,977,953      
Series B preferred stock dividend
Stock-based compensation
Net loss (1,155,329) (1,152,514) (2,815)
Balance at Jun. 30, 2021 2,095,791 $ 729,058 $ 4,975,503 $ 15,694,375 2,894,642 (21,230,351) (238,378)
Balance (in Shares) at Jun. 30, 2021   135 6,328,948 34,977,953      
Balance at Dec. 31, 2021 791,666 $ 591,558 $ 1,131 29,150,258 (28,118,245) (241,478)
Balance (in Shares) at Dec. 31, 2021   118 113,094,002      
Issuance of common shares for extension of secured note 11,480 11,480
Issuance of common shares for extension of secured note (in Shares)   20,000      
Modification of warrants for extension of promissory note to investor 68,756       68,756    
Series B preferred stock dividend (20,992) (20,992)
Stock-based compensation 1,315,750 1,315,750
Net loss (2,456,671) (2,455,084) (1,587)
Balance at Mar. 31, 2022 (290,011) $ 591,558 $ 1,131 30,546,244 (30,594,321) (243,065)
Balance (in Shares) at Mar. 31, 2022   118 113,114,002      
Balance at Dec. 31, 2021 791,666 $ 591,558 $ 1,131 29,150,258 (28,118,245) (241,478)
Balance (in Shares) at Dec. 31, 2021   118 113,094,002      
Net loss (4,594,215)            
Balance at Jun. 30, 2022 (1,105,179) $ 591,558 $ 1,132 31,887,994 (32,748,818) (245,487)
Balance (in Shares) at Jun. 30, 2022   118 113,154,002      
Balance at Mar. 31, 2022 (290,011) $ 591,558 $ 1,131 30,546,244 (30,594,321) (243,065)
Balance (in Shares) at Mar. 31, 2022   118 113,114,002      
Issuance of common shares for extension of secured note 26,001 $ 1 26,000
Issuance of common shares for extension of secured note (in Shares)   40,000      
Series B preferred stock dividend (19,375) (19,375)
Stock-based compensation 1,315,750 1,315,750
Net loss (2,137,544) (2,135,122) (2,422)
Balance at Jun. 30, 2022 $ (1,105,179) $ 591,558 $ 1,132 $ 31,887,994 $ (32,748,818) $ (245,487)
Balance (in Shares) at Jun. 30, 2022   118 113,154,002      
XML 23 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Unaudited Condensed Consolidated Statements of Cash Flows - USD ($)
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Cash Flows From Operating Activities    
Net loss $ (4,594,215) $ (2,988,543)
Loss from discontinued operations (40,263) (9,719)
Net loss from continuing operations (4,553,952) (2,978,824)
Adjustments to reconcile net loss from continuing operations to net cash from operating activities:    
Depreciation and amortization 482,240 691,075
Amortization of debt discount 37,481 328,320
Stock-based compensation 2,631,500 81,000
Modification of warrants for extension of promissory note to investor 68,756
Other income - PPP Loan forgiveness (25,424)
Change in fair value of marketable securities (11,770)
Changes in operating assets and liabilities:    
Accounts receivable (91,185) 70,530
Prepaid expenses (51,068) (10,298)
Accounts payable and accrued liabilities 433,588 (244,741)
Net cash from operating activities – continuing operations (1,042,640) (2,100,132)
Net cash from operating activities – discontinued operations (2,820)
Net cash from operating activities (1,045,460) (2,100,132)
Cash Flows From Investing Activities    
Capital expenditures (40,220)
Acquisition of certain assets of Halcyon Thruput, LLC, net of acquired cash of $224,530 (1,525,470)
Proceeds from sale of investment in common stock 34,847
Net cash from investing activities – continuing operations (1,530,843)
Net cash from investing activities – discontinued operations
Net cash from investing activities (1,530,843)
Cash Flows From Financing Activities    
Issuance of common stock units 350,000
Redemptions of Series B preferred stock   (137,500)
Series B preferred stock dividends paid   (16,500)
Proceeds from warrant exercises 2,967,000
Repayment of Halcyon bank note (995,614)
Proceeds from notes payable - related parties 1,107,569
Repayment of subordinated notes (50,000) (1,100,000)
Payment of mortgage payable (28,476) (1,938)
Net cash from financing activities – continuing operations 1,029,093 1,065,448
Net cash from financing activities – discontinued operations
Net cash from financing activities 1,029,093 1,065,448
Net change in cash (16,367) (2,565,527)
Cash, beginning of period 20,656 2,776,425
Cash, end of period $ 4,289 $ 210,898
XML 24 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
Business
6 Months Ended
Jun. 30, 2022
Business [Abstract]  
Business

1. Business

 

Generation Hemp, Inc. (the “Company”) was incorporated on August 21, 2021 in the State of Delaware. The Company was originally incorporated as Home Treasure Finders, Inc. (“HTF”) on July 28, 2008 in the State of Colorado. On November 27, 2019, HTF purchased approximately 94% of the common stock of Energy Hunter Resources, Inc. (“EHR”) in a series of transactions accounted for as a reverse merger. Upon closing, HTF changed its name to Generation Hemp, Inc.

 

On January 11, 2021, we completed the acquisition of certain assets of Halcyon Thruput, LLC (“Halcyon”). With this acquisition, we commenced providing post-harvest and midstream services to growers by drying, processing, cleaning and stripping harvested hemp directly from the field and wetbaled at our 48,000 square foot leased facility located in Hopkinsville, Kentucky. Additionally, the Company offers safe storage services for processed hemp, which enables farmers to maximize strategic market timing. In August 2021, the Company launched its small animal bedding consumer goods product line (“Rowdy Rooster”) made from the hemp hurd byproduct that is produced from its hemp processing operations.

 

We also generate revenue from rental of our “Cannabis Zoned” (Hemp) warehouse property located in Denver, Colorado currently leased to an unaffiliated hemp seed company.

 

As of June 30, 2022, EHR held an approximate 8% working interest in an oil & gas property located in Cochran County, Texas within the Slaughter-Levelland Field of the San Andres formation in the Northwest Shelf of West Texas. EHR’s oil & gas activities are currently held for sale and are presented in these consolidated financial statements as discontinued operations for each of the periods presented.

 

Our management team has been and continues to actively review acquisition candidates involved in the hemp industry that operate within a number of vertical businesses, predominantly within the midstream sector that are attractive to us and are within the hemp supply chain.

 

New Business Line – During the second quarter of 2022, management and the Board decided to enter a new but related line of business – bitcoin mining. Management determined after research that hemp biomass can be burned in a biomass boiler to generate heat and steam to drive a turbine for generating electricity. The BTU value of hemp is similar to wood waste generated at saw mills. Hemp plants grow to maturity within six to eight months whereas trees mature in excess of ten years.

 

The Company subsequently formed a new company, GenCrypto, LLC (a Delaware limited liability company) with a 50% partner, Cerberus Digital, LLC, an affiliate of Cryptech Solutions, Inc. Cryptech is one of the largest resellers of bitcoin mining equipment in North America.

 

GenCrypto now has approximately ten different bitcoin locations identified and either under contract, under letter of intent, or in final negotiating status, located in three states and in Costa Rica. All of these site locations are deemed “green” based upon the power being provided either from the local utility or co-op. They range in power size from 1.1 megawatts to 50 megawatts. GenCrypto has been contacted by several larger bitcoin mining operators concerning utilizing some of these mining locations under “hosting” arrangements.

 

The Company anticipates closing its first acquisition which is currently operational in September 2022.

 

Liquidity and Going Concern – The Company is dependent upon obtaining additional funding to continue ongoing operations and to pursue its strategy and execute its acquisition plans.

 

In the six months ended June 30, 2022, the Company used $1.0 million of cash for its operating activities. At June 30, 2022, the Company’s current liabilities, including financing obligations due within one year, totaled $6.0 million as compared with its current assets of $364 thousand.

 

The Company will continue to pursue additional capital raising opportunities in order to fund future acquisitions and meet its obligations as they become due. We may not be successful in obtaining additional financing needed. In the event financing cannot be obtained, the Company may not be able to satisfy these plans and obligations. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

 

Impact of COVID-19 Pandemic on Our Business – Our business, results of operations and financial condition were adversely affected by the COVID-19 pandemic. The COVID-19 pandemic and measures taken to contain it subjected our business, results of operations, financial condition, stock price and liquidity to a number of material risks and uncertainties, all of which may continue or may worsen.

XML 25 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
Summary of Significant Accounting Policies
6 Months Ended
Jun. 30, 2022
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

 

Basis of Presentation – These interim financial statements are unaudited and have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain disclosures have been condensed or omitted from these financial statements. Accordingly, they do not include all the information and notes required by accounting principles generally accepted in the United States of America (“GAAP”) for complete consolidated financial statements, and should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2021.

 

In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring adjustments, necessary to fairly present the financial position as of, and the results of operations for, all periods presented. In preparing the accompanying financial statements, management has made certain estimates and assumptions that affect reported amounts in the condensed consolidated financial statements and disclosures of contingencies. Actual results may differ from those estimates. The results for interim periods are not necessarily indicative of annual results. Certain reclassifications have been made to the prior period’s consolidated financial statements and related footnotes to conform them to the current period presentation. Intercompany balances and transactions between consolidated entities are eliminated.

 

Fair Value Measurement – Our financial assets and liabilities consist of cash, accounts receivable, accounts payable and indebtedness. The fair values of these instruments approximate their carrying amounts at each reporting date.

 

Major Customer and Concentration of Credit Risk – We estimate an allowance for doubtful accounts based on an analysis of specific customers, taking into consideration the age of past due accounts and an assessment of the customer’s ability to pay. An allowance for doubtful accounts was not needed as of June 30, 2022 or December 31, 2021.

 

During the three and six months ended June 30, 2022, one customer accounted for 99% of our post-harvest and midstream services revenue. A total of $91,185 was outstanding from this customer at June 30, 2022.

 

Our rental revenue is derived from a single lessee on a commercial warehouse owned by the Company. There were no amounts due from this customer at June 30, 2022 or December 31, 2021.

 

Recent Accounting Pronouncements – There are no other new accounting pronouncements that are expected to have a material impact on the consolidated financial statements.

XML 26 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
Property and Equipment
6 Months Ended
Jun. 30, 2022
Property and Equipment [Abstract]  
Property and Equipment

3. Property and Equipment

 

Property and equipment consisted of the following:

 

   Useful   June 30,   December 31, 
   Life (yrs)   2022   2021 
             
Land       $96,000   $96,000 
Warehouse   30    916,500    916,500 
Leasehold Improvements   3    473,601    473,601 
Machinery and equipment   5-7     1,506,447    1,506,447 
Vehicles   4    149,440    149,440 
Computer equipment and software   3    46,825    46,825 
Office furniture and equipment   3-5     17,294    17,294 
                
Subtotal        3,206,107    3,206,107 
Less accumulated depreciation and amortization        (814,429)   (625,445)
                
Total property and equipment, net       $2,391,678   $2,580,662 
XML 27 R10.htm IDEA: XBRL DOCUMENT v3.22.2.2
Intangible and Other Assets
6 Months Ended
Jun. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Intangible and Other Assets

4. Intangible and Other Assets

 

The following table summarizes information related to definite-lived intangible assets:

 

   June 30, 2022   December 31, 2021 
   Gross Carrying Amount   Accumulated Amortization   Net   Gross Carrying Amount   Accumulated Amortization   Net 
                         
Customer relationships  $2,612,649   $(1,079,585)  $1,533,064   $2,612,649   $(796,858)  $1,815,791 
Non-competition agreements   63,176    (31,588)   31,588    63,176    (21,059)   42,117 
                               
Total  $2,675,825   $(1,111,173)  $1,564,652   $2,675,825   $(817,917)  $1,857,908 

 

Other assets included $407,000 at June 30, 2022 and December 31, 2021 for the Company’s option to purchase the 48,000 square foot facility located in Hopkinsville, Kentucky presently leased from Halcyon. Under this option agreement, the Company may purchase the facility on or before August 25, 2022, as amended, for a purchase price of $993,000.

XML 28 R11.htm IDEA: XBRL DOCUMENT v3.22.2.2
Notes Payable – Related Parties
6 Months Ended
Jun. 30, 2022
Notes Payable – Related Parties [Abstract]  
Notes Payable – Related Parties

5. Notes Payable – Related Parties

 

Notes payable – related parties consisted of the following:

 

   June 30,   December 31, 
   2022   2021 
         
Subordinated Promissory Note to CEO  $523,551   $523,551 
Convertible Promissory Note to CEO   1,037,069    410,000 
Secured Promissory Note to Coventry Asset Management, LTD.   1,000,000    1,000,000 
Subordinated Promissory Note to Investor   200,000    250,000 
Promissory Note to Investment Hunter, LLC   480,500    
-
 
           
Total notes payable – related parties  $3,241,120   $2,183,551 

 

Subordinated Promissory Note to CEO – Our CEO made advances to the Company during 2020 under a subordinated promissory note initially due September 30, 2021. This note was amended to a new maturity date of September 30, 2022. If the Company raises new equity capital of $3 million or more, then the full amount outstanding under the note is due within five days. The note bears interest at 10% per annum. Accrued interest on this subordinated promissory note totaled $33,565 at June 30, 2022.

 

Convertible Promissory Note to CEO – In 2021, our CEO made advances totaling $410,000 to the Company under a convertible promissory note. Additional advances made in 2022 through June 30 totaled $627,069. The convertible note initially matured on January 1, 2022 but was subsequently amended to extend the maturity date to September 30, 2022. If the Company raises new equity capital of $3 million or more, then the full amount outstanding under the note is due within five days. The note bears interest at 10%. The principal and interest due on the convertible note may be converted, at the option of the holder, into restricted shares of the Company’s common stock at an initial conversion price of $0.50 per share but that was lowered in July 2022 to $0.30 per share. Accrued interest on this convertible promissory note totaled $52,291 at June 30, 2022.

 

Secured Promissory Note and Warrants to Coventry Asset Management, LTD. – On December 30, 2020, the Company received proceeds from issuance of a secured promissory note in principal amount of $1,000,000 to Coventry Asset Management, LTD, a Company stockholder. The promissory note is secured by the property acquired in the acquisition of certain assets of Halcyon. The unpaid balance of the secured promissory note bears interest at a rate of 10% per annum and initially matured on June 30, 2021. The promissory note has been extended six times including the issuance of 20,000 restricted common shares as extension fees each for the first five extensions and the issuance of 50,000 restricted common shares for the sixth extension. The maturity date of the promissory note is December 31, 2022, as amended. If before December 31, 2022, the Company raises new equity capital of $5 million or more, then the full amount outstanding under the promissory note is due within five days. As amended, a payment of 25% of the principal balance of the note is due by October 31, 2022. If the promissory note is not paid in full by December 31, 2022, the interest rate increases to 14% per annum. Accrued interest on this secured note totaled $149,864 at June 30, 2022.

 

Subordinated Promissory Note and Warrants to Investor – On December 30, 2020, the Company issued a subordinated promissory note in principal amount of $500,000 to an accredited investor who is also a Company stockholder. The unpaid balance of the Subordinated Note bears interest at a rate of 10% per annum. The Company made a principal payment of $250,000 in April 2021. The subordinated note principal together with accrued and unpaid interest was due, as previously amended, on March 31, 2022 but was subsequently extended. As subsequently amended, a payment of $50,000 was made in April 2022 and the remaining principal of $200,000 together with accrued interest was due on June 30, 2022. The Company did not make the principal payment due on June 30, 2022 and, as a result, this note is presently in default. Accrued interest on this subordinated promissory note totaled $29,932 at June 30, 2022.

 

The holder of the subordinated note received a warrant to purchase 500,000 shares of common stock exercisable for cash at an exercise price of $0.352 per share. As consideration for the April 2022 extension, the term of this warrant was extended by one year to December 30, 2023. The Company recognized $68,756 of interest expense in 2022 for this extension of the warrant term.

 

Promissory Note to Investment Hunter, LLC – In 2022, Investment Hunter, LLC, a Texas LLC controlled by our CEO, made advances totaling $492,000 to the Company under a promissory note due September 30, 2022, as amended. If the Company raises new equity capital of $3 million or more, then the full amount outstanding under the note is due within five days. The note bears interest at 10% per annum. Accrued interest on this subordinated promissory note totaled $17,864 at June 30, 2022.

XML 29 R12.htm IDEA: XBRL DOCUMENT v3.22.2.2
Other Indebtedness
6 Months Ended
Jun. 30, 2022
Other Indebtedness [Abstract]  
Other Indebtedness

6. Other Indebtedness

 

The Company is obligated under a mortgage payable dated September 15, 2014 secured by its warehouse property located in Denver, Colorado. The note provided for a 25-year amortization period and an initial interest rate of 9% annually. The note has been amended several times to a maturity date of September 30, 2022. In the latest extension, the Company made a principal payment of $25,000 plus accrued interest on July 18, 2022 and agreed to another principal payment of $25,000 plus accrued interest on August 31, 2022. The interest rate on the mortgage payable is 12%. If before the final maturity of the mortgage payable, the Company raises new equity capital of $5 million or more, then the full amount outstanding is due within ten days. The principal balance of this mortgage note payable as of June 30, 2022 was $473,192.

 

The Company leases the Denver warehouse property to a tenant under an operating lease which was renewed with a new tenant and extended to August 1, 2023 for a monthly rent of $7,500. The lease requires a true-up with the tenant for property taxes and insurance paid by the Company and requires the tenant to maintain the interior and exterior of the warehouse (except for the roof). The lease provides for a rent abatement in the first and last month of the contracted extension. Minimum future rents for the remainder of 2022 are $45,000 and for 2023 are $52,500.

XML 30 R13.htm IDEA: XBRL DOCUMENT v3.22.2.2
Commitments and Contingencies
6 Months Ended
Jun. 30, 2022
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies

7. Commitments and Contingencies

 

Leases – The Company leases office space in Fort Worth, Texas for managerial offices. This lease requires monthly payments of $2,000 and is month-to-month. Lease expense for this facility totaled $4,000 and $12,000 for the three and six months ended June 30, 2022, respectively. In the three and six months ended June 30. 2021, lease expense for this facility was $6,000 and $10,000, respectively.

 

The Company leases its operating facility in Kentucky from Oz Capital, LLC, a related party, under a lease expiring May 31, 2024. The lease provides for monthly payments of $10,249. Oz Capital, LLC is responsible for all taxes and maintenance under the lease. Lease expense for this facility totaled $31,147 and $61,494 in the three months ended June 30, 2022, respectively. In the three and six months ended June 30. 2021, lease expense for this facility was $30,747 and $57,857, respectively. A right-of-use asset and lease liability is recorded for this lease. As the lease does not provide an implicit rate, the Company used its estimated incremental borrowing rate of 10% in determining the present value of the lease payments.

 

Litigation – From time to time, we are subject to various litigation and other claims in the normal course of business. Below is a discussion of specific matters. We cannot estimate the ultimate outcome of these matters.

 

Generation Hemp, Inc. v. Colorado Mills Equipment, LLC

 

The Defendant sold to the Company a faulty piece of equipment for $16,000 and will not refund the Company the purchase price after repeated attempts to return their equipment. An original lawsuit was filed by the Company against Colorado Mills in January 2022 in Dallas County, subsequently dismissed, and a second lawsuit has been filed El Paso County, Colorado and is currently pending.

 

Halcyon Thruput, LLC, Plaintiff v. United National Insurance Company, Defendant, United States District Court for the Northern District of Texas, Dallas Division, Case No. 3:21-CV-3136-K.

 

Halcyon Thruput, LLC (Halcyon) obtained an all-risks commercial insurance policy, including an Equipment Breakdown Endorsement (Policy) from United National Insurance Company (UNIC) to provide substantial coverages for Halcyon Thruput LLC’s (Halcyon) $1,203,735 hemp processing dryer (Dryer) at its facility in Hopkinsville, Kentucky. During the Policy period, the Dryer caught fire due to the Dryer being defectively designed.

 

While UNIC paid a number of Halcyon’s claims, Halcyon’s claim for the cost of the replacement Dryer of $1,498,848 was denied as described below.

  

Buyer, a wholly owned subsidiary of the Company, pursuant to an Asset Purchase Agreement as twice amended, then acquired all the assets of Halcyon, except for the right to the proceeds of UNIC’s insurance policy since the Policy prohibited assignment. Halcyon and Buyer agreed that Buyer’s principal, Gary C. Evans, had the right to control the litigation, engage counsel for Halcyon and make all decisions relating to any proceeds received in the litigation by settlement or otherwise.

 

Halcyon’s suit against UNIC, which was removed to federal court, seeks $796,865.53 (the cost of the replacement dryer of $1,498,848, less a credit for $583,508.47 previously paid by UNIC to Halcyon for the Dryer fire=$915,339.53) plus statutory interest on that sum from August 10, 2020 for violating the Texas Insurance Code’s requirement that claims be promptly paid, additional statutory penalties, and attorneys’ fees. Certain documents have been executed between the Company, Halcyon and legal counsel, which provide for a sharing of costs and expenses and awards, if any, against UNIC. Mediation of the case was held in April 2022 where no agreement was reached by the parties. Depositions of the Company’s expert witnesses were completed in July 2022.

 

JDONE, LLC v. Grand Traverse Holdings, LLC and John Gallegos, Denver District Court Case No. 2019CV33723

 

JDONE, LLC (“JDONE”) is a wholly owned subsidiary of the Company and landlord of a commercial warehouse building that was previously leased to Grand Traverse Holdings, LLC on December 31, 2018 for a term of 61 months, with a personal guaranty from Defendant, John Gallegos. On April 12, 2019, Grand Traverse presented JDONE with an alleged forged, signed copy of the draft early termination amendment that JDONE had previously rejected. JDONE has suffered damages due to Defendant’s alleged misconduct of approximately $823,504 plus interest and attorney’s fees exceeding $400,000. A court ordered mediation was held in May 2020 without success. All material defendant motions have been denied by the court. The case is set for jury trial in July 2022. We believe that Grand Traverse Holdings, LLC and John Gallegos are jointly liable for the asserted damages which exceed $1 million plus attorney’s fees and we continue to vigorously pursue our claims.

 

KBSIII Tower at Lake Carolyn, LLC and Prime US-Tower at Lake Carolyn, LLC (collectively – “KBSIII” v. Energy Hunter Resources, Inc.)

 

Plaintiff/Counterdefendant KBSIII was seeking lost rent on office space for periods after EHR vacated office premises located in Las Colinas, Texas. EHR filed a counter suit alleging specific damages due to uninhabitable premises of the office space due to the intolerable conduct of other tenants located on the same floor. On December 23, 2020, the trial court entered a summary judgment against EHR for $230,712. The judgment provides for post-judgment interest at a rate of 5% per annum until paid and further provides for additional amounts owed should EHR pursue unsuccessful appeals to higher courts. At June 30, 2022, the Company had accrued $252,583 for this judgment, which is exclusively an EHR obligation.

XML 31 R14.htm IDEA: XBRL DOCUMENT v3.22.2.2
Income Taxes
6 Months Ended
Jun. 30, 2022
Income Taxes [Abstract]  
Income Taxes

8. Income Taxes

 

Income tax provisions for interim quarterly periods are generally based on an estimated annual effective income tax rate calculated separately from the effect of significant, infrequent or unusual items related specifically to interim periods. An income tax benefit for the three or six months ended June 30, 2022 or 2021 was not recognized because tax losses incurred were fully offset by a valuation allowance against deferred tax assets. There were no uncertain tax positions as of June 30, 2022.

XML 32 R15.htm IDEA: XBRL DOCUMENT v3.22.2.2
Equity
6 Months Ended
Jun. 30, 2022
Equity [Abstract]  
Equity

9. Equity

 

Series A Preferred Stock Our Series A Preferred Stock was originally issued in connection with HTF’s acquisition of EHR in 2019. On September 8, 2021, holders of the Company’s Series A Preferred Stock elected to convert such shares into shares of the Company’s common stock. As a result, 6,328,948 shares of Series A Preferred Stock were converted into 75,947,376 shares of common stock, with each share of Series A Preferred Stock converting into 12 shares of restricted common stock pursuant to the applicable Certificate of Designations.

 

Series B Preferred Stock Units – On December 30, 2020, the Company sold to certain accredited investors, including Gary C. Evans, our Chief Executive Officer, an aggregate of 135 preferred stock units comprised of (i) one share of Series B Redeemable Convertible Preferred Stock, no par value, and (ii) one warrant exercisable for 50,000 shares of common stock of the Company until December 30, 2022 at an exercise price of $0.352 per share.

 

The sale of the preferred stock units for $10,000 each resulted in aggregate gross proceeds of approximately $1.35 million, before deducting estimated offering expenses payable by the Company. Substantially all of the proceeds raised in the offering were used to fund the acquisition of assets of Halcyon, expenses related thereto and for general corporate purposes.

 

Each share of Series B Preferred Stock is initially convertible into 25,000 shares of common stock, subject to adjustment. Holders of Series B Preferred Stock are entitled to receive dividends of 6.00% per annum based on the stated value equal to $10,000 per share. Except as otherwise required by law, the Series B Preferred Stock does not have voting rights. However, as long as any shares of Series B Preferred Stock are outstanding, the Company will not, without the affirmative vote of the holders of a majority of the then outstanding shares of the Series B Preferred Stock, (a) alter or change adversely the powers, preferences or rights given to the Series B Preferred Stock, (b) alter or amend the related certificate of designation, (c) amend its certificate of incorporation or other charter documents in any manner that adversely affects any rights of the holders of Series B Preferred Stock, (d) repay, repurchase or offer to repay, repurchase or otherwise acquire more than a de minimis number of shares of its common stock, (e) enter into any agreement with respect to any of the foregoing, or (f) pay cash dividends or distributions on any equity securities of the Company other than pursuant to the terms of the outstanding Series B Preferred Stock. The Series B Preferred Stock does not have a preference upon any liquidation, dissolution or winding-up of the Company.

 

Any or all of the Series B Preferred Stock may be converted, at their holder’s option, into 25,000 shares of common stock, as adjusted for any stock dividends, splits, combinations or similar events.

 

At any time after the occurrence of a “Qualifying Event,” the Company, upon 5-day written notice, shall have the right to cause each share of Series B Preferred Stock (and all accrued in-kind dividends with respect thereto) to be converted into common stock. For purposes of this automatic conversion of the Series B Preferred Stock, a “Qualifying Event” shall have occurred if (A) (1) the rolling five-trading day volume-weighted average trading price of shares of the common stock exceeds $1.00, and (2) there shall be an effective registration statement under the Securities Act of 1933, as amended covering all of the shares of common stock which would be issuable upon conversion of all of the outstanding shares of Series B Preferred Stock or (B) the Company closes a firm commitment underwriting of the common stock on a Form S-1 Registration Statement with aggregate gross proceeds of at least $5,000,000 at a price per share equal to or greater than $1.00. In each instance, a conversion may not be made unless the Company has filed an amendment to its Articles of Incorporation effecting an increase in its authorized common stock so that the Company has a sufficient number of authorized and unissued shares of common stock so as to permit the conversion of all outstanding shares.

 

The Series B Preferred Stock may be redeemed by the Company for its stated value, plus accrued and unpaid dividends, at any time. Initially, redemption payments of 12.5% each of the total amount of Series B Preferred Stock then outstanding plus accrued dividends were due from the Company to each Holder of Series B Preferred Stock at the end of each calendar quarter of 2021. The first required redemption payments totaling $137,500 were made in April 2021. In May, June and October of 2021, the three holders of the Series B Preferred Stock, including the Company’s chief executive officer, entered into transactions in which they accepted the mandatory redemption payment required pursuant to the Series B Preferred Stock certificate of designation in a number of Series B Units to effectively waive the redemption requirement. All other terms of the Series B Units remain unchanged and the holders’ ownership interest in the Series B Preferred Units remains the same as it was before such transactions.

 

Common Stock – At June 30, 2022, the Company had 113,154,002 common shares outstanding. Following is a discussion of common stock issuances during the periods presented:

 

Acquisition of Certain Assets of Halcyon – In January 2021, the Company issued 6,250,000 shares of common stock valued at $2.5 million ($0.40 per share; restricted from trading for a period of up to one year) in the acquisition.

 

2021 First Quarter Issuances of Common Stock Units – In the first quarter of 2021, the Company issued 800,000 common stock units for total proceeds of $400,000. Each common stock unit consists of one share of common stock and a warrant for the purchase of two shares of common stock for $0.50 each. Each warrant is exercisable any time before its expiration on the second anniversary of its issuance. The Company allocated the total proceeds based on the relative fair values of the common stock and warrants. The fair value of the warrants was determined using an options valuation model with key assumptions including a risk-free interest rate of 0.11% and historical volatility of 272%. A total of $263,293 was allocated to the warrants and reported in additional paid-in capital.

 

Warrant Exercises – In the first quarter of 2021, the Company received $2,967,000 for the exercise of 8,428,976 outstanding warrants. In the fourth quarter of 2021, the Company received $375,000 for the exercise of 1,065,340 outstanding warrants.

 

Issuances for Exchange or Conversion of Debt – The Company issued a total of 1,618,660 common shares for the exchange or conversion of outstanding debt in the first quarter of 2021.

 

Stock-based Compensation – The Company issued 500,000 restricted common shares valued at $155,000 as incentive compensation to two executives who joined the Company in the first quarter of 2021.

 

Issuance for Extension of Secured Note – The Company issued 60,000 common shares as consideration for extensions of the maturity of a senior note in 2022. Refer to Note 5.

 

Common Stock Warrants Outstanding – Following is a summary of warrants outstanding as of June 30, 2022:

 

   # of Warrants   Exercise Price
(each)
   Expiration Date  Method of Exercise
               
Issued in December 2020 with Series B preferred units (1)   5,500,000   $               0.352   December 30, 2022  Cash
Issued in December 2020 with subordinated note to investor   500,000   $0.352   December 30, 2022  Cash
Issued in Q1 2021 with common stock units (1)   1,600,000   $0.500   January-February, 2023  Cash
Issued in Q4 2021 with common stock units (1)   958,333   $0.600   October-December, 2023  Cash
Total warrants outstanding at June 30, 2022   8,558,333            

(1)May be redeemed for $0.0001 per warrant at the Company’s option with 30 days advanced notice should the weighted average market price of common stock exceed $1.00 for any five out of seven consecutive trading days with a minimum average daily trading volume for such seven-day period of at least 25,000 shares of common stock.

 

Following is a summary of outstanding stock warrants activity for the periods presented:

 

       Weighted 
       Average 
   # of Warrants   Exercise Price 
         
Warrants as of December 31, 2021   8,808,333   $0.407 
Cancelled   (250,000)  $0.400 
Warrants as of June 30, 2022   8,558,333   $0.407 
XML 33 R16.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Compensation
6 Months Ended
Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Stock-Based Compensation

10. Stock-Based Compensation

 

We award restricted stock or stock options as incentive compensation to employees. Generally, these awards include vesting periods of up to three years from the date of grant.

 

The 2021 Omnibus Incentive Plan (“2021 Plan”) was adopted by our Board on July 1, 2021. The 2021 Plan provides for the initial reservation of 15 million shares of common stock for issuance, and provides that the maximum number of shares that may be issued pursuant to the exercise of ISOs is 15 million. The number of shares of common stock available for issuance under the 2021 Plan constituted approximately 13.1% of the Company’s fully diluted common shares outstanding as of the date of Board approval, including shares issuable upon the conversion of preferred shares, as calculated on an as-converted basis. On the one-year anniversary date of the 2021 Plan, the number of shares of common stock reserved for issuance thereunder shall automatically increase to 20% of the fully diluted common shares outstanding, including shares issuable upon the conversion of preferred shares, as calculated on an as-converted basis.

 

In the first quarter of 2021, the Company issued 500,000 restricted shares valued at $155,000 as incentive compensation to two executives who joined the Company. Compensation expense related to these awards totaled $38,750 and $81,000 for the three and six months ended June 30, 2021, respectively. These awards became fully vested in January 2022.

 

In the fourth quarter of 2021, the Company awarded options for 13,850,000 shares of the Company’s common stock as incentive compensation. One-third of the awarded options vested immediately with the remaining options vesting in two equal annual tranches over the next two years. Vested options may be exercised at any time until their expiration after 10 years at an exercise price of $0.76 per share. Unvested options are forfeited upon termination of employment.

 

Compensation expense for stock option grants was recognized based on the fair value at the date of grant using the Black-Scholes option pricing model. Key assumptions included a risk-free interest rate ranging from 1.18% to 1.28%, historical volatility ranging from 331% to 643% and an expected life of the stock options ranging from five to six years. We recognized $1.3 million of compensation expense for these option awards in each of the quarters ended June 30, 2022. As of June 30, 2022, there was $3.5 million of total unrecognized compensation cost related to options to be recognized over a remaining weighted average period of 18 months.

 

The following table summarizes options outstanding, as well as activity for the periods presented:

 

   Shares   Weighted
Average
Grant Date
Fair Value
   Weighted
Average
Exercise
Price
   Aggregate
Intrinsic
Value
 
                 
Outstanding at December 31, 2021   13,850,000   $0.76   $0.76    
   -
 
Granted   
-
   $
-
   $
-
    
-
 
Outstanding at June 30, 2022   13,850,000   $0.76   $0.76    
-
 

 

The remaining weighted average contractual life of exercisable options at June 30, 2022 was 9.3 years.

XML 34 R17.htm IDEA: XBRL DOCUMENT v3.22.2.2
Discontinued Operations
6 Months Ended
Jun. 30, 2022
Discontinued Operations [Abstract]  
Discontinued Operations

11. Discontinued Operations

 

In 2019, management determined to fully divest of EHR’s oil and gas activities. As such, these activities are presented as discontinued operations for each of the periods presented.

 

The following is a summary of the carrying amounts of major classes of assets and liabilities of the discontinued operations to assets and liabilities held for sale:

 

   June 30,   December 31, 
   2022   2021 
Assets -        
Oil and natural gas properties held for sale, at cost  $1,874,849   $1,874,849 
Accumulated DD&A   (1,874,849)   (1,874,849)
Total assets of discontinued operations held for sale  $
-
   $
-
 
           
Liabilities          
Accrued liabilities  $55,572   $48,997 
Asset retirement obligations   52,368    52,368 
Revenue payable   52,117    52,117 
Current liabilities of discontinued operations held for sale   160,057    153,482 
           
Asset retirement obligations -          
Long-term liabilities of discontinued operations held for sale   193,816    162,948 
Total liabilities of discontinued operations held for sale  $353,873   $316,430 

The following is a summary of the major classes of line items constituting loss on discontinued operations shown in the consolidated statements of operations:

 

   For the three months ended
June 30,
   For the six months ended
June 30,
 
   2022   2021   2022   2021 
Revenue -                
Oil and gas sales  $36,925   $16,119   $75,793   $38,108 
                     
Costs and Expenses                    
Lease operating expense   41,140    18,067    85,188    40,795 
Accretion   23,352    4,257    30,868    7,032 
Total costs and expenses   64,492    22,324    116,056    47,827 
                     
Loss from discontinued operations  $(27,567)  $(6,205)  $(40,263)  $(9,719)
XML 35 R18.htm IDEA: XBRL DOCUMENT v3.22.2.2
Supplemental Cash Flow Information
6 Months Ended
Jun. 30, 2022
Supplemental Cash Flow Information [Abstract]  
Supplemental Cash Flow Information

12. Supplemental Cash Flow Information

 

   For the six months ended
June 30,
 
   2022   2021 
         
Cash paid for interest  $39,295   $45,342 
Cash paid for taxes   
-
    
-
 
           
Noncash investing and financing activities:          
Acquisition of certain assets of Halcyon Thruput, LLC          
- issuance of common shares   
-
    2,500,000 
- issuance of subordinated note   
-
    850,000 
- assumption of Halcyon bank note   
-
    995,614 
Series B preferred stock dividend payable   40,367    24,000 
Issuance of common stock units previously subscribed   
-
    50,000 
Issuances of common shares for exchange or conversion of debt   
-
    2,160,269 
XML 36 R19.htm IDEA: XBRL DOCUMENT v3.22.2.2
Earnings (Loss) Per Share
6 Months Ended
Jun. 30, 2022
Earnings Per Share [Abstract]  
Earnings (Loss) per Share

13. Earnings (Loss) per Share

 

The following is the computation of earnings (loss) per basic and diluted share:

 

   For the three months ended
June 30,
   For the six months ended
June 30,
 
   2022   2021   2022   2021 
Amounts attributable to Generation Hemp:                
Numerator                
Loss from continuing operations attributable to common stockholders  $(2,109,281)  $(1,146,697)  $(4,553,952)  $(2,980,285)
Loss from discontinued operations   (25,841)   (5,817)   (40,263)   (9,111)
Less: preferred stock dividends   (20,992)   (20,250)   (20,992)   (40,500)
Net loss attributable to common stockholders  $(2,156,114)  $(1,172,764)  $(4,615,207)  $(3,029,896)
                     
Denominator                    
Weighted average shares used to compute basic EPS   113,145,211    34,977,953    113,122,510    26,691,992 
Dilutive effect of convertible note   1,164,773    
-
    1,164,773    
-
 
Dilutive effect of preferred stock   2,950,000    79,322,376    2,953,125    79,322,376 
Dilutive effect of common stock options   
-
    
-
    
-
    
-
 
Dilutive effect of common stock warrants   1,518,226    11,654,942    2,436,954    11,787,111 
Weighted average shares used to compute diluted EPS   118,778,209    125,955,271    119,677,362    117,801,479 
                     
Earnings (loss) per share:                    
Loss from continuing operations                    
Basic  $(0.02)  $(0.03)  $(0.04)  $(0.11)
Diluted  $(0.02)  $(0.03)  $(0.04)  $(0.11)
Loss from discontinued operations                    
Basic  $
-
   $
-
   $
-
   $
-
 
Diluted  $
-
   $
-
   $
-
   $
-
 
Earnings (loss) per share                    
Basic  $(0.02)  $(0.03)  $(0.04)  $(0.11)
Diluted  $(0.02)  $(0.03)  $(0.04)  $(0.11)

 

The computation of diluted earnings per common share excludes the assumed conversion of the Series B Preferred Stock and outstanding convertible notes and exercise of common stock options and warrants in periods when we report a loss. The dilutive effect of the assumed exercise of outstanding options and warrants was calculated using the treasury stock method.

XML 37 R20.htm IDEA: XBRL DOCUMENT v3.22.2.2
Subsequent Events
6 Months Ended
Jun. 30, 2022
Subsequent Events [Abstract]  
Subsequent Events

14. Subsequent Events

 

Advances under Convertible Promissory Note – In the third quarter of 2022 through the date of this filing, our CEO made advances totaling $58,000 to the Company under the existing convertible promissory note due September 30, 2022.

 

Advances under Promissory Note to Investment Hunter, LLC – In the third quarter of 2022 through the date of this filing, Investment Hunter, LLC made advances totaling $11,500 to the Company under the existing promissory note due September 30, 2022.

 

Sale of inventories – In July 2022, the Company entered into an agreement for the sale of 66,782 pounds of dried hemp biomass from its inventories on-hand for a sales price of $1.50 per pound. Deliveries and payment of the $100,173 sales proceeds are scheduled monthly through December 2022. The Company received an initial down payment of $40,069.

 

New indebtedness – In August 2022, the Company received proceeds totaling $105,000 from new notes payable to three board directors. The notes bear interest at 10% per annum and mature on September 12, 2022.

XML 38 R21.htm IDEA: XBRL DOCUMENT v3.22.2.2
Accounting Policies, by Policy (Policies)
6 Months Ended
Jun. 30, 2022
Accounting Policies [Abstract]  
Basis of Presentation

Basis of Presentation – These interim financial statements are unaudited and have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain disclosures have been condensed or omitted from these financial statements. Accordingly, they do not include all the information and notes required by accounting principles generally accepted in the United States of America (“GAAP”) for complete consolidated financial statements, and should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2021.

 

In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring adjustments, necessary to fairly present the financial position as of, and the results of operations for, all periods presented. In preparing the accompanying financial statements, management has made certain estimates and assumptions that affect reported amounts in the condensed consolidated financial statements and disclosures of contingencies. Actual results may differ from those estimates. The results for interim periods are not necessarily indicative of annual results. Certain reclassifications have been made to the prior period’s consolidated financial statements and related footnotes to conform them to the current period presentation. Intercompany balances and transactions between consolidated entities are eliminated.

 

Fair Value Measurement

Fair Value Measurement – Our financial assets and liabilities consist of cash, accounts receivable, accounts payable and indebtedness. The fair values of these instruments approximate their carrying amounts at each reporting date.

 

Major Customer and Concentration of Credit Risk

Major Customer and Concentration of Credit Risk – We estimate an allowance for doubtful accounts based on an analysis of specific customers, taking into consideration the age of past due accounts and an assessment of the customer’s ability to pay. An allowance for doubtful accounts was not needed as of June 30, 2022 or December 31, 2021.

 

During the three and six months ended June 30, 2022, one customer accounted for 99% of our post-harvest and midstream services revenue. A total of $91,185 was outstanding from this customer at June 30, 2022.

 

Our rental revenue is derived from a single lessee on a commercial warehouse owned by the Company. There were no amounts due from this customer at June 30, 2022 or December 31, 2021.

 

Recent Accounting Pronouncements

Recent Accounting Pronouncements – There are no other new accounting pronouncements that are expected to have a material impact on the consolidated financial statements.

XML 39 R22.htm IDEA: XBRL DOCUMENT v3.22.2.2
Property and Equipment (Tables)
6 Months Ended
Jun. 30, 2022
Property and Equipment [Abstract]  
Schedule of property and equipment
   Useful   June 30,   December 31, 
   Life (yrs)   2022   2021 
             
Land       $96,000   $96,000 
Warehouse   30    916,500    916,500 
Leasehold Improvements   3    473,601    473,601 
Machinery and equipment   5-7     1,506,447    1,506,447 
Vehicles   4    149,440    149,440 
Computer equipment and software   3    46,825    46,825 
Office furniture and equipment   3-5     17,294    17,294 
                
Subtotal        3,206,107    3,206,107 
Less accumulated depreciation and amortization        (814,429)   (625,445)
                
Total property and equipment, net       $2,391,678   $2,580,662 
XML 40 R23.htm IDEA: XBRL DOCUMENT v3.22.2.2
Intangible and Other Assets (Tables)
6 Months Ended
Jun. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of intangible asset
   June 30, 2022   December 31, 2021 
   Gross Carrying Amount   Accumulated Amortization   Net   Gross Carrying Amount   Accumulated Amortization   Net 
                         
Customer relationships  $2,612,649   $(1,079,585)  $1,533,064   $2,612,649   $(796,858)  $1,815,791 
Non-competition agreements   63,176    (31,588)   31,588    63,176    (21,059)   42,117 
                               
Total  $2,675,825   $(1,111,173)  $1,564,652   $2,675,825   $(817,917)  $1,857,908 

 

XML 41 R24.htm IDEA: XBRL DOCUMENT v3.22.2.2
Notes Payable – Related Parties (Tables)
6 Months Ended
Jun. 30, 2022
Notes Payable – Related Parties [Abstract]  
Schedule of notes payable – related parties
   June 30,   December 31, 
   2022   2021 
         
Subordinated Promissory Note to CEO  $523,551   $523,551 
Convertible Promissory Note to CEO   1,037,069    410,000 
Secured Promissory Note to Coventry Asset Management, LTD.   1,000,000    1,000,000 
Subordinated Promissory Note to Investor   200,000    250,000 
Promissory Note to Investment Hunter, LLC   480,500    
-
 
           
Total notes payable – related parties  $3,241,120   $2,183,551 

 

XML 42 R25.htm IDEA: XBRL DOCUMENT v3.22.2.2
Equity (Tables)
6 Months Ended
Jun. 30, 2022
Equity [Abstract]  
Schedule of warrants outstanding
   # of Warrants   Exercise Price
(each)
   Expiration Date  Method of Exercise
               
Issued in December 2020 with Series B preferred units (1)   5,500,000   $               0.352   December 30, 2022  Cash
Issued in December 2020 with subordinated note to investor   500,000   $0.352   December 30, 2022  Cash
Issued in Q1 2021 with common stock units (1)   1,600,000   $0.500   January-February, 2023  Cash
Issued in Q4 2021 with common stock units (1)   958,333   $0.600   October-December, 2023  Cash
Total warrants outstanding at June 30, 2022   8,558,333            

Schedule of outstanding stock warrants activity
       Weighted 
       Average 
   # of Warrants   Exercise Price 
         
Warrants as of December 31, 2021   8,808,333   $0.407 
Cancelled   (250,000)  $0.400 
Warrants as of June 30, 2022   8,558,333   $0.407 
XML 43 R26.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Compensation (Tables)
6 Months Ended
Jun. 30, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of summarizes options outstanding
   Shares   Weighted
Average
Grant Date
Fair Value
   Weighted
Average
Exercise
Price
   Aggregate
Intrinsic
Value
 
                 
Outstanding at December 31, 2021   13,850,000   $0.76   $0.76    
   -
 
Granted   
-
   $
-
   $
-
    
-
 
Outstanding at June 30, 2022   13,850,000   $0.76   $0.76    
-
 

 

XML 44 R27.htm IDEA: XBRL DOCUMENT v3.22.2.2
Discontinued Operations (Tables)
6 Months Ended
Jun. 30, 2022
Discontinued Operations [Abstract]  
Schedule of discontinued operations to assets and liabilities held for sale
   June 30,   December 31, 
   2022   2021 
Assets -        
Oil and natural gas properties held for sale, at cost  $1,874,849   $1,874,849 
Accumulated DD&A   (1,874,849)   (1,874,849)
Total assets of discontinued operations held for sale  $
-
   $
-
 
           
Liabilities          
Accrued liabilities  $55,572   $48,997 
Asset retirement obligations   52,368    52,368 
Revenue payable   52,117    52,117 
Current liabilities of discontinued operations held for sale   160,057    153,482 
           
Asset retirement obligations -          
Long-term liabilities of discontinued operations held for sale   193,816    162,948 
Total liabilities of discontinued operations held for sale  $353,873   $316,430 

Schedule of discontinued operations shown in the consolidated statements of operations
   For the three months ended
June 30,
   For the six months ended
June 30,
 
   2022   2021   2022   2021 
Revenue -                
Oil and gas sales  $36,925   $16,119   $75,793   $38,108 
                     
Costs and Expenses                    
Lease operating expense   41,140    18,067    85,188    40,795 
Accretion   23,352    4,257    30,868    7,032 
Total costs and expenses   64,492    22,324    116,056    47,827 
                     
Loss from discontinued operations  $(27,567)  $(6,205)  $(40,263)  $(9,719)
XML 45 R28.htm IDEA: XBRL DOCUMENT v3.22.2.2
Supplemental Cash Flow Information (Tables)
6 Months Ended
Jun. 30, 2022
Supplemental Cash Flow Information [Abstract]  
Schedule of supplemental cash flow information
   For the six months ended
June 30,
 
   2022   2021 
         
Cash paid for interest  $39,295   $45,342 
Cash paid for taxes   
-
    
-
 
           
Noncash investing and financing activities:          
Acquisition of certain assets of Halcyon Thruput, LLC          
- issuance of common shares   
-
    2,500,000 
- issuance of subordinated note   
-
    850,000 
- assumption of Halcyon bank note   
-
    995,614 
Series B preferred stock dividend payable   40,367    24,000 
Issuance of common stock units previously subscribed   
-
    50,000 
Issuances of common shares for exchange or conversion of debt   
-
    2,160,269 
XML 46 R29.htm IDEA: XBRL DOCUMENT v3.22.2.2
Earnings (Loss) Per Share (Tables)
6 Months Ended
Jun. 30, 2022
Earnings Per Share [Abstract]  
Schedule of earnings (loss) per basic and diluted share
   For the three months ended
June 30,
   For the six months ended
June 30,
 
   2022   2021   2022   2021 
Amounts attributable to Generation Hemp:                
Numerator                
Loss from continuing operations attributable to common stockholders  $(2,109,281)  $(1,146,697)  $(4,553,952)  $(2,980,285)
Loss from discontinued operations   (25,841)   (5,817)   (40,263)   (9,111)
Less: preferred stock dividends   (20,992)   (20,250)   (20,992)   (40,500)
Net loss attributable to common stockholders  $(2,156,114)  $(1,172,764)  $(4,615,207)  $(3,029,896)
                     
Denominator                    
Weighted average shares used to compute basic EPS   113,145,211    34,977,953    113,122,510    26,691,992 
Dilutive effect of convertible note   1,164,773    
-
    1,164,773    
-
 
Dilutive effect of preferred stock   2,950,000    79,322,376    2,953,125    79,322,376 
Dilutive effect of common stock options   
-
    
-
    
-
    
-
 
Dilutive effect of common stock warrants   1,518,226    11,654,942    2,436,954    11,787,111 
Weighted average shares used to compute diluted EPS   118,778,209    125,955,271    119,677,362    117,801,479 
                     
Earnings (loss) per share:                    
Loss from continuing operations                    
Basic  $(0.02)  $(0.03)  $(0.04)  $(0.11)
Diluted  $(0.02)  $(0.03)  $(0.04)  $(0.11)
Loss from discontinued operations                    
Basic  $
-
   $
-
   $
-
   $
-
 
Diluted  $
-
   $
-
   $
-
   $
-
 
Earnings (loss) per share                    
Basic  $(0.02)  $(0.03)  $(0.04)  $(0.11)
Diluted  $(0.02)  $(0.03)  $(0.04)  $(0.11)

 

XML 47 R30.htm IDEA: XBRL DOCUMENT v3.22.2.2
Business (Details)
$ in Thousands
1 Months Ended 6 Months Ended
Jan. 11, 2021
$ / ft²
Nov. 27, 2019
Jun. 30, 2022
USD ($)
Business (Details) [Line Items]      
Square Foot Facility (in Dollars per Square Foot) | $ / ft² 48,000    
Description of business, description     As of June 30, 2022, EHR held an approximate 8% working interest in an oil & gas property located in Cochran County, Texas within the Slaughter-Levelland Field of the San Andres formation in the Northwest Shelf of West Texas. EHR’s oil & gas activities are currently held for sale and are presented in these consolidated financial statements as discontinued operations for each of the periods presented. 
Excess     10 years
Business percentage     50.00%
Cash for its operating activities     $ 1,000
Financing obligations terms     1 year
Financing obligations     $ 6,000
Current Assets     $ 364
Energy Hunter Resources, Inc. [Member]      
Business (Details) [Line Items]      
Percentage of common stock   94.00%  
XML 48 R31.htm IDEA: XBRL DOCUMENT v3.22.2.2
Summary of Significant Accounting Policies (Details) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2022
Summary of Significant Accounting Policies (Details) [Line Items]    
Outstanding amount (in Dollars)   $ 91,185
One Customer [Member]    
Summary of Significant Accounting Policies (Details) [Line Items]    
Service revenue percentage 99.00% 99.00%
XML 49 R32.htm IDEA: XBRL DOCUMENT v3.22.2.2
Property and Equipment (Details) - Schedule of property and equipment - USD ($)
6 Months Ended
Jun. 30, 2022
Dec. 31, 2021
Property, Plant and Equipment [Line Items]    
Subtotal $ 3,206,107 $ 3,206,107
Less accumulated depreciation and amortization (814,429) (625,445)
Total property and equipment, net 2,391,678 2,580,662
Land [Member]    
Property, Plant and Equipment [Line Items]    
Subtotal $ 96,000 96,000
Warehouse [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, useful Life (years) 30 years  
Subtotal $ 916,500 916,500
Leasehold Improvements [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, useful Life (years) 3 years  
Subtotal $ 473,601 473,601
Machinery and equipment [Member]    
Property, Plant and Equipment [Line Items]    
Subtotal $ 1,506,447 1,506,447
Machinery and equipment [Member] | Minimum [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, useful Life (years) 5 years  
Machinery and equipment [Member] | Maximum [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, useful Life (years) 7 years  
Vehicles [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, useful Life (years) 4 years  
Subtotal $ 149,440 149,440
Computer equipment and software [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, useful Life (years) 3 years  
Subtotal $ 46,825 46,825
Office furniture and equipment [Member]    
Property, Plant and Equipment [Line Items]    
Subtotal $ 17,294 $ 17,294
Office furniture and equipment [Member] | Minimum [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, useful Life (years) 3 years  
Office furniture and equipment [Member] | Maximum [Member]    
Property, Plant and Equipment [Line Items]    
Property and equipment, useful Life (years) 5 years  
XML 50 R33.htm IDEA: XBRL DOCUMENT v3.22.2.2
Intangible and Other Assets (Details) - USD ($)
6 Months Ended
Jun. 30, 2022
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]    
Option to purchase description the Company’s option to purchase the 48,000 square foot facility located in Hopkinsville, Kentucky presently leased from Halcyon. Under this option agreement, the Company may purchase the facility on or before August 25, 2022, as amended, for a purchase price of $993,000.  
Other assets $ 407,000 $ 407,000
XML 51 R34.htm IDEA: XBRL DOCUMENT v3.22.2.2
Intangible and Other Assets (Details) - Schedule of intangible asset - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount $ 2,675,825 $ 2,675,825
Accumulated Amortization (1,111,173) (817,917)
Net 1,564,652 1,857,908
Customer Relationships [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 2,612,649 2,612,649
Accumulated Amortization (1,079,585) (796,858)
Net 1,533,064 1,815,791
Non-Competition Agreements [Member]    
Finite-Lived Intangible Assets [Line Items]    
Gross Carrying Amount 63,176 63,176
Accumulated Amortization (31,588) (21,059)
Net $ 31,588 $ 42,117
XML 52 R35.htm IDEA: XBRL DOCUMENT v3.22.2.2
Notes Payable – Related Parties (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Dec. 31, 2022
Dec. 30, 2020
Sep. 30, 2022
Jun. 30, 2022
Dec. 31, 2022
Jul. 31, 2022
Dec. 31, 2021
Apr. 30, 2021
Notes Payable – Related Parties (Details) [Line Items]                
Convertible note ,description       The convertible note initially matured on January 1, 2022 but was subsequently amended to extend the maturity date to September 30, 2022.        
Conversion price (in Dollars per share)           $ 0.3    
Restricted common shares (in Shares)   50,000            
Convertible note matured description       As subsequently amended, a payment of $50,000 was made in April 2022 and the remaining principal of $200,000 together with accrued interest was due on June 30, 2022.        
Accrued interest       $ 29,932        
Warrant term       1 year        
Extension date       Dec. 30, 2023        
Interest expense       $ 68,756        
Common Stock [Member]                
Notes Payable – Related Parties (Details) [Line Items]                
Warrant to purchase of common stock (in Shares)       500,000        
Exercise price per share (in Dollars per share)       $ 0.352        
Subordinated Promissory Note to CEO [Member]                
Notes Payable – Related Parties (Details) [Line Items]                
Subordinated promissory note due date       Sep. 30, 2021        
New maturity date       Sep. 30, 2022        
New equity capital       $ 3,000,000        
Bears interest       10.00%        
Accrued interest       $ 33,565        
Convertible Promissory Note to CEO [Member]                
Notes Payable – Related Parties (Details) [Line Items]                
New equity capital       $ 3,000,000        
Bears interest       10.00%        
Accrued interest       $ 52,291        
Convertible debt             $ 410,000  
Additional advances       $ 627,069        
Conversion price (in Dollars per share)       $ 0.5        
Subordinated Promissory Note and Warrants to Investor [Member]                
Notes Payable – Related Parties (Details) [Line Items]                
Principal amount               $ 250,000
Interest rate   10.00%            
Forecast [Member]                
Notes Payable – Related Parties (Details) [Line Items]                
Due date     Sep. 30, 2022          
Accredited Investor [Member]                
Notes Payable – Related Parties (Details) [Line Items]                
Principal amount   $ 500,000            
Secured Promissory Note and Warrants to Coventry Asset Management, LTD. [Member]                
Notes Payable – Related Parties (Details) [Line Items]                
Bears interest   10.00%            
Principal amount   $ 1,000,000            
Maturity date   Dec. 31, 2022            
Restricted common shares (in Shares)   20,000            
Interest rate percentage       25.00%        
Due date       Oct. 31, 2022        
Option exercisable         14%      
Accrued interest       $ 149,864        
Secured Promissory Note and Warrants to Coventry Asset Management, LTD. [Member] | Forecast [Member]                
Notes Payable – Related Parties (Details) [Line Items]                
New equity capital $ 5,000,000              
Promissory Note to Investment Hunter, LLC [Member]                
Notes Payable – Related Parties (Details) [Line Items]                
New equity capital       3,000,000        
Advances totaling       $ 492,000        
Promissory note due       Sep. 30, 2022        
Bears interest       10.00%        
Accrued interest       $ 17,864        
Promissory Note [Member]                
Notes Payable – Related Parties (Details) [Line Items]                
Maturity date   Jun. 30, 2021            
XML 53 R36.htm IDEA: XBRL DOCUMENT v3.22.2.2
Notes Payable – Related Parties (Details) - Schedule of notes payable – related parties - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Notes Payable – Related Parties (Details) - Schedule of notes payable – related parties [Line Items]    
Total notes payable – related parties $ 3,241,120 $ 2,183,551
Subordinated Promissory Note to CEO [Member]    
Notes Payable – Related Parties (Details) - Schedule of notes payable – related parties [Line Items]    
Total 523,551 523,551
Convertible Promissory Note to CEO [Member]    
Notes Payable – Related Parties (Details) - Schedule of notes payable – related parties [Line Items]    
Total 1,037,069 410,000
Secured Promissory Note to Coventry Asset Management, LTD. [Member]    
Notes Payable – Related Parties (Details) - Schedule of notes payable – related parties [Line Items]    
Total 1,000,000 1,000,000
Subordinated Promissory Note to Investor [Member]    
Notes Payable – Related Parties (Details) - Schedule of notes payable – related parties [Line Items]    
Total 200,000 250,000
Promissory Note to Investment Hunter, LLC [Member]    
Notes Payable – Related Parties (Details) - Schedule of notes payable – related parties [Line Items]    
Total $ 480,500
XML 54 R37.htm IDEA: XBRL DOCUMENT v3.22.2.2
Other Indebtedness (Details)
6 Months Ended
Jun. 30, 2022
USD ($)
Other Indebtedness [Abstract]  
Mortgage payable, description The note provided for a 25-year amortization period and an initial interest rate of 9% annually. The note has been amended several times to a maturity date of September 30, 2022. In the latest extension, the Company made a principal payment of $25,000 plus accrued interest on July 18, 2022 and agreed to another principal payment of $25,000 plus accrued interest on August 31, 2022.
Interest rate 12.00%
Interest expenses $ 5,000,000
Notes payable 473,192
Lease and rental expense 7,500
Minimum future of remainder of 2022 45,000
Minimum future of remainder of 2023 $ 52,500
XML 55 R38.htm IDEA: XBRL DOCUMENT v3.22.2.2
Commitments and Contingencies (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Apr. 12, 2019
Dec. 23, 2020
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2018
Commitments and Contingencies (Details) [Line Items]              
Lease requires monthly payments         $ 2,000    
Lease expense     $ 4,000 $ 6,000 $ 12,000 $ 10,000  
Lease expiring date         May 31, 2024    
Estimated incremental borrowing rate         10.00%    
Purchase price of equipment         $ 16,000    
Insurance claim for replacement     1,498,848   $ 1,498,848    
Description of suit against UNIC         Halcyon’s suit against UNIC, which was removed to federal court, seeks $796,865.53 (the cost of the replacement dryer of $1,498,848, less a credit for $583,508.47 previously paid by UNIC to Halcyon for the Dryer fire=$915,339.53) plus statutory interest on that sum from August 10, 2020 for violating the Texas Insurance Code’s requirement that claims be promptly paid, additional statutory penalties, and attorneys’ fees. Certain documents have been executed between the Company, Halcyon and legal counsel, which provide for a sharing of costs and expenses and awards, if any, against UNIC.    
Fees exceeding $ 400,000            
Amount of summary judgment   $ 230,712          
Litigation settlement interest percentage   5.00%          
Amount accrued for judgment         $ 252,583    
Oz Capital, LLC [Member]              
Commitments and Contingencies (Details) [Line Items]              
Lease requires monthly payments         10,249    
Lease expense     $ 31,147 $ 30,747 61,494 $ 57,857  
Halcyon Thruput LLC’s [Member]              
Commitments and Contingencies (Details) [Line Items]              
Substantial coverages         $ 1,203,735    
Grand Traverse Holdings, LLC [Member]              
Commitments and Contingencies (Details) [Line Items]              
Lease term             61 months
Interest and attorney fees 823,504            
Grand Traverse Holdings, LLC [Member] | John Gallegos [Member]              
Commitments and Contingencies (Details) [Line Items]              
Liable for the asserted damages $ 1,000,000            
XML 56 R39.htm IDEA: XBRL DOCUMENT v3.22.2.2
Equity (Details) - USD ($)
6 Months Ended
Dec. 30, 2020
Jun. 30, 2022
Sep. 08, 2021
Apr. 30, 2021
Equity (Details) [Line Items]        
Converted into shares of common stock   25,000    
Sale of preferred stock units (in Dollars)   $ 10,000    
Aggregate gross proceeds (in Dollars)   $ 1,350,000    
Price per share (in Dollars per share)   $ 1    
Redemption payments percentage   12.50%    
Redemption payments (in Dollars)       $ 137,500
Weighted average market price of common stock exceed (in Dollars per share)   $ 1    
Shares of Common stock   25,000    
Common Stock [Member]        
Equity (Details) [Line Items]        
Equity, description   Common Stock – At June 30, 2022, the Company had 113,154,002 common shares outstanding. Following is a discussion of common stock issuances during the periods presented:  ●Acquisition of Certain Assets of Halcyon – In January 2021, the Company issued 6,250,000 shares of common stock valued at $2.5 million ($0.40 per share; restricted from trading for a period of up to one year) in the acquisition.   ●2021 First Quarter Issuances of Common Stock Units – In the first quarter of 2021, the Company issued 800,000 common stock units for total proceeds of $400,000. Each common stock unit consists of one share of common stock and a warrant for the purchase of two shares of common stock for $0.50 each. Each warrant is exercisable any time before its expiration on the second anniversary of its issuance. The Company allocated the total proceeds based on the relative fair values of the common stock and warrants. The fair value of the warrants was determined using an options valuation model with key assumptions including a risk-free interest rate of 0.11% and historical volatility of 272%. A total of $263,293 was allocated to the warrants and reported in additional paid-in capital.   ●Warrant Exercises – In the first quarter of 2021, the Company received $2,967,000 for the exercise of 8,428,976 outstanding warrants. In the fourth quarter of 2021, the Company received $375,000 for the exercise of 1,065,340 outstanding warrants.   ●Issuances for Exchange or Conversion of Debt – The Company issued a total of 1,618,660 common shares for the exchange or conversion of outstanding debt in the first quarter of 2021.   ●Stock-based Compensation – The Company issued 500,000 restricted common shares valued at $155,000 as incentive compensation to two executives who joined the Company in the first quarter of 2021.   ●Issuance for Extension of Secured Note – The Company issued 60,000 common shares as consideration for extensions of the maturity of a senior note in 2022. Refer to Note 5.      
Price per share (in Dollars per share)   $ 1    
Warrant [Member]        
Equity (Details) [Line Items]        
Warrant per share (in Dollars per share)   $ 0.0001    
Series A Preferred Stock [Member]        
Equity (Details) [Line Items]        
Shares of preferred stock     6,328,948  
Converted into shares of common stock     75,947,376  
Preferred Stock converting into shares     12  
Series B Preferred Stock [Member]        
Equity (Details) [Line Items]        
Converted into shares of common stock   25,000    
Equity, description Series B Preferred Stock Units – On December 30, 2020, the Company sold to certain accredited investors, including Gary C. Evans, our Chief Executive Officer, an aggregate of 135 preferred stock units comprised of (i) one share of Series B Redeemable Convertible Preferred Stock, no par value, and (ii) one warrant exercisable for 50,000 shares of common stock of the Company until December 30, 2022 at an exercise price of $0.352 per share.       
Aggregate gross proceeds (in Dollars)   $ 5,000,000    
Dividends rate   6.00%    
Preferred stock stated value (in Dollars)   $ 10,000    
XML 57 R40.htm IDEA: XBRL DOCUMENT v3.22.2.2
Equity (Details) - Schedule of warrants outstanding
6 Months Ended
Jun. 30, 2022
$ / shares
shares
Class of Warrant or Right [Line Items]  
Number of Warrants 8,558,333
Issued in December 2020 [Member] | Series B preferred units [Member]  
Class of Warrant or Right [Line Items]  
Number of Warrants 5,500,000 [1]
Exercise Price (each) | $ / shares $ 0.352 [1]
Expiration Date December 30, 2022 [1]
Method of Exercise Cash [1]
Issued in December 2020 [Member] | Subordinated note to investor [Member]  
Class of Warrant or Right [Line Items]  
Number of Warrants 500,000
Exercise Price (each) | $ / shares $ 0.352
Expiration Date December 30, 2022
Method of Exercise Cash
Issued in Q1 2021 [Member] | Common stock units [Member]  
Class of Warrant or Right [Line Items]  
Number of Warrants 1,600,000 [1]
Exercise Price (each) | $ / shares $ 0.5 [1]
Expiration Date January-February, 2023 [1]
Method of Exercise Cash [1]
Issued in Q4 2021 [Member] | Common stock units [Member]  
Class of Warrant or Right [Line Items]  
Number of Warrants 958,333 [1]
Exercise Price (each) | $ / shares $ 0.6 [1]
Expiration Date October-December, 2023 [1]
Method of Exercise Cash [1]
[1] May be redeemed for $0.0001 per warrant at the Company’s option with 30 days advanced notice should the weighted average market price of common stock exceed $1.00 for any five out of seven consecutive trading days with a minimum average daily trading volume for such seven-day period of at least 25,000 shares of common stock.
XML 58 R41.htm IDEA: XBRL DOCUMENT v3.22.2.2
Equity (Details) - Schedule of outstanding stock warrants activity
6 Months Ended
Jun. 30, 2022
$ / shares
shares
Schedule Of Outstanding Stock Warrants Activity Abstract  
Number of Warrants, Warrants beginning | shares 8,808,333
Weighted Average Exercise Price, Warrants beginning | $ / shares $ 0.407
Number of Warrants, Warrants cancelled | shares (250,000)
Weighted Average Exercise Price, Cancelled | $ / shares $ 0.4
Number of Warrants, Warrants ending | shares 8,558,333
Weighted Average Exercise Price, Warrants ending | $ / shares $ 0.407
XML 59 R42.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Compensation (Details) - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2021
Mar. 31, 2021
Jun. 30, 2022
Jun. 30, 2021
Dec. 31, 2021
Stock-Based Compensation (Details) [Line Items]          
Diluted common shares outstanding percentage         20.00%
Compensation expense related to awards $ 38,750     $ 81,000  
Common stock incentive compensation         13,850,000
Weighted average contractual life         10 years
Exercise price per share         0.76
Compensation expense     1,300,000    
Total unrecognized compensation cost     $ 3,500,000    
Weighted average contractual life     9 years 3 months 18 days    
Minimum [Member]          
Stock-Based Compensation (Details) [Line Items]          
Risk free interest rate     1.18%    
Volatility ranging     331.00%    
Stock options range     5 years    
Maximum [Member]          
Stock-Based Compensation (Details) [Line Items]          
Risk free interest rate     1.28%    
Volatility ranging     643.00%    
Stock options range     6 years    
2021 Plan [Member]          
Stock-Based Compensation (Details) [Line Items]          
common stock for issuance         15,000,000
Number of shares         15,000,000
Diluted common shares outstanding percentage         13.10%
Restricted Stock [Member]          
Stock-Based Compensation (Details) [Line Items]          
Restricted shares, issued   500,000      
Restricted shares, value   $ 155,000      
XML 60 R43.htm IDEA: XBRL DOCUMENT v3.22.2.2
Stock-Based Compensation (Details) - Schedule of summarizes options outstanding
6 Months Ended
Jun. 30, 2022
USD ($)
$ / shares
shares
Schedule Of Summarizes Options Outstanding Abstract  
Shares Beginning (in Shares) | shares 13,850,000
Weighted Average Grant Date Fair Value Beginning $ 0.76
Weighted Average Exercise Price Beginning $ 0.76
Aggregate Intrinsic Value Beginning (in Dollars) | $
Shares Granted (in Shares) | shares
Weighted Average Grant Date Fair Value Granted
Weighted Average Exercise Price Granted
Aggregate Intrinsic Value Granted (in Dollars) | $
Shares Ending (in Shares) | shares 13,850,000
Weighted Average Grant Date Fair Value Ending $ 0.76
Weighted Average Exercise Price Ending $ 0.76
Aggregate Intrinsic Value Ending (in Dollars) | $
XML 61 R44.htm IDEA: XBRL DOCUMENT v3.22.2.2
Discontinued Operations (Details) - Schedule of discontinued operations to assets and liabilities held for sale - Discontinued Operations [Member] - USD ($)
Jun. 30, 2022
Dec. 31, 2021
Discontinued Operations (Details) - Schedule of discontinued operations to assets and liabilities held for sale [Line Items]    
Oil and natural gas properties held for sale, at cost $ 1,874,849 $ 1,874,849
Accumulated DD&A (1,874,849) (1,874,849)
Total assets of discontinued operations held for sale
Liabilities    
Accrued liabilities 55,572 48,997
Asset retirement obligations 52,368 52,368
Revenue payable 52,117 52,117
Current liabilities of discontinued operations held for sale 160,057 153,482
Asset retirement obligations -    
Long-term liabilities of discontinued operations held for sale 193,816 162,948
Total liabilities of discontinued operations held for sale $ 353,873 $ 316,430
XML 62 R45.htm IDEA: XBRL DOCUMENT v3.22.2.2
Discontinued Operations (Details) - Schedule of discontinued operations shown in the consolidated statements of operations - Discontinued Operations [Member] - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Revenue -        
Oil and gas sales $ 36,925 $ 16,119 $ 75,793 $ 38,108
Costs and Expenses        
Lease operating expense 41,140 18,067 85,188 40,795
Accretion 23,352 4,257 30,868 7,032
Total costs and expenses 64,492 22,324 116,056 47,827
Loss from discontinued operations $ (27,567) $ (6,205) $ (40,263) $ (9,719)
XML 63 R46.htm IDEA: XBRL DOCUMENT v3.22.2.2
Supplemental Cash Flow Information (Details) - Schedule of supplemental cash flow information - USD ($)
6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Schedule Of Supplemental Cash Flow Information Abstract    
Cash paid for interest $ 39,295 $ 45,342
Cash paid for taxes
Acquisition of certain assets of Halcyon Thruput, LLC    
- issuance of common shares 2,500,000
- issuance of subordinated note 850,000
- assumption of Halcyon bank note 995,614
Series B preferred stock dividend payable 40,367 24,000
Issuance of common stock units previously subscribed 50,000
Issuances of common shares for exchange or conversion of debt $ 2,160,269
XML 64 R47.htm IDEA: XBRL DOCUMENT v3.22.2.2
Earnings (Loss) Per Share (Details) - Schedule of earnings (loss) per basic and diluted share - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Numerator        
Loss from continuing operations attributable to common stockholders $ (2,109,281) $ (1,146,697) $ (4,553,952) $ (2,980,285)
Loss from discontinued operations (25,841) (5,817) (40,263) (9,111)
Less: preferred stock dividends (20,992) (20,250) (20,992) (40,500)
Net loss attributable to common stockholders $ (2,156,114) $ (1,172,764) $ (4,615,207) $ (3,029,896)
Denominator        
Weighted average shares used to compute basic EPS 113,145,211 34,977,953 113,122,510 26,691,992
Dilutive effect of convertible note 1,164,773 1,164,773
Dilutive effect of preferred stock 2,950,000 79,322,376 2,953,125 79,322,376
Dilutive effect of common stock options
Dilutive effect of common stock warrants 1,518,226 11,654,942 2,436,954 11,787,111
Weighted average shares used to compute diluted EPS 118,778,209 125,955,271 119,677,362 117,801,479
Loss from continuing operations        
Basic $ (0.02) $ (0.03) $ (0.04) $ (0.11)
Diluted (0.02) (0.03) (0.04) (0.11)
Loss from discontinued operations        
Basic
Diluted
Earnings (loss) per share        
Basic (0.02) (0.03) (0.04) (0.11)
Diluted $ (0.02) $ (0.03) $ (0.04) $ (0.11)
XML 65 R48.htm IDEA: XBRL DOCUMENT v3.22.2.2
Subsequent Events (Details)
1 Months Ended 3 Months Ended 6 Months Ended
Aug. 31, 2022
shares
Jul. 31, 2022
USD ($)
$ / shares
Sep. 30, 2022
USD ($)
Jun. 30, 2022
USD ($)
Subsequent Events (Details) [Line Items]        
initial down payment site       $ 40,069
Subsequent Event [Member]        
Subsequent Events (Details) [Line Items]        
Sale of agreement amount   $ 66,782    
Sales price per share (in Dollars per share) | $ / shares   $ 1.5    
payment of sales proceeds   $ 100,173    
Forecast [Member]        
Subsequent Events (Details) [Line Items]        
Convertible promissory note     $ 58,000  
Advances     $ 11,500  
Promissory note due date     Sep. 30, 2022  
Restricted common shares extension fees (in Shares) | shares 105,000      
Number of board of directors 3      
Interest rate percentage 10.00%      
Maturity date Sep. 12, 2022      
XML 66 f10q0622_generation_htm.xml IDEA: XBRL DOCUMENT 0001527102 2022-01-01 2022-06-30 0001527102 2022-08-19 0001527102 2022-06-30 0001527102 2021-12-31 0001527102 genh:SeriesBRedeemablePreferredStockMember 2022-06-30 0001527102 genh:SeriesBRedeemablePreferredStockMember 2021-12-31 0001527102 2022-04-01 2022-06-30 0001527102 2021-04-01 2021-06-30 0001527102 2021-01-01 2021-06-30 0001527102 genh:SeriesBRedeemablePreferredStockMember 2020-12-31 0001527102 us-gaap:PreferredStockMember 2020-12-31 0001527102 us-gaap:CommonStockMember 2020-12-31 0001527102 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001527102 us-gaap:RetainedEarningsMember 2020-12-31 0001527102 us-gaap:NoncontrollingInterestMember 2020-12-31 0001527102 2020-12-31 0001527102 genh:SeriesBRedeemablePreferredStockMember 2021-01-01 2021-03-31 0001527102 us-gaap:PreferredStockMember 2021-01-01 2021-03-31 0001527102 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001527102 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001527102 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001527102 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-03-31 0001527102 2021-01-01 2021-03-31 0001527102 genh:SeriesBRedeemablePreferredStockMember 2021-03-31 0001527102 us-gaap:PreferredStockMember 2021-03-31 0001527102 us-gaap:CommonStockMember 2021-03-31 0001527102 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001527102 us-gaap:RetainedEarningsMember 2021-03-31 0001527102 us-gaap:NoncontrollingInterestMember 2021-03-31 0001527102 2021-03-31 0001527102 genh:SeriesBRedeemablePreferredStockMember 2021-04-01 2021-06-30 0001527102 us-gaap:PreferredStockMember 2021-04-01 2021-06-30 0001527102 us-gaap:CommonStockMember 2021-04-01 2021-06-30 0001527102 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2021-06-30 0001527102 us-gaap:RetainedEarningsMember 2021-04-01 2021-06-30 0001527102 us-gaap:NoncontrollingInterestMember 2021-04-01 2021-06-30 0001527102 genh:SeriesBRedeemablePreferredStockMember 2021-06-30 0001527102 us-gaap:PreferredStockMember 2021-06-30 0001527102 us-gaap:CommonStockMember 2021-06-30 0001527102 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001527102 us-gaap:RetainedEarningsMember 2021-06-30 0001527102 us-gaap:NoncontrollingInterestMember 2021-06-30 0001527102 2021-06-30 0001527102 genh:SeriesBRedeemablePreferredStockMember 2021-12-31 0001527102 us-gaap:PreferredStockMember 2021-12-31 0001527102 us-gaap:CommonStockMember 2021-12-31 0001527102 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001527102 us-gaap:RetainedEarningsMember 2021-12-31 0001527102 us-gaap:NoncontrollingInterestMember 2021-12-31 0001527102 genh:SeriesBRedeemablePreferredStockMember 2022-01-01 2022-03-31 0001527102 us-gaap:PreferredStockMember 2022-01-01 2022-03-31 0001527102 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001527102 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001527102 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001527102 us-gaap:NoncontrollingInterestMember 2022-01-01 2022-03-31 0001527102 2022-01-01 2022-03-31 0001527102 genh:SeriesBRedeemablePreferredStockMember 2022-03-31 0001527102 us-gaap:PreferredStockMember 2022-03-31 0001527102 us-gaap:CommonStockMember 2022-03-31 0001527102 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001527102 us-gaap:RetainedEarningsMember 2022-03-31 0001527102 us-gaap:NoncontrollingInterestMember 2022-03-31 0001527102 2022-03-31 0001527102 genh:SeriesBRedeemablePreferredStockMember 2022-04-01 2022-06-30 0001527102 us-gaap:PreferredStockMember 2022-04-01 2022-06-30 0001527102 us-gaap:CommonStockMember 2022-04-01 2022-06-30 0001527102 us-gaap:AdditionalPaidInCapitalMember 2022-04-01 2022-06-30 0001527102 us-gaap:RetainedEarningsMember 2022-04-01 2022-06-30 0001527102 us-gaap:NoncontrollingInterestMember 2022-04-01 2022-06-30 0001527102 genh:SeriesBRedeemablePreferredStockMember 2022-06-30 0001527102 us-gaap:PreferredStockMember 2022-06-30 0001527102 us-gaap:CommonStockMember 2022-06-30 0001527102 us-gaap:AdditionalPaidInCapitalMember 2022-06-30 0001527102 us-gaap:RetainedEarningsMember 2022-06-30 0001527102 us-gaap:NoncontrollingInterestMember 2022-06-30 0001527102 genh:EnergyHunterResourcesIncMember 2019-11-02 2019-11-27 0001527102 2021-01-05 2021-01-11 0001527102 genh:OneCustomerMember 2022-04-01 2022-06-30 0001527102 genh:OneCustomerMember 2022-01-01 2022-06-30 0001527102 us-gaap:LandMember 2022-06-30 0001527102 us-gaap:LandMember 2021-12-31 0001527102 pf0:WarehouseMember 2022-01-01 2022-06-30 0001527102 pf0:WarehouseMember 2022-06-30 0001527102 pf0:WarehouseMember 2021-12-31 0001527102 us-gaap:LeaseholdImprovementsMember 2022-01-01 2022-06-30 0001527102 us-gaap:LeaseholdImprovementsMember 2022-06-30 0001527102 us-gaap:LeaseholdImprovementsMember 2021-12-31 0001527102 pf0:MinimumMember us-gaap:MachineryAndEquipmentMember 2022-01-01 2022-06-30 0001527102 pf0:MaximumMember us-gaap:MachineryAndEquipmentMember 2022-01-01 2022-06-30 0001527102 us-gaap:MachineryAndEquipmentMember 2022-06-30 0001527102 us-gaap:MachineryAndEquipmentMember 2021-12-31 0001527102 us-gaap:VehiclesMember 2022-01-01 2022-06-30 0001527102 us-gaap:VehiclesMember 2022-06-30 0001527102 us-gaap:VehiclesMember 2021-12-31 0001527102 us-gaap:ComputerEquipmentMember 2022-01-01 2022-06-30 0001527102 us-gaap:ComputerEquipmentMember 2022-06-30 0001527102 us-gaap:ComputerEquipmentMember 2021-12-31 0001527102 pf0:MinimumMember us-gaap:FurnitureAndFixturesMember 2022-01-01 2022-06-30 0001527102 pf0:MaximumMember us-gaap:FurnitureAndFixturesMember 2022-01-01 2022-06-30 0001527102 us-gaap:FurnitureAndFixturesMember 2022-06-30 0001527102 us-gaap:FurnitureAndFixturesMember 2021-12-31 0001527102 us-gaap:CustomerRelationshipsMember 2022-06-30 0001527102 us-gaap:CustomerRelationshipsMember 2021-12-31 0001527102 us-gaap:NoncompeteAgreementsMember 2022-06-30 0001527102 us-gaap:NoncompeteAgreementsMember 2021-12-31 0001527102 genh:SubordinatedPromissoryNoteToCEOMember 2022-01-01 2022-06-30 0001527102 genh:SubordinatedPromissoryNoteToCEOMember 2022-06-30 0001527102 genh:ConvertiblePromissoryNoteToCEOMember 2021-12-31 0001527102 genh:ConvertiblePromissoryNoteToCEOMember 2022-01-01 2022-06-30 0001527102 genh:ConvertiblePromissoryNoteToCEOMember 2022-06-30 0001527102 2022-07-31 0001527102 genh:ConventryAssetManagementLTDMember 2020-12-30 0001527102 us-gaap:ConvertibleNotesPayableMember 2020-12-01 2020-12-30 0001527102 genh:ConventryAssetManagementLTDMember 2020-12-01 2020-12-30 0001527102 2020-12-01 2020-12-30 0001527102 pf0:ScenarioForecastMember genh:ConventryAssetManagementLTDMember 2022-12-01 2022-12-31 0001527102 genh:ConventryAssetManagementLTDMember 2022-06-30 0001527102 genh:ConventryAssetManagementLTDMember 2022-01-01 2022-06-30 0001527102 genh:ConventryAssetManagementLTDMember 2022-01-01 2022-12-31 0001527102 genh:AccreditedInvestorMember 2020-12-30 0001527102 genh:SubordinatedPromissoryNoteMember 2020-12-01 2020-12-30 0001527102 genh:SubordinatedPromissoryNoteMember 2021-04-30 0001527102 genh:PromissoryNoteToInvestmentHunterLLCMember 2022-01-01 2022-06-30 0001527102 genh:SubordinatedPromissoryNoteMember 2022-06-30 0001527102 genh:SubordinatedPromissoryNoteMember 2021-12-31 0001527102 genh:SecuredPromissoryNoteToCoventryAssetManagementLtdMember 2022-06-30 0001527102 genh:SecuredPromissoryNoteToCoventryAssetManagementLtdMember 2021-12-31 0001527102 genh:SubordinatedPromissoryNoteToInvestorMember 2022-06-30 0001527102 genh:SubordinatedPromissoryNoteToInvestorMember 2021-12-31 0001527102 genh:PromissoryNoteToInvestmentHunterLLCMember 2022-06-30 0001527102 genh:PromissoryNoteToInvestmentHunterLLCMember 2021-12-31 0001527102 genh:OzCapitalLLCMember 2022-01-01 2022-06-30 0001527102 genh:OzCapitalLLCMember 2022-04-01 2022-06-30 0001527102 genh:OzCapitalLLCMember 2021-04-01 2021-06-30 0001527102 genh:OzCapitalLLCMember 2021-01-01 2021-06-30 0001527102 genh:HalcyonThruputLLCsMember 2022-01-01 2022-06-30 0001527102 genh:GrandTraverseHoldingsLLCMember 2018-12-31 0001527102 genh:GrandTraverseHoldingsLLCMember 2019-04-01 2019-04-12 0001527102 2019-04-01 2019-04-12 0001527102 genh:JohnGallegosMember genh:GrandTraverseHoldingsLLCMember 2019-04-01 2019-04-12 0001527102 2020-12-01 2020-12-23 0001527102 us-gaap:SeriesAPreferredStockMember 2021-09-08 0001527102 us-gaap:SeriesBPreferredStockMember 2020-12-30 2020-12-30 0001527102 us-gaap:SeriesBPreferredStockMember 2022-06-30 0001527102 us-gaap:SeriesBPreferredStockMember 2022-01-01 2022-06-30 0001527102 2021-04-30 0001527102 us-gaap:CommonStockMember 2022-01-01 2022-06-30 0001527102 us-gaap:WarrantMember 2022-06-30 0001527102 genh:DecemberTwoThousandTwentyMember genh:SeriesBPreferredStockUnitsMember 2022-06-30 0001527102 genh:DecemberTwoThousandTwentyMember genh:SeriesBPreferredStockUnitsMember 2022-01-01 2022-06-30 0001527102 genh:DecemberTwoThousandTwentyMember genh:SubordinatedNoteToInvestorMember 2022-06-30 0001527102 genh:DecemberTwoThousandTwentyMember genh:SubordinatedNoteToInvestorMember 2022-01-01 2022-06-30 0001527102 genh:MarchTwoThousandTwentyOneMember genh:CommonStockUnitsMember 2022-06-30 0001527102 genh:MarchTwoThousandTwentyOneMember genh:CommonStockUnitsMember 2022-01-01 2022-06-30 0001527102 genh:DecemberTwoThousandTwentyOneMember genh:CommonStockUnitsMember 2022-06-30 0001527102 genh:DecemberTwoThousandTwentyOneMember genh:CommonStockUnitsMember 2022-01-01 2022-06-30 0001527102 genh:TwoThousandTwentyOnePlanMember 2021-01-01 2021-12-31 0001527102 2021-01-01 2021-12-31 0001527102 us-gaap:RestrictedStockMember 2021-01-01 2021-03-31 0001527102 pf0:MinimumMember 2022-01-01 2022-06-30 0001527102 pf0:MaximumMember 2022-01-01 2022-06-30 0001527102 us-gaap:SegmentDiscontinuedOperationsMember 2022-06-30 0001527102 us-gaap:SegmentDiscontinuedOperationsMember 2021-12-31 0001527102 us-gaap:SegmentDiscontinuedOperationsMember 2022-04-01 2022-06-30 0001527102 us-gaap:SegmentDiscontinuedOperationsMember 2021-04-01 2021-06-30 0001527102 us-gaap:SegmentDiscontinuedOperationsMember 2022-01-01 2022-06-30 0001527102 us-gaap:SegmentDiscontinuedOperationsMember 2021-01-01 2021-06-30 0001527102 pf0:ScenarioForecastMember 2022-07-01 2022-09-30 0001527102 pf0:ScenarioForecastMember 2022-09-30 0001527102 us-gaap:SubsequentEventMember 2022-07-01 2022-07-31 0001527102 us-gaap:SubsequentEventMember 2022-07-31 0001527102 pf0:ScenarioForecastMember 2022-08-01 2022-08-31 0001527102 pf0:ScenarioForecastMember 2022-08-31 shares iso4217:USD iso4217:USD shares pure iso4217:USD utr:sqft 10-Q true 2022-06-30 2022 false 000-55019 GENERATION HEMP, INC. DE 26-3119496 8533 Midway Road Dallas TX 75209 (469) 209-6154 Yes Yes Non-accelerated Filer true false false 113154002 4289 20656 91185 212518 212518 55791 4723 363783 237897 2391678 2580662 213706 263065 1564652 1857908 799888 799888 407000 407000 5740707 6146420 1169006 883485 421234 410990 382197 204007 106406 101238 3241120 2183551 473192 501668 160057 153482 5953212 4438421 107300 161827 193816 162948 6254328 4763196 10000 10000 300 300 118 118 135 135 591558 591558 0.00001 0.00001 200000000 200000000 0.00001 0.00001 200000000 200000000 113154002 113154002 113094002 113094002 1132 1131 31887994 29150258 -32748818 -28118245 -859692 1033144 -245487 -241478 -1105179 791666 5740707 6146420 331900 3355 331933 47965 22500 22500 45000 45000 354400 25855 376933 92965 164479 112195 268844 270260 261491 341447 482240 691075 16115 1914644 514299 3892528 1635231 2340614 967941 4643612 2612681 -1986214 -942086 -4266679 -2519716 25424 25424 11770 -123763 -232462 -287273 -496302 123763 207038 287273 459108 -2109977 -1149124 -4553952 -2978824 -27567 -6205 -40263 -9719 -2137544 -1155329 -4594215 -2988543 -2422 -2815 -4009 853 -2135122 -1152514 -4590206 -2989396 -0.02 -0.03 -0.04 -0.11 -0.02 -0.03 -0.04 -0.11 -0.02 -0.03 -0.04 -0.11 -0.02 -0.03 -0.04 -0.11 135 729058 6328948 4975503 17380317 6083480 4436018 -18220705 -239231 -2964935 6250000 2500000 2500000 800000 136707 263293 400000 8428976 4771669 -1804669 2967000 618660 217769 217769 1000000 1942500 1942500 20250 20250 500000 42250 42250 -1836882 3668 -1833214 135 729058 6328948 4975503 34977953 15694375 2894642 -20077837 -235563 3251120 -1152514 -2815 -1155329 135 729058 6328948 4975503 34977953 15694375 2894642 -21230351 -238378 2095791 118 591558 113094002 1131 29150258 -28118245 -241478 791666 20000 11480 11480 68756 68756 20992 20992 1315750 1315750 -2455084 -1587 -2456671 118 591558 113114002 1131 30546244 -30594321 -243065 -290011 40000 1 26000 26001 19375 19375 1315750 1315750 -2135122 -2422 -2137544 118 591558 113154002 1132 31887994 -32748818 -245487 -1105179 -4594215 -2988543 40263 9719 -4553952 -2978824 482240 691075 37481 328320 2631500 81000 68756 -25424 11770 91185 -70530 51068 10298 433588 -244741 -1042640 -2100132 -2820 -1045460 -2100132 40220 -1525470 34847 -1530843 -1530843 350000 137500 16500 2967000 995614 1107569 50000 1100000 28476 1938 1029093 1065448 1029093 1065448 -16367 -2565527 20656 2776425 4289 210898 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>1. Business</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">Generation Hemp, Inc. (the “Company”) was incorporated on August 21, 2021 in the State of Delaware. The Company was originally incorporated as Home Treasure Finders, Inc. (“HTF”) on July 28, 2008 in the State of Colorado. On November 27, 2019, HTF purchased approximately 94% of the common stock of Energy Hunter Resources, Inc. (“EHR”) in a series of transactions accounted for as a reverse merger. Upon closing, HTF changed its name to Generation Hemp, Inc.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">On January 11, 2021, we completed the acquisition of certain assets of Halcyon Thruput, LLC (“Halcyon”). With this acquisition, we commenced providing post-harvest and midstream services to growers by drying, processing, cleaning and stripping harvested hemp directly from the field and wetbaled at our 48,000 square foot leased facility located in Hopkinsville, Kentucky. Additionally, the Company offers safe storage services for processed hemp, which enables farmers to maximize strategic market timing. In August 2021, the Company launched its small animal bedding consumer goods product line (“Rowdy Rooster”) made from the hemp hurd byproduct that is produced from its hemp processing operations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">We also generate revenue from rental of our “Cannabis Zoned” (Hemp) warehouse property located in Denver, Colorado currently leased to an unaffiliated hemp seed company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">As of June 30, 2022, EHR held an approximate 8% working interest in an oil &amp; gas property located in Cochran County, Texas within the Slaughter-Levelland Field of the San Andres formation in the Northwest Shelf of West Texas. EHR’s oil &amp; gas activities are currently held for sale and are presented in these consolidated financial statements as discontinued operations for each of the periods presented.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">Our management team has been and continues to actively review acquisition candidates involved in the hemp industry that operate within a number of vertical businesses, predominantly within the midstream sector that are attractive to us and are within the hemp supply chain.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "><i>New Business Line </i>– During the second quarter of 2022, management and the Board decided to enter a new but related line of business – bitcoin mining. Management determined after research that hemp biomass can be burned in a biomass boiler to generate heat and steam to drive a turbine for generating electricity. The BTU value of hemp is similar to wood waste generated at saw mills. Hemp plants grow to maturity within six to eight months whereas trees mature in excess of ten years.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">The Company subsequently formed a new company, GenCrypto, LLC (a Delaware limited liability company) with a 50% partner, Cerberus Digital, LLC, an affiliate of Cryptech Solutions, Inc. Cryptech is one of the largest resellers of bitcoin mining equipment in North America.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">GenCrypto now has approximately ten different bitcoin locations identified and either under contract, under letter of intent, or in final negotiating status, located in three states and in Costa Rica. All of these site locations are deemed “green” based upon the power being provided either from the local utility or co-op. They range in power size from 1.1 megawatts to 50 megawatts. GenCrypto has been contacted by several larger bitcoin mining operators concerning utilizing some of these mining locations under “hosting” arrangements.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">The Company anticipates closing its first acquisition which is currently operational in September 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "><i>Liquidity and Going Concern – </i>The Company is dependent upon obtaining additional funding to continue ongoing operations and to pursue its strategy and execute its acquisition plans.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">In the six months ended June 30, 2022, the Company used $1.0 million of cash for its operating activities. At June 30, 2022, the Company’s current liabilities, including financing obligations due within one year, totaled $6.0 million as compared with its current assets of $364 thousand.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">The Company will continue to pursue additional capital raising opportunities in order to fund future acquisitions and meet its obligations as they become due. We may not be successful in obtaining additional financing needed. In the event financing cannot be obtained, the Company may not be able to satisfy these plans and obligations. These factors raise substantial doubt about the Company’s ability to continue as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "><i>Impact of COVID-19 Pandemic on Our Business </i>– Our business, results of operations and financial condition were adversely affected by the COVID-19 pandemic. The COVID-19 pandemic and measures taken to contain it subjected our business, results of operations, financial condition, stock price and liquidity to a number of material risks and uncertainties, all of which may continue or may worsen.</p> 0.94 48000 As of June 30, 2022, EHR held an approximate 8% working interest in an oil & gas property located in Cochran County, Texas within the Slaughter-Levelland Field of the San Andres formation in the Northwest Shelf of West Texas. EHR’s oil & gas activities are currently held for sale and are presented in these consolidated financial statements as discontinued operations for each of the periods presented.  P10Y 0.50 1000000 P1Y 6000000 364000 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>2. Summary of Significant Accounting Policies</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Basis of Presentation</i> – These interim financial statements are unaudited and have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain disclosures have been condensed or omitted from these financial statements. Accordingly, they do not include all the information and notes required by accounting principles generally accepted in the United States of America (“GAAP”) for complete consolidated financial statements, and should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring adjustments, necessary to fairly present the financial position as of, and the results of operations for, all periods presented. In preparing the accompanying financial statements, management has made certain estimates and assumptions that affect reported amounts in the condensed consolidated financial statements and disclosures of contingencies. Actual results may differ from those estimates. The results for interim periods are not necessarily indicative of annual results. Certain reclassifications have been made to the prior period’s consolidated financial statements and related footnotes to conform them to the current period presentation. Intercompany balances and transactions between consolidated entities are eliminated.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Fair Value Measurement</i> – Our financial assets and liabilities consist of cash, accounts receivable, accounts payable and indebtedness. The fair values of these instruments approximate their carrying amounts at each reporting date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Major Customer and Concentration of Credit Risk</i> – We estimate an allowance for doubtful accounts based on an analysis of specific customers, taking into consideration the age of past due accounts and an assessment of the customer’s ability to pay. An allowance for doubtful accounts was not needed as of June 30, 2022 or December 31, 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">During the three and six months ended June 30, 2022, one customer accounted for 99% of our post-harvest and midstream services revenue. A total of $91,185 was outstanding from this customer at June 30, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our rental revenue is derived from a single lessee on a commercial warehouse owned by the Company. There were no amounts due from this customer at June 30, 2022 or December 31, 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Recent Accounting Pronouncements – </i>There are no other new accounting pronouncements that are expected to have a material impact on the consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Basis of Presentation</i> – These interim financial statements are unaudited and have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting. Certain disclosures have been condensed or omitted from these financial statements. Accordingly, they do not include all the information and notes required by accounting principles generally accepted in the United States of America (“GAAP”) for complete consolidated financial statements, and should be read in conjunction with the audited consolidated financial statements and notes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In the opinion of management, the accompanying unaudited condensed consolidated financial statements include all adjustments, consisting of normal recurring adjustments, necessary to fairly present the financial position as of, and the results of operations for, all periods presented. In preparing the accompanying financial statements, management has made certain estimates and assumptions that affect reported amounts in the condensed consolidated financial statements and disclosures of contingencies. Actual results may differ from those estimates. The results for interim periods are not necessarily indicative of annual results. Certain reclassifications have been made to the prior period’s consolidated financial statements and related footnotes to conform them to the current period presentation. Intercompany balances and transactions between consolidated entities are eliminated.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Fair Value Measurement</i> – Our financial assets and liabilities consist of cash, accounts receivable, accounts payable and indebtedness. The fair values of these instruments approximate their carrying amounts at each reporting date.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Major Customer and Concentration of Credit Risk</i> – We estimate an allowance for doubtful accounts based on an analysis of specific customers, taking into consideration the age of past due accounts and an assessment of the customer’s ability to pay. An allowance for doubtful accounts was not needed as of June 30, 2022 or December 31, 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">During the three and six months ended June 30, 2022, one customer accounted for 99% of our post-harvest and midstream services revenue. A total of $91,185 was outstanding from this customer at June 30, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Our rental revenue is derived from a single lessee on a commercial warehouse owned by the Company. There were no amounts due from this customer at June 30, 2022 or December 31, 2021.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p> 0.99 0.99 91185 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Recent Accounting Pronouncements – </i>There are no other new accounting pronouncements that are expected to have a material impact on the consolidated financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>3. Property and Equipment</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">Property and equipment consisted of the following:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Useful</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">June 30,</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Life (yrs)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Land</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: center"> </td><td style="width: 9%; text-align: center"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">96,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">96,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Warehouse</td><td> </td> <td style="text-align: center"> </td><td style="text-align: center">30</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">916,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">916,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Leasehold Improvements</td><td> </td> <td style="text-align: center"> </td><td style="text-align: center">3</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">473,601</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">473,601</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Machinery and equipment</td><td> </td> <td style="text-align: center"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5-7 </span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,506,447</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,506,447</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Vehicles</td><td> </td> <td style="text-align: center"> </td><td style="text-align: center">4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">149,440</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">149,440</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Computer equipment and software</td><td> </td> <td style="text-align: center"> </td><td style="text-align: center">3</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">46,825</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">46,825</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Office furniture and equipment</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3-5 </span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,294</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,294</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Subtotal</td><td> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,206,107</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,206,107</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Less accumulated depreciation and amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(814,429</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(625,445</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-align: left">Total property and equipment, net</td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: center"> </td><td style="padding-bottom: 4pt; text-align: center"> </td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,391,678</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,580,662</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Useful</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">June 30,</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Life (yrs)</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2" style="text-align: center"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Land</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: center"> </td><td style="width: 9%; text-align: center"> </td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">96,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">96,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Warehouse</td><td> </td> <td style="text-align: center"> </td><td style="text-align: center">30</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">916,500</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">916,500</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Leasehold Improvements</td><td> </td> <td style="text-align: center"> </td><td style="text-align: center">3</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">473,601</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">473,601</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Machinery and equipment</td><td> </td> <td style="text-align: center"> </td><td style="text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5-7 </span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,506,447</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,506,447</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Vehicles</td><td> </td> <td style="text-align: center"> </td><td style="text-align: center">4</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">149,440</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">149,440</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Computer equipment and software</td><td> </td> <td style="text-align: center"> </td><td style="text-align: center">3</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">46,825</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">46,825</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Office furniture and equipment</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3-5 </span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,294</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">17,294</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Subtotal</td><td> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,206,107</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,206,107</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Less accumulated depreciation and amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(814,429</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(625,445</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-align: left">Total property and equipment, net</td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: center"> </td><td style="padding-bottom: 4pt; text-align: center"> </td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,391,678</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,580,662</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> 96000 96000 P30Y 916500 916500 P3Y 473601 473601 P5Y P7Y 1506447 1506447 P4Y 149440 149440 P3Y 46825 46825 P3Y P5Y 17294 17294 3206107 3206107 814429 625445 2391678 2580662 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>4. Intangible and Other Assets</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">The following table summarizes information related to definite-lived intangible assets:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Gross Carrying Amount</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accumulated Amortization</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Net</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Gross Carrying Amount</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accumulated Amortization</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Net</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; text-align: left">Customer relationships</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,612,649</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(1,079,585</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,533,064</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,612,649</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(796,858</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,815,791</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Non-competition agreements</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">63,176</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(31,588</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">31,588</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">63,176</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(21,059</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">42,117</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Total</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,675,825</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1,111,173</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,564,652</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,675,825</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(817,917</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,857,908</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; text-indent: 0.25in; margin: 0pt 0">Other assets included $407,000 at June 30, 2022 and December 31, 2021 for the Company’s option to purchase the 48,000 square foot facility located in Hopkinsville, Kentucky presently leased from Halcyon. Under this option agreement, the Company may purchase the facility on or before August 25, 2022, as amended, for a purchase price of $993,000.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">June 30, 2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="10" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">December 31, 2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Gross Carrying Amount</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accumulated Amortization</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Net</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Gross Carrying Amount</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Accumulated Amortization</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Net</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 28%; text-align: left">Customer relationships</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,612,649</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(1,079,585</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,533,064</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">2,612,649</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(796,858</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,815,791</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Non-competition agreements</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">63,176</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(31,588</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">31,588</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">63,176</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(21,059</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">42,117</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Total</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,675,825</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1,111,173</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,564,652</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,675,825</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(817,917</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">1,857,908</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> 2612649 -1079585 1533064 2612649 -796858 1815791 63176 -31588 31588 63176 -21059 42117 2675825 -1111173 1564652 2675825 -817917 1857908 407000 407000 the Company’s option to purchase the 48,000 square foot facility located in Hopkinsville, Kentucky presently leased from Halcyon. Under this option agreement, the Company may purchase the facility on or before August 25, 2022, as amended, for a purchase price of $993,000. <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>5. Notes Payable – Related Parties</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Notes payable – related parties consisted of the following:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Subordinated Promissory Note to CEO</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">523,551</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">523,551</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Convertible Promissory Note to CEO</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,037,069</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">410,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Secured Promissory Note to Coventry Asset Management, LTD.</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Subordinated Promissory Note to Investor</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">200,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">250,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Promissory Note to Investment Hunter, LLC</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">480,500</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-156">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total notes payable – related parties</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">3,241,120</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,183,551</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Subordinated Promissory Note to CEO – </i>Our CEO made advances to the Company during 2020 under a subordinated promissory note initially due September 30, 2021. This note was amended to a new maturity date of September 30, 2022. If the Company raises new equity capital of $3 million or more, then the full amount outstanding under the note is due within five days. The note bears interest at 10% per annum. Accrued interest on this subordinated promissory note totaled $33,565 at June 30, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Convertible Promissory Note to CEO</i> – In 2021, our CEO made advances totaling $410,000 to the Company under a convertible promissory note. Additional advances made in 2022 through June 30 totaled $627,069. The convertible note initially matured on January 1, 2022 but was subsequently amended to extend the maturity date to September 30, 2022. If the Company raises new equity capital of $3 million or more, then the full amount outstanding under the note is due within five days. The note bears interest at 10%. The principal and interest due on the convertible note may be converted, at the option of the holder, into restricted shares of the Company’s common stock at an initial conversion price of $0.50 per share but that was lowered in July 2022 to $0.30 per share. Accrued interest on this convertible promissory note totaled $52,291 at June 30, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "><i>Secured Promissory Note and Warrants to Coventry Asset Management, LTD. – </i>On December 30, 2020, the Company received proceeds from issuance of a secured promissory note in principal amount of $1,000,000 to Coventry Asset Management, LTD, a Company stockholder. The promissory note is secured by the property acquired in the acquisition of certain assets of Halcyon. The unpaid balance of the secured promissory note bears interest at a rate of 10% per annum and initially matured on June 30, 2021. The promissory note has been extended six times including the issuance of 20,000 restricted common shares as extension fees each for the first five extensions and the issuance of 50,000 restricted common shares for the sixth extension. The maturity date of the promissory note is December 31, 2022, as amended. If before December 31, 2022, the Company raises new equity capital of $5 million or more, then the full amount outstanding under the promissory note is due within five days. As amended, a payment of 25% of the principal balance of the note is due by October 31, 2022. If the promissory note is not paid in full by December 31, 2022, the interest rate increases to 14% per annum. Accrued interest on this secured note totaled $149,864 at June 30, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "><i>Subordinated Promissory Note and Warrants to Investor – </i>On December 30, 2020, the Company issued a subordinated promissory note in principal amount of $500,000 to an accredited investor who is also a Company stockholder. The unpaid balance of the Subordinated Note bears interest at a rate of 10% per annum. The Company made a principal payment of $250,000 in April 2021. The subordinated note principal together with accrued and unpaid interest was due, as previously amended, on March 31, 2022 but was subsequently extended. As subsequently amended, a payment of $50,000 was made in April 2022 and the remaining principal of $200,000 together with accrued interest was due on June 30, 2022. The Company did not make the principal payment due on June 30, 2022 and, as a result, this note is presently in default. Accrued interest on this subordinated promissory note totaled $29,932 at June 30, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The holder of the subordinated note received a warrant to purchase 500,000 shares of common stock exercisable for cash at an exercise price of $0.352 per share. As consideration for the April 2022 extension, the term of this warrant was extended by one year to December 30, 2023. The Company recognized $68,756 of interest expense in 2022 for this extension of the warrant term.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "><i>Promissory Note to Investment Hunter, LLC</i> – In 2022, Investment Hunter, LLC, a Texas LLC controlled by our CEO, made advances totaling $492,000 to the Company under a promissory note due September 30, 2022, as amended. If the Company raises new equity capital of $3 million or more, then the full amount outstanding under the note is due within five days. The note bears interest at 10% per annum. Accrued interest on this subordinated promissory note totaled $17,864 at June 30, 2022.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">June 30,</td><td style="font-weight: bold"> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Subordinated Promissory Note to CEO</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">523,551</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">523,551</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Convertible Promissory Note to CEO</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,037,069</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">410,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Secured Promissory Note to Coventry Asset Management, LTD.</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Subordinated Promissory Note to Investor</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">200,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">250,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Promissory Note to Investment Hunter, LLC</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">480,500</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-156">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Total notes payable – related parties</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">3,241,120</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">2,183,551</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b> </b></p> 523551 523551 1037069 410000 1000000 1000000 200000 250000 480500 3241120 2183551 2021-09-30 2022-09-30 3000000 0.10 33565 410000 627069 The convertible note initially matured on January 1, 2022 but was subsequently amended to extend the maturity date to September 30, 2022. 3000000 0.10 0.5 0.3 52291 1000000 0.10 2021-06-30 20000 50000 2022-12-31 5000000 0.25 2022-10-31 14% 149864 500000 0.10 250000 As subsequently amended, a payment of $50,000 was made in April 2022 and the remaining principal of $200,000 together with accrued interest was due on June 30, 2022. 29932 500000 0.352 P1Y 2023-12-30 68756 492000 2022-09-30 3000000 0.10 17864 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>6. Other Indebtedness</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">The Company is obligated under a mortgage payable dated September 15, 2014 secured by its warehouse property located in Denver, Colorado. The note provided for a 25-year amortization period and an initial interest rate of 9% annually. The note has been amended several times to a maturity date of September 30, 2022. In the latest extension, the Company made a principal payment of $25,000 plus accrued interest on July 18, 2022 and agreed to another principal payment of $25,000 plus accrued interest on August 31, 2022. The interest rate on the mortgage payable is 12%. If before the final maturity of the mortgage payable, the Company raises new equity capital of $5 million or more, then the full amount outstanding is due within ten days. The principal balance of this mortgage note payable as of June 30, 2022 was $473,192.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">The Company leases the Denver warehouse property to a tenant under an operating lease which was renewed with a new tenant and extended to August 1, 2023 for a monthly rent of $7,500. The lease requires a true-up with the tenant for property taxes and insurance paid by the Company and requires the tenant to maintain the interior and exterior of the warehouse (except for the roof). The lease provides for a rent abatement in the first and last month of the contracted extension. Minimum future rents for the remainder of 2022 are $45,000 and for 2023 are $52,500.</p> The note provided for a 25-year amortization period and an initial interest rate of 9% annually. The note has been amended several times to a maturity date of September 30, 2022. In the latest extension, the Company made a principal payment of $25,000 plus accrued interest on July 18, 2022 and agreed to another principal payment of $25,000 plus accrued interest on August 31, 2022. 0.12 5000000 473192 7500 45000 52500 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>7. <span>Commitments and Contingencies</span></b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "><i>Leases – </i>The Company leases office space in Fort Worth, Texas for managerial offices. This lease requires monthly payments of $2,000 and is month-to-month. Lease expense for this facility totaled $4,000 and $12,000 for the three and six months ended June 30, 2022, respectively. In the three and six months ended June 30. 2021, lease expense for this facility was $6,000 and $10,000, respectively.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The Company leases its operating facility in Kentucky from Oz Capital, LLC, a related party, under a lease expiring May 31, 2024. The lease provides for monthly payments of $10,249. Oz Capital, LLC is responsible for all taxes and maintenance under the lease. Lease expense for this facility totaled $31,147 and $61,494 in the three months ended June 30, 2022, respectively. In the three and six months ended June 30. 2021, lease expense for this facility was $30,747 and $57,857, respectively. A right-of-use asset and lease liability is recorded for this lease. As the lease does not provide an implicit rate, the Company used its estimated incremental borrowing rate of 10% in determining the present value of the lease payments.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Litigation – </i>From time to time, we are subject to various litigation and other claims in the normal course of business. Below is a discussion of specific matters. We cannot estimate the ultimate outcome of these matters.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="text-decoration:underline">Generation Hemp, Inc. v. Colorado Mills Equipment, LLC</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">The Defendant sold to the Company a faulty piece of equipment for $16,000 and will not refund the Company the purchase price after repeated attempts to return their equipment. An original lawsuit was filed by the Company against Colorado Mills in January 2022 in Dallas County, subsequently dismissed, and a second lawsuit has been filed El Paso County, Colorado and is currently pending.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="text-decoration:underline">Halcyon Thruput, LLC, Plaintiff v. United National Insurance Company, Defendant, United States District Court for the Northern District of Texas, Dallas Division, Case No. 3:21-CV-3136-K.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Halcyon Thruput, LLC (Halcyon) obtained an all-risks commercial insurance policy, including an Equipment Breakdown Endorsement (Policy) from United National Insurance Company (UNIC) to provide substantial coverages for Halcyon Thruput LLC’s (Halcyon) $1,203,735 hemp processing dryer (Dryer) at its facility in Hopkinsville, Kentucky. During the Policy period, the Dryer caught fire due to the Dryer being defectively designed.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">While UNIC paid a number of Halcyon’s claims, Halcyon’s claim for the cost of the replacement Dryer of $1,498,848 was denied as described below.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">  </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Buyer, a wholly owned subsidiary of the Company, pursuant to an Asset Purchase Agreement as twice amended, then acquired all the assets of Halcyon, except for the right to the proceeds of UNIC’s insurance policy since the Policy prohibited assignment. Halcyon and Buyer agreed that Buyer’s principal, Gary C. Evans, had the right to control the litigation, engage counsel for Halcyon and make all decisions relating to any proceeds received in the litigation by settlement or otherwise.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Halcyon’s suit against UNIC, which was removed to federal court, seeks $796,865.53 (the cost of the replacement dryer of $1,498,848, less a credit for $583,508.47 previously paid by UNIC to Halcyon for the Dryer fire=$915,339.53) plus statutory interest on that sum from August 10, 2020 for violating the Texas Insurance Code’s requirement that claims be promptly paid, additional statutory penalties, and attorneys’ fees. Certain documents have been executed between the Company, Halcyon and legal counsel, which provide for a sharing of costs and expenses and awards, if any, against UNIC. Mediation of the case was held in April 2022 where no agreement was reached by the parties. Depositions of the Company’s expert witnesses were completed in July 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="text-decoration:underline">JDONE, LLC v. Grand Traverse Holdings, LLC and John Gallegos, Denver District Court Case No. 2019CV33723</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; ">JDONE, LLC (“JDONE”) is a wholly owned subsidiary of the Company and landlord of a commercial warehouse building that was previously leased to Grand Traverse Holdings, LLC on December 31, 2018 for a term of 61 months, with a personal guaranty from Defendant, John Gallegos. On April 12, 2019, Grand Traverse presented JDONE with an alleged forged, signed copy of the draft early termination amendment that JDONE had previously rejected. JDONE has suffered damages due to Defendant’s alleged misconduct of approximately $823,504 plus interest and attorney’s fees exceeding $400,000. A court ordered mediation was held in May 2020 without success. All material defendant motions have been denied by the court. The case is set for jury trial in July 2022. We believe that Grand Traverse Holdings, LLC and John Gallegos are jointly liable for the asserted damages which exceed $1 million plus attorney’s fees and we continue to vigorously pursue our claims.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><span style="text-decoration:underline">KBSIII Tower at Lake Carolyn, LLC and Prime US-Tower at Lake Carolyn, LLC (collectively – “KBSIII” v. Energy Hunter Resources, Inc.)</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; ">Plaintiff/Counterdefendant KBSIII was seeking lost rent on office space for periods after EHR vacated office premises located in Las Colinas, Texas. EHR filed a counter suit alleging specific damages due to uninhabitable premises of the office space due to the intolerable conduct of other tenants located on the same floor. On December 23, 2020, the trial court entered a summary judgment against EHR for $230,712. The judgment provides for post-judgment interest at a rate of 5% per annum until paid and further provides for additional amounts owed should EHR pursue unsuccessful appeals to higher courts. At June 30, 2022, the Company had accrued $252,583 for this judgment, which is exclusively an EHR obligation.</p> 2000 4000 12000 6000 10000 2024-05-31 10249 31147 61494 30747 57857 0.10 16000 1203735 1498848 Halcyon’s suit against UNIC, which was removed to federal court, seeks $796,865.53 (the cost of the replacement dryer of $1,498,848, less a credit for $583,508.47 previously paid by UNIC to Halcyon for the Dryer fire=$915,339.53) plus statutory interest on that sum from August 10, 2020 for violating the Texas Insurance Code’s requirement that claims be promptly paid, additional statutory penalties, and attorneys’ fees. Certain documents have been executed between the Company, Halcyon and legal counsel, which provide for a sharing of costs and expenses and awards, if any, against UNIC. P61M 823504 400000 1000000 230712 0.05 252583 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>8. Income Taxes</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Income tax provisions for interim quarterly periods are generally based on an estimated annual effective income tax rate calculated separately from the effect of significant, infrequent or unusual items related specifically to interim periods. An income tax benefit for the three or six months ended June 30, 2022 or 2021 was not recognized because tax losses incurred were fully offset by a valuation allowance against deferred tax assets. There were no uncertain tax positions as of June 30, 2022.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>9. Equity</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i>Series A Preferred Stock <b>– </b></i>Our Series A Preferred Stock was originally issued in connection with HTF’s acquisition of EHR in 2019. On September 8, 2021, holders of the Company’s Series A Preferred Stock elected to convert such shares into shares of the Company’s common stock. As a result, 6,328,948 shares of Series A Preferred Stock were converted into 75,947,376 shares of common stock, with each share of Series A Preferred Stock converting into 12 shares of restricted common stock pursuant to the applicable Certificate of Designations.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "><i>Series B Preferred Stock Units – </i>On December 30, 2020, the Company sold to certain accredited investors, including Gary C. Evans, our Chief Executive Officer, an aggregate of 135 preferred stock units comprised of (i) one share of Series B Redeemable Convertible Preferred Stock, no par value, and (ii) one warrant exercisable for 50,000 shares of common stock of the Company until December 30, 2022 at an exercise price of $0.352 per share.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">The sale of the preferred stock units for $10,000 each resulted in aggregate gross proceeds of approximately $1.35 million, before deducting estimated offering expenses payable by the Company. Substantially all of the proceeds raised in the offering were used to fund the acquisition of assets of Halcyon, expenses related thereto and for general corporate purposes.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">Each share of Series B Preferred Stock is initially convertible into 25,000 shares of common stock, subject to adjustment. Holders of Series B Preferred Stock are entitled to receive dividends of 6.00% per annum based on the stated value equal to $10,000 per share. Except as otherwise required by law, the Series B Preferred Stock does not have voting rights. However, as long as any shares of Series B Preferred Stock are outstanding, the Company will not, without the affirmative vote of the holders of a majority of the then outstanding shares of the Series B Preferred Stock, (a) alter or change adversely the powers, preferences or rights given to the Series B Preferred Stock, (b) alter or amend the related certificate of designation, (c) amend its certificate of incorporation or other charter documents in any manner that adversely affects any rights of the holders of Series B Preferred Stock, (d) repay, repurchase or offer to repay, repurchase or otherwise acquire more than a de minimis number of shares of its common stock, (e) enter into any agreement with respect to any of the foregoing, or (f) pay cash dividends or distributions on any equity securities of the Company other than pursuant to the terms of the outstanding Series B Preferred Stock. The Series B Preferred Stock does not have a preference upon any liquidation, dissolution or winding-up of the Company.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">Any or all of the Series B Preferred Stock may be converted, at their holder’s option, into 25,000 shares of common stock, as adjusted for any stock dividends, splits, combinations or similar events.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">At any time after the occurrence of a “Qualifying Event,” the Company, upon 5-day written notice, shall have the right to cause each share of Series B Preferred Stock (and all accrued in-kind dividends with respect thereto) to be converted into common stock. For purposes of this automatic conversion of the Series B Preferred Stock, a “Qualifying Event” shall have occurred if (A) (1) the rolling five-trading day volume-weighted average trading price of shares of the common stock exceeds $1.00, and (2) there shall be an effective registration statement under the Securities Act of 1933, as amended covering all of the shares of common stock which would be issuable upon conversion of all of the outstanding shares of Series B Preferred Stock or (B) the Company closes a firm commitment underwriting of the common stock on a Form S-1 Registration Statement with aggregate gross proceeds of at least $5,000,000 at a price per share equal to or greater than $1.00. In each instance, a conversion may not be made unless the Company has filed an amendment to its Articles of Incorporation effecting an increase in its authorized common stock so that the Company has a sufficient number of authorized and unissued shares of common stock so as to permit the conversion of all outstanding shares.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">The Series B Preferred Stock may be redeemed by the Company for its stated value, plus accrued and unpaid dividends, at any time. Initially, redemption payments of 12.5% each of the total amount of Series B Preferred Stock then outstanding plus accrued dividends were due from the Company to each Holder of Series B Preferred Stock at the end of each calendar quarter of 2021. The first required redemption payments totaling $137,500 were made in April 2021. In May, June and October of 2021, the three holders of the Series B Preferred Stock, including the Company’s chief executive officer, entered into transactions in which they accepted the mandatory redemption payment required pursuant to the Series B Preferred Stock certificate of designation in a number of Series B Units to effectively waive the redemption requirement. All other terms of the Series B Units remain unchanged and the holders’ ownership interest in the Series B Preferred Units remains the same as it was before such transactions.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "><i>Common Stock – </i>At June 30, 2022, the Company had 113,154,002 common shares outstanding. Following is a discussion of common stock issuances during the periods presented:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">●</span></td><td style="text-align: left"><span style="font-size: 10pt"><i>Acquisition of Certain Assets of Halcyon </i>– In January 2021, the Company issued 6,250,000 shares of common stock valued at $2.5 million ($0.40 per share; restricted from trading for a period of up to one year) in the acquisition.</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">●</span></td><td style="text-align: left"><span style="font-size: 10pt"><i>2021 First Quarter Issuances of Common Stock Units</i> – In the first quarter of 2021, the Company issued 800,000 common stock units for total proceeds of $400,000. Each common stock unit consists of one share of common stock and a warrant for the purchase of two shares of common stock for $0.50 each. Each warrant is exercisable any time before its expiration on the second anniversary of its issuance. The Company allocated the total proceeds based on the relative fair values of the common stock and warrants. The fair value of the warrants was determined using an options valuation model with key assumptions including a risk-free interest rate of 0.11% and historical volatility of 272%. A total of $263,293 was allocated to the warrants and reported in additional paid-in capital.</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">●</span></td><td style="text-align: left"><span style="font-size: 10pt"><i>Warrant Exercises </i>– In the first quarter of 2021, the Company received $2,967,000 for the exercise of 8,428,976 outstanding warrants. In the fourth quarter of 2021, the Company received $375,000 for the exercise of 1,065,340 outstanding warrants.</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><i>●</i></span></td><td style="text-align: left"><span style="font-size: 10pt"><i>Issuances for Exchange or Conversion of Debt </i>– The Company issued a total of 1,618,660 common shares for the exchange or conversion of outstanding debt in the first quarter of 2021.</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">●</span></td><td style="text-align: left"><span style="font-size: 10pt"><i>Stock-based Compensation </i>– The Company issued 500,000 restricted common shares valued at $155,000 as incentive compensation to two executives who joined the Company in the first quarter of 2021.</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt"><span style="font-size: 10pt"> </span></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"/><td style="width: 0.25in; text-align: left"><span style="font-size: 10pt">●</span></td><td style="text-align: left"><span style="font-size: 10pt"><i>Issuance for Extension of Secured Note – </i>The Company issued 60,000 common shares as consideration for extensions of the maturity of a senior note in 2022. Refer to Note 5.</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"><i>Common Stock Warrants Outstanding – </i>Following is a summary of warrants outstanding as of June 30, 2022:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><b> </b></p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-left: 0.125in; white-space: nowrap"> </td><td style="text-align: center; white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"># of Warrants</td><td style="text-align: center; white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Exercise Price<br/> (each)</td><td style="text-align: center; white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Expiration Date</td><td style="text-align: center; white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Method of Exercise</td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td> </td><td> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 48%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued in December 2020 with Series B preferred units <sup>(1)</sup></span></td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">5,500,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">               0.352</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 11%">December 30, 2022</td><td style="width: 1%"> </td> <td style="width: 11%; text-align: center">Cash</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Issued in December 2020 with subordinated note to investor</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.352</td><td style="text-align: left"> </td><td> </td> <td>December 30, 2022</td><td> </td> <td style="text-align: center">Cash</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued in Q1 2021 with common stock units <sup>(1)</sup></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,600,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.500</td><td style="text-align: left"> </td><td> </td> <td style="white-space: nowrap">January-February, 2023</td><td> </td> <td style="text-align: center">Cash</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued in Q4 2021 with common stock units <sup>(1)</sup></span></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">958,333</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">0.600</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="white-space: nowrap; padding-bottom: 1.5pt">October-December, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt">Cash</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total warrants outstanding at June 30, 2022</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">8,558,333</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right"> </td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"/><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0in; margin-bottom: 0in; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in; text-align: left"><span style="font-size: 10pt"><sup>(1)</sup></span></td><td style="text-align: left"><span style="font-size: 10pt">May be redeemed for $0.0001 per warrant at the Company’s option with 30 days advanced notice should the weighted average market price of common stock exceed $1.00 for any five out of seven consecutive trading days with a minimum average daily trading volume for such seven-day period of at least 25,000 shares of common stock.</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in">Following is a summary of outstanding stock warrants activity for the periods presented:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td><td style="white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">Weighted</td><td style="white-space: nowrap; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td><td style="white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">Average</td><td style="white-space: nowrap; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"># of Warrants</td><td style="white-space: nowrap; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Exercise Price</td><td style="white-space: nowrap; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">Warrants as of December 31, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">8,808,333</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.407</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in">Cancelled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(250,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">0.400</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Warrants as of June 30, 2022</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">8,558,333</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left">$</td><td style="padding-bottom: 4pt; text-align: right">0.407</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> 6328948 75947376 12 Series B Preferred Stock Units – On December 30, 2020, the Company sold to certain accredited investors, including Gary C. Evans, our Chief Executive Officer, an aggregate of 135 preferred stock units comprised of (i) one share of Series B Redeemable Convertible Preferred Stock, no par value, and (ii) one warrant exercisable for 50,000 shares of common stock of the Company until December 30, 2022 at an exercise price of $0.352 per share.  10000 1350000 25000 0.06 10000 25000 1 5000000 1 0.125 137500 Common Stock – At June 30, 2022, the Company had 113,154,002 common shares outstanding. Following is a discussion of common stock issuances during the periods presented:  ●Acquisition of Certain Assets of Halcyon – In January 2021, the Company issued 6,250,000 shares of common stock valued at $2.5 million ($0.40 per share; restricted from trading for a period of up to one year) in the acquisition.   ●2021 First Quarter Issuances of Common Stock Units – In the first quarter of 2021, the Company issued 800,000 common stock units for total proceeds of $400,000. Each common stock unit consists of one share of common stock and a warrant for the purchase of two shares of common stock for $0.50 each. Each warrant is exercisable any time before its expiration on the second anniversary of its issuance. The Company allocated the total proceeds based on the relative fair values of the common stock and warrants. The fair value of the warrants was determined using an options valuation model with key assumptions including a risk-free interest rate of 0.11% and historical volatility of 272%. A total of $263,293 was allocated to the warrants and reported in additional paid-in capital.   ●Warrant Exercises – In the first quarter of 2021, the Company received $2,967,000 for the exercise of 8,428,976 outstanding warrants. In the fourth quarter of 2021, the Company received $375,000 for the exercise of 1,065,340 outstanding warrants.   ●Issuances for Exchange or Conversion of Debt – The Company issued a total of 1,618,660 common shares for the exchange or conversion of outstanding debt in the first quarter of 2021.   ●Stock-based Compensation – The Company issued 500,000 restricted common shares valued at $155,000 as incentive compensation to two executives who joined the Company in the first quarter of 2021.   ●Issuance for Extension of Secured Note – The Company issued 60,000 common shares as consideration for extensions of the maturity of a senior note in 2022. Refer to Note 5.   <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-left: 0.125in; white-space: nowrap"> </td><td style="text-align: center; white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"># of Warrants</td><td style="text-align: center; white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Exercise Price<br/> (each)</td><td style="text-align: center; white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Expiration Date</td><td style="text-align: center; white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Method of Exercise</td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in"> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td> </td><td> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; width: 48%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued in December 2020 with Series B preferred units <sup>(1)</sup></span></td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 11%; text-align: right">5,500,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 11%; text-align: right">               0.352</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 11%">December 30, 2022</td><td style="width: 1%"> </td> <td style="width: 11%; text-align: center">Cash</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left">Issued in December 2020 with subordinated note to investor</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">500,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.352</td><td style="text-align: left"> </td><td> </td> <td>December 30, 2022</td><td> </td> <td style="text-align: center">Cash</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued in Q1 2021 with common stock units <sup>(1)</sup></span></td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,600,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">0.500</td><td style="text-align: left"> </td><td> </td> <td style="white-space: nowrap">January-February, 2023</td><td> </td> <td style="text-align: center">Cash</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Issued in Q4 2021 with common stock units <sup>(1)</sup></span></td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">958,333</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">0.600</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="white-space: nowrap; padding-bottom: 1.5pt">October-December, 2023</td><td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt">Cash</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Total warrants outstanding at June 30, 2022</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">8,558,333</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right"> </td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"/> 5500000 0.352 December 30, 2022 Cash 500000 0.352 December 30, 2022 Cash 1600000 0.5 January-February, 2023 Cash 958333 0.6 October-December, 2023 Cash 8558333 0.0001 1 25000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td><td style="white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">Weighted</td><td style="white-space: nowrap; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td><td style="white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">Average</td><td style="white-space: nowrap; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center"># of Warrants</td><td style="white-space: nowrap; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">Exercise Price</td><td style="white-space: nowrap; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td> <td colspan="2" style="white-space: nowrap"> </td><td style="white-space: nowrap"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">Warrants as of December 31, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">8,808,333</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.407</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in">Cancelled</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(250,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right">0.400</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Warrants as of June 30, 2022</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">8,558,333</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left">$</td><td style="padding-bottom: 4pt; text-align: right">0.407</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table> 8808333 0.407 -250000 0.4 8558333 0.407 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>10. Stock-Based Compensation</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">We award restricted stock or stock options as incentive compensation to employees. Generally, these awards include vesting periods of up to three years from the date of grant.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">The 2021 Omnibus Incentive Plan (“2021 Plan”) was adopted by our Board on July 1, 2021. The 2021 Plan provides for the initial reservation of 15 million shares of common stock for issuance, and provides that the maximum number of shares that may be issued pursuant to the exercise of ISOs is 15 million. The number of shares of common stock available for issuance under the 2021 Plan constituted approximately 13.1% of the Company’s fully diluted common shares outstanding as of the date of Board approval, including shares issuable upon the conversion of preferred shares, as calculated on an as-converted basis. On the one-year anniversary date of the 2021 Plan, the number of shares of common stock reserved for issuance thereunder shall automatically increase to 20% of the fully diluted common shares outstanding, including shares issuable upon the conversion of preferred shares, as calculated on an as-converted basis.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">In the first quarter of 2021, the Company issued 500,000 restricted shares valued at $155,000 as incentive compensation to two executives who joined the Company. Compensation expense related to these awards totaled $38,750 and $81,000 for the three and six months ended June 30, 2021, respectively. These awards became fully vested in January 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">In the fourth quarter of 2021, the Company awarded options for 13,850,000 shares of the Company’s common stock as incentive compensation. One-third of the awarded options vested immediately with the remaining options vesting in two equal annual tranches over the next two years. Vested options may be exercised at any time until their expiration after 10 years at an exercise price of $0.76 per share. Unvested options are forfeited upon termination of employment.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">Compensation expense for stock option grants was recognized based on the fair value at the date of grant using the Black-Scholes option pricing model. Key assumptions included a risk-free interest rate ranging from 1.18% to 1.28%, historical volatility ranging from 331% to 643% and an expected life of the stock options ranging from five to six years. We recognized $1.3 million of compensation expense for these option awards in each of the quarters ended June 30, 2022. As of June 30, 2022, there was $3.5 million of total unrecognized compensation cost related to options to be recognized over a remaining weighted average period of 18 months.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; ">The following table summarizes options outstanding, as well as activity for the periods presented:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Grant Date<br/> Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate<br/> Intrinsic<br/> Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%">Outstanding at December 31, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">13,850,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.76</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.76</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-157">   -</div></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in">Granted</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-158">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-159">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-160">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-161">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding at June 30, 2022</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">13,850,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left">$</td><td style="padding-bottom: 4pt; text-align: right">0.76</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left">$</td><td style="padding-bottom: 4pt; text-align: right">0.76</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-162">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The remaining weighted average contractual life of exercisable options at June 30, 2022 was 9.3 years.</p> 15000000 15000000 0.131 0.20 500000 155000 38750 81000 13850000 P10Y 0.76 0.0118 0.0128 3.31 6.43 P5Y P6Y 1300000 3500000 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Shares</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Grant Date<br/> Fair Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Weighted<br/> Average<br/> Exercise<br/> Price</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Aggregate<br/> Intrinsic<br/> Value</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%">Outstanding at December 31, 2021</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right">13,850,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.76</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">0.76</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td><td style="width: 9%; text-align: right"><div style="-sec-ix-hidden: hidden-fact-157">   -</div></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in">Granted</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><div style="-sec-ix-hidden: hidden-fact-158">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-159">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left">$</td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-160">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-161">-</div></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Outstanding at June 30, 2022</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">13,850,000</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left">$</td><td style="padding-bottom: 4pt; text-align: right">0.76</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left">$</td><td style="padding-bottom: 4pt; text-align: right">0.76</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt; text-align: right"><div style="-sec-ix-hidden: hidden-fact-162">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in; "> </p> 13850000 0.76 0.76 13850000 0.76 0.76 P9Y3M18D <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>11. Discontinued Operations</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">In 2019, management determined to fully divest of EHR’s oil and gas activities. As such, these activities are presented as discontinued operations for each of the periods presented.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following is a summary of the carrying amounts of major classes of assets and liabilities of the discontinued operations to assets and liabilities held for sale:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">June 30,</td><td style="white-space: nowrap; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">December 31,</td><td style="white-space: nowrap; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in">Assets -</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; width: 76%; text-align: left">Oil and natural gas properties held for sale, at cost</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,874,849</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,874,849</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-align: left">Accumulated DD&amp;A</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,874,849</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,874,849</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-align: left">Total assets of discontinued operations held for sale</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-163">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-164">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in">Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-align: left">Accrued liabilities</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">55,572</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">48,997</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-align: left">Asset retirement obligations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">52,368</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">52,368</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-align: left">Revenue payable</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">52,117</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">52,117</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.25in; text-align: left">Current liabilities of discontinued operations held for sale</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">160,057</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">153,482</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-align: left">Asset retirement obligations -</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.25in; text-align: left">Long-term liabilities of discontinued operations held for sale</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">193,816</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">162,948</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-align: left">Total liabilities of discontinued operations held for sale</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">353,873</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">316,430</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following is a summary of the major classes of line items constituting loss on discontinued operations shown in the consolidated statements of operations:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center; white-space: nowrap"> </td><td style="text-align: center; white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">For the three months ended <br/> June 30,</td><td style="text-align: center; white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">For the six months ended<br/> June 30,</td><td style="text-align: center; white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td>Revenue -</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; width: 52%; text-align: left">Oil and gas sales</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">36,925</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">16,119</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">75,793</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">38,108</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Costs and Expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-align: left">Lease operating expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">41,140</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,067</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">85,188</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">40,795</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Accretion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">23,352</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,257</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">30,868</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,032</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-align: left">Total costs and expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">64,492</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">22,324</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">116,056</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">47,827</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Loss from discontinued operations</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(27,567</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(6,205</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(40,263</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(9,719</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="white-space: nowrap"> </td><td style="white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">June 30,</td><td style="white-space: nowrap; font-weight: bold"> </td><td style="white-space: nowrap; font-weight: bold"> </td> <td colspan="2" style="white-space: nowrap; font-weight: bold; text-align: center">December 31,</td><td style="white-space: nowrap; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 0.125in">Assets -</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; width: 76%; text-align: left">Oil and natural gas properties held for sale, at cost</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,874,849</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">1,874,849</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-align: left">Accumulated DD&amp;A</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,874,849</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,874,849</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-align: left">Total assets of discontinued operations held for sale</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-163">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right"><div style="-sec-ix-hidden: hidden-fact-164">-</div></td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in">Liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-align: left">Accrued liabilities</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">55,572</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">48,997</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-align: left">Asset retirement obligations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">52,368</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">52,368</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-align: left">Revenue payable</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">52,117</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">52,117</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.25in; text-align: left">Current liabilities of discontinued operations held for sale</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">160,057</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">153,482</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-align: left">Asset retirement obligations -</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.25in; text-align: left">Long-term liabilities of discontinued operations held for sale</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">193,816</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">162,948</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-align: left">Total liabilities of discontinued operations held for sale</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">353,873</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">316,430</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"/> 1874849 1874849 -1874849 -1874849 55572 48997 52368 52368 52117 52117 160057 153482 193816 162948 353873 316430 <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center; white-space: nowrap"> </td><td style="text-align: center; white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">For the three months ended <br/> June 30,</td><td style="text-align: center; white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; white-space: nowrap; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; white-space: nowrap; font-weight: bold; text-align: center">For the six months ended<br/> June 30,</td><td style="text-align: center; white-space: nowrap; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td>Revenue -</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; width: 52%; text-align: left">Oil and gas sales</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">36,925</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">16,119</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">75,793</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">38,108</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Costs and Expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-align: left">Lease operating expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">41,140</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">18,067</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">85,188</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">40,795</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Accretion</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">23,352</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,257</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">30,868</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">7,032</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-align: left">Total costs and expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">64,492</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">22,324</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">116,056</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">47,827</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Loss from discontinued operations</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(27,567</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(6,205</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(40,263</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(9,719</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr> </table> 36925 16119 75793 38108 41140 18067 85188 40795 23352 4257 30868 7032 64492 22324 116056 47827 -27567 -6205 -40263 -9719 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>12. Supplemental Cash Flow Information</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the six months ended<br/> June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0in; width: 76%; text-align: left">Cash paid for interest</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">39,295</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">45,342</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0in; text-align: left">Cash paid for taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-165">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-166">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0in; text-align: left">Noncash investing and financing activities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-align: left">Acquisition of certain assets of Halcyon Thruput, LLC</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.25in">- issuance of common shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-167">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,500,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.25in; text-align: left">- issuance of subordinated note</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-168">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">850,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.25in; text-align: left">- assumption of Halcyon bank note</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-169">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">995,614</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-align: left">Series B preferred stock dividend payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">40,367</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">24,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-align: left">Issuance of common stock units previously subscribed</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-170">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">50,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-align: left">Issuances of common shares for exchange or conversion of debt</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-171">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,160,269</td><td style="text-align: left"> </td></tr> </table> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">For the six months ended<br/> June 30,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0in; width: 76%; text-align: left">Cash paid for interest</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">39,295</td><td style="width: 1%; text-align: left"> </td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">45,342</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0in; text-align: left">Cash paid for taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-165">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-166">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0in; text-align: left">Noncash investing and financing activities:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-align: left">Acquisition of certain assets of Halcyon Thruput, LLC</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.25in">- issuance of common shares</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-167">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,500,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.25in; text-align: left">- issuance of subordinated note</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-168">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">850,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.25in; text-align: left">- assumption of Halcyon bank note</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-169">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">995,614</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-align: left">Series B preferred stock dividend payable</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">40,367</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">24,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-left: 0.125in; text-align: left">Issuance of common stock units previously subscribed</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-170">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">50,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 0.125in; text-align: left">Issuances of common shares for exchange or conversion of debt</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-171">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,160,269</td><td style="text-align: left"> </td></tr> </table> 39295 45342 2500000 850000 995614 40367 24000 50000 2160269 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>13. Earnings (Loss) per Share</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following is the computation of earnings (loss) per basic and diluted share:</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; white-space: nowrap"> </td><td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; white-space: nowrap; font-weight: bold">For the three months ended <br/> June 30,</td><td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; white-space: nowrap; font-weight: bold">For the six months ended<br/> June 30,</td><td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in">Amounts attributable to Generation Hemp:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in">Numerator</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; width: 52%; text-align: left">Loss from continuing operations attributable to common stockholders</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(2,109,281</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(1,146,697</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(4,553,952</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(2,980,285</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Loss from discontinued operations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(25,841</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(5,817</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(40,263</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(9,111</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Less: preferred stock dividends</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(20,992</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(20,250</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(20,992</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(40,500</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Net loss attributable to common stockholders</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(2,156,114</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1,172,764</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(4,615,207</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(3,029,896</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in">Denominator</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Weighted average shares used to compute basic EPS</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">113,145,211</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">34,977,953</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">113,122,510</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">26,691,992</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Dilutive effect of convertible note</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,164,773</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-172">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,164,773</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-173">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Dilutive effect of preferred stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,950,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">79,322,376</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,953,125</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">79,322,376</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Dilutive effect of common stock options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-174">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-175">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-176">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-177">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Dilutive effect of common stock warrants</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,518,226</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,654,942</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,436,954</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,787,111</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Weighted average shares used to compute diluted EPS</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">118,778,209</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">125,955,271</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">119,677,362</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">117,801,479</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in">Earnings (loss) per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Loss from continuing operations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.375in">Basic</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.02</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.03</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.04</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.11</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.375in">Diluted</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.02</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.03</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.04</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.11</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Loss from discontinued operations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.375in">Basic</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-178">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-179">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-180">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-181">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.375in">Diluted</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-182">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-183">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-184">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-185">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in">Earnings (loss) per share</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.375in">Basic</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.02</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.03</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.04</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.11</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.375in">Diluted</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.02</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.03</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.04</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.11</td><td style="text-align: left">)</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The computation of diluted earnings per common share excludes the assumed conversion of the Series B Preferred Stock and outstanding convertible notes and exercise of common stock options and warrants in periods when we report a loss. The dilutive effect of the assumed exercise of outstanding options and warrants was calculated using the treasury stock method.</p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in; white-space: nowrap"> </td><td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; white-space: nowrap; font-weight: bold">For the three months ended <br/> June 30,</td><td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; text-align: center; white-space: nowrap; font-weight: bold">For the six months ended<br/> June 30,</td><td style="padding-bottom: 1.5pt; white-space: nowrap; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.125in"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2022</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in">Amounts attributable to Generation Hemp:</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="text-indent: -0.125in; padding-left: 0.125in">Numerator</td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; width: 52%; text-align: left">Loss from continuing operations attributable to common stockholders</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(2,109,281</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(1,146,697</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(4,553,952</td><td style="width: 1%; text-align: left">)</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">(2,980,285</td><td style="width: 1%; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Loss from discontinued operations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(25,841</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(5,817</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(40,263</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(9,111</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Less: preferred stock dividends</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(20,992</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(20,250</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(20,992</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(40,500</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Net loss attributable to common stockholders</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(2,156,114</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(1,172,764</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(4,615,207</td><td style="padding-bottom: 4pt; text-align: left">)</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td><td style="border-bottom: Black 4pt double; text-align: right">(3,029,896</td><td style="padding-bottom: 4pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in">Denominator</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Weighted average shares used to compute basic EPS</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">113,145,211</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">34,977,953</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">113,122,510</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">26,691,992</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Dilutive effect of convertible note</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,164,773</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-172">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,164,773</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-173">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Dilutive effect of preferred stock</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,950,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">79,322,376</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,953,125</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">79,322,376</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Dilutive effect of common stock options</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-174">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-175">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-176">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-177">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Dilutive effect of common stock warrants</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,518,226</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,654,942</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,436,954</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">11,787,111</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 4pt; text-indent: -0.125in; padding-left: 0.25in; text-align: left">Weighted average shares used to compute diluted EPS</td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">118,778,209</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">125,955,271</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">119,677,362</td><td style="padding-bottom: 4pt; text-align: left"> </td><td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left"> </td><td style="border-bottom: Black 4pt double; text-align: right">117,801,479</td><td style="padding-bottom: 4pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.125in"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.125in">Earnings (loss) per share:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Loss from continuing operations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.375in">Basic</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.02</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.03</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.04</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.11</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.375in">Diluted</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.02</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.03</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.04</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.11</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.25in; text-align: left">Loss from discontinued operations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.375in">Basic</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-178">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-179">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-180">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-181">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.375in">Diluted</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-182">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-183">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-184">-</div></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td style="text-align: right"><div style="-sec-ix-hidden: hidden-fact-185">-</div></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.25in">Earnings (loss) per share</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -0.125in; padding-left: 0.375in">Basic</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.02</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.03</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.04</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.11</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -0.125in; padding-left: 0.375in">Diluted</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.02</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.03</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.04</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">(0.11</td><td style="text-align: left">)</td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p> -2109281 -1146697 -4553952 -2980285 -25841 -5817 -40263 -9111 -20992 -20250 -20992 -40500 -2156114 -1172764 -4615207 -3029896 113145211 34977953 113122510 26691992 1164773 1164773 2950000 79322376 2953125 79322376 1518226 11654942 2436954 11787111 118778209 125955271 119677362 117801479 -0.02 -0.03 -0.04 -0.11 -0.02 -0.03 -0.04 -0.11 -0.02 -0.03 -0.04 -0.11 -0.02 -0.03 -0.04 -0.11 <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>14. Subsequent Events</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><i> </i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Advances under Convertible Promissory Note</i> – In the third quarter of 2022 through the date of this filing, our CEO made advances totaling $58,000 to the Company under the existing convertible promissory note due September 30, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Advances under Promissory Note to Investment Hunter, LLC </i>– In the third quarter of 2022 through the date of this filing, Investment Hunter, LLC made advances totaling $11,500 to the Company under the existing promissory note due September 30, 2022.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i> </i></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>Sale of inventories</i> – In July 2022, the Company entered into an agreement for the sale of 66,782 pounds of dried hemp biomass from its inventories on-hand for a sales price of $1.50 per pound. Deliveries and payment of the $100,173 sales proceeds are scheduled monthly through December 2022. The Company received an initial down payment of $40,069.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><i>New indebtedness</i> – In August 2022, the Company received proceeds totaling $105,000 from new notes payable to three board directors. The notes bear interest at 10% per annum and mature on September 12, 2022.</p> 58000 11500 2022-09-30 66782 1.5 100173 40069 105000 3 0.10 2022-09-12 false --12-31 Q2 0001527102 May be redeemed for $0.0001 per warrant at the Company’s option with 30 days advanced notice should the weighted average market price of common stock exceed $1.00 for any five out of seven consecutive trading days with a minimum average daily trading volume for such seven-day period of at least 25,000 shares of common stock. EXCEL 67 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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end XML 68 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 69 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 70 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 173 324 1 true 48 0 false 5 false false R1.htm 000 - Document - Document And Entity Information Sheet http://www.genhempinc.com/role/DocumentAndEntityInformation Document And Entity Information Cover 1 false false R2.htm 001 - Statement - Unaudited Condensed Consolidated Balance Sheets Sheet http://www.genhempinc.com/role/ConsolidatedBalanceSheet Unaudited Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 002 - Statement - Unaudited Condensed Consolidated Balance Sheets (Parentheticals) Sheet http://www.genhempinc.com/role/ConsolidatedBalanceSheet_Parentheticals Unaudited Condensed Consolidated Balance Sheets (Parentheticals) Statements 3 false false R4.htm 003 - Statement - Unaudited Condensed Consolidated Statements of Operations Sheet http://www.genhempinc.com/role/ConsolidatedIncomeStatement Unaudited Condensed Consolidated Statements of Operations Statements 4 false false R5.htm 004 - Statement - Unaudited Condensed Consolidated Statements of Equity (Deficit) Sheet http://www.genhempinc.com/role/ShareholdersEquityType2or3 Unaudited Condensed Consolidated Statements of Equity (Deficit) Statements 5 false false R6.htm 005 - Statement - Unaudited Condensed Consolidated Statements of Cash Flows Sheet http://www.genhempinc.com/role/ConsolidatedCashFlow Unaudited Condensed Consolidated Statements of Cash Flows Statements 6 false false R7.htm 006 - Disclosure - Business Sheet http://www.genhempinc.com/role/Business Business Notes 7 false false R8.htm 007 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.genhempinc.com/role/SummaryofSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 8 false false R9.htm 008 - Disclosure - Property and Equipment Sheet http://www.genhempinc.com/role/PropertyandEquipment Property and Equipment Notes 9 false false R10.htm 009 - Disclosure - Intangible and Other Assets Sheet http://www.genhempinc.com/role/IntangibleandOtherAssets Intangible and Other Assets Notes 10 false false R11.htm 010 - Disclosure - Notes Payable ??? Related Parties Notes http://www.genhempinc.com/role/NotesPayableRelatedParties Notes Payable ??? Related Parties Notes 11 false false R12.htm 011 - Disclosure - Other Indebtedness Sheet http://www.genhempinc.com/role/OtherIndebtedness Other Indebtedness Notes 12 false false R13.htm 012 - Disclosure - Commitments and Contingencies Sheet http://www.genhempinc.com/role/CommitmentsandContingencies Commitments and Contingencies Notes 13 false false R14.htm 013 - Disclosure - Income Taxes Sheet http://www.genhempinc.com/role/IncomeTaxes Income Taxes Notes 14 false false R15.htm 014 - Disclosure - Equity Sheet http://www.genhempinc.com/role/Equity Equity Notes 15 false false R16.htm 015 - Disclosure - Stock-Based Compensation Sheet http://www.genhempinc.com/role/StockBasedCompensation Stock-Based Compensation Notes 16 false false R17.htm 016 - Disclosure - Discontinued Operations Sheet http://www.genhempinc.com/role/DiscontinuedOperations Discontinued Operations Notes 17 false false R18.htm 017 - Disclosure - Supplemental Cash Flow Information Sheet http://www.genhempinc.com/role/SupplementalCashFlowInformation Supplemental Cash Flow Information Notes 18 false false R19.htm 018 - Disclosure - Earnings (Loss) Per Share Sheet http://www.genhempinc.com/role/EarningsLossPerShare Earnings (Loss) Per Share Notes 19 false false R20.htm 019 - Disclosure - Subsequent Events Sheet http://www.genhempinc.com/role/SubsequentEvents Subsequent Events Notes 20 false false R21.htm 020 - Disclosure - Accounting Policies, by Policy (Policies) Sheet http://www.genhempinc.com/role/AccountingPoliciesByPolicy Accounting Policies, by Policy (Policies) Policies http://www.genhempinc.com/role/SummaryofSignificantAccountingPolicies 21 false false R22.htm 021 - Disclosure - Property and Equipment (Tables) Sheet http://www.genhempinc.com/role/PropertyandEquipmentTables Property and Equipment (Tables) Tables http://www.genhempinc.com/role/PropertyandEquipment 22 false false R23.htm 022 - Disclosure - Intangible and Other Assets (Tables) Sheet http://www.genhempinc.com/role/IntangibleandOtherAssetsTables Intangible and Other Assets (Tables) Tables http://www.genhempinc.com/role/IntangibleandOtherAssets 23 false false R24.htm 023 - Disclosure - Notes Payable ??? Related Parties (Tables) Notes http://www.genhempinc.com/role/NotesPayableRelatedPartiesTables Notes Payable ??? Related Parties (Tables) Tables http://www.genhempinc.com/role/NotesPayableRelatedParties 24 false false R25.htm 024 - Disclosure - Equity (Tables) Sheet http://www.genhempinc.com/role/EquityTables Equity (Tables) Tables http://www.genhempinc.com/role/Equity 25 false false R26.htm 025 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.genhempinc.com/role/StockBasedCompensationTables Stock-Based Compensation (Tables) Tables http://www.genhempinc.com/role/StockBasedCompensation 26 false false R27.htm 026 - Disclosure - Discontinued Operations (Tables) Sheet http://www.genhempinc.com/role/DiscontinuedOperationsTables Discontinued Operations (Tables) Tables http://www.genhempinc.com/role/DiscontinuedOperations 27 false false R28.htm 027 - Disclosure - Supplemental Cash Flow Information (Tables) Sheet http://www.genhempinc.com/role/SupplementalCashFlowInformationTables Supplemental Cash Flow Information (Tables) Tables http://www.genhempinc.com/role/SupplementalCashFlowInformation 28 false false R29.htm 028 - Disclosure - Earnings (Loss) Per Share (Tables) Sheet http://www.genhempinc.com/role/EarningsLossPerShareTables Earnings (Loss) Per Share (Tables) Tables http://www.genhempinc.com/role/EarningsLossPerShare 29 false false R30.htm 029 - Disclosure - Business (Details) Sheet http://www.genhempinc.com/role/BusinessDetails Business (Details) Details http://www.genhempinc.com/role/Business 30 false false R31.htm 030 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.genhempinc.com/role/SummaryofSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) Details 31 false false R32.htm 031 - Disclosure - Property and Equipment (Details) - Schedule of property and equipment Sheet http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable Property and Equipment (Details) - Schedule of property and equipment Details http://www.genhempinc.com/role/PropertyandEquipmentTables 32 false false R33.htm 032 - Disclosure - Intangible and Other Assets (Details) Sheet http://www.genhempinc.com/role/IntangibleandOtherAssetsDetails Intangible and Other Assets (Details) Details http://www.genhempinc.com/role/IntangibleandOtherAssetsTables 33 false false R34.htm 033 - Disclosure - Intangible and Other Assets (Details) - Schedule of intangible asset Sheet http://www.genhempinc.com/role/ScheduleofintangibleassetTable Intangible and Other Assets (Details) - Schedule of intangible asset Details http://www.genhempinc.com/role/IntangibleandOtherAssetsTables 34 false false R35.htm 034 - Disclosure - Notes Payable ??? Related Parties (Details) Notes http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails Notes Payable ??? Related Parties (Details) Details http://www.genhempinc.com/role/NotesPayableRelatedPartiesTables 35 false false R36.htm 035 - Disclosure - Notes Payable ??? Related Parties (Details) - Schedule of notes payable ??? related parties Notes http://www.genhempinc.com/role/ScheduleofnotespayablerelatedpartiesTable Notes Payable ??? Related Parties (Details) - Schedule of notes payable ??? related parties Details http://www.genhempinc.com/role/NotesPayableRelatedPartiesTables 36 false false R37.htm 036 - Disclosure - Other Indebtedness (Details) Sheet http://www.genhempinc.com/role/OtherIndebtednessDetails Other Indebtedness (Details) Details http://www.genhempinc.com/role/OtherIndebtedness 37 false false R38.htm 037 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.genhempinc.com/role/CommitmentsandContingenciesDetails Commitments and Contingencies (Details) Details http://www.genhempinc.com/role/CommitmentsandContingencies 38 false false R39.htm 038 - Disclosure - Equity (Details) Sheet http://www.genhempinc.com/role/EquityDetails Equity (Details) Details http://www.genhempinc.com/role/EquityTables 39 false false R40.htm 039 - Disclosure - Equity (Details) - Schedule of warrants outstanding Sheet http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable Equity (Details) - Schedule of warrants outstanding Details http://www.genhempinc.com/role/EquityTables 40 false false R41.htm 040 - Disclosure - Equity (Details) - Schedule of outstanding stock warrants activity Sheet http://www.genhempinc.com/role/ScheduleofoutstandingstockwarrantsactivityTable Equity (Details) - Schedule of outstanding stock warrants activity Details http://www.genhempinc.com/role/EquityTables 41 false false R42.htm 041 - Disclosure - Stock-Based Compensation (Details) Sheet http://www.genhempinc.com/role/StockBasedCompensationDetails Stock-Based Compensation (Details) Details http://www.genhempinc.com/role/StockBasedCompensationTables 42 false false R43.htm 042 - Disclosure - Stock-Based Compensation (Details) - Schedule of summarizes options outstanding Sheet http://www.genhempinc.com/role/ScheduleofsummarizesoptionsoutstandingTable Stock-Based Compensation (Details) - Schedule of summarizes options outstanding Details http://www.genhempinc.com/role/StockBasedCompensationTables 43 false false R44.htm 043 - Disclosure - Discontinued Operations (Details) - Schedule of discontinued operations to assets and liabilities held for sale Sheet http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable Discontinued Operations (Details) - Schedule of discontinued operations to assets and liabilities held for sale Details http://www.genhempinc.com/role/DiscontinuedOperationsTables 44 false false R45.htm 044 - Disclosure - Discontinued Operations (Details) - Schedule of discontinued operations shown in the consolidated statements of operations Sheet http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationsshownintheconsolidatedstatementsofoperationsTable Discontinued Operations (Details) - Schedule of discontinued operations shown in the consolidated statements of operations Details http://www.genhempinc.com/role/DiscontinuedOperationsTables 45 false false R46.htm 045 - Disclosure - Supplemental Cash Flow Information (Details) - Schedule of supplemental cash flow information Sheet http://www.genhempinc.com/role/ScheduleofsupplementalcashflowinformationTable Supplemental Cash Flow Information (Details) - Schedule of supplemental cash flow information Details http://www.genhempinc.com/role/SupplementalCashFlowInformationTables 46 false false R47.htm 046 - Disclosure - Earnings (Loss) Per Share (Details) - Schedule of earnings (loss) per basic and diluted share Sheet http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable Earnings (Loss) Per Share (Details) - Schedule of earnings (loss) per basic and diluted share Details http://www.genhempinc.com/role/EarningsLossPerShareTables 47 false false R48.htm 047 - Disclosure - Subsequent Events (Details) Sheet http://www.genhempinc.com/role/SubsequentEventsDetails Subsequent Events (Details) Details http://www.genhempinc.com/role/SubsequentEvents 48 false false All Reports Book All Reports f10q0622_generation.htm f10q0622ex10-1_generation.htm f10q0622ex10-2_generation.htm f10q0622ex10-3_generation.htm f10q0622ex10-4_generation.htm f10q0622ex10-5_generation.htm f10q0622ex10-6_generation.htm f10q0622ex10-7_generation.htm f10q0622ex10-8_generation.htm f10q0622ex10-9_generation.htm f10q0622ex31-1_generation.htm f10q0622ex32-1_generation.htm genh-20220630.xsd genh-20220630_cal.xml genh-20220630_def.xml genh-20220630_lab.xml genh-20220630_pre.xml http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 72 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "f10q0622_generation.htm": { "axisCustom": 0, "axisStandard": 16, "contextCount": 173, "dts": { "calculationLink": { "local": [ "genh-20220630_cal.xml" ] }, "definitionLink": { "local": [ "genh-20220630_def.xml" ] }, "inline": { "local": [ "f10q0622_generation.htm" ] }, "labelLink": { "local": [ "genh-20220630_lab.xml" ] }, "presentationLink": { "local": [ "genh-20220630_pre.xml" ] }, "schema": { "local": [ "genh-20220630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd", "https://xbrl.sec.gov/sic/2022/sic-2022.xsd" ] } }, "elementCount": 486, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 142, "http://www.genhempinc.com/20220630": 44, "http://xbrl.sec.gov/dei/2022": 4, "total": 190 }, "keyCustom": 85, "keyStandard": 239, "memberCustom": 22, "memberStandard": 24, "nsprefix": "genh", "nsuri": "http://www.genhempinc.com/20220630", "report": { "R1": { "firstAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "000 - Document - Document And Entity Information", "role": "http://www.genhempinc.com/role/DocumentAndEntityInformation", "shortName": "Document And Entity Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "p", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "dei:EntityRegistrantName", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "009 - Disclosure - Intangible and Other Assets", "role": "http://www.genhempinc.com/role/IntangibleandOtherAssets", "shortName": "Intangible and Other Assets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "010 - Disclosure - Notes Payable \u2013 Related Parties", "role": "http://www.genhempinc.com/role/NotesPayableRelatedParties", "shortName": "Notes Payable \u2013 Related Parties", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MortgageNotesPayableDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "011 - Disclosure - Other Indebtedness", "role": "http://www.genhempinc.com/role/OtherIndebtedness", "shortName": "Other Indebtedness", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MortgageNotesPayableDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "012 - Disclosure - Commitments and Contingencies", "role": "http://www.genhempinc.com/role/CommitmentsandContingencies", "shortName": "Commitments and Contingencies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "013 - Disclosure - Income Taxes", "role": "http://www.genhempinc.com/role/IncomeTaxes", "shortName": "Income Taxes", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "014 - Disclosure - Equity", "role": "http://www.genhempinc.com/role/Equity", "shortName": "Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "015 - Disclosure - Stock-Based Compensation", "role": "http://www.genhempinc.com/role/StockBasedCompensation", "shortName": "Stock-Based Compensation", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "016 - Disclosure - Discontinued Operations", "role": "http://www.genhempinc.com/role/DiscontinuedOperations", "shortName": "Discontinued Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "017 - Disclosure - Supplemental Cash Flow Information", "role": "http://www.genhempinc.com/role/SupplementalCashFlowInformation", "shortName": "Supplemental Cash Flow Information", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashFlowSupplementalDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "018 - Disclosure - Earnings (Loss) Per Share", "role": "http://www.genhempinc.com/role/EarningsLossPerShare", "shortName": "Earnings (Loss) Per Share", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:EarningsPerShareTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "001 - Statement - Unaudited Condensed Consolidated Balance Sheets", "role": "http://www.genhempinc.com/role/ConsolidatedBalanceSheet", "shortName": "Unaudited Condensed Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "019 - Disclosure - Subsequent Events", "role": "http://www.genhempinc.com/role/SubsequentEvents", "shortName": "Subsequent Events", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "020 - Disclosure - Accounting Policies, by Policy (Policies)", "role": "http://www.genhempinc.com/role/AccountingPoliciesByPolicy", "shortName": "Accounting Policies, by Policy (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "021 - Disclosure - Property and Equipment (Tables)", "role": "http://www.genhempinc.com/role/PropertyandEquipmentTables", "shortName": "Property and Equipment (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "022 - Disclosure - Intangible and Other Assets (Tables)", "role": "http://www.genhempinc.com/role/IntangibleandOtherAssetsTables", "shortName": "Intangible and Other Assets (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "genh:ScheduleOfNotesPayableRelatedPartiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "023 - Disclosure - Notes Payable \u2013 Related Parties (Tables)", "role": "http://www.genhempinc.com/role/NotesPayableRelatedPartiesTables", "shortName": "Notes Payable \u2013 Related Parties (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "genh:ScheduleOfNotesPayableRelatedPartiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "024 - Disclosure - Equity (Tables)", "role": "http://www.genhempinc.com/role/EquityTables", "shortName": "Equity (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "025 - Disclosure - Stock-Based Compensation (Tables)", "role": "http://www.genhempinc.com/role/StockBasedCompensationTables", "shortName": "Stock-Based Compensation (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "genh:ScheduleOfDiscontinuedOperationsToAssetsAndLiabilitiesHeldForSaleTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "026 - Disclosure - Discontinued Operations (Tables)", "role": "http://www.genhempinc.com/role/DiscontinuedOperationsTables", "shortName": "Discontinued Operations (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "genh:ScheduleOfDiscontinuedOperationsToAssetsAndLiabilitiesHeldForSaleTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "027 - Disclosure - Supplemental Cash Flow Information (Tables)", "role": "http://www.genhempinc.com/role/SupplementalCashFlowInformationTables", "shortName": "Supplemental Cash Flow Information (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "028 - Disclosure - Earnings (Loss) Per Share (Tables)", "role": "http://www.genhempinc.com/role/EarningsLossPerShareTables", "shortName": "Earnings (Loss) Per Share (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c2", "decimals": "5", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "002 - Statement - Unaudited Condensed Consolidated Balance Sheets (Parentheticals)", "role": "http://www.genhempinc.com/role/ConsolidatedBalanceSheet_Parentheticals", "shortName": "Unaudited Condensed Consolidated Balance Sheets (Parentheticals)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c2", "decimals": "5", "first": true, "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "usdPershares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c76", "decimals": "0", "first": true, "lang": null, "name": "genh:SquareFootFacility", "reportCount": 1, "unique": true, "unitRef": "usdPersqft", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "029 - Disclosure - Business (Details)", "role": "http://www.genhempinc.com/role/BusinessDetails", "shortName": "Business (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c76", "decimals": "0", "first": true, "lang": null, "name": "genh:SquareFootFacility", "reportCount": 1, "unique": true, "unitRef": "usdPersqft", "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OtherCostOfOperatingRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "030 - Disclosure - Summary of Significant Accounting Policies (Details)", "role": "http://www.genhempinc.com/role/SummaryofSignificantAccountingPoliciesDetails", "shortName": "Summary of Significant Accounting Policies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OtherCostOfOperatingRevenue", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "031 - Disclosure - Property and Equipment (Details) - Schedule of property and equipment", "role": "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable", "shortName": "Property and Equipment (Details) - Schedule of property and equipment", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PropertyPlantAndEquipmentGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "genh:OptionToPurchaseDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "032 - Disclosure - Intangible and Other Assets (Details)", "role": "http://www.genhempinc.com/role/IntangibleandOtherAssetsDetails", "shortName": "Intangible and Other Assets (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "genh:OptionToPurchaseDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "033 - Disclosure - Intangible and Other Assets (Details) - Schedule of intangible asset", "role": "http://www.genhempinc.com/role/ScheduleofintangibleassetTable", "shortName": "Intangible and Other Assets (Details) - Schedule of intangible asset", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "genh:ConvertibleNoteDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "034 - Disclosure - Notes Payable \u2013 Related Parties (Details)", "role": "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails", "shortName": "Notes Payable \u2013 Related Parties (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "genh:ConvertibleNoteDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "genh:ScheduleOfNotesPayableRelatedPartiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NotesPayableRelatedPartiesClassifiedCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "035 - Disclosure - Notes Payable \u2013 Related Parties (Details) - Schedule of notes payable \u2013 related parties", "role": "http://www.genhempinc.com/role/ScheduleofnotespayablerelatedpartiesTable", "shortName": "Notes Payable \u2013 Related Parties (Details) - Schedule of notes payable \u2013 related parties", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "genh:ScheduleOfNotesPayableRelatedPartiesTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NotesPayableRelatedPartiesClassifiedCurrent", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "genh:MortgagePayableDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "036 - Disclosure - Other Indebtedness (Details)", "role": "http://www.genhempinc.com/role/OtherIndebtednessDetails", "shortName": "Other Indebtedness (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "genh:MortgagePayableDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseLeaseIncomeLeasePayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "037 - Disclosure - Commitments and Contingencies (Details)", "role": "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails", "shortName": "Commitments and Contingencies (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseLeaseIncomeLeasePayments", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PreferredStockConvertibleSharesIssuable", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "038 - Disclosure - Equity (Details)", "role": "http://www.genhempinc.com/role/EquityDetails", "shortName": "Equity (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c2", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PreferredStockConvertibleSharesIssuable", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c6", "decimals": "0", "first": true, "lang": null, "name": "genh:PostharvestAndMidstreamServices", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "003 - Statement - Unaudited Condensed Consolidated Statements of Operations", "role": "http://www.genhempinc.com/role/ConsolidatedIncomeStatement", "shortName": "Unaudited Condensed Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c6", "decimals": "0", "first": true, "lang": null, "name": "genh:PostharvestAndMidstreamServices", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c2", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "039 - Disclosure - Equity (Details) - Schedule of warrants outstanding", "role": "http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable", "shortName": "Equity (Details) - Schedule of warrants outstanding", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c2", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockByClassTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c3", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "040 - Disclosure - Equity (Details) - Schedule of outstanding stock warrants activity", "role": "http://www.genhempinc.com/role/ScheduleofoutstandingstockwarrantsactivityTable", "shortName": "Equity (Details) - Schedule of outstanding stock warrants activity", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfStockByClassTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c3", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightOutstanding", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c157", "decimals": "2", "first": true, "lang": null, "name": "genh:CommonSharesDiluted", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "041 - Disclosure - Stock-Based Compensation (Details)", "role": "http://www.genhempinc.com/role/StockBasedCompensationDetails", "shortName": "Stock-Based Compensation (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c157", "decimals": "2", "first": true, "lang": null, "name": "genh:CommonSharesDiluted", "reportCount": 1, "unique": true, "unitRef": "pure", "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "042 - Disclosure - Stock-Based Compensation (Details) - Schedule of summarizes options outstanding", "role": "http://www.genhempinc.com/role/ScheduleofsummarizesoptionsoutstandingTable", "shortName": "Stock-Based Compensation (Details) - Schedule of summarizes options outstanding", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c3", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "shares", "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "genh:ScheduleOfDiscontinuedOperationsToAssetsAndLiabilitiesHeldForSaleTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c161", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "043 - Disclosure - Discontinued Operations (Details) - Schedule of discontinued operations to assets and liabilities held for sale", "role": "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable", "shortName": "Discontinued Operations (Details) - Schedule of discontinued operations to assets and liabilities held for sale", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "genh:ScheduleOfDiscontinuedOperationsToAssetsAndLiabilitiesHeldForSaleTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c161", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c163", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "044 - Disclosure - Discontinued Operations (Details) - Schedule of discontinued operations shown in the consolidated statements of operations", "role": "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationsshownintheconsolidatedstatementsofoperationsTable", "shortName": "Discontinued Operations (Details) - Schedule of discontinued operations shown in the consolidated statements of operations", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c163", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InterestPaid", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "045 - Disclosure - Supplemental Cash Flow Information (Details) - Schedule of supplemental cash flow information", "role": "http://www.genhempinc.com/role/ScheduleofsupplementalcashflowinformationTable", "shortName": "Supplemental Cash Flow Information (Details) - Schedule of supplemental cash flow information", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:InterestPaid", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c6", "decimals": "0", "first": true, "lang": null, "name": "genh:NetLossFromContinuingOperationsAttributableToCommonStockholders", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "046 - Disclosure - Earnings (Loss) Per Share (Details) - Schedule of earnings (loss) per basic and diluted share", "role": "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable", "shortName": "Earnings (Loss) Per Share (Details) - Schedule of earnings (loss) per basic and diluted share", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c6", "decimals": "0", "first": true, "lang": null, "name": "genh:NetLossFromContinuingOperationsAttributableToCommonStockholders", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SupplementalDeferredPurchasePrice", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "047 - Disclosure - Subsequent Events (Details)", "role": "http://www.genhempinc.com/role/SubsequentEventsDetails", "shortName": "Subsequent Events (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "p", "ix:continuation", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SupplementalDeferredPurchasePrice", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c15", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "004 - Statement - Unaudited Condensed Consolidated Statements of Equity (Deficit)", "role": "http://www.genhempinc.com/role/ShareholdersEquityType2or3", "shortName": "Unaudited Condensed Consolidated Statements of Equity (Deficit)", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c22", "decimals": "0", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodValueAcquisitions", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "usd", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "005 - Statement - Unaudited Condensed Consolidated Statements of Cash Flows", "role": "http://www.genhempinc.com/role/ConsolidatedCashFlow", "shortName": "Unaudited Condensed Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": "0", "lang": null, "name": "us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax", "reportCount": 1, "unique": true, "unitRef": "usd", "xsiNil": "false" } }, "R7": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "006 - Disclosure - Business", "role": "http://www.genhempinc.com/role/Business", "shortName": "Business", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "007 - Disclosure - Summary of Significant Accounting Policies", "role": "http://www.genhempinc.com/role/SummaryofSignificantAccountingPolicies", "shortName": "Summary of Significant Accounting Policies", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "008 - Disclosure - Property and Equipment", "role": "http://www.genhempinc.com/role/PropertyandEquipment", "shortName": "Property and Equipment", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "div", "body", "html" ], "baseRef": "f10q0622_generation.htm", "contextRef": "c0", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 48, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date", "terseLabel": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus", "terseLabel": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus", "terseLabel": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "gYearItemType" }, "dei_DocumentInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "localname": "DocumentInformationLineItems", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package." } } }, "localname": "DocumentInformationTable", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r467" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report", "terseLabel": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r468" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report", "terseLabel": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r466" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding", "terseLabel": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status", "terseLabel": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r466" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r466" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category", "terseLabel": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r470" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current", "terseLabel": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "yesNoItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r466" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r466" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company", "terseLabel": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r466" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business", "terseLabel": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r466" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://www.genhempinc.com/role/DocumentAndEntityInformation" ], "xbrltype": "normalizedStringItemType" }, "genh_AccreditedInvestorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accredited Investor Member", "terseLabel": "Accredited Investor [Member]" } } }, "localname": "AccreditedInvestorMember", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "genh_AccruedInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of accrued interest.", "label": "Accrued Interest", "terseLabel": "Accrued interest" } } }, "localname": "AccruedInterest", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "genh_AcquisitionOfCertainAssetsOfHalcyonThruputLlcAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Acquisition Of Certain Assets Of Halcyon Thruput Llc Abstract", "terseLabel": "Acquisition of certain assets of Halcyon Thruput, LLC" } } }, "localname": "AcquisitionOfCertainAssetsOfHalcyonThruputLlcAbstract", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsupplementalcashflowinformationTable" ], "xbrltype": "stringItemType" }, "genh_AdditionalAdvances": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of additional advances.", "label": "Additional Advances", "terseLabel": "Additional advances" } } }, "localname": "AdditionalAdvances", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "genh_AdvancesTotaling": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Advances totaling.", "label": "Advances Totaling", "terseLabel": "Advances totaling" } } }, "localname": "AdvancesTotaling", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "genh_AggregateGrossProceeds": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of proceeds from the gross.", "label": "Aggregate Gross Proceeds", "terseLabel": "Aggregate gross proceeds (in Dollars)" } } }, "localname": "AggregateGrossProceeds", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "monetaryItemType" }, "genh_AggregateIntrinsicValueGranted": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Number of aggregate intrinsic value granted.", "label": "Aggregate Intrinsic Value Granted", "terseLabel": "Aggregate Intrinsic Value Granted (in Dollars)" } } }, "localname": "AggregateIntrinsicValueGranted", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsummarizesoptionsoutstandingTable" ], "xbrltype": "monetaryItemType" }, "genh_AssetRetirementObligationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Asset Retirement Obligations Abstract", "terseLabel": "Asset retirement obligations -" } } }, "localname": "AssetRetirementObligationsAbstract", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable" ], "xbrltype": "stringItemType" }, "genh_AssumptionOfHalcyonBankNote": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Assumption of Halcyon bank note.", "label": "Assumption Of Halcyon Bank Note", "terseLabel": "- assumption of Halcyon bank note" } } }, "localname": "AssumptionOfHalcyonBankNote", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsupplementalcashflowinformationTable" ], "xbrltype": "monetaryItemType" }, "genh_BearsInterest": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Bears Interest", "terseLabel": "Bears interest" } } }, "localname": "BearsInterest", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "percentItemType" }, "genh_BusinessDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business (Details) [Line Items]" } } }, "localname": "BusinessDetailsLineItems", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/BusinessDetails" ], "xbrltype": "stringItemType" }, "genh_BusinessDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business (Details) [Table]" } } }, "localname": "BusinessDetailsTable", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/BusinessDetails" ], "xbrltype": "stringItemType" }, "genh_BusinessPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Percentage", "terseLabel": "Business percentage" } } }, "localname": "BusinessPercentage", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/BusinessDetails" ], "xbrltype": "percentItemType" }, "genh_ChangeInFairValueOfMarketableSecurity": { "auth_ref": [], "calculation": { "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_OtherNonoperatingExpense", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Change in fair value of marketable security.", "label": "Change In Fair Value Of Marketable Security", "negatedLabel": "Change in fair value of marketable security" } } }, "localname": "ChangeInFairValueOfMarketableSecurity", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "genh_CommitmentsandContingenciesDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies (Details) [Line Items]" } } }, "localname": "CommitmentsandContingenciesDetailsLineItems", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "genh_CommitmentsandContingenciesDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies (Details) [Table]" } } }, "localname": "CommitmentsandContingenciesDetailsTable", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "genh_CommonSharesDiluted": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Shares Diluted", "terseLabel": "Diluted common shares outstanding percentage" } } }, "localname": "CommonSharesDiluted", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "percentItemType" }, "genh_CommonStockForIssuance": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock for issuance.", "label": "Common Stock For Issuance", "terseLabel": "common stock for issuance" } } }, "localname": "CommonStockForIssuance", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "sharesItemType" }, "genh_CommonStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Common Stock Units Member", "terseLabel": "Common stock units [Member]" } } }, "localname": "CommonStockUnitsMember", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable" ], "xbrltype": "domainItemType" }, "genh_ConventryAssetManagementLTDMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Conventry Asset Management LTDMember", "terseLabel": "Secured Promissory Note and Warrants to Coventry Asset Management, LTD. [Member]" } } }, "localname": "ConventryAssetManagementLTDMember", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "genh_ConvertibleNoteDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible note ,description.", "label": "Convertible Note Description", "terseLabel": "Convertible note ,description" } } }, "localname": "ConvertibleNoteDescription", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "stringItemType" }, "genh_ConvertiblePromissoryNote": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Convertible promissory note.", "label": "Convertible Promissory Note", "terseLabel": "Convertible promissory note" } } }, "localname": "ConvertiblePromissoryNote", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "genh_ConvertiblePromissoryNoteToCEOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Convertible Promissory Note To CEOMember", "terseLabel": "Convertible Promissory Note to CEO [Member]" } } }, "localname": "ConvertiblePromissoryNoteToCEOMember", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails", "http://www.genhempinc.com/role/ScheduleofnotespayablerelatedpartiesTable" ], "xbrltype": "domainItemType" }, "genh_CurrentLiabilitiesOfDiscontinuedOperationsHeldForSale": { "auth_ref": [], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Current liabilities of discontinued operations held for sale.", "label": "Current Liabilities Of Discontinued Operations Held For Sale", "terseLabel": "Current liabilities of discontinued operations held for sale" } } }, "localname": "CurrentLiabilitiesOfDiscontinuedOperationsHeldForSale", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "genh_DecemberTwoThousandTwentyMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "December Two Thousand Twenty Member", "terseLabel": "Issued in December 2020 [Member]" } } }, "localname": "DecemberTwoThousandTwentyMember", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable" ], "xbrltype": "domainItemType" }, "genh_DecemberTwoThousandTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "December Two Thousand Twenty One Member", "terseLabel": "Issued in Q4 2021 [Member]" } } }, "localname": "DecemberTwoThousandTwentyOneMember", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable" ], "xbrltype": "domainItemType" }, "genh_DenominatorAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Denominator Abstract", "terseLabel": "Denominator" } } }, "localname": "DenominatorAbstract", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "stringItemType" }, "genh_DescriptionOfBusinessDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Description Of Business Description", "terseLabel": "Description of business, description" } } }, "localname": "DescriptionOfBusinessDescription", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/BusinessDetails" ], "xbrltype": "stringItemType" }, "genh_DescriptionOfSuitAgainstUNIC": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Description Of Suit Against UNIC", "terseLabel": "Description of suit against UNIC" } } }, "localname": "DescriptionOfSuitAgainstUNIC", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "genh_DilutiveEffectOfCommonStockOptions": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dilutive effect of common stock options.", "label": "Dilutive Effect Of Common Stock Options", "terseLabel": "Dilutive effect of common stock options" } } }, "localname": "DilutiveEffectOfCommonStockOptions", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "sharesItemType" }, "genh_DilutiveEffectOfCommonStockWarrants": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dilutive Effect Of Common Stock Warrants", "terseLabel": "Dilutive effect of common stock warrants" } } }, "localname": "DilutiveEffectOfCommonStockWarrants", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "sharesItemType" }, "genh_DilutiveEffectOfConvertibleNote": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Dilutive effect of convertible note.", "label": "Dilutive Effect Of Convertible Note", "terseLabel": "Dilutive effect of convertible note" } } }, "localname": "DilutiveEffectOfConvertibleNote", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "sharesItemType" }, "genh_DilutiveEffectOfPreferredStock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Dilutive Effect Of Preferred Stock", "terseLabel": "Dilutive effect of preferred stock" } } }, "localname": "DilutiveEffectOfPreferredStock", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "sharesItemType" }, "genh_DiscontinuedOperationsDetailsScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Discontinued Operations (Details) - Schedule of discontinued operations to assets and liabilities held for sale [Line Items]" } } }, "localname": "DiscontinuedOperationsDetailsScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleLineItems", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable" ], "xbrltype": "stringItemType" }, "genh_DiscontinuedOperationsDetailsScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Discontinued Operations (Details) - Schedule of discontinued operations to assets and liabilities held for sale [Table]" } } }, "localname": "DiscontinuedOperationsDetailsScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable" ], "xbrltype": "stringItemType" }, "genh_DisposaGroupIncludingDiscontinuedOperationAccumulatedDDA": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accumulated DD&A.", "label": "Disposa Group Including Discontinued Operation Accumulated DDA", "terseLabel": "Accumulated DD&A" } } }, "localname": "DisposaGroupIncludingDiscontinuedOperationAccumulatedDDA", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable" ], "xbrltype": "monetaryItemType" }, "genh_DisposalGroupIncludingDiscontinuedOperationAccretion": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Disposal Group Including Discontinued Operation Accretion", "terseLabel": "Accretion" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAccretion", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationsshownintheconsolidatedstatementsofoperationsTable" ], "xbrltype": "monetaryItemType" }, "genh_DisposalGroupIncludingDiscontinuedOperationCostsAndExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs and expenses.", "label": "Disposal Group Including Discontinued Operation Costs And Expenses", "terseLabel": "Total costs and expenses" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationCostsAndExpenses", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationsshownintheconsolidatedstatementsofoperationsTable" ], "xbrltype": "monetaryItemType" }, "genh_DocumentAndEntityInformationAbstract": { "auth_ref": [], "localname": "DocumentAndEntityInformationAbstract", "nsuri": "http://www.genhempinc.com/20220630", "xbrltype": "stringItemType" }, "genh_EarningsLossPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Loss Per Share Abstract", "terseLabel": "Earnings (loss) per share" } } }, "localname": "EarningsLossPerShareAbstract", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "genh_EarningsLossPerShareAbstract0": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Loss Per Share Abstract0", "terseLabel": "Earnings (loss) per share:" } } }, "localname": "EarningsLossPerShareAbstract0", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "stringItemType" }, "genh_EarningsLossPerShareAbstract1": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Loss Per Share Abstract1", "terseLabel": "Earnings (loss) per share" } } }, "localname": "EarningsLossPerShareAbstract1", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "stringItemType" }, "genh_EnergyHunterResourcesIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Energy Hunter Resources Inc Member", "terseLabel": "Energy Hunter Resources, Inc. [Member]" } } }, "localname": "EnergyHunterResourcesIncMember", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/BusinessDetails" ], "xbrltype": "domainItemType" }, "genh_EquityDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equity description.", "label": "Equity Description", "terseLabel": "Equity, description" } } }, "localname": "EquityDescription", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "stringItemType" }, "genh_EquityDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity (Details) [Line Items]" } } }, "localname": "EquityDetailsLineItems", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "stringItemType" }, "genh_EquityDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity (Details) [Table]" } } }, "localname": "EquityDetailsTable", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "stringItemType" }, "genh_Excess": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Excess", "terseLabel": "Excess" } } }, "localname": "Excess", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/BusinessDetails" ], "xbrltype": "durationItemType" }, "genh_ExtensionDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension date.", "label": "Extension Date", "terseLabel": "Extension date" } } }, "localname": "ExtensionDate", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "dateItemType" }, "genh_ExtensionFees": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Extension Fees", "terseLabel": "Restricted common shares extension fees (in Shares)" } } }, "localname": "ExtensionFees", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "sharesItemType" }, "genh_FeesExceeding": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fees Exceeding.", "label": "Fees Exceeding", "terseLabel": "Fees exceeding" } } }, "localname": "FeesExceeding", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "genh_FinancingObligations": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of financing obligations.", "label": "Financing Obligations", "terseLabel": "Financing obligations" } } }, "localname": "FinancingObligations", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/BusinessDetails" ], "xbrltype": "monetaryItemType" }, "genh_FinancingObligationsTerms": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Financing Obligations Terms", "terseLabel": "Financing obligations terms" } } }, "localname": "FinancingObligationsTerms", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/BusinessDetails" ], "xbrltype": "durationItemType" }, "genh_GainLossChangeInFairValueOfMarketableSecurities": { "auth_ref": [], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Change in fair value of marketable securities.", "label": "Gain Loss Change In Fair Value Of Marketable Securities", "negatedLabel": "Change in fair value of marketable securities" } } }, "localname": "GainLossChangeInFairValueOfMarketableSecurities", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "genh_GrandTraverseHoldingsLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Grand Traverse Holdings LLCMember", "terseLabel": "Grand Traverse Holdings, LLC [Member]" } } }, "localname": "GrandTraverseHoldingsLLCMember", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "domainItemType" }, "genh_HalcyonThruputLLCsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Halcyon Thruput LLCs Member", "terseLabel": "Halcyon Thruput LLC\u2019s [Member]" } } }, "localname": "HalcyonThruputLLCsMember", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "domainItemType" }, "genh_InterestAndAttorneyFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Interest and attorney fees.", "label": "Interest And Attorney Fees", "terseLabel": "Interest and attorney fees" } } }, "localname": "InterestAndAttorneyFees", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "genh_InterestExpenses": { "auth_ref": [], "calculation": { "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": 3.0, "parentTag": "us-gaap_OtherNonoperatingExpense", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Interest expense.", "label": "Interest Expenses", "negatedLabel": "Interest expense" } } }, "localname": "InterestExpenses", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "genh_InterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Interest rate.", "label": "Interest Rate", "terseLabel": "Interest rate" } } }, "localname": "InterestRate", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/OtherIndebtednessDetails" ], "xbrltype": "percentItemType" }, "genh_IssuanceOfCommonShares": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of common shares.", "label": "Issuance Of Common Shares", "terseLabel": "- issuance of common shares" } } }, "localname": "IssuanceOfCommonShares", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsupplementalcashflowinformationTable" ], "xbrltype": "monetaryItemType" }, "genh_IssuanceOfCommonSharesForExtensionOfSecuredNote": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The value of issuance of common shares for extension of secured note.", "label": "Issuance Of Common Shares For Extension Of Secured Note", "terseLabel": "Issuance of common shares for extension of secured note" } } }, "localname": "IssuanceOfCommonSharesForExtensionOfSecuredNote", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "genh_IssuanceOfCommonSharesForExtensionOfSecuredNoteinShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The shares of issuance for common shares for extension of secured note.", "label": "Issuance Of Common Shares For Extension Of Secured Notein Shares", "terseLabel": "Issuance of common shares for extension of secured note (in Shares)" } } }, "localname": "IssuanceOfCommonSharesForExtensionOfSecuredNoteinShares", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "genh_IssuanceOfCommonStockUnits": { "auth_ref": [], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Issuance Of Common Stock Units", "terseLabel": "Issuance of common stock units" } } }, "localname": "IssuanceOfCommonStockUnits", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "genh_IssuanceOfCommonStockUnitsPreviouslySubscribed": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of common stock units previously subscribed.", "label": "Issuance Of Common Stock Units Previously Subscribed", "terseLabel": "Issuance of common stock units previously subscribed" } } }, "localname": "IssuanceOfCommonStockUnitsPreviouslySubscribed", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsupplementalcashflowinformationTable" ], "xbrltype": "monetaryItemType" }, "genh_IssuanceOfSubordinatedNote": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of subordinated note", "label": "Issuance Of Subordinated Note", "terseLabel": "- issuance of subordinated note" } } }, "localname": "IssuanceOfSubordinatedNote", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsupplementalcashflowinformationTable" ], "xbrltype": "monetaryItemType" }, "genh_IssuancesOfCommonSharesForExchangeOrConversionOfDebt": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuances of common shares for exchange or conversion of debt.", "label": "Issuances Of Common Shares For Exchange Or Conversion Of Debt", "terseLabel": "Issuances of common shares for exchange or conversion of debt" } } }, "localname": "IssuancesOfCommonSharesForExchangeOrConversionOfDebt", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsupplementalcashflowinformationTable" ], "xbrltype": "monetaryItemType" }, "genh_JohnGallegosMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "John Gallegos Member", "terseLabel": "John Gallegos [Member]" } } }, "localname": "JohnGallegosMember", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "domainItemType" }, "genh_LeaseAndRentalExpenses": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Lease And Rental Expenses", "terseLabel": "Lease and rental expense" } } }, "localname": "LeaseAndRentalExpenses", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/OtherIndebtednessDetails" ], "xbrltype": "monetaryItemType" }, "genh_LessPreferredStockDividends": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Less Preferred Stock Dividends", "terseLabel": "Less: preferred stock dividends" } } }, "localname": "LessPreferredStockDividends", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "monetaryItemType" }, "genh_LiableForTheAssertedDamages": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Liable For The Asserted Damages", "terseLabel": "Liable for the asserted damages" } } }, "localname": "LiableForTheAssertedDamages", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "genh_LitigationSettlementInterestPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Litigation Settlement interest percentage.", "label": "Litigation Settlement Interest Percentage", "terseLabel": "Litigation settlement interest percentage" } } }, "localname": "LitigationSettlementInterestPercentage", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "percentItemType" }, "genh_LongtermLiabilitiesOfDiscontinuedOperationsHeldForSale": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Long-term liabilities of discontinued operations held for sale.", "label": "Longterm Liabilities Of Discontinued Operations Held For Sale", "terseLabel": "Long-term liabilities of discontinued operations held for sale" } } }, "localname": "LongtermLiabilitiesOfDiscontinuedOperationsHeldForSale", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable" ], "xbrltype": "monetaryItemType" }, "genh_LossFromContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Loss From Continuing Operations Abstract", "terseLabel": "Loss from continuing operations" } } }, "localname": "LossFromContinuingOperationsAbstract", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "stringItemType" }, "genh_LossFromDiscontinuedOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Loss From Discontinued Operations Abstract", "terseLabel": "Loss from discontinued operations" } } }, "localname": "LossFromDiscontinuedOperationsAbstract", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "stringItemType" }, "genh_MarchTwoThousandTwentyOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "March Two Thousand Twenty One Member", "terseLabel": "Issued in Q1 2021 [Member]" } } }, "localname": "MarchTwoThousandTwentyOneMember", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable" ], "xbrltype": "domainItemType" }, "genh_MergerAndAcquisitionCosts": { "auth_ref": [], "calculation": { "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": 3.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Merger And Acquisition Costs", "terseLabel": "Merger and acquisition costs" } } }, "localname": "MergerAndAcquisitionCosts", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "genh_MortgagePayableDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Mortgage Payable Description", "terseLabel": "Mortgage payable, description" } } }, "localname": "MortgagePayableDescription", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/OtherIndebtednessDetails" ], "xbrltype": "stringItemType" }, "genh_NetAcquiredCash": { "auth_ref": [], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "label": "Net Acquired Cash", "terseLabel": "Acquisition of certain assets of Halcyon Thruput, LLC, net of acquired cash of $224,530" } } }, "localname": "NetAcquiredCash", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "genh_NetLossFromContinuingOperationsAttributableToCommonStockholders": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Net Loss From Continuing Operations Attributable To Common Stockholders", "terseLabel": "Loss from continuing operations attributable to common stockholders" } } }, "localname": "NetLossFromContinuingOperationsAttributableToCommonStockholders", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "monetaryItemType" }, "genh_NewEquityCapital": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "New Equity Capital", "terseLabel": "New equity capital" } } }, "localname": "NewEquityCapital", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "genh_NotesPayableRelatedPartiesClassifiedAsCurrent": { "auth_ref": [], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Notes Payable Related Parties Classified As Current", "terseLabel": "Notes payable \u2013 related parties" } } }, "localname": "NotesPayableRelatedPartiesClassifiedAsCurrent", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "genh_NotesPayableRelatedPartiesDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable \u2013 Related Parties (Details) [Line Items]" } } }, "localname": "NotesPayableRelatedPartiesDetailsLineItems", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "stringItemType" }, "genh_NotesPayableRelatedPartiesDetailsScheduleofnotespayablerelatedpartiesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable \u2013 Related Parties (Details) - Schedule of notes payable \u2013 related parties [Line Items]" } } }, "localname": "NotesPayableRelatedPartiesDetailsScheduleofnotespayablerelatedpartiesLineItems", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofnotespayablerelatedpartiesTable" ], "xbrltype": "stringItemType" }, "genh_NotesPayableRelatedPartiesDetailsScheduleofnotespayablerelatedpartiesTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable \u2013 Related Parties (Details) - Schedule of notes payable \u2013 related parties [Table]" } } }, "localname": "NotesPayableRelatedPartiesDetailsScheduleofnotespayablerelatedpartiesTable", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofnotespayablerelatedpartiesTable" ], "xbrltype": "stringItemType" }, "genh_NotesPayableRelatedPartiesDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable \u2013 Related Parties (Details) [Table]" } } }, "localname": "NotesPayableRelatedPartiesDetailsTable", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "stringItemType" }, "genh_NumberOfBoardOfDirectors": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of board of directors.", "label": "Number Of Board Of Directors", "terseLabel": "Number of board of directors" } } }, "localname": "NumberOfBoardOfDirectors", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "integerItemType" }, "genh_NumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares.", "label": "Number Of Shares", "terseLabel": "Number of shares" } } }, "localname": "NumberOfShares", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "sharesItemType" }, "genh_NumeratorAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Numerator Abstract", "terseLabel": "Numerator" } } }, "localname": "NumeratorAbstract", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "stringItemType" }, "genh_OneCustomerMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "One Customer Member", "terseLabel": "One Customer [Member]" } } }, "localname": "OneCustomerMember", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "genh_OperatingLeasesFutureMinimumPaymentsRentTwelveMonths": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Operating Leases Future Minimum Payments Rent Twelve Months", "terseLabel": "Minimum future of remainder of 2022" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsRentTwelveMonths", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/OtherIndebtednessDetails" ], "xbrltype": "monetaryItemType" }, "genh_OperatingLeasesFutureMinimumPaymentsRentTwoYears": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "label": "Operating Leases Future Minimum Payments Rent Two Years", "terseLabel": "Minimum future of remainder of 2023" } } }, "localname": "OperatingLeasesFutureMinimumPaymentsRentTwoYears", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/OtherIndebtednessDetails" ], "xbrltype": "monetaryItemType" }, "genh_OptionToPurchaseDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Option To Purchase Description", "terseLabel": "Option to purchase description" } } }, "localname": "OptionToPurchaseDescription", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/IntangibleandOtherAssetsDetails" ], "xbrltype": "stringItemType" }, "genh_OtherIndebtednessCurrent": { "auth_ref": [], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Other indebtedness - current.", "label": "Other Indebtedness Current", "terseLabel": "Other indebtedness - current" } } }, "localname": "OtherIndebtednessCurrent", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "genh_OwnsApproximatelysPercent": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Owns Approximatelys Percent", "terseLabel": "Percentage of common stock" } } }, "localname": "OwnsApproximatelysPercent", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/BusinessDetails" ], "xbrltype": "percentItemType" }, "genh_OzCapitalLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Oz Capital LLCMember", "terseLabel": "Oz Capital, LLC [Member]" } } }, "localname": "OzCapitalLLCMember", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "domainItemType" }, "genh_PaymentOfMortgagePayable": { "auth_ref": [], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of The fair value of transfer of mortgage payable in financing activities.", "label": "Payment Of Mortgage Payable", "negatedLabel": "Payment of mortgage payable" } } }, "localname": "PaymentOfMortgagePayable", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "genh_PostharvestAndMidstreamServices": { "auth_ref": [], "calculation": { "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Post-harvest and midstream services.", "label": "Postharvest And Midstream Services", "terseLabel": "Post-harvest and midstream services" } } }, "localname": "PostharvestAndMidstreamServices", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "genh_PreferredStockStatedValues": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "label": "Preferred Stock Stated Values", "terseLabel": "Preferred stock, Stated Value (in Dollars)", "verboseLabel": "Preferred stock stated value (in Dollars)" } } }, "localname": "PreferredStockStatedValues", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "monetaryItemType" }, "genh_ProceedsFromSaleOfInvestmentInCommonStock": { "auth_ref": [], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from sale of investment in common stock.", "label": "Proceeds From Sale Of Investment In Common Stock", "terseLabel": "Proceeds from sale of investment in common stock" } } }, "localname": "ProceedsFromSaleOfInvestmentInCommonStock", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "genh_PromissoryNoteDue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Promissory note due.", "label": "Promissory Note Due", "terseLabel": "Promissory note due" } } }, "localname": "PromissoryNoteDue", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "dateItemType" }, "genh_PromissoryNoteToInvestmentHunterLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Promissory Note To Investment Hunter LLCMember", "terseLabel": "Promissory Note to Investment Hunter, LLC [Member]" } } }, "localname": "PromissoryNoteToInvestmentHunterLLCMember", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails", "http://www.genhempinc.com/role/ScheduleofnotespayablerelatedpartiesTable" ], "xbrltype": "domainItemType" }, "genh_PropertyAndEquipmentUsefulLifeyrs": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Property and equipment, Useful Life.", "label": "Property And Equipment Useful Lifeyrs", "terseLabel": "Property and equipment, useful Life (years)" } } }, "localname": "PropertyAndEquipmentUsefulLifeyrs", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable" ], "xbrltype": "durationItemType" }, "genh_RedemptionsOfSeriesBPreferredStock": { "auth_ref": [], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of Redemptions preferred stock.", "label": "Redemptions Of Series BPreferred Stock", "negatedLabel": "Redemptions of Series B preferred stock" } } }, "localname": "RedemptionsOfSeriesBPreferredStock", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "genh_Rental": { "auth_ref": [], "calculation": { "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_Revenues", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "label": "Rental", "terseLabel": "Rental" } } }, "localname": "Rental", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "genh_RepaymentOfSubordinatedNotes": { "auth_ref": [], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of subordinated notes.", "label": "Repayment Of Subordinated Notes", "negatedLabel": "Repayment of subordinated notes" } } }, "localname": "RepaymentOfSubordinatedNotes", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "genh_RestrictedCommonShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Restricted common shares.", "label": "Restricted Common Shares", "terseLabel": "Restricted common shares (in Shares)" } } }, "localname": "RestrictedCommonShares", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "sharesItemType" }, "genh_RevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue Abstract", "terseLabel": "Revenue -" } } }, "localname": "RevenueAbstract", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationsshownintheconsolidatedstatementsofoperationsTable" ], "xbrltype": "stringItemType" }, "genh_SaleOfPreferredStockUnits": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of preffered stock units.", "label": "Sale Of Preferred Stock Units", "terseLabel": "Sale of preferred stock units (in Dollars)" } } }, "localname": "SaleOfPreferredStockUnits", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "monetaryItemType" }, "genh_ScheduleOfDiscontinuedOperationsShownInTheConsolidatedStatementsOfOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Discontinued Operations Shown In The Consolidated Statements Of Operations Abstract" } } }, "localname": "ScheduleOfDiscontinuedOperationsShownInTheConsolidatedStatementsOfOperationsAbstract", "nsuri": "http://www.genhempinc.com/20220630", "xbrltype": "stringItemType" }, "genh_ScheduleOfDiscontinuedOperationsToAssetsAndLiabilitiesHeldForSaleAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Discontinued Operations To Assets And Liabilities Held For Sale Abstract" } } }, "localname": "ScheduleOfDiscontinuedOperationsToAssetsAndLiabilitiesHeldForSaleAbstract", "nsuri": "http://www.genhempinc.com/20220630", "xbrltype": "stringItemType" }, "genh_ScheduleOfDiscontinuedOperationsToAssetsAndLiabilitiesHeldForSaleTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Discontinued Operations To Assets And Liabilities Held For Sale Table Text Block", "terseLabel": "Schedule of discontinued operations to assets and liabilities held for sale" } } }, "localname": "ScheduleOfDiscontinuedOperationsToAssetsAndLiabilitiesHeldForSaleTableTextBlock", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/DiscontinuedOperationsTables" ], "xbrltype": "textBlockItemType" }, "genh_ScheduleOfEarningsLossPerBasicAndDilutedShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Earnings Loss Per Basic And Diluted Share Abstract" } } }, "localname": "ScheduleOfEarningsLossPerBasicAndDilutedShareAbstract", "nsuri": "http://www.genhempinc.com/20220630", "xbrltype": "stringItemType" }, "genh_ScheduleOfIntangibleAssetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Intangible Asset Abstract" } } }, "localname": "ScheduleOfIntangibleAssetAbstract", "nsuri": "http://www.genhempinc.com/20220630", "xbrltype": "stringItemType" }, "genh_ScheduleOfNotesPayableRelatedPartiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Notes Payable Related Parties Abstract" } } }, "localname": "ScheduleOfNotesPayableRelatedPartiesAbstract", "nsuri": "http://www.genhempinc.com/20220630", "xbrltype": "stringItemType" }, "genh_ScheduleOfNotesPayableRelatedPartiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Notes Payable Related Parties Table Text Block", "terseLabel": "Schedule of notes payable \u2013 related parties" } } }, "localname": "ScheduleOfNotesPayableRelatedPartiesTableTextBlock", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesTables" ], "xbrltype": "textBlockItemType" }, "genh_ScheduleOfOutstandingStockWarrantsActivityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Outstanding Stock Warrants Activity Abstract" } } }, "localname": "ScheduleOfOutstandingStockWarrantsActivityAbstract", "nsuri": "http://www.genhempinc.com/20220630", "xbrltype": "stringItemType" }, "genh_ScheduleOfPropertyAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Property And Equipment Abstract" } } }, "localname": "ScheduleOfPropertyAndEquipmentAbstract", "nsuri": "http://www.genhempinc.com/20220630", "xbrltype": "stringItemType" }, "genh_ScheduleOfSummarizesOptionsOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Summarizes Options Outstanding Abstract" } } }, "localname": "ScheduleOfSummarizesOptionsOutstandingAbstract", "nsuri": "http://www.genhempinc.com/20220630", "xbrltype": "stringItemType" }, "genh_ScheduleOfSupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Supplemental Cash Flow Information Abstract" } } }, "localname": "ScheduleOfSupplementalCashFlowInformationAbstract", "nsuri": "http://www.genhempinc.com/20220630", "xbrltype": "stringItemType" }, "genh_ScheduleOfWarrantsOutstandingAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Schedule Of Warrants Outstanding Abstract" } } }, "localname": "ScheduleOfWarrantsOutstandingAbstract", "nsuri": "http://www.genhempinc.com/20220630", "xbrltype": "stringItemType" }, "genh_SecuredPromissoryNoteToCoventryAssetManagementLtdMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Secured Promissory Note To Coventry Asset Management Ltd Member", "terseLabel": "Secured Promissory Note to Coventry Asset Management, LTD. [Member]" } } }, "localname": "SecuredPromissoryNoteToCoventryAssetManagementLtdMember", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofnotespayablerelatedpartiesTable" ], "xbrltype": "domainItemType" }, "genh_SeriesBPreferredStockDividendPayable": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Series B preferred stock dividend payable.", "label": "Series BPreferred Stock Dividend Payable", "terseLabel": "Series B preferred stock dividend payable" } } }, "localname": "SeriesBPreferredStockDividendPayable", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsupplementalcashflowinformationTable" ], "xbrltype": "monetaryItemType" }, "genh_SeriesBPreferredStockUnitsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series BPreferred Stock Units Member", "terseLabel": "Series B preferred units [Member]" } } }, "localname": "SeriesBPreferredStockUnitsMember", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable" ], "xbrltype": "domainItemType" }, "genh_SeriesBRedeemablePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Series BRedeemable Preferred Stock Member", "terseLabel": "Series B Redeemable Preferred Stock" } } }, "localname": "SeriesBRedeemablePreferredStockMember", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "genh_ServiceRevenuePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Service Revenue Percentage", "terseLabel": "Service revenue percentage" } } }, "localname": "ServiceRevenuePercentage", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "percentItemType" }, "genh_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesCancelledInPeriod": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share Based Compensation Arrangement By Share Based Payment Award Shares Cancelled In Period", "terseLabel": "Number of Warrants, Warrants cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesCancelledInPeriod", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofoutstandingstockwarrantsactivityTable" ], "xbrltype": "sharesItemType" }, "genh_SharesOfCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares of Common stock.", "label": "Shares Of Common Stock", "terseLabel": "Shares of Common stock" } } }, "localname": "SharesOfCommonStock", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "sharesItemType" }, "genh_SquareFootFacility": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Square Foot Facility", "label": "Square Foot Facility", "terseLabel": "Square Foot Facility (in Dollars per Square Foot)" } } }, "localname": "SquareFootFacility", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/BusinessDetails" ], "xbrltype": "perUnitItemType" }, "genh_StockBasedCompensationDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock-Based Compensation (Details) [Line Items]" } } }, "localname": "StockBasedCompensationDetailsLineItems", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "genh_StockBasedCompensationDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stock-Based Compensation (Details) [Table]" } } }, "localname": "StockBasedCompensationDetailsTable", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "genh_StockIssuedDuringPeriodValueIssuanceofCommonSharesForSeniorSecuredPromissoryShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issuance of common shares for Senior Secured Promissory Note (in Shares)", "label": "Stock Issued During Period Value Issuanceof Common Shares For Senior Secured Promissory Shares", "terseLabel": "Issuance of common shares for Senior Secured Promissory Note (in Shares)" } } }, "localname": "StockIssuedDuringPeriodValueIssuanceofCommonSharesForSeniorSecuredPromissoryShares", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "genh_StockIssuedDuringSharesOfIssuanceOfCommonSharesForConvertiblePromissoryNote": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during shares of Issuance of common shares for Convertible Promissory Note.", "label": "Stock Issued During Shares Of Issuance Of Common Shares For Convertible Promissory Note", "terseLabel": "Issuance of common shares for Convertible Promissory Note (in Shares)" } } }, "localname": "StockIssuedDuringSharesOfIssuanceOfCommonSharesForConvertiblePromissoryNote", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "genh_StockIssuedDuringThePeriodValueIssuanceOfCommonSharesForSeniorSecuredPromissoryNotes": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Issuance of common shares for Senior Secured Promissory Note", "label": "Stock Issued During The Period Value Issuance Of Common Shares For Senior Secured Promissory Notes", "terseLabel": "Issuance of common shares for Senior Secured Promissory Note" } } }, "localname": "StockIssuedDuringThePeriodValueIssuanceOfCommonSharesForSeniorSecuredPromissoryNotes", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "genh_SubordinatedNoteToInvestorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subordinated Note To Investor Member", "terseLabel": "Subordinated note to investor [Member]" } } }, "localname": "SubordinatedNoteToInvestorMember", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable" ], "xbrltype": "domainItemType" }, "genh_SubordinatedPromissoryNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subordinated Promissory Note Member", "terseLabel": "Subordinated Promissory Note to CEO [Member]", "verboseLabel": "Subordinated Promissory Note and Warrants to Investor [Member]" } } }, "localname": "SubordinatedPromissoryNoteMember", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails", "http://www.genhempinc.com/role/ScheduleofnotespayablerelatedpartiesTable" ], "xbrltype": "domainItemType" }, "genh_SubordinatedPromissoryNoteToCEOMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subordinated Promissory Note To CEOMember", "terseLabel": "Subordinated Promissory Note to CEO [Member]" } } }, "localname": "SubordinatedPromissoryNoteToCEOMember", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "genh_SubordinatedPromissoryNoteToInvestorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subordinated Promissory Note To Investor Member", "terseLabel": "Subordinated Promissory Note to Investor [Member]" } } }, "localname": "SubordinatedPromissoryNoteToInvestorMember", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofnotespayablerelatedpartiesTable" ], "xbrltype": "domainItemType" }, "genh_SubordinatedPromissouryNoteDueDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Subordinated promissoury note due date.", "label": "Subordinated Promissoury Note Due Date", "terseLabel": "Subordinated promissory note due date" } } }, "localname": "SubordinatedPromissouryNoteDueDate", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "dateItemType" }, "genh_SubsequentEventsDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events (Details) [Line Items]" } } }, "localname": "SubsequentEventsDetailsLineItems", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "genh_SubsequentEventsDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events (Details) [Table]" } } }, "localname": "SubsequentEventsDetailsTable", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "genh_SummaryofSignificantAccountingPoliciesDetailsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) [Line Items]" } } }, "localname": "SummaryofSignificantAccountingPoliciesDetailsLineItems", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "genh_SummaryofSignificantAccountingPoliciesDetailsTable": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Summary of Significant Accounting Policies (Details) [Table]" } } }, "localname": "SummaryofSignificantAccountingPoliciesDetailsTable", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "genh_TotalUnrecognizedCompensationCost": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total unrecognized compensation cost.", "label": "Total Unrecognized Compensation Cost", "terseLabel": "Total unrecognized compensation cost" } } }, "localname": "TotalUnrecognizedCompensationCost", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "genh_TwoThousandTwentyOnePlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Two Thousand Twenty One Plan Member", "terseLabel": "2021 Plan [Member]" } } }, "localname": "TwoThousandTwentyOnePlanMember", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "genh_WarrantToPurchaseOfCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant to purchase of common stock.", "label": "Warrant To Purchase Of Common Stock", "terseLabel": "Warrant to purchase of common stock (in Shares)" } } }, "localname": "WarrantToPurchaseOfCommonStock", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "sharesItemType" }, "genh_WarrantsAndRightsOutstandingMaturityDateDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified.", "label": "Warrants And Rights Outstanding Maturity Date Description", "terseLabel": "Expiration Date" } } }, "localname": "WarrantsAndRightsOutstandingMaturityDateDescription", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable" ], "xbrltype": "stringItemType" }, "genh_WeightedAveragePriceExceed": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "weighted average price exceed.", "label": "Weighted Average Price Exceed", "terseLabel": "Weighted average market price of common stock exceed (in Dollars per share)" } } }, "localname": "WeightedAveragePriceExceed", "nsuri": "http://www.genhempinc.com/20220630", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "perShareItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r175", "r270", "r272", "r449" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.genhempinc.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r212", "r213", "r214", "r215", "r234", "r246", "r275", "r277", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r448", "r450", "r464", "r465" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]", "terseLabel": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable", "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r212", "r213", "r214", "r215", "r234", "r246", "r275", "r277", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r448", "r450", "r464", "r465" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]", "terseLabel": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable", "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r175", "r270", "r272", "r449" ], "lang": { "en-us": { "role": { "label": "Customer [Domain]" } } }, "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.genhempinc.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r207", "r212", "r213", "r214", "r215", "r234", "r246", "r273", "r275", "r277", "r307", "r308", "r309", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r448", "r450", "r464", "r465" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable", "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r207", "r212", "r213", "r214", "r215", "r234", "r246", "r273", "r275", "r277", "r307", "r308", "r309", "r390", "r391", "r392", "r393", "r394", "r395", "r396", "r448", "r450", "r464", "r465" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Domain]" } } }, "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable", "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioForecastMember": { "auth_ref": [ "r126", "r276" ], "lang": { "en-us": { "role": { "label": "Forecast [Member]", "terseLabel": "Forecast [Member]" } } }, "localname": "ScenarioForecastMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails", "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r126", "r131", "r211", "r276" ], "lang": { "en-us": { "role": { "label": "Scenario [Domain]" } } }, "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails", "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r126", "r131", "r211", "r276", "r388" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails", "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r176", "r379" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Title of Individual [Domain]" } } }, "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "srt_WarehouseMember": { "auth_ref": [ "r458", "r463" ], "lang": { "en-us": { "role": { "label": "Warehouse [Member]", "terseLabel": "Warehouse [Member]" } } }, "localname": "WarehouseMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable" ], "xbrltype": "domainItemType" }, "us-gaap_AccountingPoliciesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "localname": "AccountingPoliciesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_AccountsPayableCurrent": { "auth_ref": [ "r59", "r385" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts Payable, Current", "terseLabel": "Accounts payable" } } }, "localname": "AccountsPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r177", "r178" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "terseLabel": "Accounts receivable" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r63" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued Liabilities, Current", "terseLabel": "Accrued liabilities" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r38", "r201" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Less accumulated depreciation and amortization" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapital": { "auth_ref": [ "r49", "r385" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.", "label": "Additional Paid in Capital", "terseLabel": "Additional paid-in capital" } } }, "localname": "AdditionalPaidInCapital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r118", "r119", "r120", "r315", "r316", "r317", "r349" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]", "terseLabel": "Additional Paid-In Capital" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Adjustments to reconcile net loss from continuing operations to net cash from operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_AdvancesToAffiliate": { "auth_ref": [ "r457" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Long-Term advances receivable from a party that is affiliated with the reporting entity by means of direct or indirect ownership. This does not include advances to clients.", "label": "Advances to Affiliate", "terseLabel": "Advances" } } }, "localname": "AdvancesToAffiliate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r90", "r101", "r235", "r363" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Amortization of Debt Discount (Premium)", "terseLabel": "Amortization of debt discount" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_Assets": { "auth_ref": [ "r42", "r114", "r162", "r165", "r171", "r180", "r218", "r219", "r220", "r222", "r223", "r224", "r225", "r226", "r227", "r229", "r230", "r337", "r342", "r353", "r383", "r385", "r414", "r434" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets", "totalLabel": "Total Assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets [Abstract]", "terseLabel": "Assets", "verboseLabel": "Assets -" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r34", "r57", "r114", "r180", "r218", "r219", "r220", "r222", "r223", "r224", "r225", "r226", "r227", "r229", "r230", "r337", "r342", "r353", "r383", "r385" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets, Current [Abstract]", "terseLabel": "Current Assets:" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "auth_ref": [ "r2", "r3", "r22", "r24", "r28", "r198", "r203" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Assets, Current", "terseLabel": "Total assets of discontinued operations held for sale" } } }, "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_AuctionMarketPreferredSecuritiesStockSeriesSharesAuthorized": { "auth_ref": [ "r47", "r260" ], "lang": { "en-us": { "role": { "documentation": "The number of shares of a preferred security the entity has authorized through an auction process.", "label": "Auction Market Preferred Securities, Stock Series, Shares Authorized", "terseLabel": "Shares of preferred stock" } } }, "localname": "AuctionMarketPreferredSecuritiesStockSeriesSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r280", "r281", "r282", "r284", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r301", "r302", "r304", "r305", "r306", "r307", "r308", "r309", "r310" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r117" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.", "label": "Basis of Presentation and Significant Accounting Policies [Text Block]", "terseLabel": "Basis of Presentation" } } }, "localname": "BasisOfPresentationAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_Capital": { "auth_ref": [ "r431" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of total capital as defined by regulatory framework.", "label": "Banking Regulation, Total Capital, Actual", "terseLabel": "New equity capital" } } }, "localname": "Capital", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r31", "r36", "r103" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "terseLabel": "Cash" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "auth_ref": [ "r98", "r103", "r108" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents", "periodEndLabel": "Cash, end of period", "periodStartLabel": "Cash, beginning of period" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "auth_ref": [ "r98", "r354" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect", "totalLabel": "Net change in cash" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFlowSupplementalDisclosuresTextBlock": { "auth_ref": [ "r109" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for supplemental cash flow activities, including cash, noncash, and part noncash transactions, for the period. Noncash is defined as information about all investing and financing activities of an enterprise during a period that affect recognized assets or liabilities but that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Cash Flow, Supplemental Disclosures [Text Block]", "terseLabel": "Supplemental Cash Flow Information" } } }, "localname": "CashFlowSupplementalDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/SupplementalCashFlowInformation" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations": { "auth_ref": [ "r98" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) of financing activities of discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Cash Provided by (Used in) Financing Activities, Discontinued Operations", "terseLabel": "Net cash from financing activities \u2013 discontinued operations" } } }, "localname": "CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations": { "auth_ref": [ "r21", "r98" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) of investing activities of discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Cash Provided by (Used in) Investing Activities, Discontinued Operations", "terseLabel": "Net cash from investing activities \u2013 discontinued operations" } } }, "localname": "CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations": { "auth_ref": [ "r21", "r98" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Cash Provided by (Used in) Operating Activities, Discontinued Operations", "terseLabel": "Net cash from operating activities \u2013 discontinued operations" } } }, "localname": "CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r45", "r47", "r48", "r111", "r114", "r134", "r135", "r140", "r143", "r145", "r154", "r155", "r156", "r180", "r218", "r223", "r224", "r225", "r229", "r230", "r243", "r244", "r248", "r252", "r259", "r353", "r469" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.", "label": "Class of Stock [Domain]" } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r268", "r278" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.", "label": "Class of Warrant or Right [Domain]" } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r260" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights", "terseLabel": "Exercise Price (each)", "verboseLabel": "Exercise price per share (in Dollars per share)" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails", "http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Warrant or Right [Line Items]" } } }, "localname": "ClassOfWarrantOrRightLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r260" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights", "terseLabel": "Number of Warrants" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of warrants or rights outstanding.", "label": "Class of Warrant or Right, Outstanding", "periodEndLabel": "Number of Warrants, Warrants ending", "periodStartLabel": "Number of Warrants, Warrants beginning" } } }, "localname": "ClassOfWarrantOrRightOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofoutstandingstockwarrantsactivityTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of reason for issuing warrant or right.", "label": "Warrant or Right, Reason for Issuance, Description", "terseLabel": "Method of Exercise" } } }, "localname": "ClassOfWarrantOrRightReasonForIssuingToNonemployees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightTable": { "auth_ref": [ "r268", "r278" ], "lang": { "en-us": { "role": { "documentation": "Disclosure for warrants or rights issued, which includes the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Class of Warrant or Right [Table]" } } }, "localname": "ClassOfWarrantOrRightTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r69", "r420", "r440" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and Contingencies", "terseLabel": "Commitments and contingencies" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r208", "r209", "r210", "r216", "r459" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "Commitments and Contingencies Disclosure [Text Block]", "terseLabel": "Commitments and Contingencies" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r118", "r119", "r349" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]", "terseLabel": "Common Stock", "verboseLabel": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EquityDetails", "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails", "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common Stock, Par or Stated Value Per Share", "terseLabel": "Common stock, par value (in Dollars per share)" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common Stock, Shares Authorized", "terseLabel": "Common stock, shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common Stock, Shares, Issued", "terseLabel": "Common stock, shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r48", "r259" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common Stock, Shares, Outstanding", "terseLabel": "Common stock, shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r48", "r385" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Common Stock, Value, Issued", "terseLabel": "Common stock, $0.00001 par value; 200,000,000 shares authorized, 113,154,002 and 113,094,002 shares issued and outstanding at June 30, 2022 and December 31, 2021, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ComputerEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.", "label": "Computer Equipment [Member]", "terseLabel": "Computer equipment and software\t[Member]" } } }, "localname": "ComputerEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r157", "r432" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]", "terseLabel": "Major Customer and Concentration of Credit Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertibleDebt": { "auth_ref": [ "r44", "r416", "r435" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying amount of debt identified as being convertible into another form of financial instrument (typically the entity's common stock) as of the balance sheet date, which originally required full repayment more than twelve months after issuance or greater than the normal operating cycle of the company.", "label": "Convertible Debt", "terseLabel": "Convertible debt" } } }, "localname": "ConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConvertibleNotesPayableMember": { "auth_ref": [ "r43", "r415", "r433", "r456" ], "lang": { "en-us": { "role": { "documentation": "Written promise to pay a note which can be exchanged for a specified quantity of securities (typically common stock), at the option of the issuer or the holder.", "label": "Convertible Notes Payable [Member]", "terseLabel": "Promissory Note [Member]" } } }, "localname": "ConvertibleNotesPayableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": { "auth_ref": [ "r46", "r47", "r255", "r260", "r263" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.", "label": "Convertible Preferred Stock, Shares Issued upon Conversion", "terseLabel": "Preferred Stock converting into shares" } } }, "localname": "ConvertiblePreferredStockSharesIssuedUponConversion", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r87", "r114", "r180", "r218", "r219", "r220", "r223", "r224", "r225", "r226", "r227", "r229", "r230", "r353" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of Revenue", "terseLabel": "Cost of revenue (exclusive of items shown separately below)" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpenses": { "auth_ref": [ "r85" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Total costs of sales and operating expenses for the period.", "label": "Costs and Expenses", "totalLabel": "Total costs and expenses" } } }, "localname": "CostsAndExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostsAndExpensesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Costs and Expenses [Abstract]", "terseLabel": "Costs and Expenses:", "verboseLabel": "Costs and Expenses" } } }, "localname": "CostsAndExpensesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement", "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationsshownintheconsolidatedstatementsofoperationsTable" ], "xbrltype": "stringItemType" }, "us-gaap_CustomerRelationshipsMember": { "auth_ref": [ "r332" ], "lang": { "en-us": { "role": { "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.", "label": "Customer Relationships [Member]", "terseLabel": "Customer Relationships [Member]" } } }, "localname": "CustomerRelationshipsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofintangibleassetTable" ], "xbrltype": "domainItemType" }, "us-gaap_DebtConversionOriginalDebtInterestRateOfDebt": { "auth_ref": [ "r105", "r107" ], "lang": { "en-us": { "role": { "documentation": "The rate of interest that was being paid on the original debt issue that is being converted in the noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Debt Conversion, Original Debt, Interest Rate of Debt", "terseLabel": "Interest rate" } } }, "localname": "DebtConversionOriginalDebtInterestRateOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Indebtedness [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r233", "r236" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "terseLabel": "Conversion price (in Dollars per share)" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentConvertibleTermsOfConversionFeature": { "auth_ref": [ "r67", "r260", "r264", "r265" ], "lang": { "en-us": { "role": { "documentation": "Description of conversion terms for debt instrument.", "label": "Debt Instrument, Convertible, Terms of Conversion Feature", "terseLabel": "Option exercisable" } } }, "localname": "DebtInstrumentConvertibleTermsOfConversionFeature", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r231", "r237", "r238", "r364", "r366", "r367" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt Instrument, Face Amount", "terseLabel": "Principal amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentIncreaseAccruedInterest": { "auth_ref": [ "r113" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase for accrued, but unpaid interest on the debt instrument for the period.", "label": "Debt Instrument, Increase, Accrued Interest", "terseLabel": "Accrued interest" } } }, "localname": "DebtInstrumentIncreaseAccruedInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r65", "r232" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Debt Instrument, Interest Rate, Stated Percentage", "terseLabel": "Bears interest" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r66", "r234", "r352" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Debt Instrument, Maturity Date", "terseLabel": "New maturity date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentMaturityDateDescription": { "auth_ref": [ "r66" ], "lang": { "en-us": { "role": { "documentation": "Description of the maturity date of the debt instrument including whether the debt matures serially and, if so, a brief description of the serial maturities.", "label": "Debt Instrument, Maturity Date, Description", "terseLabel": "Convertible note matured description" } } }, "localname": "DebtInstrumentMaturityDateDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "auth_ref": [ "r430" ], "lang": { "en-us": { "role": { "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.", "label": "Debt Instrument, Redemption Price, Percentage", "terseLabel": "Redemption payments percentage" } } }, "localname": "DebtInstrumentRedemptionPricePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DepreciationAndAmortization": { "auth_ref": [ "r101", "r199" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production.", "label": "Depreciation, Depletion and Amortization, Nonproduction", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationDepletionAndAmortization": { "auth_ref": [ "r101", "r161" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.", "label": "Depreciation, Depletion and Amortization", "terseLabel": "Depreciation and amortization" } } }, "localname": "DepreciationDepletionAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeFixedInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fixed interest rate related to the interest rate derivative.", "label": "Derivative, Fixed Interest Rate", "terseLabel": "Interest rate percentage" } } }, "localname": "DerivativeFixedInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_DerivativeMaturityDates": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date the derivative contract matures, in YYYY-MM-DD format.", "label": "Derivative, Maturity Date", "terseLabel": "Maturity date" } } }, "localname": "DerivativeMaturityDates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "dateItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r279", "r280", "r311", "r312", "r313", "r318" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "Share-Based Payment Arrangement [Text Block]", "terseLabel": "Stock-Based Compensation" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensation" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax": { "auth_ref": [ "r8", "r9", "r10", "r11", "r12", "r19", "r82", "r443" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of income (loss) from a discontinued operation. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, before Income Tax", "terseLabel": "Loss from discontinued operations" } } }, "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationBeforeIncomeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Basic Share", "terseLabel": "Basic (in Dollars per share)", "verboseLabel": "Basic" } } }, "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement", "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "perShareItemType" }, "us-gaap_DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per diluted share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation.", "label": "Discontinued Operation, Income (Loss) from Discontinued Operation, Net of Tax, Per Diluted Share", "terseLabel": "Diluted (in Dollars per share)", "verboseLabel": "Diluted" } } }, "localname": "DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement", "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "perShareItemType" }, "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Discontinued Operations [Abstract]" } } }, "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupClassificationAxis": { "auth_ref": [ "r24" ], "lang": { "en-us": { "role": { "documentation": "Information by disposal group classification.", "label": "Disposal Group Classification [Axis]" } } }, "localname": "DisposalGroupClassificationAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationsshownintheconsolidatedstatementsofoperationsTable", "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable" ], "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent": { "auth_ref": [ "r2", "r3", "r22", "r198", "r203" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as accrued liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Accrued Liabilities, Current", "terseLabel": "Accrued liabilities" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold": { "auth_ref": [ "r20", "r28" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Costs of Goods Sold", "terseLabel": "Oil and gas sales" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationsshownintheconsolidatedstatementsofoperationsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent": { "auth_ref": [ "r2", "r3", "r22", "r198", "r203" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as deferred revenue attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Deferred Revenue, Current", "terseLabel": "Revenue payable" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationDeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense": { "auth_ref": [ "r20" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Operating Expense", "terseLabel": "Lease operating expense" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationsshownintheconsolidatedstatementsofoperationsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets": { "auth_ref": [ "r2", "r3", "r22", "r198", "r203" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Other Assets, Current", "terseLabel": "Oil and natural gas properties held for sale, at cost" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOtherCurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationPostretirementPlanBenefitObligationCurrent": { "auth_ref": [ "r3", "r22", "r203" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as defined benefit non-pension postretirement plan obligations attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Postretirement Plan Benefit Obligation, Current", "terseLabel": "Asset retirement obligations" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationPostretirementPlanBenefitObligationCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": { "auth_ref": [ "r29", "r206" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]", "terseLabel": "Discontinued Operations" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/DiscontinuedOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_DividendsPreferredStock": { "auth_ref": [ "r267", "r429" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).", "label": "Dividends, Preferred Stock", "negatedLabel": "Series B preferred stock dividend" } } }, "localname": "DividendsPreferredStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesCurrent": { "auth_ref": [ "r59", "r116", "r221", "r223", "r224", "r228", "r229", "r230", "r377" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties. For classified balance sheets, represents the current portion of such liabilities (due within one year or within the normal operating cycle if longer).", "label": "Due to Related Parties, Current", "terseLabel": "Payables to related parties" } } }, "localname": "DueToRelatedPartiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_DueToRelatedPartiesCurrentAndNoncurrent": { "auth_ref": [ "r116", "r221", "r223", "r224", "r228", "r229", "r230", "r377", "r419", "r441" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount as of the balance sheet date of obligations due all related parties.", "label": "Due to Related Parties", "terseLabel": "Total" } } }, "localname": "DueToRelatedPartiesCurrentAndNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofnotespayablerelatedpartiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Earnings Per Share [Abstract]", "terseLabel": "Earnings (loss) per common share:" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r84", "r123", "r124", "r125", "r126", "r127", "r132", "r134", "r143", "r144", "r145", "r149", "r150", "r350", "r351", "r425", "r446" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Earnings Per Share, Basic", "terseLabel": "Basic (in Dollars per share)", "verboseLabel": "Basic" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement", "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareDiluted": { "auth_ref": [ "r84", "r123", "r124", "r125", "r126", "r127", "r134", "r143", "r144", "r145", "r149", "r150", "r350", "r351", "r425", "r446" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Earnings Per Share, Diluted", "terseLabel": "Diluted (in Dollars per share)", "verboseLabel": "Diluted" } } }, "localname": "EarningsPerShareDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement", "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerShareTextBlock": { "auth_ref": [ "r146", "r147", "r148", "r151" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for earnings per share.", "label": "Earnings Per Share [Text Block]", "terseLabel": "Earnings (Loss) per Share" } } }, "localname": "EarningsPerShareTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EarningsLossPerShare" ], "xbrltype": "textBlockItemType" }, "us-gaap_EmployeeBenefitsAndShareBasedCompensation": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for employee benefit and equity-based compensation.", "label": "Employee Benefits and Share-Based Compensation", "terseLabel": "Compensation expense related to awards" } } }, "localname": "EmployeeBenefitsAndShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r75", "r76", "r77", "r118", "r119", "r120", "r122", "r128", "r130", "r153", "r181", "r259", "r267", "r315", "r316", "r317", "r323", "r324", "r349", "r355", "r356", "r357", "r358", "r359", "r360", "r373", "r451", "r452", "r453" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.", "label": "Equity Component [Domain]" } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EquityDetails", "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails", "http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable", "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.", "label": "Fair Value Measurement, Policy [Policy Text Block]", "terseLabel": "Fair Value Measurement" } } }, "localname": "FairValueMeasurementPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r40", "r194" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Accumulated Amortization", "terseLabel": "Accumulated Amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofintangibleassetTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r190", "r191", "r194", "r195", "r398", "r399" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofintangibleassetTable" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r194", "r399" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Gross", "terseLabel": "Gross Carrying Amount" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofintangibleassetTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofintangibleassetTable" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r190", "r193" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.", "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]" } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofintangibleassetTable" ], "xbrltype": "domainItemType" }, "us-gaap_FurnitureAndFixturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.", "label": "Furniture and Fixtures [Member]", "terseLabel": "Office furniture and equipment [Member]" } } }, "localname": "FurnitureAndFixturesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable" ], "xbrltype": "domainItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r89" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": 4.0, "parentTag": "us-gaap_CostsAndExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and Administrative Expense", "terseLabel": "General and administrative" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r39", "r185", "r186", "r187", "r188", "r385", "r413" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill", "terseLabel": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeLossFromContinuingOperations": { "auth_ref": [ "r86", "r102", "r123", "r124", "r125", "r126", "r141", "r145", "r335" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.", "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent", "totalLabel": "Net loss from continuing operations" } } }, "localname": "IncomeLossFromContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest [Abstract]", "terseLabel": "Loss from continuing operations" } } }, "localname": "IncomeLossFromContinuingOperationsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r81", "r162", "r164", "r167", "r170", "r172", "r412", "r422", "r427", "r447" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "terseLabel": "Loss from continuing operations" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": { "auth_ref": [ "r78", "r84", "r121", "r123", "r124", "r125", "r126", "r134", "r143", "r144", "r351", "r421", "r423", "r425", "r442" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.", "label": "Income (Loss) from Continuing Operations, Per Basic Share", "terseLabel": "Basic (in Dollars per share)", "verboseLabel": "Basic" } } }, "localname": "IncomeLossFromContinuingOperationsPerBasicShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement", "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromContinuingOperationsPerDilutedShare": { "auth_ref": [ "r78", "r84", "r121", "r123", "r124", "r125", "r126", "r134", "r143", "r144", "r145", "r351", "r425", "r442", "r445", "r446" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.", "label": "Income (Loss) from Continuing Operations, Per Diluted Share", "terseLabel": "Diluted (in Dollars per share)", "verboseLabel": "Diluted" } } }, "localname": "IncomeLossFromContinuingOperationsPerDilutedShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement", "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": { "auth_ref": [ "r8", "r9", "r10", "r11", "r12", "r25", "r28", "r327", "r443" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "negatedLabel": "Loss from discontinued operations", "terseLabel": "Loss from discontinued operations" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow", "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationsshownintheconsolidatedstatementsofoperationsTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent [Abstract]", "terseLabel": "Loss from discontinued operations" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationsshownintheconsolidatedstatementsofoperationsTable" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": { "auth_ref": [ "r3", "r13", "r14", "r15", "r16", "r17", "r18", "r23", "r26", "r27", "r28", "r204", "r205" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table]" } } }, "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationsshownintheconsolidatedstatementsofoperationsTable" ], "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Taxes [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r115", "r319", "r321", "r322", "r325", "r326", "r328", "r329", "r330" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "Income Tax Disclosure [Text Block]", "terseLabel": "Income Taxes" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExaminationInterestAccrued": { "auth_ref": [ "r320" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of estimated interest accrued as of the balance sheet date arising from income tax examinations.", "label": "Income Tax Examination, Interest Accrued", "terseLabel": "Accrued interest" } } }, "localname": "IncomeTaxExaminationInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r104" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Income Taxes Paid, Net", "terseLabel": "Cash paid for taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsupplementalcashflowinformationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r100" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "terseLabel": "Accounts payable and accrued liabilities" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r100" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInInterestPayableNet": { "auth_ref": [ "r100" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in interest payable, which represents the amount owed to note holders, bond holders, and other parties for interest earned on loans or credit extended to the reporting entity.", "label": "Increase (Decrease) in Interest Payable, Net", "terseLabel": "Other income - PPP Loan forgiveness" } } }, "localname": "IncreaseDecreaseInInterestPayableNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Increase (Decrease) in Operating Capital [Abstract]", "terseLabel": "Changes in operating assets and liabilities:" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInPrepaidExpense": { "auth_ref": [ "r100" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amount of outstanding money paid in advance for goods or services that bring economic benefits for future periods.", "label": "Increase (Decrease) in Prepaid Expense", "negatedLabel": "Prepaid expenses" } } }, "localname": "IncreaseDecreaseInPrepaidExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_InsuranceSettlementsReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due in settlement of a claim for reimbursement from an insurance company when the Company has suffered a loss covered under an insurance policy.", "label": "Insurance Settlements Receivable", "terseLabel": "Insurance claim for replacement" } } }, "localname": "InsuranceSettlementsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r196" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "Intangible Assets Disclosure [Text Block]", "terseLabel": "Intangible and Other Assets" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/IntangibleandOtherAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r189", "r192" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible Assets, Net (Excluding Goodwill)", "terseLabel": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestAndOtherIncome": { "auth_ref": [], "calculation": { "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_OtherNonoperatingExpense", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of interest income and other income recognized during the period. Included in this element is interest derived from investments in debt securities, cash and cash equivalents, and other investments which reflect the time value of money or transactions in which the payments are for the use or forbearance of money and other income from ancillary business-related activities (that is, excluding major activities considered part of the normal operations of the business).", "label": "Interest and Other Income", "negatedLabel": "Interest and other income" } } }, "localname": "InterestAndOtherIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpense": { "auth_ref": [ "r79", "r160", "r362", "r365", "r426" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.", "label": "Interest Expense", "terseLabel": "Interest expenses" } } }, "localname": "InterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/OtherIndebtednessDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestExpenseOther": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest expense classified as other.", "label": "Interest Expense, Other", "terseLabel": "Interest expense" } } }, "localname": "InterestExpenseOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaid": { "auth_ref": [ "r104" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, including, but not limited to, capitalized interest and payment to settle zero-coupon bond attributable to accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount; classified as operating and investing activities.", "label": "Interest Paid, Including Capitalized Interest, Operating and Investing Activities", "terseLabel": "Cash paid for interest" } } }, "localname": "InterestPaid", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsupplementalcashflowinformationTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestReceivableAndOtherAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of interest receivable and assets classified as other.", "label": "Interest Receivable and Other Assets", "terseLabel": "Accrued interest" } } }, "localname": "InterestReceivableAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InventoryNet": { "auth_ref": [ "r32", "r54", "r385" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.", "label": "Inventory, Net", "terseLabel": "Inventories" } } }, "localname": "InventoryNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": { "auth_ref": [ "r101" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.", "label": "Issuance of Stock and Warrants for Services or Claims", "terseLabel": "Modification of warrants for extension of promissory note to investor" } } }, "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_LandMember": { "auth_ref": [ "r271" ], "lang": { "en-us": { "role": { "documentation": "Part of earth's surface not covered by water.", "label": "Land [Member]", "terseLabel": "Land [Member]" } } }, "localname": "LandMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable" ], "xbrltype": "domainItemType" }, "us-gaap_LeaseExpirationDate1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date which lease or group of leases is set to expire, in YYYY-MM-DD format.", "label": "Lease Expiration Date", "terseLabel": "Lease expiring date" } } }, "localname": "LeaseExpirationDate1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "dateItemType" }, "us-gaap_LeaseholdImprovementsMember": { "auth_ref": [ "r200" ], "lang": { "en-us": { "role": { "documentation": "Additions or improvements to assets held under a lease arrangement.", "label": "Leasehold Improvements [Member]", "terseLabel": "Leasehold Improvements [Member]" } } }, "localname": "LeaseholdImprovementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable" ], "xbrltype": "domainItemType" }, "us-gaap_LegalFees": { "auth_ref": [ "r88" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.", "label": "Legal Fees", "terseLabel": "Amount accrued for judgment" } } }, "localname": "LegalFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LessorOperatingLeaseTermOfContract": { "auth_ref": [ "r371" ], "lang": { "en-us": { "role": { "documentation": "Term of lessor's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessor, Operating Lease, Term of Contract", "terseLabel": "Lease term" } } }, "localname": "LessorOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r62", "r114", "r166", "r180", "r218", "r219", "r220", "r223", "r224", "r225", "r226", "r227", "r229", "r230", "r338", "r342", "r343", "r353", "r383", "r384" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities [Abstract]", "terseLabel": "Liabilities" } } }, "localname": "LiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r53", "r114", "r180", "r353", "r385", "r418", "r438" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total Liabilities and Equity (Deficit)" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and Equity [Abstract]", "terseLabel": "Liabilities and Equity (Deficit)" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r35", "r64", "r114", "r180", "r218", "r219", "r220", "r223", "r224", "r225", "r226", "r227", "r229", "r230", "r338", "r342", "r343", "r353", "r383", "r384", "r385" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities, Current [Abstract]", "terseLabel": "Current Liabilities:" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation": { "auth_ref": [ "r2", "r3", "r22", "r24", "r28", "r203" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Liabilities", "terseLabel": "Total liabilities of discontinued operations held for sale" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "auth_ref": [ "r2", "r3", "r22", "r24", "r28", "r198", "r203" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Liabilities, Current", "terseLabel": "Current liabilities of discontinued operations held for sale" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent": { "auth_ref": [ "r2", "r3", "r22", "r24", "r28", "r197", "r203" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent", "terseLabel": "Long-term liabilities of discontinued operations held for sale" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_LitigationSettlementAmountAwardedFromOtherParty": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount awarded from other party in judgment or settlement of litigation.", "label": "Litigation Settlement, Amount Awarded from Other Party", "terseLabel": "Amount of summary judgment" } } }, "localname": "LitigationSettlementAmountAwardedFromOtherParty", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongtermDebtTypeAxis": { "auth_ref": [ "r68" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-term debt.", "label": "Long-Term Debt, Type [Axis]" } } }, "localname": "LongtermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails", "http://www.genhempinc.com/role/ScheduleofnotespayablerelatedpartiesTable" ], "xbrltype": "stringItemType" }, "us-gaap_LongtermDebtTypeDomain": { "auth_ref": [ "r68", "r217" ], "lang": { "en-us": { "role": { "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.", "label": "Long-Term Debt, Type [Domain]" } } }, "localname": "LongtermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails", "http://www.genhempinc.com/role/ScheduleofnotespayablerelatedpartiesTable" ], "xbrltype": "domainItemType" }, "us-gaap_MachineryAndEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.", "label": "Machinery and Equipment [Member]", "terseLabel": "Machinery and equipment [Member]" } } }, "localname": "MachineryAndEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable" ], "xbrltype": "domainItemType" }, "us-gaap_MalpracticeInsuranceAnnualCoverageLimit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Annual coverage limit provided by the insurance arrangement for malpractice claims.", "label": "Malpractice Insurance, Annual Coverage Limit", "terseLabel": "Substantial coverages" } } }, "localname": "MalpracticeInsuranceAnnualCoverageLimit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MinorityInterest": { "auth_ref": [ "r72", "r114", "r180", "r218", "r223", "r224", "r225", "r229", "r230", "r353", "r417", "r437" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (that is, noncontrolling interest, previously referred to as minority interest).", "label": "Stockholders' Equity Attributable to Noncontrolling Interest", "terseLabel": "Noncontrolling interest" } } }, "localname": "MinorityInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_MortgageNotesPayableDisclosureTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for mortgage notes payable.", "label": "Mortgage Notes Payable Disclosure [Text Block]", "terseLabel": "Other Indebtedness" } } }, "localname": "MortgageNotesPayableDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/OtherIndebtedness" ], "xbrltype": "textBlockItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r98" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash from financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]", "terseLabel": "Cash Flows From Financing Activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations": { "auth_ref": [ "r98" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations", "totalLabel": "Net cash from financing activities \u2013 continuing operations" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r98" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash from investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]", "terseLabel": "Cash Flows From Investing Activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations": { "auth_ref": [ "r98" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations", "totalLabel": "Net cash from investing activities \u2013 continuing operations" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r98", "r99", "r102" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]", "terseLabel": "Cash Flows From Operating Activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations": { "auth_ref": [ "r98", "r99", "r102" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations", "totalLabel": "Net cash from operating activities \u2013 continuing operations" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r28", "r73", "r74", "r77", "r83", "r102", "r114", "r121", "r123", "r124", "r125", "r126", "r129", "r130", "r141", "r162", "r164", "r167", "r170", "r172", "r180", "r218", "r219", "r220", "r223", "r224", "r225", "r226", "r227", "r229", "r230", "r351", "r353", "r424", "r444" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net Income (Loss) Attributable to Parent", "totalLabel": "Net loss attributable to Generation Hemp" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAttributableToNoncontrollingInterest": { "auth_ref": [ "r73", "r74", "r77", "r129", "r130", "r340", "r345" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of Net Income (Loss) attributable to noncontrolling interest.", "label": "Net Income (Loss) Attributable to Noncontrolling Interest", "terseLabel": "Less: net income (loss) attributable to noncontrolling interests" } } }, "localname": "NetIncomeLossAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": { "auth_ref": [ "r133", "r136", "r137", "r138", "r139", "r142", "r145" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.", "label": "Net Income (Loss) Available to Common Stockholders, Diluted", "terseLabel": "Net loss attributable to common stockholders" } } }, "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) from discontinued operations available to common shareholders.", "label": "Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic", "terseLabel": "Loss from discontinued operations" } } }, "localname": "NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "New Accounting Pronouncements, Policy [Policy Text Block]", "terseLabel": "Recent Accounting Pronouncements" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/AccountingPoliciesByPolicy" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncompeteAgreementsMember": { "auth_ref": [ "r331" ], "lang": { "en-us": { "role": { "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.", "label": "Noncompete Agreements [Member]", "terseLabel": "Non-Competition Agreements [Member]" } } }, "localname": "NoncompeteAgreementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofintangibleassetTable" ], "xbrltype": "domainItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r118", "r119", "r120", "r267", "r333" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]", "terseLabel": "Noncontrolling Interest" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_NotesPayableCurrent": { "auth_ref": [ "r61" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer.", "label": "Notes Payable, Current", "terseLabel": "Notes payable" } } }, "localname": "NotesPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/OtherIndebtednessDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesPayableRelatedPartiesClassifiedCurrent": { "auth_ref": [ "r58", "r116", "r378" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount for notes payable (written promise to pay), due to related parties. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Notes Payable, Related Parties, Current", "terseLabel": "Total notes payable \u2013 related parties" } } }, "localname": "NotesPayableRelatedPartiesClassifiedCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofnotespayablerelatedpartiesTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r162", "r164", "r167", "r170", "r172" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Operating loss" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseExpense": { "auth_ref": [ "r370" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease expense. Excludes sublease income.", "label": "Operating Lease, Expense", "terseLabel": "Lease expense" } } }, "localname": "OperatingLeaseExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLeaseIncomeLeasePayments": { "auth_ref": [ "r152", "r372" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease income from lease payments paid and payable to lessor. Excludes variable lease payments not included in measurement of lease receivable.", "label": "Operating Lease, Lease Income, Lease Payments", "terseLabel": "Lease requires monthly payments" } } }, "localname": "OperatingLeaseLeaseIncomeLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r369" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Operating Lease, Liability", "terseLabel": "Operating lease liability - related party" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r369" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating Lease, Liability, Current", "terseLabel": "Operating lease liability - related party, net of current portion" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r368" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Operating Lease, Right-of-Use Asset", "terseLabel": "Operating lease right-of-use asset" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "auth_ref": [ "r30", "r347" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "terseLabel": "Business" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/Business" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsCurrent": { "auth_ref": [ "r56", "r385" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current assets classified as other.", "label": "Other Assets, Current", "terseLabel": "Current Assets" } } }, "localname": "OtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/BusinessDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r41" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other Assets, Noncurrent", "terseLabel": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet", "http://www.genhempinc.com/role/IntangibleandOtherAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCostOfOperatingRevenue": { "auth_ref": [ "r87" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other costs incurred during the reporting period related to other revenue generating activities.", "label": "Other Cost of Operating Revenue", "terseLabel": "Outstanding amount (in Dollars)" } } }, "localname": "OtherCostOfOperatingRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/SummaryofSignificantAccountingPoliciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherIntangibleAssetsNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated amortization of finite-lived and indefinite-lived intangible assets classified as other.", "label": "Other Intangible Assets, Net", "terseLabel": "Net" } } }, "localname": "OtherIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofintangibleassetTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingExpense": { "auth_ref": [ "r91" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense related to nonoperating activities, classified as other.", "label": "Other Nonoperating Expense", "totalLabel": "Total other expense" } } }, "localname": "OtherNonoperatingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherNonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Nonoperating Income (Expense) [Abstract]", "terseLabel": "Other expense (income):" } } }, "localname": "OtherNonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_OtherOperatingActivitiesCashFlowStatement": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example, cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).", "label": "Other Operating Activities, Cash Flow Statement", "terseLabel": "Cash for its operating activities" } } }, "localname": "OtherOperatingActivitiesCashFlowStatement", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/BusinessDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForCapitalImprovements": { "auth_ref": [ "r92" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for acquisition of or capital improvements to properties held for investment (operating, managed, leased) or for use.", "label": "Payments for Capital Improvements", "negatedLabel": "Capital expenditures" } } }, "localname": "PaymentsForCapitalImprovements", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForProceedsFromInvestments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net cash paid (received) associated with the acquisition or disposal of all investments, including securities and other assets.", "label": "Payments for (Proceeds from) Investments", "terseLabel": "payment of sales proceeds" } } }, "localname": "PaymentsForProceedsFromInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDividendsPreferredStockAndPreferenceStock": { "auth_ref": [ "r95" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow in the form of ordinary dividends to preferred shareholders of the parent entity.", "label": "Payments of Ordinary Dividends, Preferred Stock and Preference Stock", "negatedLabel": "Series B preferred stock dividends paid" } } }, "localname": "PaymentsOfDividendsPreferredStockAndPreferenceStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireMachineryAndEquipment": { "auth_ref": [ "r92" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for acquisition of machinery and equipment.", "label": "Payments to Acquire Machinery and Equipment", "terseLabel": "Purchase price of equipment" } } }, "localname": "PaymentsToAcquireMachineryAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockConvertibleSharesIssuable": { "auth_ref": [ "r245" ], "lang": { "en-us": { "role": { "documentation": "Number of common shares issuable upon conversion of preferred stock.", "label": "Preferred Stock, Convertible, Shares Issuable", "terseLabel": "Converted into shares of common stock" } } }, "localname": "PreferredStockConvertibleSharesIssuable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockDividendRatePercentage": { "auth_ref": [ "r244" ], "lang": { "en-us": { "role": { "documentation": "The percentage rate used to calculate dividend payments on preferred stock.", "label": "Preferred Stock, Dividend Rate, Percentage", "terseLabel": "Dividends rate" } } }, "localname": "PreferredStockDividendRatePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "percentItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]", "terseLabel": "Series A Preferred Stock" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r47", "r243" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred Stock, Par or Stated Value Per Share", "terseLabel": "Preferred stock, par value (in Dollars per share)" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockRedemptionAmount": { "auth_ref": [ "r70", "r242" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The redemption (or callable) amount of currently redeemable preferred stock. Includes amounts representing dividends not currently declared or paid but which will be payable under the redemption features or for which ultimate payment is solely within the control of the issuer.", "label": "Preferred Stock, Redemption Amount", "terseLabel": "Redemption payments (in Dollars)" } } }, "localname": "PreferredStockRedemptionAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r47" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred Stock, Shares Authorized", "terseLabel": "Preferred stock, shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r47", "r243" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred Stock, Shares Issued", "terseLabel": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r47" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred Stock, Shares Outstanding", "terseLabel": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet_Parentheticals" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockValue": { "auth_ref": [ "r47", "r385" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Preferred Stock, Value, Issued", "terseLabel": "Preferred stock, $0.00001 par value; 200,000,000 shares authorized, none outstanding" } } }, "localname": "PreferredStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_PrepaidExpenseCurrent": { "auth_ref": [ "r33", "r55", "r183", "r184" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.", "label": "Prepaid Expense, Current", "terseLabel": "Prepaid expenses" } } }, "localname": "PrepaidExpenseCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r93" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds from Issuance of Warrants", "terseLabel": "Proceeds from warrant exercises" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSubordinatedShortTermDebt": { "auth_ref": [ "r94" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from an obligation which places a lender in a lien position behind debt having a higher priority of repayment (senior loan) in liquidation of the entity's assets scheduled to be repaid within one year or in the normal operating cycle of the entity, if longer.", "label": "Proceeds from Subordinated Short-Term Debt", "terseLabel": "Proceeds from notes payable - related parties" } } }, "localname": "ProceedsFromSubordinatedShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r28", "r73", "r74", "r77", "r97", "r114", "r121", "r129", "r130", "r162", "r164", "r167", "r170", "r172", "r180", "r218", "r219", "r220", "r223", "r224", "r225", "r226", "r227", "r229", "r230", "r336", "r339", "r341", "r345", "r346", "r351", "r353", "r427" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": 1.0 }, "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest", "terseLabel": "Net loss", "totalLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow", "http://www.genhempinc.com/role/ConsolidatedIncomeStatement", "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r202" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r206", "r460", "r461", "r462" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property, Plant and Equipment Disclosure [Text Block]", "terseLabel": "Property and Equipment" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/PropertyandEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r37", "r200" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Gross", "terseLabel": "Subtotal" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r202", "r385", "r428", "r439" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property, Plant and Equipment, Net", "terseLabel": "Property and equipment, net", "verboseLabel": "Total property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet", "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r202" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table Text Block]", "terseLabel": "Schedule of property and equipment" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/PropertyandEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r200" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.", "label": "Long-Lived Tangible Asset [Domain]" } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r274", "r376", "r377" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Domain]" } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/BusinessDetails", "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails", "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionAxis": { "auth_ref": [ "r274", "r376", "r377", "r380" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party transaction.", "label": "Related Party Transaction [Axis]" } } }, "localname": "RelatedPartyTransactionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionDomain": { "auth_ref": [ "r274" ], "lang": { "en-us": { "role": { "documentation": "Transaction between related party.", "label": "Related Party Transaction [Domain]" } } }, "localname": "RelatedPartyTransactionDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Notes Payable \u2013 Related Parties [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r274", "r376", "r380", "r400", "r401", "r402", "r403", "r404", "r405", "r406", "r407", "r408", "r409", "r410", "r411" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/BusinessDetails", "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails", "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r374", "r375", "r377", "r381", "r382" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "Related Party Transactions Disclosure [Text Block]", "terseLabel": "Notes Payable \u2013 Related Parties" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedParties" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfShortTermDebt": { "auth_ref": [ "r96" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.", "label": "Repayments of Short-Term Debt", "negatedLabel": "Repayment of Halcyon bank note" } } }, "localname": "RepaymentsOfShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedStockMember": { "auth_ref": [ "r146" ], "lang": { "en-us": { "role": { "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.", "label": "Restricted Stock [Member]", "terseLabel": "Restricted Shares [Member]", "verboseLabel": "Restricted Stock [Member]" } } }, "localname": "RestrictedStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number, after shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.", "label": "Restricted Stock, Shares Issued Net of Shares for Tax Withholdings", "terseLabel": "Restricted shares, issued" } } }, "localname": "RestrictedStockSharesIssuedNetOfSharesForTaxWithholdings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_RestrictedStockValueSharesIssuedNetOfTaxWithholdings": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after value of shares used to satisfy grantee's tax withholding obligation for award under share-based payment arrangement, of restricted shares issued. Excludes cash used to satisfy grantee's tax withholding obligation.", "label": "Restricted Stock, Value, Shares Issued Net of Tax Withholdings", "terseLabel": "Restricted shares, value" } } }, "localname": "RestrictedStockValueSharesIssuedNetOfTaxWithholdings", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r50", "r267", "r385", "r436", "r454", "r455" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings (Accumulated Deficit)", "terseLabel": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r118", "r119", "r120", "r122", "r128", "r130", "r181", "r315", "r316", "r317", "r323", "r324", "r349", "r451", "r453" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]", "terseLabel": "Accumulated Deficit" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "domainItemType" }, "us-gaap_Revenues": { "auth_ref": [ "r80", "r114", "r158", "r159", "r163", "r168", "r169", "r173", "r174", "r175", "r180", "r218", "r219", "r220", "r223", "r224", "r225", "r226", "r227", "r229", "r230", "r353", "r427" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedIncomeStatement": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).", "label": "Revenues", "totalLabel": "Total revenue" } } }, "localname": "Revenues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenuesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenues [Abstract]", "terseLabel": "Revenue:" } } }, "localname": "RevenuesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedIncomeStatement" ], "xbrltype": "stringItemType" }, "us-gaap_SaleOfStockPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.", "label": "Sale of Stock, Price Per Share", "terseLabel": "Warrant per share (in Dollars per share)", "verboseLabel": "Sales price per share (in Dollars per share)" } } }, "localname": "SaleOfStockPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EquityDetails", "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented.", "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]", "terseLabel": "Schedule of supplemental cash flow information" } } }, "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/SupplementalCashFlowInformationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": { "auth_ref": [ "r3", "r13", "r14", "r15", "r16", "r17", "r18", "r23", "r26", "r27", "r28", "r204", "r205" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "Disposal Groups, Including Discontinued Operations [Table Text Block]", "terseLabel": "Schedule of discontinued operations shown in the consolidated statements of operations" } } }, "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/DiscontinuedOperationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "auth_ref": [ "r145" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "terseLabel": "Schedule of earnings (loss) per basic and diluted share" } } }, "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EarningsLossPerShareTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r190", "r193", "r398" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofintangibleassetTable" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r190", "r193" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]", "terseLabel": "Schedule of intangible asset" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/IntangibleandOtherAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r202" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r283", "r300", "r303" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "Share-Based Payment Arrangement, Option, Activity [Table Text Block]", "terseLabel": "Schedule of summarizes options outstanding" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockByClassTextBlock": { "auth_ref": [ "r46", "r47", "r48", "r239", "r240", "r241", "r260", "r261", "r262", "r264", "r265", "r266", "r267" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.", "label": "Schedule of Stock by Class [Table Text Block]", "terseLabel": "Schedule of outstanding stock warrants activity" } } }, "localname": "ScheduleOfStockByClassTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r268", "r278" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]", "terseLabel": "Schedule of warrants outstanding" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EquityTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SecuritiesPurchasedUnderAgreementsToResellDecrease": { "auth_ref": [ "r182" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of decrease from sale of security purchased under agreement to resell.", "label": "Securities Purchased under Agreements to Resell, Decrease", "terseLabel": "Sale of agreement amount" } } }, "localname": "SecuritiesPurchasedUnderAgreementsToResellDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_SegmentDiscontinuedOperationsMember": { "auth_ref": [ "r4", "r5", "r6", "r7" ], "lang": { "en-us": { "role": { "documentation": "Component or group of components disposed of or classified as held-for-sale and representing a strategic shift that has or will have a major effect on operations and financial results. Includes a business or nonprofit activity on acquisition classified as held-for-sale.", "label": "Discontinued Operations [Member]", "terseLabel": "Discontinued Operations [Member]" } } }, "localname": "SegmentDiscontinuedOperationsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationsshownintheconsolidatedstatementsofoperationsTable", "http://www.genhempinc.com/role/ScheduleofdiscontinuedoperationstoassetsandliabilitiesheldforsaleTable" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [ "r45", "r47", "r259" ], "lang": { "en-us": { "role": { "documentation": "Series A preferred stock.", "label": "Series A Preferred Stock [Member]", "terseLabel": "Series A Preferred Stock [Member]" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SeriesBPreferredStockMember": { "auth_ref": [ "r45", "r47", "r259" ], "lang": { "en-us": { "role": { "documentation": "Series B preferred stock.", "label": "Series B Preferred Stock [Member]", "terseLabel": "Series B Preferred Stock [Member]" } } }, "localname": "SeriesBPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r100" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedCashFlow": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "terseLabel": "Stock-based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedCashFlow" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r309" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate", "terseLabel": "Volatility ranging" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum", "terseLabel": "Risk free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum", "terseLabel": "Risk free interest rate" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": { "auth_ref": [ "r292" ], "lang": { "en-us": { "role": { "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period", "terseLabel": "Compensation expense" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r288" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price of options that were either forfeited or expired.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price, Cancelled" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofoutstandingstockwarrantsactivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r289" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Gross", "terseLabel": "Shares Granted (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsummarizesoptionsoutstandingTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r301" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value", "terseLabel": "Weighted Average Grant Date Fair Value Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsummarizesoptionsoutstandingTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r284", "r286" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Shares Ending (in Shares)", "periodStartLabel": "Shares Beginning (in Shares)" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsummarizesoptionsoutstandingTable" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease": { "auth_ref": [ "r288" ], "lang": { "en-us": { "role": { "documentation": "The increase or decrease in number of shares reserved for issuance under stock option agreements awarded under the plan that validly exist and are outstanding, including vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Period Increase (Decrease)", "terseLabel": "Common stock incentive compensation" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingPeriodIncreaseDecrease", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r284", "r286" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted Average Exercise Price Ending", "periodStartLabel": "Weighted Average Exercise Price Beginning" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsummarizesoptionsoutstandingTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r280", "r281", "r282", "r284", "r286", "r287", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r301", "r302", "r304", "r305", "r306", "r307", "r308", "r309", "r310" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement.", "label": "Award Type [Domain]" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r289" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Share-Based Compensation Arrangements by Share-Based Payment Award, Options, Grants in Period, Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price Granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsummarizesoptionsoutstandingTable" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions": { "auth_ref": [ "r299" ], "lang": { "en-us": { "role": { "documentation": "The number of shares reserved for issuance pertaining to the outstanding exercisable stock options as of the balance sheet date in the customized range of exercise prices for which the market and performance vesting condition has been satisfied.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Shares Exercisable", "terseLabel": "Exercise price per share" } } }, "localname": "ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share Price", "terseLabel": "Price per share (in Dollars per share)" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding", "periodEndLabel": "Aggregate Intrinsic Value Ending (in Dollars)", "periodStartLabel": "Aggregate Intrinsic Value Beginning (in Dollars)" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsummarizesoptionsoutstandingTable" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r306" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions, Expected Term", "terseLabel": "Stock options range" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r314" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted average contractual life" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price", "periodEndLabel": "Weighted Average Grant Date Fair Value Ending", "periodStartLabel": "Weighted Average Grant Date Fair Value Beginning" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofsummarizesoptionsoutstandingTable" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1": { "auth_ref": [ "r285" ], "lang": { "en-us": { "role": { "documentation": "The weighted average price as of the balance sheet date at which grantees could acquire the underlying shares with respect to all outstanding stock options which are in the customized range of exercise prices.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Exercise Price", "terseLabel": "Weighted Average Exercise Price, Warrants beginning", "verboseLabel": "Weighted Average Exercise Price, Warrants ending" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofoutstandingstockwarrantsactivityTable" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r304" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term of outstanding stock options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Share-Based Payment Arrangement, Option, Exercise Price Range, Outstanding, Weighted Average Remaining Contractual Term", "terseLabel": "Weighted average contractual life" } } }, "localname": "SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/StockBasedCompensationDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance (in Shares)", "periodStartLabel": "Balance (in Shares)" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermDebtPercentageBearingFixedInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The portion of the carrying amount of short-term borrowings outstanding as of the balance sheet date which accrues interest at a set, unchanging rate.", "label": "Short-Term Debt, Percentage Bearing Fixed Interest Rate", "terseLabel": "Interest rate percentage" } } }, "localname": "ShortTermDebtPercentageBearingFixedInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "percentItemType" }, "us-gaap_ShortTermDebtTypeAxis": { "auth_ref": [ "r60" ], "lang": { "en-us": { "role": { "documentation": "Information by type of short-term debt arrangement.", "label": "Short-Term Debt, Type [Axis]" } } }, "localname": "ShortTermDebtTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTypeDomain": { "auth_ref": [ "r59" ], "lang": { "en-us": { "role": { "documentation": "Type of short-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing.", "label": "Short-Term Debt, Type [Domain]" } } }, "localname": "ShortTermDebtTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r110", "r117" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.", "label": "Significant Accounting Policies [Text Block]", "terseLabel": "Summary of Significant Accounting Policies" } } }, "localname": "SignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/SummaryofSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r45", "r47", "r48", "r111", "r114", "r134", "r135", "r140", "r143", "r145", "r154", "r155", "r156", "r180", "r218", "r223", "r224", "r225", "r229", "r230", "r243", "r244", "r248", "r252", "r259", "r353", "r469" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r71", "r75", "r76", "r77", "r118", "r119", "r120", "r122", "r128", "r130", "r153", "r181", "r259", "r267", "r315", "r316", "r317", "r323", "r324", "r349", "r355", "r356", "r357", "r358", "r359", "r360", "r373", "r451", "r452", "r453" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EquityDetails", "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails", "http://www.genhempinc.com/role/ScheduleofwarrantsoutstandingTable", "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r118", "r119", "r120", "r153", "r397" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet_Parentheticals", "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r47", "r48", "r267" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Stock Issued During Period, Shares, Acquisitions", "terseLabel": "Acquisition of Certain Assets of Halcyon Thruput, LLC (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r47", "r48", "r259", "r267" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Stock Issued During Period, Shares, New Issues", "terseLabel": "Issuances of common stock units (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": { "auth_ref": [ "r47", "r48", "r259", "r267" ], "lang": { "en-us": { "role": { "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Stock-based compensation (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r47", "r48", "r259", "r267", "r290" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "terseLabel": "Warrant exercises (in Shares)" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueAcquisitions": { "auth_ref": [ "r71", "r259", "r267" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued pursuant to acquisitions during the period.", "label": "Stock Issued During Period, Value, Acquisitions", "terseLabel": "Acquisition of Certain Assets of Halcyon Thruput, LLC" } } }, "localname": "StockIssuedDuringPeriodValueAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r71", "r259", "r267" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Stock Issued During Period, Value, Conversion of Convertible Securities", "terseLabel": "Issuance of common shares for Convertible Promissory Note" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r47", "r48", "r259", "r267" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Stock Issued During Period, Value, New Issues", "terseLabel": "Issuances of common stock units" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued attributable to transactions classified as other.", "label": "Stock Issued During Period, Value, Other", "terseLabel": "Modification of warrants for extension of promissory note to investor" } } }, "localname": "StockIssuedDuringPeriodValueOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": { "auth_ref": [ "r47", "r48", "r267", "r301" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).", "label": "Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture", "terseLabel": "Stock-based compensation" } } }, "localname": "StockIssuedDuringPeriodValueShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": { "auth_ref": [ "r71", "r259", "r267" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of stock issued as a result of the exercise of stock options.", "label": "Stock Issued During Period, Value, Stock Options Exercised", "terseLabel": "Warrant exercises" } } }, "localname": "StockIssuedDuringPeriodValueStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r48", "r51", "r52", "r114", "r179", "r180", "r353", "r385" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "totalLabel": "Generation Hemp equity" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders' Equity Attributable to Parent [Abstract]", "terseLabel": "Equity (Deficit):" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r0", "r1", "r76", "r114", "r118", "r119", "r120", "r122", "r128", "r180", "r181", "r267", "r315", "r316", "r317", "r323", "r324", "r333", "r334", "r344", "r349", "r353", "r355", "r356", "r360", "r373", "r452", "r453" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "periodEndLabel": "Balance", "periodStartLabel": "Balance", "totalLabel": "Total equity (deficit)" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet", "http://www.genhempinc.com/role/ShareholdersEquityType2or3" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "StockholdersEquityNoteAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r112", "r244", "r247", "r248", "r249", "r250", "r251", "r252", "r253", "r254", "r256", "r257", "r258", "r267", "r269", "r348" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "Stockholders' Equity Note Disclosure [Text Block]", "terseLabel": "Equity" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/Equity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubordinatedBorrowingDueDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date the payments are due on subordinated debt, in YYYY-MM-DD format.", "label": "Subordinated Borrowing, Due Date", "terseLabel": "Due date", "verboseLabel": "Promissory note due date" } } }, "localname": "SubordinatedBorrowingDueDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails", "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "dateItemType" }, "us-gaap_SubordinatedBorrowingInterestRate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stated interest rate of the subordinated debt.", "label": "Subordinated Borrowing, Interest Rate", "terseLabel": "Estimated incremental borrowing rate" } } }, "localname": "SubordinatedBorrowingInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/CommitmentsandContingenciesDetails" ], "xbrltype": "percentItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r361", "r387" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]", "terseLabel": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r361", "r387" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r361", "r387" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Domain]" } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsDate": { "auth_ref": [ "r386" ], "lang": { "en-us": { "role": { "documentation": "Date the event occurred after the balance sheet date but before financial statements are issues or available to be issued, in YYYY-MM-DD format.", "label": "Subsequent Event, Date", "terseLabel": "Maturity date" } } }, "localname": "SubsequentEventsDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "dateItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r386", "r389" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "Subsequent Events [Text Block]", "terseLabel": "Subsequent Events" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowElementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental Cash Flow Information [Abstract]" } } }, "localname": "SupplementalCashFlowElementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SupplementalDeferredPurchasePrice": { "auth_ref": [ "r105", "r106", "r107" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A device of credit enhancement where a part of the purchase price for the receivable/ payable is retained to serve as a cash collateral.", "label": "Supplemental Deferred Purchase Price", "terseLabel": "initial down payment site" } } }, "localname": "SupplementalDeferredPurchasePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/SubsequentEventsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [ "r218", "r223", "r224", "r225", "r229", "r230" ], "calculation": { "http://www.genhempinc.com/role/ConsolidatedBalanceSheet": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Carrying Amount, Attributable to Parent", "terseLabel": "Series B redeemable preferred stock, no par value, $10,000 stated value, 300 shares authorized, 118 and 135 shares issued and outstanding at June 30, 2022 and December 31, 2021" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ConsolidatedBalanceSheet" ], "xbrltype": "monetaryItemType" }, "us-gaap_VehiclesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Equipment used primarily for road transportation.", "label": "Vehicles [Member]", "terseLabel": "Vehicles [Member]" } } }, "localname": "VehiclesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofpropertyandequipmentTable" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]", "terseLabel": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/EquityDetails" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r352" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and Rights Outstanding, Term", "terseLabel": "Warrant term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/NotesPayableRelatedPartiesDetails" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "auth_ref": [ "r133", "r145" ], "lang": { "en-us": { "role": { "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.", "label": "Weighted Average Number of Shares Outstanding, Diluted", "terseLabel": "Weighted average shares used to compute diluted EPS" } } }, "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "sharesItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r132", "r145" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted Average Number of Shares Outstanding, Basic", "terseLabel": "Weighted average shares used to compute basic EPS" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://www.genhempinc.com/role/ScheduleofearningslossperbasicanddilutedshareTable" ], "xbrltype": "sharesItemType" } }, "unitCount": 5 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "3B", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r109": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "230", "URI": "https://asc.fasb.org/topic&trid=2134446" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r117": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r144": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r151": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "260", "URI": "https://asc.fasb.org/topic&trid=2144383" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900988&loc=SL77927221-108306" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=126905020&loc=d3e5879-108316" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "340", "URI": "https://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r187": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r196": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144471" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2510-110228" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2473-110228" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230" }, "r206": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r210": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r216": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=SL6230698-112601" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r222": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r224": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r228": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(C))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21564-112644" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r25": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r251": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r26": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r260": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r269": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045" }, "r271": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r283": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)-(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r287": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r29": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/subtopic&trid=2122178" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r293": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759" }, "r30": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r318": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r330": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613673-111683" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r343": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r347": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "230", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919359-209981" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r376": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r382": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r389": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721491-107759" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.15(3),(4))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(20))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.9)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "505", "Subparagraph": "(c)(1)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=117337116&loc=SL5958568-112826" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(24))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.17)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(11))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r454": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04(13))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.6-04.2)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401414&loc=d3e603758-122996" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "310", "Subparagraph": "(SX 210.12-29(Footnote 4))", "Topic": "948", "URI": "https://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "360", "Subparagraph": "(SX 210.12-28(Footnote 2))", "Topic": "970", "URI": "https://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691" }, "r466": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r467": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r468": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r469": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721494-107759" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(6))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(7))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(8))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(5))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721501-107759" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(5))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721503-107759" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.27(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(13))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868656-224227" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(210.5-03(11))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(1))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(14))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.13)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.9)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" } }, "version": "2.1" } ZIP 73 0001213900-22-049719-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001213900-22-049719-xbrl.zip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